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SYNTHESIS OF TOGAVIRUS RNA 
M.C. Horzinek 
Instituut voor Virologie, Faculteit der Diergeneeskunde 
Rijkuniversiteit - UTRECHT - The Netherlands 
The present Virus Replication meeting has been arranged 
by the Commission of European Communities, more precisely by its 
swine fever virus group. The causative agent of one of the di-
seases, European swine fever or hog cholera has been identified 
as a member of the toga-family of viruses (26) and this is why 
I have been asked to summarize the present knowledge on the syn-
thesis of togavirus RNAs. 
Most of the data which will be discussed have been obtai-
ned with arthropod-borne togaviruses of the serological group A 
(alphaviruses 65), Sindbis (SIN) and Semliki forest virus (SF) 
being the most exhaustively studied representatives. Members of 
the serological group B (flavoviruses 65), such as dengue, 
Japanese encefalitis, St. Louis encefalitis viruses and others 
have been investigated, too, and of the nonarbo togaviruses (25) 
rubella virus has been analyzed. For the sake of clearness in 
presentation I should like to r6View in the first place results 
obtained with the alphagroup of togaviruses. 
Togaviruees are spherical enveloped single-stranded RNA 
viruses. The RNA is in one piece and is infectious when extrac-
ted and assayed appropriately. In the virion it wa~ shown to play 
a structural role since treatment of isolated nucleocapsids with 
pancreatic RNase resulted not only in a reduction in sedimenta-
tion coefficient and RNA content (33) but also in size (5). RNA 
extracted from the virion shows properties indicating significant 
secondary structure which is necessary for infectivity. When 
heating of an RNA preparation was followed by rapid cooling, the 
residual infectivity i~reased with salt concentration. Slow 
cooling resulted in a better survival than rapid cooling. These 
conditions did not favour survival of poliovirus RNA, included 
for comparison (54). With other alphavirusee hyperohromicity has 
been demonstrated for the RNA (WEE: Tm = 57.5° C (57)J 
SIN1 Tm = 57.5° C (43); SFV1 Tm = 65° C (Io), in contrast to 
ribosomal RNA serving as a marker. When SIN virus RNA was 
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chromatographed on columns of cellulose CF-II at different tem-
peratures, the ratio of the amounts of RNA eluting in the single-
stranded peaks to those eluting in the double-stranded peak in-
creased at higher temperatures (I8). When prepared from the vi-
rion or its nucleocapsid alphavirus RNA sediments at 40 (57) to 
49 S (50) on sucrose gradients and moves as a homogeneous frac-
tion on polyacrylamide gels (57,IO, I4). To avoid confusion 
arising from the difference in s20 - values given by different 
authors this nucleic acid will be termed "virion RNA" in this 
paper. From infected cells an additional single-stranded RNA 
species possessing a seaimentation coefficient of 26 S could be 
extrated (2I, 7, 53, 57). Virion RNA could be transformed into 
the 26 S ("interjacent") species by treatments which are known 
to break hydrogen bonds (heating/rapid cooling, urea, DKSO 57, 
I3, I2). However, if precautions had been taken to warrant vi-
rion RNA preparations free of hidden breaks, no changes towards 
a lower sedimentation coefficient were observed after heating or 
treatment with denaturing agents (I). Based on the observation 
that both RNA species have the same base ratios (20, 53, 57), it 
hasbeen suggested that they may differ in configuration (57) or 
might be polymerization/depolymerization products (9, I3, I4, 12). 
Recently, it was shown for SIN virus by hybridization-competition 
experiments using double-stranded RNA isolated from infected cells 
that 26 S RNA represents a unique fraction of the viral genome, 
containing I/3 of the base sequences in the parental strand (50). 
Little is known on the primary structure of togavirus RNA. 
Since the terminal RNA oligonucleotide sequences are accessible 
for characterization by several techniques, viral RNAs have also 
been studied in this respect, Poly(A) sequences were observed 
in the genome of togavirus (alphagroup) representatives, namely 
EEE (?), SIN (I7, 30, 3I) and SF (I5, II). They were also found 
in poliovirus (2) and Columbia SK-virus, but lack in vesicular 
stomatitis virus which is negative-stranded (3I). As togaviruses 
do not possess a virion associated polymerase (3), it was sug-
gested that parental RNA might serve as the initial messenger 
molecule during infection, From polysomes of SIN-infected cells 
poly (A) strands could be liberated (I6), The size of the polya-
denylic fragment in virion RNA was estimated as being 50 - IOO 
nucleotides in length (2, 30, II). However, using membrane-binding 
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and sequential extraction at different pH, a still greater hete-
rogeneity among the SIN RNA species was found with respect to 
their poly (A) content, which ranged from 60 - 250 nucleotides 
(I7). Virion and interjacent RNA differ in their polyadenylic 
acid content, the former containing IOO - IIO and the latter 
63 - 67 residues (II). -The poly (A) sequence of SIN virus is 
not located at the 3 1 - terminus but about 6% in from it; the 
virion RNA possesses a 3 1 -terminal uridine residue (I5). 
After infection of a cell, a double-stranded RNA sedi-
menting at I6 - 20 S after RNase treatment (2I, 13, I9, 38) can 
be extracted as the first species. This has been determined 
either by labelling early (one hour) in infection (I9) or by 
using short pulses (2I,9); also in vitro it was the earliest and 
main product of a virus specified polymerase (37 1 36, 58, 35, 38). 
This double-stranded RNA, which is termed replicative form (RF) 
has been demonstrated after extraction by serological methods 
(60). By most workers it has been produced after RNase treat-
ment of a RNA with a polydisperse sedimentation profile (52, 2I, 
53, 4I, 8), the replicative intermediate (RI) which shows proper-
ties of both single- and double- stranded RNA (I9). The question 
of whether the double-stranded RNAs are actually present as such 
or are artifacts of deproteinization and isolation has been ans-
wered by their demonstration in infected cells using fluoresceine-
labelled antibodies against double-stranded polyribonucleotides 
(6I). Replicative internediates of alphaviruses have been found 
to sediment between I4 - 30 S (42, I9 1 32); they are considered 
as molecules consisting of a double-stranded core (the RF) with 
single-stranded tails of nascent RNA attached to it, which can be 
removed by controlled degradation with pancreatic RNase. Kinetic 
and pulse chase experiments in vitro and in vivo have shown that 
the double-stranded RNAs are the precursors of all single-stranded 
species (47, 38). 
With the aim of obtaining information on the sequence of 
events during viral RNA synthesis, the RF has been studied in de-
tail, since it can be isolated with comparative ease from RNase-
treated extracts of infected cells. Further evidence for its 
double-stranded nature comes from its high melting temperature 
Tm • I03° C in O.I5 I NaCI (53); II0°C in 0.2I M phosphate; 
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97°C in 0.02 M KCI (cf.20). The concept of a single, homogeneous 
RF had to be abandoned when more than on species of double-stran-
ded RNA was identified (35. 51). The RFs with estimated molecular 
weights of 8.8 x 106 (23.5 S- RF I), 5.6 x I06 (20.I S - RF II) 
and 2.9 x I06 (I6 S - RF III) could be separated from each other 
by gradient centrifugation and gel electrophoresis and their mo-
lar ratios determined throughout the infection cycle. The two 
smaller forms RF II and RF III were always found to exist in a 
Iti ratio in the cell, although varying in their total amounts. 
The molar ratio of RF I to the other forms was constant at 0.4 1 
I between 2 and 6 hours post infectionem, which is in the middle 
of the replication cycle. All three RFs could be liberated by 
RNase treatment from the peak of Ris, which have molecular weights 
of 8.8 x Io6 • This indicated that the two smaller forms (RF II 
and RF III) were joined together in the RI before enzyme treat-
ment, a suggestion which is supported by the constant Iti propor-
tion of their occurrence. The rates of label incorporation into 
the three RFs were determined; they oan be considered as a mea-
sure of single strand synthesis from the respective templates. 
It was demonstrated that RF II was labelled 20 to 50 times more 
slowly than the other forms, which were labelled equally rapidly. 
This would imply that the corresponding single-stranded RNA spe-
cies would be synthesized in comparatively small amounts. - From 
hybridization comPetition experiments it became clear that the 
minus strand of the smallest RF (RF III) is complementary to the 
single-stranded 26 S RNA species and the minus strand of RF II 
is complementary to the remainder of the viral genome. A precur-
sor-product relationship has been postulated between RF I and the 
virion RNA and between RF III and the 26 S RNA found in infected 
cells (5I). Early in the replication cycle (before 3 hours post 
infectionem) the 26 S RNA is the first single-stranded species 
detected after short pulses (2I) and showing the highest rate of 
synthesis (53). When examined in vitro 4 hours post infectionem 
the 26 S and the virion RNA species were synthesized at an equal 
linear rate for about IO min after which time 26 S RNA synthesis 
decreased (38). Later in infection, a relative increase in 
virion RNA synthesis was stated in vivo (5I) and in vitro (38). 
A third species of virus-specific RNA with a base sequence 
complementary to the minus trand of RF II had to be expected, 
which, on the basis of its low rate of label incorporation, 
would occur in comparatively small amounts. Meanwhile, 
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a further single-stranded 33 S RNA has indeed been detected 
(35, 34, 38, II) which may well be the- candidate for the RF II 
product. Since this species was isolated from polysomes of in-
fected cells (34) and was shown to contain a polyadenylic se-
~uence (II) there is strong suggestion that this molecule serves 
a messenger function, too, 
In summarizing the data on RNA species encountered in 
alphaviru~nfected cells, the following list can be made up : 
I. The predominant infectious (64), single-stranded (parental or 
prospective) virion RNA, sedimenting at 40 (57) to 49 S (50). 
2 0 A minor single-stranded 38 s RNA (35, II) • 
3. A minor single-stranded 33 s RNA (35, 34, II) 
4· A single-stranded "interjaoent" 26 s species (53) 0 
5· A single-stranded 20 to 22 S RNA (32, 35, 38). 
6. A polydisperse, partly double-stranded replicative interme-
diate (RI) sedimenting at I4 - 30 S (I9, 32) which contains a 
RNase resistant I6 S-core (I9). 
7o A double-stranded replicative form (RF), sedimenting at about 
20 S (20, 53), which is analogous to the resistant core produ-
ced by RNase treatment of the RI. It is heterogeneous, con-
sisting of at least three forms (35, 5I)o 
8. Further double-stranded RNAs sedimenting at I5 S (49,60); these 
species were specifically detected in cells infected at high 
multiplicities with virus stocks containing incomplete parti-
cles which had been derived by repeated passages at high 
m.o.i. ( 29, 46). 
Not all of these forms have been invariably detected by 
different authors; it has been demonstrated that their relative 
amounts can vary with the virus (SF, SIN) or cell culture (human, 
chick) employed (35). 
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From the experimental results published in about 40 pa-
pers during the last ten years, the following - although still 
incomplete - picture of the replication of alphavirus RNA emerges: 
when the genome of the infecting virion had been decoated it will 
serve as a messenger, coding for an enzyme which allows its con-
version into a double-stranded form; both virus-specific RNA and 
protein have been found associated with rapidly sedimenting, de-
tergent sensitive structures in the infected cell (20, 4, 56, 32, 
23, 55, 68, 38). A membrane-associated replication complex con-
taining the RNA polymerase with its products and consisting of 
unique membraneous vesicles (type I cytopathic vacuoles) has been 
isolated (22, 24). Two types of RI with nearly identical sedi-
mentation characteristics are then formed,one of them being a 
continuous double-stranded molecule with nascent polynucleotide 
chains. Its minus a~and is the template for the virion RNA. The 
other RI has a gap in a specific region of the plus strand with a 
corresponding RNase susceptible single-stranded nucleotide se-
quence. This explains the appearance of RF II and RF III after 
enzymatic hydrolysis, whose molecular weights add up to approxi-
mately the weight of RF I. The product of the smallest RF, the 
26 S RNA, most probably is the messenger for the virion structu-
ral proteins, which are translated as a large polypeptide chain 
and cleaved subsequently (for literature see 62, 40). Sinoethe 
minor 33 S (and 38 S) RNA are not prominent in infection they may 
be required only in small amounts and may have late regulatory 
function (35). 
In the flavovirus genus of the togavirus family similar 
observations as those reviewed for the alphaviruses have been 
made. The genome appears slightly smaller and is denatured to 
slower sedimenting RNA species by urea treatment (6). Besides 
the virion progeny RNA, 26 S and doubl~s~anded 20 S species have 
been detected in extracts of cells infected with JBE (67), Dengue 
(59) and SLE (63, 44) viruses. The only nonarbo togavirus repre-
sentative studied, rubella virus, has equally been shown to con-
tain single-stranded infectious RNA sedimenting at 38 - 40 S; 
in infected cells an additional (partially) double-stranded RNA 
was detected and indications for an interjacent species were 
found (66, 27, 28, 48). 
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More data on the RNAs of animal viruses classified with 
the togafamily on the basis of their size, ether-lability and 
substructure are certainly needed. A beginning was made in our 
laboratory (39) by studing mucosal disease/diarrhea virus of 
cattle (MD-virus), which serologically is closely related to hog 
cholera virus. The reason for selecting this virus was that it 
can be assayed by plaque titration whereas hog cholera virus must 
be quantitated by immunofluorescent focus counts. Using the phe-
nol-SDS method an infectious RNA could be extracted from MD virus-
infected cells, which was assayed in calf testicle cell mono-
layers after pretreatment with hypertonic buffers. From gradient 
centrifugations in o.I M NaCl a value of 37 to 40 S was determi-
ned for the infectious RNA (Figure I). A peak of TCA-precipita-
ble radioactivity was found to coincide with RNA-infectivity in 
a preparation, where 32P-labelled MD virus had been treated with 
sodium deoxycholate (Figure 2). Until now, only togaviruses 
have been demonstrated to yield infectious RNA after mild deter-
gent treatment (25). The hydrodynamic properties of MD virus 
RNA were indicative for an essentially single-stranded molecule 
with secondary structure; lowering of the salt molarity resulted 
in a reduction in sedimentation coefficient, whereas Ca++ and 
Mg++ ions increased the velocity of the molecules in sucrose gra-
dients. SIN virus RNA behaved accordingly under the conditions 
described (Figures 3a, b; 4a, b). Preliminary data obtained by 
J. Zeegers from our group on the incorporation of 3H uridine into 
PK I5 cells infected with hog cholera virus show its dependence 
on the multiplicity of infection (Figure 5). A further characte-
ristic is that incorporation starts only six hours post infectio-
nem which is very late as compared with e.g. SIN virus. 
In conclusion one may say that much more work is required 
especially on the nonarbo togavirus RNAs in order to learn whether 
the replication mechanisms found for alphaviruses are valid for 
them, too. However, rapid progress has been hampered in the case 
of hog cholera virus by tedious assay procedures, growth to only 
moderate titers and poor labelling under actinomycin D. 
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DISCUSSION 
Dr. s. Schleaingera When you look at incorporation of the uri-
dine why do not the uninfected cells incorporate ? 
Do you have actinomycin D there ? 
Dr. Horzineka We work under actinomycin D. 
Dr. s. Schlesingera Is hog cholera virus not sensitive to acti-
nomycin D ? 
Dr. Horzineka It is not. In our hands it was not, but 
perhaps Jean-Marie Aynaud can comment on this later. He has done 
the first actinomycin D experiments to my knowledge. 
Dr. Scholtisaeka Concerning the replicative intermediate 
structures of the RNAa have these RNA been analysed after treat-
ment with phenol or with detergent ? 
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Dr. Horzineks The usual extraction procedure included 
phenol and detergents. 
Dr.Scholtisseks How can you exclude that these structures 
are artefacts caused by this extraction ? Because, for example 
Weisman, Oberg and Phillipson suggested an open structure in 
which the two strands of RNA template and growing strands are 
held together just by the polymerase ? And if you now use phenol 
you just get then the double-stranded Parts; but these are arte-
facts. 
Dr. Horzineks Well, first of all I am commenting on re-
sults and interpretations presented by others. Then on the 
other hand it has been shown that using antibodies directed against 
double-stranded RNA you can immunologically identify double-
stranded structures and I think under these conditions it is less 
likely that these double-stranded molecules would be artifacts. 
Dr. Scholtisseks Coacerning the analysis by these antibodies, 
I do not doubt the results and I do not doubt that you in your 
infected cells have double-stranded structures but the replica-
tive intermediates I am sure are artifacts. 
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CHARACTERISTICS OF THE IN VITRO MULTIPLICATION OF HOG CHOLERA VIRUS 
and 
THE IN VITRO GENETIC MARKERS IN RELATION TO PATHOOl!:NICITY FOR THE fiG 
{a summary) 
J.M. AYNAUD 
Laboratoire de Pathologie porcine -
Station de Recherches de Virolo~e et d'Immunologie - I.N.R.A. 
THIVERVAL-GRIGNON, France 
I. - INTRODUCTION 
With Rubella, Equine arteritis and Bovine ciiarrhea 
vi:rus, Hog cholera virus (Swine fever virus) is classified as a non arbo-
TOGAVIRUS (11 ). Hog cholera virus is a small envelopped RNA virus (40- 50 
nm). Viral particle appears roughly spherical, displaying an internal core 
and an envelopping membrane ( 101 18 ). 
II. - IN VITRO MULTIPLICATION OF H~~ .~ 
In vitro multiplication of' Hog cholera virus has been 
observed in a variety of' oells , mainly of' porcine origin (bone marrow, 
leucocytes, spleen, testis, lung, kidney and trachea) but also of' other 
111811D11alian origin {bovine, lamb, goat, guinea-pig, rabbit, dolphin, etc ••• ) 
(15). Usually Hog cholera virus grows without cytopathic ef'f'ect in tissue 
culture. In 1960, experiments reported growth of' Hog cholera virus with 
cytopathic ef'f'ect under special conditions ( 8) but cytopathic strains have 
been shown to be contaminated with porcine adenoviruses, parvoviruses or 
Bovine viral diarrhea virus (41 9 ). 
A technique f'or production of' plaques by Hog cholera 
virus using secondary pig kidney cells under an agarose overlay was des-
cribed {3). Hog cholera virus plaques only became visible after prolonged 
incubation of stained cultures with neutral red in the dark. In infected 
cultures, non cytopathological changes could be detected. 
Hog cholera virus enhances the replication of' Newcastle 
Disease virus (E.N.D. phenomenon) (5), Teschen virus (E.T.V. phenomenon) 
(5) and Rubella virus in pig testicle cells. This enhancement seems 
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to be a result of the suppression by Hog cholera virus of the production of 
interferon in swine testicle cells When they are infected with Newcastle 
Disease virus or Rubella virus. Inversely, in pig kidney cells, Hog 
cholera virus inhibits the normally cytopathogenic Newcastle Disease virus 
(H.E.I.c. phenomenon) (5). 
O,ytogenetio alterations in swine kidney cells persis-
tently infected with Hog cholera virus have been described. The infected 
cells showed chromosomal doubling during interphase for four passages after 
infection (15). Aoute end persistent infections of PK. 15 cells with Hog 
cholera virus extended the period of DNA synthesis 0,9 end o, 1 hours, 
respectively ( 17 ). 
Replication of Hog cholera virus at 37°C in single 
growth cycle conditions in PK. 15 cells was studied by means of the highly 
reliable titration method of infectivity using the immunofluorescent micro-
plaques techniques (1, 6, 14). Viral antigen was first detected 4 hours 
post infection and progeny virus 6 hours P.I. The latent period is followed 
by an exponential rise until the 15th hour. By means of electron micro-
scop,y using ultra thin sections of infected PK. 15 cells under single 
growth cycle conditions, new viral particles were observed at 10 hours 
post infection in extracellular spaces, in Golgi apparatus and also in 
cytoplasmic vesicles (18). The infectivity of cell-bound virus is 10 to 
100 times that of the medium (6). Identification of antigen exclusively 
in the cytoplasm of infected cells suggested that Hog cholera virus repli-
cation was entirely extra-nuclear. 
Hog cholera virus multiplies in the presence of DNA 
qnthesis inhibitors : analog (BUDR, IUDR, FUDR) and mitomycine (1 ). 
Virus growth is not inhibited by actinomycin D. An enhancement of virus 
production (fig. 1 and fig. 2) is observed in presence of actinomycin end 
mitomycine (1). Probably, Hog cholera virus does not require the DN~ 
dependant RNA s,ynthesis for viral replication. Hog cholera virus and B.V.D. 
virus have the sue properties of inhibition by acriflavine, but equine 
arteritis virus and Rubella virus obviously do not (7). Studies of viral 
RNA replication is in progress (HORZINEK). 
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In summary the main feature of Hog cholera virus repli-
cation is the absence of cytopathogenic activity. After virus infection, 
there is no inhibition of host cell synthesis and apparently cell growth 
is not affected. In these conditions often the labeling of viral material 
with radioactive precursors (nuoleotides or aminoaoids) is uneffioient. 
III. - THE IN VITRO GENETIC MARKERS OF THE VIRUS,CONNECTED TO PATHOGENICITY 
FOR PIG 
Using in vitro genetic markers, we are now able to 
differentiate between virulent and attenuated strains of Hog cholera virus 
in the laboratory. Recently, two reliable and workable genetic markers 
were characterized (2) : 
1) determination of the optimal temperature for 
maximum virus yield in tissue culture under conditions of single growth 
cycle (fig. 3). 
2) heat infectivity resistance (30 minutes at 56°C) 
(fig. 4). 
These two genetic markers are highly related to the 
virulence for pig. 
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MARKER I MARKER II 
STRAINS optimal temperature heat infectivity resAstance 
for virus growth (30 mn at 56 C) 
FULLY VIRULENT 39- 40°C 1,5 log decrease in 
STRAINS infectivity 
(ALFORT, ALD) = "HOT STRAINS" = "SOLID STRAINS" 
LOW OR MODERATELY 35 - 39°C 2 - 2,5 log decrease 
~IRULENT STRAINS in infectivity 
ATTENUATED STRAINS 33 - 37°C 3 - 4 log decrease 
( THIVERV AL, GPE) = "COLD STRAINS" in infectivity 
= "FRAGILE STRAINS" 
Fully virulent strains are "hot" and "solid". Inversely 
completely attenuated strains are "cold" and "fragile". Low or modera~ely 
virulent strains and also some lapinized strains (chinese) are in an inte:r-
mediate position. Being "hot", virulent strains can grow intensively in 
the pig, the normal temperature of which is about 39.0°C. Inversely, being 
"cold", the growth of attenuated strains is limited by the normal body 
temperature of the pig. Virus diffusion from cell to cell and from pig to 
pig is limited or suppressed by the fragility of attenuated strains. 
The "cold" (or ''hot") marker probably is connected with some viral enzy-
matic functions occuring during viral replication, while the "fragile" 
(or "solid") marker is connected with general properties of structural 
proteins of the virion. 
IV - APPLICATION OF THE IN VITRO GENETIC MARKERS TO DEVELOPMENT OF A NEW 
TISSUE CULTURE VACCINE : THE COLD STRAIN VACCINE 
The in vitro genetic markers open the way for studies 
on cold strains of Hog cholera virus in regards to their practical use 
as vaccinee. 
Recently a cold strain was described (2, 12, 13) : 
isolated in tissue culture at 29- 30°C, the u.610 clone (THIVERVAL strain) 
has the in vitro properties of being "cold" and "fragile". This strain 
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is attenuated for pig and has good immunogenic properties. Inoculated into 
sows on the 30th or 60th day of pregnancy in field conditions, this strain 
has no unfavorable effects on the development of pregnancy or on the 
quality of offspring. Innocuity for pig embryo suggests that cold strain 
"Thiverval" is devoid of residual virulence. Piglets born to these 
vaccinated sows showed normal growth rates and were observed to be :f'ully 
susceptible to vaccination or to challenge carried out at the 3rd month 
of their life. 
Conoerning immunity, challenge resistance and anti Hog 
cholera virus neutralizing activity of hish level (neutralization index 
) 5) persisted and were constant during an observation period of 18 months. 
Diffusibility of vaccinal virus was not detectable in laboratory experi-
mental conditions even after 18 months of cohabitation. 
Concerning genetic stability of the cold strain : even 
after 10 serial passages in tissue culture at 37°C or in susceptible piB-
lets1 the in vitro and ~2. characters of the oold strain are not 
modified {13). Attenuation for pig and in vitro properties are apparently 
genetically stable. 
DISCUSSION 
Dr. Scholtissek : What is the physical particle relation to infectivity? 
Dr. Scherrer Excess of physical particles exists comparatively 
because When examining the cell preparations if they are infected the cal-
culation seems to indicate that when a cell may get about 5 to 10 particles 
the ratio physical particles/infectivity appear then to be probably very 
near to one. 
Dr. Rott: 
effect ? 
What is your interpreta:':ion about th.·~ actinomycine n 
Dr. Aynaud 1 There are several interpretations 1 the first one is 
the reduction of interferon synthesis observed in others systems (arbovi-
ruses, measles virus). Actinomycin D reduces the general level of host 
cell protein synthesis and consequently the interferon synthesis. 
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The second one is,·in presence of actinomycin D1 the most part of host cell 
synthesis machinery (membranes and ribosomes) are available to viral syn-
thesis. 
Dr. Liess : What bothers me always is the question of dependency 
between optimal temperature for the multiplication of the hog cholera virus 
and what you called "cold" strain and "hot" strain. How did you check the 
virulence and dep~dence from different temperatures for multiplication? 
:Or. !vnaud 1 Now it is well established that ''hot" strains are 
highly virulent for pig in contrast to "cold" strains 'Which are not. These 
results are determined by means of the study of the influence of incubation 
tel!lperature on the virus yield under one step growth cycle conditions in 
PK-15 cells. 
I must notice that we h~ve shown that virulence is also connected with two 
other genetic markers : heat resistance at 56°C of virus infectivity 
("solid" strains are virulent, "fragile" strains are not), and the in vitro 
multiplication rate (fluorescent microplaques size). For example, the 
f'ull virulent "ALFORT" which is able to kill pigs in one week is hot 
(maximum virus yield at 40?c), solid (1 1 5 log decrease in infectivity after 
30 mn at 56°c), and large fluorescent plaque strain. Inversely, the comp-
letely attenuated "THIVERVAL" strain is a cold (maximum virus yield at 
33-34°0)1 fragile (3-4 log decrease in infectivity after 30 mn at 56°0). 
Dr. Liess I am not quite satisfied because of the question whether 
virulence is judged from mortality or is it connected with clinical disease 
or is it connected with multiplication in the animal itself or how is 
virulence defined ? 
For "lapinized" strains it is known th~t they multiply in the pig. We know 
for virulent strains that they Cl!lll lead to death in some animals and in 
others they produce just a transcient clinical disease and th~ those 
animals recover. Now the question is the definition for virulence. 
I think this is very necessary in order to find a correlation to an optimum 
of temperature. 
Dr A,ynaud : I call virulent strains, strains which are able to kill 
pigs in a week for example. 
Low virulent strains cause irregular clinic symptoms, mortality, or lesions. 
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Frequently in fields, reproductive failures are associated with low virul-
ent strains of swine fever. 
Dr. Bachrach : Do you find evidence of defective interferring parti-
olea in hog cholera analogous to the defective interfering particles of 
poliovirus or of vesicular stomatitis virus having smaller pieces of RNA 
than in the infective particle ? 
Dr. Axnaud I did not look for such particles and I do not think 
that there is such a sort of particle because the ratio between infectious 
particles and physical particles is about one 1 in relation to Dr. Scherrer 1 s 
observations in electron microscope. 
Dr. Schlesinger : In your opinion is it possible to work with a plaque-
purified strain of the virus ? 
Dr. Aypaud Yes, that's very easy. 
Dr. Schlesinger And do you get the same low infection with a plaque-
purified strain? and low multiplicity infection? 
Dr. A,ynaud : We have isolated several clones by limited dilution 
techniques using fluorescence techniques. We did not observe differences 
between different clones of the same level of selection in regards to 
virulence for pig. 
Dr. Horzinek : I should like to aek one question about the influence 
of actinomycine D. You found that you had a steeper slope of the decrease 
in titer in actinomycine D at higher concentrations as compared with those 
of lower concentrations. Could not this be a consequence of simply the 
decay of PK 15 cells which we know are very sensitive to actinomycine D 
with concomitant release of proteases~ We know that all toga's are very 
sensitive to proteases. 
Dr. J\ynaud : With one microgram of actinomycien D by ml PK 15 cells 
are killed after 24 hours in our experimental conditions. PK 15 cells 
are very sensitive to actinomycine D. 
I agree with you it is possible that in PK 15 oells affected by the drug 
toxicity, the concomitant release of proteases could have an indirect 
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inhibition effect on the virus production. Swine fever virus is highly 
sensitive to proteases and phospholipases. 
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THE RNA POLD!ERASES OF MYXOVIRUSES 
R.D. Barry 
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ABSTRACT 
All negative strand RNA viruses, including the ortho-
myxoviruses and the paramyxoviruses, contain virion associated RNA trans-
criptases. The optimal requirements for the in vitro reaction catalysed 
by myxovirus transcriptases will be discussed. Details of the transcrip-
tion process, such as the extent to which the genome is transcribed, and 
the nature of initiation have been determined only for orthomyxoviruses. 
The products of enzyme activity are small pieces of c.RI"A. It is not 
known for certain what structural polypeptides constitute the transcriptase, 
as the enzyme is bound tightly to nucleocapsid structures, but high mole-
cular weight proteins (P1 and P2 96,000, 83,000 daltons, influenza; P-
78,000 daltons, Sendai) are al~s associated with the transcription 
complex. While the biological activity of paramyxovirus transcriptases 
is concerned directly with the formation of complementary m RNA in infected 
cells, the role of orthomyxovirus transcriptases is less clear. 
Initiation of orthomyxovirus transcription in vivo is slow, is sensitive 
to actinomyxin D, and m~ require host cell factors. 
RNA dependent RNA polymerases found in the cytoplasm 
of cell infected with both types of myxovirus resemble virion transcrip-
tases, and m~ represent the accumulation of newly synthesised transcrip-
tase in infected cells. The replication of orthomyxovirus RNA is also 
characterized by a stimulation of DNA-dependent RNA polymerase activity 
in host cell nuclei, and the development of RNA dependent RNA polymerase 
activity in nuclei. 
INTRODUCTION 
The term 'myxovirus' was adopted in the early ~s of 
virus taxonomy to describe those RNA containing animal viruses that adsorb 
40 
readily to muco-proteins (Andrews et al., 1955); other characteristics 
of these viruses that were originally considered to be important were their 
ability to agglutinate red cells (Hirst, 1942) and the presence of the en-
~e neuraminidase as a structural component of the virus (Gottschalk1 1958). 
The original members of the group were the human and animal influenza 
viruses, Newcastle disease virus and mumps virus; some years later the 
newly recognized pare-influenza viruses were added to the group (Andrews 
et al. 1959). On further investigation, it became apparent that signifi-
cant morphological and biological differences existed between the influenza 
viruses and the remaining myxoviruses (Waterson, 1962). Although both 
types of virus contain a helical ribonucleoprotein surrounded by a lipid-
containing envelope in which are embedded the radiating, spike-like surface 
glycoproteins1 the influenza viruses possess a fragmented RNA genome 
(Davies & Barry, 1966), and there are differences both in the dimensions 
of the nucleocapsid and the average diameter of each type of virus particle. 
Unlike the pare-influenza viruses, the multiplication of influenza viruses 
is characterized by a variety of co-operative phenomena (Barry, 1961 a,b) 
and is sensitive in its early stages to inhibitors of DNA function (Barry 
et al 1962; Barry1 1964). A further taxonomic problem arose when it was 
found that at least three other viruses - measles, rinderpest and distemper, 
were morphologically identical to the pare-influenza viruses (Waterson 
et al., 1961; Cruiokshank et al, 1962; Plowright et al., 1962)1 although 
they have no affinity for mucoprotein and lack neuraminidase. 
A1 though all the viruses mentioned above are still known popularly as myxo-
viruses it is now the convention to classify viruses of the influenza type 
as 1ortho-myxoviruses1 1 and viruses of the pare-influenza type as 1para.-
myxoviruses1 ( Andrewes & Pereira, 1972). 
Knowledge of the general principles of RNA virus repli-
cation has accumulated rapidly in recent years. The finding that small 
RNA containing viruses multiply normally in the absence of DNA synthesis 
(Simon, 1961; Cooper and Zinder1 1962) or DNA-directed RNA synthesis (Reich 
et al 1961) firmly established the concept that viral RNA replication is 
independent of the genetic material of the host cell. The detection of 
ribonuclease resistant, virus specific RNA in cells infected with EMC virus 
(Montagnier & Saunders, 1963) implied that viral RNA replicates by way of 
a double stranded base paired intermediate. The existence of such repli-
cative forms has been established for many animal and bacterial RNA viruses 
(Bishop & Levintow, 1971) and it is now accepted that the replication of 
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viral RNA is a two stage proces~. in Which the first step is the ~thesis 
of a complementary polynucleotide strand that acts as a template in the 
second step for the ~thesis of progeny strands of viral RNA; in the case 
of the RNA tumour viruses, the complementary polynucleotide template is 
probably DNA (Temin, 1970). In those instances Where the isolated viral 
RNA is infectious, the RNA serves as both genome and messenger RNA (plus 
strand), While the complementary RNA (virus strand) acts only as a template 
for plus strand formation. Cells infected with RNA viruses contain virus 
specific RNA dependent RNA polymerase(s) (Baltimore & Franklin, 1962; 
Baltimore et al 1963); these en~es are not found in uninfected cells and 
they are responsible for the synthesis of both template and progeny RNA 
(replicase). 
The RNA of the paramyxoviruses and probably also the 
ortho~oviruses lacks infectivity, and the messenger RNA associated with 
polysomes of cells infected by these viruses is complementary to virion RNA 
(Pons, 19721 Vincent & Barry1 1974). The myxoviruses, as well as the 
rhabdoviruses (Huang et al., 1970) differ therefore from other RNA viruses 
in that v. RNA is not m. RNA, and they have been described collectively 
as 'Negative Strand Viruses 1 (Barry & Mahy, 1974). An essential require-
ment for this type of virus is the presence within the virion of an RNA 
polymerase capable of transcribing virion RNA into m. RNA following infec>- · 
tion. Such virus associated transcriptases have been described for NDV 
(Huang et al, 1971), pare-influenza I- Sendai (Robinson, 1971; Stone et al., 
1971) and influenza viruses (Chow & Simpson, 1971 1 Penhoet et al., 1971). 
Among the rhabdoviruses, the RNA"transcriptase of vesicular stomatitis 
virus (VSV) has been studied in detail (Baltimore et al., 1970). 
Certain general features of the multiplication of myxc>-
viruses can be stated. The paramyxoviruses contain a single stranded, non-
infectious RNA of molecular weight 5 x 106 daltons (Kolakofsky, et a1.1974). 
The first stage of RNA replication involves the transcription of v. RNA 
by the virion associated transcriptase with the formation of complementary 
polyribonucleotides that range in molecular weight from 3 x 1cY to 2 x 106 
daltons (Kingsbury1 1966; Bratt & Robinson, 1967); these products are 
probably monocystronic m RNA molecules. Replication of v. RNA proceeds 
from a replicative intermediate (Portner & Kingsbury1 1972)1 in Which a 
virus induced RNA replicase is presumably involved. Both transcription 
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and replication are unaffected by actinOmlfCin D. 
The multiplication of orthom;yxovirus RNA is less clear. 
These viruses contain an 'imknown number of single stranded RNA moleuul.es. 
The total molecular weight of the RNA of each particle has been estimated 
to be 5 x 106 daltons1 made ap by 8- 9 pieces (Skehel 1 1972). Like the 
paramyxoviruses1 influenza viruses have a transcriptase that catalyzes the 
formation of c. RNA in vitro (Bishop et al, 1971b)1 and the reaction is not 
affected by the presence of actinomlfcin D (Chow & Simpson, 1971), When cells 
are infected in the presence of actin~cin D however, no transcription 
occurs (Bean & Simpscn1 1974). Influenza viruses cannot replicate in 
anucleate cell fragments (Che.yne & White, 1969)1 enucleated cells (Follett 
et al 1 1974) or in cells in which there has been an inhibition of DNA 
function (Barry1 1964) or DNA transcription (Mahy et al 1 1972). This evi-
dence suggests that, unlike any other RNA virus, the replication of crtho-
myxoviruses may require the participation of the genetic material of their 
host cells. 
Despite the axistence of a number of RNA ~thesising 
enzymes in preparations of virus and in infected cells, comparatively 
little is known of the details of myxovirus RNA replication. In the follo-
wing sections of this paper, the properties of the virion associated trans-
criptase& of myxoviruses will be reviewed first, followed by a considera-
tion of the nature of polymerase enzymes found in infected oells. 
VmiON TRANSCRIPTASES 
Baltimore (1971) has summarized aptly the concept of 
how viruses carry cut their initial transcription process. The discovery 
of virion associated DNA dependent RNA polymerase in vaccinia virus (K&tes 
& McAuslan1 1967; Munyon et al 1967) led the way to the discovery of other 
virus associated RNA polymerases. In the case of the myxoviruses1 RNA 
dependent transcriptases have been identified in both infiuenza A viruses 
(Chow & Simpson1 1971; Penhoet et al 1 1971; Skehel 1 1971) and influenza B 
viruses (Oxford, 1973)1 NDV (Huang et al, 1971) and Sendai virus (Robinson, 
1971; Stone et al, 1971; Hutchinson and Mahy1 1972). 
Properties of the Enmes 
General requirements for en;yme activity 
Transcriptase activity is detected b,y the incorporation 
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of a radioactively labelled ribonucleoside triphosphate into acid insoluble 
product when the reaction mixture contains virus particles, detergents such 
as Triton N 101 or Noridet P40, divalent cations and all four ribonucleo-
side triphosphates. The complete ingredients of a typical reaction mixture 
used for the detection of transcriptase activity in the orth~ovirus 
fowl plague virus (FPV) are listed in the footnote to Table 1. The follo-
wing features of the system (Table 1) can be noted. 
'.Phe reaction is dependent on the presence of all four 
ribonucleoside triphosphates, and only proceeds when the virus particles 
are disrupted by detergent, implying that the enzyme is located inside the 
virus particle. The template for the reaction is RNA, since incorporation 
is completely blocked by the presence of ribonuclease. Deoxyribonuclease 
has no effect on the reaction (Chow & Simpson, 1971). Inhibitors of DNA 
polymerases, such as actinomycin D, do not affect the reaction. Maximum 
activity for the FPV reaction depends on the presence of both Mn++ and 
Mg++ ions (see below). The levels of enzyme activity associated with 
different strains of influenza viruses vary over approximately a 20 fold 
range (Chow & Simpson, 1971 ). 
Paramyxovirus transcriptasee require approximately the 
same type of reaction conditions as those described for orthomyxoviruses 
{Robinson, 1971; Stone et al, 1971). The reaction is totally dependent 
on virions and Mg++ but does not require Mn ++; ribonuclease added to the 
reaction at zero-time completely inhibits the reaction, but it is unaffeo-
ted by actinomycin D or deoxyribonuclease. A feature common to·all para-
myxovirus transcriptase assays reported so far is their relatively low 
specific activity. NDV polymerase has less than 3% of the activity of VSV 
(Huang et al, 1971); the level of activity quoted for NDV by Huang et al. 
(1971) is approximately 4% of that found with FPV {Table 1). 
Effects of metal ions 
In reactions primed by influenza WSN there is a 3 - 4 
fold stimulation ot activity when monovalent cations are present (Bishop 
et al, 1971a), and sodium, lithium, potassium, or ammonium ions are equally 
effective. Like WSN, the optimal concentration of monovalent cations for 
FPV is around 0.1 to 0.2 M {Fig. 1 c). Enzyme activity is inhibited at 
high { o.6M) concentrations of NaCl. 
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TABL'I 1 
REQUIREMENTS FOR IN VITRO RNA POLYMERASE ACTMTY 
OF INFLUENZA VIRUS (FPV) PARTICLES 
Components 
Complete * 
- ATP, GTP &: CTP 
- Mn* 
- Mg* 
- Mn +t &: Mg* 
- NP40 
- Dithiothreitol 
+ RNase 
+ Actinomycin D 
+ Rifampicin " 
+ Streptlydigin " 
+ Rifamycin AF/103 150~ml 
% Incorporation of 
3H-UTP 
100 
2 
34 
42 
0 
0 
60 
0 
100 
100 
100 
100 
* The complete ass&¥ mixture contained the following components:-
5<AnM Tris-HCL buffer (pH 8.2), 2.<AnM each of ATP, CTP and GTP, 
0.4mM )M-UTP (42~i/ mol), 8mM MgC1 2, 0.2mM MnCl , 5mM Dithiothreitol, 150mM KCL, 33mM NaCl and 0.5% Nonidet-P40. The ~otal reaction volume 
was 150~ containing 5D-150rg of viral protein. 
Reaction mixtures were incubated at 31°C and duplicate samples of 50~1 
were removed and spotted on to Whatman G@-A glass fibre filters and dried 
at 60°C for 2 mins. The filters were then washed in 0.5NTCA containing 
0.1M Sodium PyrogJ:osphate (xl), 0.5NTCA (x4) and finally in methanol and 
then dried at 60 c. When dry the filters were counted in a liquid 
scintillation counter in a toluene based scintillant. Background counts 
were removed and specific activities calculated. A typical 1oo% value 
was 5 nano-mol/mg Protein/Hour. 
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For the orthomyxovirus1 there is some disagreement 
concerning divalent metal requirements. Chow & Simpson (1971) using influ-
enza WSN report that there is an absolute requirement for Mn ++ ions and 
Mg++ ions are not required. Both Penhoet et al. (1971) and Horisberger 
and Gusk:ey (1974) using influenza NWS find that the enzyme is inactive 
When Mg++ is substituted for Mn*. Bishop et al. (1971a) demonstrated 
that the WSN reaction requires both Mn ++ and Mg*; in the absence of Mn ++, 
2C1'/o of optimal activity was obtained. In our experience with F'PV (Figure 1 )1 
we find that When Mg++ is used as sole divalent cation (Figure 1A), a 
concentration between 6 - 8 m M Mg++ stimulates enzyme activity to about 
65% of the level obtained at optimal Mn++ concentration, When the latter 
is used as sole source of divalent cation (Figure 1B). HoWever, the 
levels of activity obtained at maximum concentrations of either divalent 
cation alone are less than 5o% of the activity obtained When both ions 
are present at optimal concentration (0.2 m M Mn++, 8 m M Mn*)(Figure 1D). 
The metal requirements of param.yxoviruses have been 
studied in less detail. Sendai virus polymerase requires 10 m M Mg++ for 
optimum activity (Robinson, 1971), and almost no enzyme activity was 
found with MnC1 2 or Co 012 over a concentration range from 0.1 to 10 m M. 
The effects of temperature and pH 
Both types of myxovirus transcriptase activity mea-
sured in vitro have a temperature optimum in the range 28-33°C (Bishop 
et al., 1971a, Stone et al., 1971). At 37°C1 approximately 25% of maxi-
mum activity was obtained. When reactions initiated at 401 45 or 55°C 
were shifted to 31°C after 5 hours incubation, no further increase in 
enzyme activity was noticed, suggesting that the enzyme or template has 
been inactivated. 
The optimal pH for FPV transcriptase is 8.2 (Figure 2), 
similar to that for other myxovirus transcriptases (Bishop et al. 1971a, 
Stone et al 1971). 
Kinetics of nucleoside triphosphate incorporation 
The incorporation of 32B-labelled nucleoside triphos-
phate catalyzed by influenza WSN transcriptase into acid insoluble mat-
erial can proceed for at least 6 hours When incubated at 31-33°C 
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Figure 1 : Legend. 
The effect of metal ion concentrations of the activity of fowl plague 
virus virion transcriptase. Using a standard reaction mixture (Table 1) 1 
the concentrations of the cations K+, Mg++ and Mn++ were varied. 
A. Effect of increas1ng Mg++ ion concentration alone (0-- -0) or in the 
presence of lm M Mn ++ ( t- -e). 
B. Effect of 1ncreasing Mn++ ion concentration. 
c. Effect of increasing K+ ion concentration. 
D. Effect of increasing Mn++ concentration in the presence of 8 m M Mg ++. 
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Figure 2. The effect of pH on the activity of fowl plague virion trans-
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(Bishop et al., 1971a). Using the reaction conditions shown in Table 11 
the incorporation of 1a-UTP by the FPV transcriptase is linear for at least 
one hour (Figure 3). The kinetics of Sendai tranwcriptase resemble those 
of the orthomyxoviruses (Stone et al., 1971; Hutchinson & Mahy, 1972). 
Termination of the reaction is probably not the result of exhaustion of 
substrata, but could possib~ be attributed to inability of the enzyme to 
re-initiate, thermal instability of the enzyme, or loss of template. 
However, it has been found that during in vitro product synthesis, the 
virion RNA template is prese~Ted (Bishop et al., 1971a). 
Attempts to separate en;yme from template 
The transcriptase activity of VSV is dissociated from 
the virus particles by treatment with Triton X-100 in high ionic strength 
buffer (Emerson and Wagner, 1972). Considerable enzyme activity could be 
restored by re-combining inactive sedimentable and non-sedimentable frac-
tions. Attempts were made to solubilize the transcriptase of FPV by treat-
ment of a purified virus suspension with Triton-high-salt solubilizer1 
composed of 3·74% Triton X-100 and 1.4 M NaCl. Samples were incubated at 
28°C for 1 hour with occasional mixing. Both treated virus and controls 
were centrifuged at 401 000 rpm for 40 minutes in a Beckman 40.3 rotor. 
Resuspended pellets and supernatants were tested separately and after re-
combination for transcriptase activity (Figure 4). Despite repeated att-
empts using different solubilizer conditions, the transcriptase activity. 
of FPV remains associated with virus cores. 
Marx et al., (1974) report that the Sendai transcrip-
tase complex consists of two polypeptides, the largest virion polypeptide 
and the nucleocapsid structural unit. The large polypeptide is evidently 
bound more tightly with nucleocapsid than the L polypeptide of VSV1 because 
it could not be dislodged at very high ionic strength. 
Nature of the transcription process 
Detailed analysis of the amount of RNA involved in 
transcription, the extent of the transcription process and the nature of 
the initiation site have been reported only for myxoviruses. Bishop et al 
(1971b) 1 using WSN found that only 7% of the virion RNA was involved in 
transcription and at least 14% of the genome was transcribed. Using the 
more aotive influenza A strain WS 1 at least Bo% of the genome was trane-
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Figure 3. Kinetics of 3a-UTP incorporation by fowl plague virion transcrip-
tase. A ten fold reaction mixture (Table 1) was prepared and incubated 
at 31°C for the times indicateq. Duplicate 50;tl samples were removed at 
each time point, and the TCA precipitable counts determined. The extent 
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cribed1 and the process appeared to be repetitive (Bishop et al., 1972). 
In vitro, the transcription process is slow, even with the relatively act-
ive WS transcriptase. In our experience, 4o% of the template RNA of FPV 
is protected when the 2 hro in vitro reaction product is self annealed. 
More than 95% of the product is complementary to template RNA ( Ca.rroll, 
personal communication). It is not known whether the varying extent to 
which transcription occurs for different strains of virus reflects differ-
ences in the enzymes concerned. It has been found (Bishop et al., 1974) 
that although there are multiple initiation sites for the influenza trans-
criptase, the initial sequence for each site is unique, beginning pppG C p P• 
The nature of the transcription product 
Paramyxovirus transcriptase synthesise RNA that is 
completely complementary to virion RNA (Huang et al., 1971 1 Robinson 1 1971a). 
No detailed analysis of size or complexity of the transcriptase product has 
been reported. 
Orthomyxovirus transcriptases also synthesise comple-
mentary RNA (Chow & Simpson1 1971; Penhoet et al. 1971; Skehel, 1971) and 
at least 95% of the product is complementary to viral RNA species (Bishop 
et al. 1971b). RNA was extracted from in vitro WSN transcriptase reactions 
at 101 20 minutes and 2 hrs and subjected to polyacrylamide gel electropho-
resis. It was found that the template was preserved throughout the reao-
tion, and that the product RNA had essentially the same electrophoretic 
profile as the template. However, when the product was released from 
template by heat treatment it was found to occur as single stranded, ribo-
nuclease sensitive polyribonucleotides of MW about 105 daltons (Bishop 
et al. 1 1971b ). 
For both types of transcriptase, the product thus app-
ears to be completely complementary. This data suggests that product RNA 
species probably have some important function in infection, particularly 
as polysome associated RNA for both types of virus is complementary to the 
virion genome (Pons, 1972; Vincent & Barry, 1974). 
The identity of the transcriptase 
Sendai virus transcriptase was found to be associated 
with nucleocapsids (Robinson 1 1971a). When nucleocapsids are separated 
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from other virion proteins by gradient centrifugation, the transcriptase 
activity had a 9 fold greater specific activity than When transcriptase 
was assayed as unfractionated, detergent disrupted virus. These enz.yme 
active nucleocapsids contain only two polypeptides, a large polypeptide 
of MW 75 1 000 and the nucleocapsid polypeptide of MW 60,000 (Marx et al., 
1974 ). 
Biological function of transcriptases 
The logical role of virion associated RNA polymerases 
in ortho - and para.myxoviruses is the synthesis of cRNA, Which in turn 
would act as mRNA for the production of virus induced protein synthesis. 
However, the report by Siegert et al (1973) that influenza virus RNA is 
translated in a cell free system from E. coli casts doubt on the need for 
a virion transcriptase, at least in the case of orthomyxoviruses. However, 
it has also been claimed that cRNA and-not vRNA is the true messenger for 
influenza (Kingsbury & Webster, 1973) as is the case with para.myxoviruses 
(Kingsbury, 1973). 
It has been reported that primary transcription in vivo 
occurs in paramyxovirus infected cells, in the absence of host cell protein 
synthesis (Robinson, 1971b). The possible in vivo activity of influenza 
WSN transcriptase has been reported by Bean & Simpson (1973), Who used 
32P-labelled virus to infect cells and monitored the conversion of labelled 
virus RNA into ribonuclease resistant RNA before and after annealing. 
They could not find any 'primary transcription' until 40-60 minutes after 
infection, and the process accelerated only after 90-120 minutes. 
An example of this type of experiment is shown if Figure 5· No transcrip-
tion occurred in the presence of actinomycin D, and very little in the 
presence of cycloheximide. 
These results are strikingly different from those ob-
tained with VSV. In the latter case, complete primary transcription occurs 
within 4 minutes of infection (Flamand & Bishop, 1973), and the process 
is unaffected by either actinomycin D or cycloheximide. Since the influe-
nza virion transcriptase is insensitive to actinomycin D (Table 1), the 
implication of Bean & Simpson 1 s experiment is that primary genome trans-
cription in influenza infected cells requires host cell factors that must 
be synthesised after infection; transcription proceeds normally only after 
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Figure 5· Primary transcription in vivo in chick embryo cells infected 
with FPV virus. 32P-labelled FPV of high specific activity was prepared 
in the following way. Monolayer cul titres of CEF, pre-incubated in phos-
phate free 199 medium, supplemented with 50 C/ml 32P, were infected with 
FPV and the medium was harvested 24 hours later. The virus was purified 
by conventional methods and used to infect monolayers of CEF at high multi-
plicity. At intervals following infection, cells were harvested, separa-
ted into nuclear and cytoplasmic fractions (Hastie & Mahy, 1973) and extra-
cted for RNA. At each time point, the amount of ribonuclease resistant 
32P-RNA was determined for both nuclear (open symbols) cytoplasmic frac-
tions (closed symbols), before or after annealing (ref.Bean & Simpson,1973). 
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cellular RNA ~thesis and protein ~thesis has occurred. 
Conclusions 
All negative strand viruses have virion associated 
transcriptases. The properties of these transcriptases are summarized in 
Table 2. The rhabdoviruses have been included in this Table because they 
contain by far the most active enzyme (Huang et al. 1971 ), and they have 
been studied in greater detail than either of the two myxovirus transcrip-
tases. Certain interesting differences are apparent between the rhabdo-
and orthomyxovirus enzymes, notably that the enzyme of VSV can be separated 
from its template and characterized separately, that it has distinct and 
different initiation sites, and that it is undoubtedly responsible for 
primary transcription with the formation of mRNA. Paramyxovirus transcrip-
tions have low activity; transcription occurs in cells in the absence of 
protein ~thests implying that, like the VSV enzyme, paramyxovirus trans-
criptases undertake primary transcription. The role of orthomyxovirus 
transcriptases in primary transcription is unknown. 
RNA POLYMERASES m INFECTED CELLS 
RNA dependent RNA polymerase activity associated with 
myxoviruses was reported first for influenza viruses by Ho and Walters 
(1966), and later for NDV (Scholtissek & Rott, 1969b) and Sendai virus 
(R&hy et al., 1970). As will be outlined below, it now appears that the 
predominant polymerase activity detected in cells infected with either type 
of myxovirus closely resembles the virion transcriptase, and might repres-
ent the accumulation of newly ~thesised transcriptase in infected cells. 
The replication of orthomyxovirus RNA is complicated 
by the existence of at least three types of polymerase in infected cells. 
Early in the replicative cycle, there is a stimulation of DNA-dependent RNA 
polymerase activity in host cell nuclei (Borland & Mahy, 1968; Mahy et al., 
1972), which may be related to the unusual sensitivity of influenza virus 
growth to inhibitors of DNA function (Barry, 1964). RNA dependent RNA 
polymerase activity has been detected in both the microsomal and nuclear 
fractions of infected cells (Ho & Walters, 1966; Ruck et al., 1969; 
Scholtissek & Rott, 1969a; Skehel & Burke, 1969; Mahy & Bromley, 1970). 
The microsomal enzyme ~thesises RNA that is complementary to virion RNA 
(Scholtissek, 1969), and may represent newly ~thesised transcriptase 
Table 2 
Properties of Negative Strand Virus Transcriptases 
Rhabdoviruses Orthomyxoviruses Paramyxoviruses 
(VSV) * (Influenza) ( NDV, Sendai ) 
Template s.s. RNA, sjngle molecule s.s. RNA, 7-9 pieces s.s. RNAt single molecule 
3.8 X 10 M.W. -' 5 X 106 M.W. 5 X 10 M.W. 
Enme re~rements 
Temp. in vitro 28 c 28-31 c 28-31 c 
" 
in vivo 36-40 c N.T. N.T. 
pH 8~ Mn!h.:Mg++ 8~ divalent cations Mg Mg 
Transcrietion 
Repetitive + + N.T. 
Complete + + N.T. 
Sequential + 
-
N.T. 
Initiation Multiple Multiple N.T. 
Initiation sequances Distinct & distinguishable Same and unique N.T. 
(A C G ;G C ; G G C ) etc. (G C ) N.T. 
PPPPP PPP pp 
Structure of enme 
Transcription complex L,NS,NP P1,P2,NP,X P, NP Separation ftom 1 t + - -emp a e 
Possible transcriptasE L P1,P2 p 
Nature of product Multiple, smaller than As for VSV As for VSV 
template C.RNA 
In vivo activity Immediate Delayed + 
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rather than replicase. The nuclear RNA dependent RNA polymerase is most 
active in cells at the time of maximal virus RNA synthesis, and less than 
4o% of its product is complementary to virion RNA (Hastie & Mahy, 1973). 
The properties of myxovirus polymerases from infected 
cells will now be considered briefly. 
ParSffiYXOVirus pol;ymerases 
Scholtissek and Rott (1969b) were the first to report 
para.my:x:ovirus polymerase activity in infected cells. They found that the 
cytoplasm of NDV infected chick cells contain an RNA dependent RNA nucleo-
tide transferase, not present in uninfected cells. The en~e activity 
was first detected at 3 hours after infection, and reached its highest 
activity at 5 hours after infection; it was not inhibited by actinOIDlfcin D. 
Mahy et al., (1970) detected a similar activity associated with the 1micro-
somes1 of chick cells infected with Sendai virus. In this case, maximum 
detectable activity was 18 hours after infection, and the reaction was 
actinorolfcin D insensitive. 
General properties of the en;ymes 
Both NDV and Sendai virus induced polymerases have 
general requirements for activity that resemble closely those described for 
virion transcriptases (see above). En~e activity in vitro is dependent 
on Mg++ions and all four nucleoside triphosphates. The en~e from cells 
has a b,igher specific activity than the en~e from virions, but the kine-
tics of the reaction are similar (Stone et al., 1971). 
Nature of the product 
Both nearest neighbour analysis (Scholtissek & Rott, 
1969) and annealing procedures (Mahy et al., 1970) indicate that the pro-
duct of the paramyxovirus polymerases is complementary to virion RNA. 
Sedimentation analysis indicates that it is variable in size, and smaller 
than the 50S virion RNA. 
Nature of the enz;yme 
Both transcriptive and replicative intermediates have 
been isolated from Sendai virus infected cells (Portner & Kingsbury, 1972; 
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Bukrinskaya 1973). The transcriptase complexes have a structure resembling 
viral nucleocapsids (Stone et al., 1972). These transcriptases have physi-
cal properties that would place them in the 'microsomal' fraction of cells, 
and they represent the source of microsomal polymerase. The complex con-
tains two polypeptides1 the viral nucleocapsid structural unit and the 
largest virion polypeptide (MW 751 000). From the foregoing, it appears 
that the polymerase activity isolated and characterized from cells infected 
with paramyxoviruses represents the synthesis and accumulation of nucleo-
capsids in infected cells. Thus the cellular and viral enzymes are identi-
cal; no information is available concerning a possible replicase for the 
production of v.RNA. 
Orthosyxovirus polymerases 
Compared to the virion transcriptases1 little is known 
of the properties of RNA-dependent RNA polymerases found in cells infected 
with orthomJ~oviruses, particularly concerning the optimal conditions for 
the in vitro reaction, the nature of the product synthesised by the enzymes 
or the biological function of the enzymes. 
Ho and Walters (1966) detected RNA polymerase activity 
in the microsomal fraction of influenza virus-infected cells; the in vitro 
activity of this enzyme was inhibited by ribonuclease but not by deoxyrib-
onuclease. The enzyme activity was not inhibited by the presence of acti-
nomycin D, but treatment of infected cells at any time during the first 
hour following infection with this drug prevented its appearance. 
The polymerase required Mg++ ions and all four ribonucleoside triphosphates, 
but not the addition of an RNA template. 
The findings of Ho and Walters were confirmed and ext-
ended by Scholtissek and Rott (1969a) 1 Page et al., (1969) 1 Skehel and 
Burke (1969) and Mahy and Bromley (1970). In each case, the properties 
reported for the enzyme are very similar. Each enzyme was detected in the 
cytoplasmic fraction of cells, they were inhibited by ribonuclease, required 
all four triphosphates, and could not be purified from associated template. 
More recently, it has been shown that the cytoplasmic enzyme is associated 
with ribonucleoprotein complexes, similar in morphology to the viral inter-
nal components (Compans & Caliguiri 1 1973) 1 and it is highly likely that 
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this cytoplasmic en~e is a transcriptase. This conclusion is supported 
by the finding that the in vitro product of the en~e is 85-1 oafo comple-
mentary to virion RNA (Scholtissek1 1969). 
Nuclear RNA dependent RNA polymerase 
Several authors reported the presence of RNA polymerase 
activity in infected cell nuclei (Scholtissek & Rott, 1969a1 Skehel & Burke, 
1969) 1 but the levels of activity were low and could represent contamina-
tion of nuclei with microsomes. Careful purification of nuclei, using cyto-
chrome C reductase as an assay for cytoplasmic contamination, indicate that 
nuclei from chick embryo fibroblasts (CEF) infected .tth FPV contain an 
RNA dependent RNA polymerase (Hastie & Mahy, 1973). Although the in vitro 
requirements for the nuclear RNA dependent RNA polymerase resemble those 
required by the cytoplasmic en~e, annealing reactions indicate that only 
4o% of the in vitro reaction product is complementary to virion RNA. 
This finding suggests that the nuclear enzyme may have replicase activity. 
Time of appearance of RNA dependent RNA polymerases 
Scholtissek & Rott (1969a) reported that in both micro-
somas and impure nuclei of CEF infected with FPV1 polymerase activity con-
tinues to increase up to 9 hours after infection. Using purified nuclei, 
Hastie & Mahy (1973) found that the nuclear en~e activity increased rap-
idly from one hour after infection reached a maximum at 3-4 hours and then 
declined; the microsomal en~e increased from 2 hours after infection and 
reached a maximum at 5-6 hours after infection. 
Armstrong & Barry (1974) have examined both the activ-
ity and intracellular localization of various RNA-dependent RNA polymerases 
(in situ polymerase activity) by incubating Whole, fixed cells with the 
RNA dependent RNA polymerase reaction mixture and determining the distri-
bution of polymerase activity by autoradiography. A peak of en~e acti-
vity was detected at 3 hours after infection in the nucleoplasm; a second 
peak of activity was detected at 6 hours in the cell cytoplasm (Figure 6). 
DNA dependent RNA polymerase 
Evidence for the participation of nucleoplasmic DNA 
dependent RNA polymerase II in the multiplication of ortho~oviruses has 
been reviewed recently by Mahy et al (1974). The evidence is based mainly 
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Figure 6. Incorporation of (~)-uridine triphosphate into the nuclei and 
cytoplasm of cells infected with FPV, fixed at various times after infec-
tion and incubated with an RNA dependent RNA polymerase reaction mixture 
containing actinomycin D. Infected and control CEF cells were fixed at 
hourly intervals in cold alcohol-acetone. Cell strips were incubated with 
the reaction mixture at 32° for 45 minutes, fixed and washed in TCA, and 
prepared for autoradiography. cytoplasmic and nuclear grains were counted 
for 100 cells at each time point. The background levels (4.60 grains I 
cell for cytoplasm, 1.97 grain I cell for nucleus) were deducted from mean 
values. 0------0 nuclear grains ,. - - - - .1. cytoplasmic grains. 
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on the sensitivity of virus replication to treatment with ~anitin, 
a bicyclic octapeptide from the toadstool, Amanita phalloides, that inhib-
its DNA transcription in vitro by binding specifically to the RNA polymerase, 
form II of eukaryotic cells without affecting polymerase I (Kedinger et al., 
1970). 
The replication of FPV in CEF is inhibited by .<-amani tin, 
if the drug is added during the first two hours following infection at 
concentrations similar to those used to inhibit cellular DNA dependent RNA 
polymerase (Many et al., 1972). Of two periods of increased RNA synthesis 
in infected cells only the first, occurring from 0 to 2 hours after infec-
tion, is sensitive to ~amanitin. During this early period there is a 
stimulation of the activity of DNA-dependent RNA polymerase II. 
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DISCUSSION 
Dr. Scholtissek : What evidence do you have that P-1 protein in Sendai 
virus is the polymerase ? 
Dr. Barry We ha.ve no direct evidence. The American group led by 
Kingsbury claim that the replicative complex from infected cells and the 
virion transcriptase itself consists on the nucleoprotein, and a large 
molecular weight protein MW 75• 000. 
Dr. Scholtissek : One comment concerning the corresponding protein of 
influenza virus. There is other evidence, or there are some suggestions at 
least, that the P proteins of influenza are not polymerases. Galiguiri for 
example has purified the enzyme and finds that it contains only nucleoprot-
ein. 
Dr. Barry : There may be problems concerning the interpretation of 
Compans and Galiguiri's experiment, firstly because they could not ressolve 
protein X1 Which we find reproducibly in cells and virus. Secondly, their 
conclusions are based on a pulse-labelled experiment and it could be that 
P proteins are in the enzyme complex, but not labelled under the conditions 
of the experiment. 
Dr. Scholtissek I see, but other evidence by Klenk indicates that 
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when cells are fractionated, practically all the P protein stayed in the 
supernatant, but this fraction is free of enz.yme activity. 
Dr. BarrY : I do not have any strong views concerning the role of 
P proteins in enzyme function. I have mentioned them as possible candid-
ates for this job, since they are the only structural polypeptides to Which 
a function has not yet been assigned. 
Dr. s. Schlesinger :Did I understand you correctly ? Does 6o% of 32F-labelled 
virion RNA become double-stranded ? 
Dr. Barry : Because I was hurrying, I may have missed a crucial 
point in my explanation of this experiment. The infecting virus is labe-
lled with 32P, and at intervals after infection the total cell RNA is ~ 
tracted and self-annealed. 
Dr.S,Schlesinger : !ozy question had to do with the fact that the ratio of 
infectivity of particles in influenza is usually quite low. It seems to 
me that there is an awful lot of RNA Which is not really going to produce 
virions, but is still able to be transcribed into the complementary strand. 
DPo BarfY : I do not think that this experiment indicates how much 
input virion RNA is actually transcribed. ~at is contributing to the 
double stranded RNA is newly synthezised complementary RNA. Its production 
may be initiated and continued by only a small amount of the total input 
RNA. Once produced however, newly formed c RNA may soak up any excess, 
non-functional virion RNA. 
Dr.S.SchlAisinger : Where does the figure of 6o% came from ? Is it the 
total amount of input RNA converted into RNAse insensitive material after 
self-annealing~ 
Dr. BarfY I Yes. 
Dr. Beaker 1 I am wondering about the fragmented genome, and Whether 
or not it would be worthWhile to check this problem again. I happened to 
see a short While ago a repPint from Ruth Kravineff on reovirus double 
stranded RNA, and this I think agreed that it has a fragaented genome. 
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When she changed the cond.i tions of extraction, she found that the genome is 
circular and complete. It is my interpretation that the virion might con-
tain a restriction en~e that al~s cleaves the RNA in the same position. 
What is the possibility of testing this hypothesis, at least in the case of 
influenza virus, to see whether or not you have the complete genome which 
is always fragmented in the same position, and this is why we have always 
six to seven tragments? I also have a second question. What is the mech-
anism of replication or synthesis of the plus strand ? Is it the same as 
we think about other single-stranded RNA viruses ? 
Dr. Barcy : To take the second question first - all the RNA depen-
dent RNA polymerases we detect in cells infected by either class of myxovirus 
makes predominantly, if not totally, complementary RNA. Nobody has found 
reaction conditions where the;:e is a significant increase of virion RNA. 
The replicase has not yet been identified. In answer to the first question, 
it is possible that the RNA in the virion is a single polyribonucleotide. 
Several years ago, S&to claimed that RNA released from influenza Virus 
by very gentle extraction procedures and examined by electron microscopy 
was much longer than any of the RNA fragments identified by gel elecilro-
ph~esis. The possibility remains that the RNA obtained from influenza 
viruses after detergent treatment and phenol extraction is the product of a 
restriction enzyme. There is no information on this point. 
Dr. M. Schlesinger :Is it possible to look at the product of your in vitro 
reaction on gels and get some indication of its size ? 
Dr. BarEY : This problem has been examined by Bishop and colleagues. 
When the reaction mixture is placed directly on gels, the product has 
migratory properties similar to template RNA. However, in this case, it 
is not clear whether this is completed, new product, or whether it is 
partly formed products still associated with template. When the product 
is melted before electrophoresis, it is found to be much smaller than any 
template RNA. However, this analysis was carried out on a sub-optimal 
reaction product, and needs to be repeated, using the best available virus 
and reaction mixture. 
Dr. M. Schlesinger :I would like to ask one further question. In the in-
fected cell 1 do all these different fragments show up in equal molar quan-
tities ? 
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Dr. Barr:y No. 
Dr. M. Schlesinger :You said they were monoqystronic ? 
Dr. Barry : Yes, because polysome associated complementary RNA for 
both types of virus is predominantly 15-20 s, even though the para.-influenza 
virus template is 50 s. 
Dr. M. Schlesinger :You do not know Whether one species occurs in greater 
amounts than another . 
Dr. Barry : Gel electrophoresis suggests that RNA of approximately 
18 S is relatively more abunda.nt than RNA that is 20 S or larger. 
Dr. Van Oirschot Do you have any information about the role of the nuo-
leocapsid in the in Vivo transcriptional process ? 
Dr. Barry : The so-called "microsomal" enzyme found in infected 
cells, and described originally by Ho and Walters (1966), appears to contain 
the ribonucleoprotein nucleocapsid, as shown by Compans and Galiguiri. 
Furthermore, these workers could not detect P protein in this complex. 
Since it has so far proved impossible to separate enzyme activity from nu-
cleocapsid, it would seem that either the ribonucleoprotein is the enzyme, 
or there is another protein present that is of a similar molecular weight. 
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REPLICATION OF MYXOVffiUS RNA 
c. Scholtissek 
Institut fUr Virologie1 Justus Liebig-Universitat, 
GIESSEN - Germany 
Mlfxoviruses contain single-stranded RNA as genetic mat-
erial. In contrast to parainfluenza viruses, Which have a single RNA-
molecule with a molecular weight of about 7 x 106 (1) 1 influenza virus RNA 
was found to exist and to fgnction in pieces (2 1 314). Regardless of this 
fundamental difference in the structure of RNA both types of RNA have to be 
replicated in such a way that the virion RNA functions first as a template 
for the viral RNA polymerase to form the complementary RNA, Which again 
serves as template either for the same, or a modified, or a totally diffe-
rent viral enzyme to form the progeny virion RNA. 
I shall mainly concentrate my talk on the in vivo s,yn-
thesis of myxovirus RNA considering the following problems: 
1. What is the time course of the appearance of viral RNA 
polymerase activity ? 
2. What is the time course of the appearance of viral 
RNA? 
3. What is the stability of viral RNA in vivo ? 
4. Are the virion RNA and complementary RNA synthesized 
by completely different enzymes ? 
5· Does the viral enzyme synthesizing the virion RNA 
use the same nucleoside triphosphate pools as the 
cellular enzymes do ? 
6. How far can the synthesis of viral RNA be influenced 
by inhibitors ? 
I want to select one virus of each group of the myxo-
viruses as examples: for the influenza virus I want to talk about results 
obtained with fowl plague virus (FPV), Which is an influenza A virus. 
For the parainfluenza viruses I will present data obtained with the New-
castle disease virus (NDV). 
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1 • Time course of appearance of viral RNA polymerase 
Fig. 1 (left) shows the appearance of the FPV RNA poly-
merase activity in chick embryo cells after infection (5). The en~e 
activity slightly preceeds the appearance of the RNP-antigen in the infec-
ted cells. Up to 2o% of the enzyme activity is tightly bound to the nuc-
lear fraction. In our hands only complementary RNA is synthesized by the 
enzyme preparation in vitro (6). Even the en~e of the nuclear fraction 
produces between 50 and So% complementary RNA. When the nuclei of FPV-
infected cells were incubated with ( -'Ji)-GTP, there was no significant rad-
ioactive material hybridizable with non-labelled complementary RNA (un-
published). 
Fig. 1 (right) shows the corresponding data for NDV. 
The NDV-RNA polymerase, too, produces in vitro mainly complementary RNA. 
All viral components, including polymerase, are synthesized at a slower 
rate compared with FPV-infected cells (7). 
2. Time course of appearance of viral RNA in vivo 
In the case of influenza viruses actinomycin D cannot 
be used to trace viral RNA synthesis, since this antibiotic does not only 
inhibit cellular RNA synthesis but it also completely suppresses the pro-
duction of influenza viruses (8,9,10). Therefore we used the method of 
specific hybridization of newly synthesized labelled viral RNA with a sur-
plus of either non-labelled virion RNA or complementary RNA. The experi-
ment is done in the following way: at different times after infection a 
pulse with labelled uridine is given, the total RNA is extracted by phenol, 
and aliquots are hybridized with the various non-labelled viral RNA samples. 
The results are presented in Fig. 2. Two hours after infection there is a 
maximal production of complementary RNA, one hour later mainly virion RNA 
is being synthesized. Double-stranded RNA is found only in very low 
amounts ( 11 ). 
With parainfiuenza viruses the time course of virus-
specific RNA can be determined with the aid of actinomycin D, since these 
viruses multiply in the presence of the antibiotic (8,9). Kingsbury (12) 
was the first one who used the technique to follow NDV-RNA synthesis. 
Fig. 3 demonstrates the time course of NDV-RNA synthesis in our system (13). 
The curve is comparable to that of Fig.1 (right). Kingsbury (14) found 
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~· Appearance of RNA polymerase activity in the cytoplasm of cells 
infected either with FPV (left) or NDV (right). 
Cytoplasmic fractions were prepared at the times after infection as indi-
cated on the abscissa. They were incubated with (3a)-GTP and cofactors 
for 10 min in the case of FPV (left), or either for 3 min (•) or 5 min 
( o) in the case of NDV (right). The radioactivity was determined in RNA. 
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~· Synthesis of virion and complementary RNA of FPV in vivo. 
To 6 infected cultures 10 )lCi (~)-uridine, each, was added at the times 
as indicated on the abscissa; 30 min later total RNA was isolated and 
dissolved in 1 ml Tris-HCl (5 mM) plus EDTA (1 mM). Aliquots of 0.1 ml 
were used for the determination of total RNA (•, x 10-4), Yirion RNA 
(o, x 10-3 ), complementary RNA (~, x 10-3 ),double-stranded RNA (~, x 10-3), 
and self-annealed RNA (1, x 10-3). 
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~· Time course of NDV-RNA synthesis in vivo. 
Viral RNA was measured by adding ( 14c)-uridine (1 ;u.Ci/culture) to the 
infected cultures at the times indicated on the abscissa. Half an hour 
later the cultures were processed for the determination of the radioactiv-
ity in the RNA. Cellular RNA synthesis was suppressed by addition of 
5 p.g/ml of actinomycin D. 
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that most of the in vivo s,ynthesized NDV-RNA is complementary to virion RNA. 
Most of this RNA has a sedimentation constant of 18 S (15). Fig. 4 shows 
a corresponding sucrose gradient profile (16). 
3· Stability of m;yxovirus RNA 
Since virus-specific RNA also functions as messenger 
for protein s,ynthesis1 we wanted to know how stable the different kinds of 
viral RNA are in vivo. Since there is no specific inhibitor for viral RNA 
synthesis available like actinomycin D for cellular RNA s,ynthesis1 pulse-
chase experiments had to be performed. In animal cells, however, labelled 
nucleosides cannot be used for such pulse-chase experiments, since the 
nucleoside triphosphate pools are too large to be sufficiently diluted with 
the non-labelled nucleoside after the pulse in order to follow the fate of 
the newly synthesized macromolecule. For this reason we have incubated in-
fected cells with glucosamine either prior to the pulse with(~)- uridine 
or immediately thereafter. Glucosamine specifically reduces the UTP-pool 
( 17). In the case of FPV we incubated the infected cells with ( ~) -uri-
dine at 4°. At this temperature uridine is phosphorylated to UTP but is 
not further metabolized (18). After washing off the surplus of (~)- uri-
dine1 the infected cells were further incubated with glucosamine at 37°. 
Now the viral RNA becomes labelled by the prelabelled ( ~) - UTP. After 30 
or 40 min a surplus of non-labelled uridine is added, the uptake of which is 
facilitated by lowering the UTF-pool by glucosamine (19). This stops 
further incorporation of labelled UTP into RNA. Now the fate of labelled 
viral RNA can be studied (16). 
Table 1 shows that under these conditions FPV-RNA1 the 
virion as well as the complementary RNA, is completely stable for at least 
90 min. Fig. 4• shows corresponding data for NDV. The sucrose gradient 
pattern of NDV-RNA does not change significantly during a chase of 140 
min. Thus both types of viral RNA are not catabolized significantly during 
a reasonable time of the infectious cycle. 
4. The en;yme(s) gynthesising virion and complementary RNA of FPV 
If two completely different enzymes were involved in 
the s,ynthesis of virion and complementary RNA1 one should not be able to 
find a single gene mutant in which~ steps are inhibited. We have been 
searching for temperature sensitive mutants of FPV1 and Table 2 presents 
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data on such a mutant induced by 5-fluorouracil (20). At the permissive 
temperature (33°) this mutant synthesizes both kinds of RNA. If we shift 
the temperature at 4 hr after infection from 33° to the non-permissive 
temperature of 40°, virion as well as complementary RNA synthesis is comp-
letely abolished. As soon as we come down to 33° again, synthesis of both 
types of RNA is resumed. These results strongly suggest that either both 
enzymes are identical or that they contain at least one common virus-spec-
ific protein Which is necessary for enzyme activity in vivo. There are no 
comparable data available for NDV. 
TABLE 1 
STABILITY OF FPV-RNA IN VIVO 
Counts/min in Cold chase (min.) 
0 30 90 
Total RNA 15,800 13,000 10,600 
Virion RNA 2,200 2,100 2,150 
Complementary RNA 1,550 1 t 380 1,450 
After infection for 2.5 hr, each culture was incubated for 1 hr at 4° with 
25 _,uCi ( ~) - uridine. After removal of surplus ( ~) - uridine the cultures 
were incubated with 10 mM glucosamine at 37° for 30 min (= pulse). 
Thereafter, 0.1 mg/ml of non-labelled uridine was added (= cold chase). 
Each value is the mean for the RNA component analysed on five separate 
cultures. 
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~· Stability of NDV-RNA. 
To NDV-infected cells 5 hr after infection 2 pg/ml of actinomycin D and 
10 mM glucosamine were added. A pulse with 25 pCi/culture of (~)- uri-
dine was started 90 min later. After 40 min part of the cultures were 
processed (17) (A) or received 0.1 mg/ml non-labelled uridine to stop 
further incorporation. Either 50 min (B) or 140 min (C) later the other 
cultures were processed for isolation of RNA and sucrose gradient analysis 
( 16 ). 
Virion RNA 
Complementary RNA 
TABLE 2 
SYNTHESIS OF VIRAL RNA BY A TEMPERATURE-SENSITIVE MUTANT OF FPV 
0 - 4 hr 
33° 
20.0 
0 - 5· 5 hr 
33° 
3-3 
o.o 
o.o 
0 - 4 hrr 33° 
4- 5·5 hr, 40° 
0.6 
0.6 
0 0 - 4 hr, 33 0 4 - 5·5 hr, 40 0 5·5 - 6.5 hr, 33 
9·9 
1.8 
Chick embryo cells were infected with the ts-mutant and were incubated either at 33° or at 40° at the times after 
infection as indicated. Each value is the average of three cultures, Which were labelled with 25yCi (1H)- uri-
dine, each, starting 1 hr before the cultures were processed. The values are expressed as% radioactivity in each 
virus RNA strand compared with total newly synthesized RNA (about 1007 000 counts/min/sample). The corresponding 
background values of non-infected control cells were subtracted before calculation (11). 
00 
..... 
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5· Nucleoside triphosphate pools used for viral RNA aynthesis 
In order to get an idea whether different nucleoside 
triphosphate pools are used for viral and cellular RNA s,ynthesis we have 
to manipulate these pools and look how far this manipulation affects virus 
and cellular RNA synthesis. We used for this purpose again glucosamine 
Which is known to reduce specifically the UTF-pool (17). When Earle's 
medium containing glucose is used for incubation, there is no signifioant 
inhibirory effect on viral RNA s,ynthesis (Table 3), although no infectious 
virus is produced (21), as will be shown later on by Dr. Rott. If, however, 
glucose is replaced ~ fructose as energy source of the medium, glucosamine 
is about 10 times more effective concerning the effect on the UTF-pool, 
because fructose does not interfere with the uptake of gluoosamine as glu-
cose does (22). Under these conditions the amino sugar specifically inter-
feres with the production of viral RNA s,ynthesis leaving cellular RNA B,Yn-
thesis intact (Table 3). The effect is most pronounced on the s,ynthesis 
of virion RNA and less on complementary RNA (22). In the Semliki Forest 
virus system actino~cin D can be used to suppress cellular RNA s,ynthesis; 
and (~) - adenosine was investigated instead of (~) - uridine to label 
the viral RNA. Therefore with this virus system it could be shown that the 
effect of glucosamine on viral RNA s,ynthesis can be counteracted by adding 
uridine to the culture medium, but not by guanosine or cytidine (22). 
Thus viral RNA s,ynthesis is inhibited because the UTF-pool becomes rate 
limiting specifically for viral RNA s,ynthesis. 
This observation can be explained in two ways: either 
the viral RNA polymerase has a lower affinity for UTP as compared to the 
cellular en~e using the same UTF-pool, or different and more or less 
independent UTB-pools are used for the s,ynthesis of viral and cellular RNA. 
To study this problem further we have performed the following experiment: 
We incubated oells infected with FPV from 4 to 5 hr after infection with 
(~)- uridine,isolated total RNA, hybridized the labelled virion RNA with 
a surplus of non-labelled complementary RNA and after digestion with RNase 
the acid soluble material (= cellular plus complementary RNA) and acid 
precipitable RNA (= virion RNA) were digested further by alkali to the 
2',3'- nucleotides. Then we determined the ratio of the specific radio-
activity of CMP to UMP. The radioactivity found in CMP is obtained from 
the de novo s,ynthesis of CTP via the UTF-pool. If the cellular en~e uses 
the same pyrimidine nucleoside triphosphate pools as the viral en~e then 
2 
Exp. 
No. 
Medium 
10 mM 
glucose 
fructose 
fructose 
TA:BLE 3 
EFFECT OF GLUCOSAMINE ON FPV-RNA SYNTHESIS IN VIVO 
Glucosamine 
mM 
0 
5 
0 
5 
0 
5 
Pulse from 
to •••• hr 
after infection 
3- 4 
3-4 
3- 4 
3-4 
3- 4·3 
3- 4·3 
Virion RNA 
%of total 
23.3 
21.8 
21.0 
6.7 
37·0 
3.0 
Complementary RNA 
% of total 
4.6 
8.8 
10.6 
3.0 
Glucosamine was added immediately after infection of chick embryo cells with FPV. The medium contained either 
10 mM of glucose or fructose as energy ~ource. For further details see Table-2. 
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the ratio of ( ~) - CMP to ( ~) - UMP should be the same for both types of 
RNA. If the ratio is different for both types of RNA then the viral enz,yme 
uses other pools. As shown in Table 4 the ratios of the specific activities 
of (~)- CMP to (~)- UMP are completely different demonstrating that two 
different pyrimidine nucleoside triphosphate pools are used for viral and 
cellular RNA synthesis (23). This observation does not rule out the possi-
bility that in addition there might be a difference in the affinity of the 
two enz,ymes for the same substrates. 
TABLE 4 
RATIO OF THE SPECIFIC RADIOACTIVITY OF CMP/UMP AFTER LABELLING 
OF FPV VIRION - AND CELLULAR RNA BY ( ~) - URIDINE 
Virion RNA Cellular RNA 
Dpm in CMP 9,:J95 10,665 
Dpm in UMP 166,615 292,454 
% of CMP in RNA 25.2 30.2 
% of UMP in RNA 32.0 18.4 
Spec. activity 0.075 0.022 
CMP/UMP 
Chick embryo cultures were labelled with 50 ,uCi of ( ~) - uridine, each, 
from 4 to 5 hr after infection with FPV. Thereafter total RNA was extrao-
ted by phenol plus 0.5% sodium dodecyl sulfate at room temperature. After 
hybridization with a surplus of non-labelled complementary RNA the perch-
loric acid-precipitated (=virion RNA) as well as soluble material (= cell-
ular plus about 1 o% complementary RNA) was digested by 0.5 M KOH at 65° 
for 45 min. Radioactivity was determined in CMP and UMP. For the calcula... 
tion of specific radioactivity the base composition of fowl plague virus 
was taken from Rott et al. (26); that for total cellular RNA from Scholti-
ssek ( 27 ). 
The multiplication of NDV also can be inhibited by 
glucosamine when glucose is replaced by fructose in the medium (22). 
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Although we have not yet studied the NDV-RNA synthesis under these condi-
tions, the effect of the amino sugar might also involve viral RNA synthesis. 
6. Inhibition of viral RNA grnthesis by antibiotics 
I mentioned at the beginning that the multiplication of 
influenza viruses can be inhibited by actinomycin D, while that of par&-
influenza viruses cannot (8,9,10). If the antibiotic is added later in the 
infectious cycle when the influenza RNA polymerase is already present, 
virus maturation is not much impaired. 
In Table 5 data are presented which demonstrate that 
FPV-virion RNA synthesis proceeds for at least some time when actinomycin D 
is added to the infected cultures 2 or 3 hr after infection, while synthe-
sis of complementary RNA is almost completely suppressed. Thus we know 
that this antibiotic interferes with the production of complementary RNA 
in vivo, although we do not know anything about its mechanism. In vitro 
actinomycin D is without the effect. We can isolate the enzyme from acti-
nomycin treated cells and synthesize the complementary RNA in the test 
tube. Therefore, it must have been synthesized in the actinomycin D-treated 
cells, although it is not functional in vivo (11). 
If we inhibit protein synthesis 2 or 3 hr after infec-
tion with FPV by adding cycloheximide we suppress specifically the produc-
tion of virion RNA, but not that of complementary RNA (Table 5). We have 
interpreted this observation by assuming that we need a viral protein for 
the switch from synthesizing mainly complementary RNA to virion RNA. 
This viral protein has to be continuously synthesized and might remove the 
virion RNA as template for the synthesis of complementary RNA. If we stop 
the synthesis of this protein, then production of complementary RNA pre-
vails (11). A candidate for such an effect would be the NF-protein. 
Other antibiotics like mithramycin (24) and~amanitin 
(25) have a similar effect as actinomycin D concerning viral RNA synthesis. 
All these antibiotics under comparable conditions do not interfere with the 
production of NDV-RNA in vivo. 
Concluding remarks 
The first virus-specific activity found in chick embryo 
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TABLE 5 
INHIBITION OF FPV-RNA SYNTHESIS IN VIVO BY ACTINOMYCIN D AND 
CYCLOHEXIMIDE 
Addition at 
2 hr after 
infection 
None 
Cycloheximide 
10~ml 
Actinomycin D 
2p.g/ml 
Radioactivity 
in RNA 
total RNA 
virion RNA 
compl. RNA 
total RNA 
virion RNA 
compl. RNA 
total RNA 
virion RNA 
compl. RNA 
Counts/min 
42,000 
3,400 
1,600 
37,800 
320 
1,700 
1,700 
1,000 
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Chick embryo cells were infected with FPV. Two hr later either cyclohe~ 
imide or actinomycin D as indicated were added. The pulse with 25 pCi 
( ~) - uridine per culture was started 3 hr after infection. The cultures 
were processed 1 hr later. For further details see Table 2. 
cells infected either with an influenza (FPV) or parainfluenza virus (NDV) 
is the RNA-dependent RNA polymerase synthesizing viral complementary RNA. 
In the case of FPV the synthesis of complementary RNA preceeds that of vir-
ion RNA. There is at least one common viral protein involved in the s,yn-
thesis of virion and complementary RNA. In NDV-infected cells mainly 
complementary RNA with a sedimentation value of about 18 S accumulates. 
All viral RNA once synthesized is stable during the infectious cycle. The 
multiplication of both viruses can be inhibited by glucosamine, When glu-
cose of the medium is replaced by fructose. For FPV it is shown that the 
effect is on viral RNA synthesis. It is suggested that virion RNA synthe-
sis gets its precursor supplies from different pyrimidine nucleoside tri-
phosphate pools than the corresponding cellular enzymes. Concerning the 
effect of various antibiotics on viral RNA synthesis, there are fundamen-
tal differences between influenza and parainfluenza viruses. Actinomycin D, 
mithramycin and~amanitin specifically interfere with the production of 
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influenza complementary RNA in vivo, While cycloheximide prevents produo-
tion of virion RNA, When added 2 to 3 hr after infection. All these anti-
biotics have no effect on the production of NDV-RNA under comparable con-
ditions. Especially these and other differences mentioned have to be taken 
into consideration when one deals with the molecular biology of myxovirus-
ea as a Whole group. 
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DISCUSSION 
Dr. M. Schlesinger :In the mutant that you mentioned where do you think the 
mutation is? Do you think that the mutation is in a structural protein ? 
Do you denature it by bringing the infected cells to high temperature and 
after lowering the temperature do you need de novo synthesis of this pro-
tein ? 
Dr. Scholtissek : The polymerase is not denatured at the non permissive 
temperature, it is functional when checked in vitro. The polymerase of the 
mutant works in vitro but in vivo it is net functional. There is some 
similarity to the actinomwcin D effect. We do not denature the polymerase 
at 40°t. 
Dr •. Van der Zei.jst :I should like to ask what do you think of the contro-
versary results about the polarity of RNAs in viral polysomes and the 
functioning of the viral RNAs as a messenger RNA in the cells? 
Dr. Scholtissek : People call the influenza viruses negative stranded 
viruses because the RNA complementary to viral RNA should be the messenger 
RNA. But it could well be that for example one piece of the virion RNA 
functions as template for the production, for example of the nucleocapsid 
protein while another piece of RNA which is complementary to the virion RNA 
might function for the synthesis of anothe~ virus specific protein for 
example, for the matrix protein as found by Kingsbury. So it is difficult 
to define influenza virus as a negative strand virus at the moment. 
Furthermore contradictory results have been published concerning the kind 
of RNA bound to polysomes Nayak found mainly virion RNA with polysomes, 
while Pons found complementary RNA. Even this point is not clear. 
Dr. Barry : It seems that this question is directed both to Dr. Schol-
tissek and mwself. I disagree slightly in that both by reason of circumstan-
tial evidence and because of some data we have ourselves, that the RNA asso-
ciated with polysomes of influenza virus infected cells, particularly with 
fowl plague, is more than 9o% complementary and contains poly A. I think 
that the Hofschneider-experiment has to be considered in the light of the 
fact that many preparations of RNA from influenza virus show a certain 
degree of self complementarity. So one could argue that the translation 
you see in an in vitro system using influenza RNA is due to a low level of 
complementary RNA that has been incorporated into the virion. We find 
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looking in virus particles that the sort of RNA that is there is not only 
virion RNA but there is also a small amount of cellular RNA. This is not 
complementary. This is ribosomal RNA and it is in the virus particles. 
So it is my impression that the assembly process of influenza viruses is 
such that quite frequently it incorporates other RNA. Sometimes this may 
be complementary RNA, sometimes it's cellular ribosomal RNA. So my read-
ing of the Hofschneider-result is that this is contributed by a small prop-
ortion of complementary RNA accidently incorporated into a certain propor-
tion of virions. 
Dr. Scholtissek : Yes, this is a possible explanation of this discrepancy 
tool. There are other explanations, I mean, we ourselves did not find any 
complementary RNA virions. It was not more than 0.5.% Which is just back-
ground of the method. But this again might be strain-dependent. I know for 
example from people looking for complementarity of the Newcastle disease 
virus RNA that there were differences between 3 and 2o% self complementary 
depending on the strain used. It could be that there are also influenza 
strains Which incorporate the complementary RNA, because our own studies on 
in vitro experiments using nucleocapsid protein and virion RNA as well 
as complementary RNA had shown that both strands have the same affinity to 
the NP protein. 
Dr. Becker : You mentioned polysomes and RNA in the polysomes and 
different sorts of RNA on the polysomes. I have the feeling that people 
are using the word "polysome" in a very loose manner these days. We all 
know especially from the experiments of Baltimore about ten years ago that 
RNA can bind to a protein and sediment non-specifically so to say in the 
polysome region. Now if you look at the RNA which sediments together with 
the polysomes you might make a mistake if you think that all the RNA is 
there because it is bound to ribosomes. If you really want to know what 
is associated with the ribosomes you have to fix the polysome region with 
glutaraldehyde and then run in a Caesium chloride gradient and see what 
proportion of the radioactivity will sediment at a density of 1.54 which 
is the density of the ribosomes or the polysomes. Now when we did exper-
iments of that sort in another system we discovered that although we have 
a beautiful profile of polysomes and RNA sedimenting with the polysomes; 
only a small amount of radioactive RNA is really bound to ribosomes ; 
ao if people are discussing polysomes these days I think that they have to 
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subject a more stringent test ; this is one thing ; the other thing is1 
I would like perhaps to ask Dr. Scholtissek and Dr. Horzinek how this tech-
nique of replacing glucose with fructose would be helpfull in labelling the 
classical svrlne fever virus which is, I understand, very hard to label 
these days. 
Dr. Scholtissek : You might get radioactivity into this RNA if you apply 
this method. I have labelled different kinds of RNA at the moment only 
using glucose in the medium, but the labelling is about ten times better 
when glucose is replaced hv fructose. Concerning the polysomes, I complete-
ly agree with you that one has to be very careful in talking about the 
virus-specific RNA found in the polysome region. I do not think that any-
body has done this very stringent experiments. And another point is that 
it is also very difficult to remove the RNP antigen, this means nucleocap-
sid + RNA which might migrate into the polysome region. 
Dr. Becker : Not if you fix it with glutaraldehyde. This complex 
should have an entirely different density I believe so. I did not do any 
experiments but the ribosome-RNA complex has a very distinct property to 
bound at particular densities. But may I ask you to give perhaps a little 
more detail about this fructose experiment. How much you use and how gen-
eral is this phenomenon ? 
Dr. Scholtissek : I first have to say that it is very important to know 
the enz.ymatic state of the cell. For example when we used chick embryo 
cells 22 hours after seeding we had completely different results compared 
with cells 48 hours after seeding. It is very important that the corres-
ponding enz.ymes are very active in these cells. If you are working with 
liver cells you better use galactosamine, because liver cells have high 
levels of galactokinase and also converts galactosamine into the corres-
ponding intermediates depleting the cell of UTP. So we have to check the 
cells very carefully in order to be sure that they work. For example we 
also tried KB cells and in the KB cells the effect is much less pronounced, 
but here again if you replace glucose by fructose you might be able to 
succeed. So, if at the first trial you do not get a corresponding result 
you then have to play a little bit around with the method and you might 
also use other energy sources like pyruvate for example. Pyruvate is also 
a very good compound which you can use as energy source and which does not 
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interfere with the uptake of glucosamine. And if glucosamine does not 
work you might use or try other amino sugars. With 2-dioxyglucose, I 
should mention you get a very similar effect. It is a dogma that 2-dioxy 
glucose is not further metabolized than to the level of the 6-phosphate. 
Cori and others have published this already several years ago and people 
are using 2-dioxy glucose as a probe to study transport. But we found that 
we can deplete the UTP and we get all the activated 2-dioxy glucose inter-
mediates in our cells in large quantities. 
95 
STRUCTURE AND SYNTHESIS OF INFECTIOUS PANCREATIC NECROSIS 
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ABSTRACT 
Data are presented concerning the structure of IPN 
virus genome, the kinetics of both single-stranded and double-stranded virus-
directed RNA s,ynthesis in infected FHM cells, and the effect of temperature 
on virus replication and virus-directed RNA formation. 
The IPN virus RNA was found to be double-stranded ace>-o 
ording to several physico-chemical characteristics, namely : resistance to 
pancreatic RNase, low density in Cs2so4(1.616) 1 sharp melting curve with 
a Tm of 89°C in hypotonic buffer, and base composition. By gel electro-
phoresis, the virus RNA was resolved into three peaks corresponding to 
double-stranded molecules with mol. weights ranging from 2.85x.106 to 2.55x 
106• 
In FHM cells (temperature optima : 34°C) the optimal 
temperature for virus replication was found to be close to 20°C. IPN virus 
replication in FHM cells was unaffected by 0.5 ug Actinomycin per ml., 
a concentration Which reduces the amount of host-cell RNA synthesis to neg-
ligible levels within 5 hours. Under these conditions of selective inhibi-
tion, the s,ynthesis of virus--directed single-stranded and double-stranded 
RNA was first detected 5 hours post infection. Maximum amounts of total 
RNA were found at 16 hours after infection. On further incubation these 
amounts decreased, suggesting that a degradation process, affecting most 
probably the viral messenger RNA, prevails from this time over any further 
synthesis. By 16 hours post-infection, the amounts of double-stranded 
molecules had also reached a maximum, representing about 2o% of total RNA. 
We noticed that there was a strict temporal relationship between virion 
synthesis and double-stranded RNA formation. 
When infected cells were maintained at 20°C for three 
hours and then shifted to supraoptimal temperatures (24°C 1 26°C1 28°C) 
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it was found that virus multiplication was inhibited by 15% after a shift 
to 24°C and by 8o% after a shift to 26°C. A shift to 28°C effected a com-
plete block in virus multiplication. As co"ld be expected, the overall 
virus-directed RNA synthesis after shifting the cells to 24°C 1 was not sig-
nificantly affected. At 26°C the apparent rate of synthesis was consider-
ably reduced, and at 28°C no virus directed RNA synthesis could be detected. 
When infected cells were shifted to 28°C at different 
times after infection, virus directed RNA synthesis was either apparently 
suppressed without delay (late shifts) or slightly enhanced during a space 
of time and then supressed (early shifts), suggesting that some chain term-
inatio~ may occur even at 28°C. At 20°C and at 28°C we noticed that the rate 
of degradation of single-stranded RNA was very much the same. Therefore, 
it seems reasonable to assume that supraoptimal temperatures affect direct-
ly the mechanisms involved in viral RNA transcription and replication. 
INTRODUCTION 
Infectious pancreatic necrosis virus is the etiologic 
agent of an acute disease which may cause high mortality specifically among 
yotmg salmonid fishes (WOLF et QUIMBY 1967 ; WOLF et al. 1960). Although 
the classification of the virus has been a matter of controversy (MALSBER-
GER et CERINI 1963 ; ARGOT 1969 ; NICHOLSON 1971 ; KELLY et LOH 1972), 
data have accumulated which indicate that the virus may well be classified 
among reolike viruses, specially because of double-strandedness and segmen-
tation of its RNA genome (COHEN et al. 1973), size, symetry and structure 
of the capsid (COHEN et SCHERRER 1972) and cytoplasmic site of replication 
(MOSS et GRAVELL 1969). 
A few studies have already been published concerning the 
multiplication of IPN virus in fish cell cultures (MALSBERGER et CERINI 
1965, MOSS et GRAVELL 1969). Therefore, the main characteristics of the 
viral growth-cycle are at present known. However, the biochemistry of 
virus replication is still tmknown although some attempts have been made 
to analyse the synthesis of viral RNA (NICHOLSON 1971) or viral proteins 
(PIPER et al. 1973) in the infected cells. 
In our laboratory we have focused our attention since 
a couple of years on the effects of temperature on virus replication since 
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the elucidation of a viral thermosensitive step can supply much information 
on the mode of IPN replication and especially on the nature of the virus-
cell interactions. The IPN-FHM system exhibits the following particularity: 
the temperature at Which virus synthesis is completely shut off, i.e. 28°c, 
is a perfectly normal temperature for cell metabolism, since we usually grow 
FHM cells at 28°C. Such a situation is rarely encountered in homeothermic 
systems Where non permissive temperatures for the viruses are usually supra-
optimal for the host-cells (ZEBOVITZ and BROWN, 1967). This study should 
provide us with some preliminary data for subsequent work on interferon 
induction by IPN virus in FHM cells. Indeed we already know that IPN virus 
is a good int·erferon inducer not only at permissive temperatures but also 
at non permissive temperatures i.e. at 28°C, 30°C or 34°c (SCHERRER et al. 
1974). Knowing the mechanism by Which temperature shuts off virus multi-
plication would enable us to determine Which viral structure (or Which 
viral function) is sufficient to trigger interferon synthesis in the infec-
ted cell. 
In the present work we intend to recall first some data 
obtained in our laboratory concerning the structure of the viral genome ; 
concerning the effect of temperature on IPN virus multiplication, the study 
presented here is still in progress and the results thus far obtained permit 
us to elaborate some interesting hypothesis. 
RESULTS 
A - Propsrties of the virus RNA 
Viral RNA labelled with 32P or 14c was extracted from 
purified virus by phenol-SDS (MONTAGNIER 1968 ; HAREL et MONTAGNIER 1971) 
and analysed using a variety of different techniques. All the results ob-
tained in our laboratory (COHEN et al. 1973) indicate that the viral genome 
is double-stranded and that it may consist of a single size-group of RNA 
segments having a mol. Wt. ranging from 2.85 x 106 to 2.55 x 106• 
a) Reaistance to h.ydrolysis by RNase. 
Resistance of the virus RNA to lzy!drolysis by pancreatic 
RNase A has been tested by meaauring the amount of nucleic acid rendered 
soluble after treatment with the enzyme, in different buffers. It is shown 
in table I that, at a molari ty greater than 0.1 SSC 14c labelled virus-RNA 
is resistant to hydrolysis, but at lower molarities (0.1 ssc or 0.01 ssc) 
the RNA becomes highly susceptible to the enzyme. It is also shown in 
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table I that, at low ionic strength (10-2 M-tris Hcl, pH 7.4) the resistance 
of IPN RNA is markedly increased by Mg2+. 
b) Melting behaviour. 
To obtain information on the melting behaviour, the 
virus RNA was heated in 0.1 SSC at a given temperature for 10 min. and then 
rapidly cooled in ice. Subsequently the percentage of radioactivity rend-
ered acid soluble, after treatment with pancreatic RNase (10 ~mi. ; 
0.2 M NaCl ; 30 min. ; 37°C) was determined by precipitation with 5% TCA. 
As it is shown if fig. 1 the viral RNA exhibited a sharp melting profile 
with a Tm value of 89°C. Thus, the Tm value for IPN virus RNA is slightly 
higher than that reported for reovirus type 3 (SHATKIN 1965). 
TABLE 1 
RNase susceptibility of IPN virus RNA 
Acid-insoluble 
RNA Buffer radioactivity Hydrolysed 
(ct/min) (%) 
RNA only 1 X SSC 8961 
-
RNA+ RNase (10 y.g/ml) 2 X SSC 8003 11 
RNA+ RNase (10 )l<5/ml) 1 X SSC 6850 24 
RNA+ RNase (10 pg/ml) 0.1 X :JSC 791 91 
RNA+ RNase (10 p.g/ml) 0.01 X SSC 709 92 
RNA only 0.01 M-tris HCl, pH 7•4 2720 
-
RNA+ RNase (10 pg/ml) 0.01 M-tris HCl, pH 7·4 2420 12 
10-~Mg2+ 
RNA+ RNase (10 p.g/ml) 0.01 M-tris HCl, pH 7•4 20o6 26 
5 x 1 o-4 M-Mg2+ 
RNA+ RNase (10 _pg/ml) 0.01 M-tris HCl, pH 7·4 77 97 
10-4 M-Mg2+ 
Figure 
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Thermal denaturation of IPN RNA. The virus nucleic acid extrac-
ted by phenol-SD5-pronase, resuspended in 15 mM NaCl, 1.5 mM 
sodium citrate, was heated at indicated temperatures for 10 min. 
and then rapidly cooled in ice. The percentage of radioactivity 
rendered acid-soluble after treatment with pancreatic RNase 
(10~ml, 0.2 NaCl, 30 min., 37°C) was determined by precipi-
tation with 5% trichloracetic acid. 
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c) Density in caesium sulfate and sedimentation analysis in sucrose 
gradients 
As determined by equilibrium density gradient centri-
fugation in cs2so4 , the buoyant density of IPN virus RNA was found to be 
1.615 (fig. 2). In a 5% to 2o% sucrose gradient, a single pie of RNA was 
resolved, The sedimentation coefficient was calculated to be close to 14 s, 
using 28 S and 18 S BHK1 s rRNA as markers (fig. 3), Additionally, the dis-
tribution of the label remained unchanged when the sample was reacted in 
1 x SSC with pancreatic RNase A before being applied to the gradient. Under 
the same conditions, the BHK 1 s markers were completely hydrolysed. When 
the digestion was performed in 0,1 or 0.01 SSC the radioactivity ~dE 260 
were found exclusively at the top of the gradient, indicating that virus 
RNA and marker RNA had been hydrolysed. 
d) Base composition 
For analysis of the base composition, virus RNA was 
precipitated with 5% TCA, collected by centrifuging, washed twice with 
ethanol to remove TCA and hydrolysed in 0.3 N-KOH for 18 h. at 37°C. The 
hydrolysate was neutralized with perchloric acid and the ribonucleotides 
separated by two dimensional cellulose thin-layer chromatography (SCHERRER 
et al. 1966). Table II presents the results concerning the base composi-
tion of total virus RNA (whole virus) as well as RNA obtained after banding 
in sucrose gradients. The results indicate a perfect base pairing with 
A/U and G/C equal to 1. 
e) Polyacrylamide gels electrophoresis of virus RNA 
Electrophoresis of 32P virus RNA in 5% acrylamide gels 
for 17 h.to 20 h. revealed two closely positionned bands located close to 
the position occupied by the L cl&ss of reovirus RNA (fig. 4). By electro-
phoresis in 2.5% acrylamide a third intermediate peak could be resolved. 
Using reovirus type 3 RNA as mol. weight standard, the 
estimated mol. weight of IPN RNA segments was found to be in the range of 
2.85 x 106 (segment I) to 2.55 x 106 (segment III). These values are ob-
tained either with virus solubilized in urea-SDS or with virus RNA extrac-
ted by phenol. 
Evidence was also obtianed that, RNA which had denatured 
by heating at 100°C in 0.1.SSC and quick cooling, migrated about twice 
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Figure 2 Isopycnic sedimentation in caesium sulfate of RNA extracted from 
purified virus. Centrifugation was continued for 2 days in the 
Spinco SW 65 rotor at 401 000 rev/min. Density was determined by 
measuring the refractive index. The arrow indicates the position 
of ~ ribosomal RNA used as a marker. 
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Figure 3 Sedimentation pattern of IPN RNA. 14(}-uridine-labelled RNA 
extracted by phenol-SD8-pronase1 resuspended in 150 mM NaC1 1 
15 mM sodium citrate (A and B) or in 15 mM NaC1 1 1.5 mM Sodium 
ci trate (c), was layered on to 5%-2<1% sucrose gradient and cent-
rifuged for 17 hours at a 241 000 rev/min. in the Spinco SW 25 
rotor. BHK ribosomal RNA was used as a marker. 
A : before treatment with pancreatic RNase 
B and C : after treatment with pancreatic RNase ( 10 pg/ml 1 30 min. 
at 37°C) - 14c count E260 
RNA source 
IPN Virus (whole virus) ( 1) 
IPN Virus (sucrose ~adient 
purified RNA) (2 
Reovirus 3 (whole virus} ( 3) 
Reovirus 3 (sucrose gradient 
purified RNA) (4) 
Table 2 Nucleotide composition of IPN virus RNA 
14s 
( 1 ) 
g~ 
(4) 
32P activity (%) Aju G/C 
A u G c 
24.1 .! 0.8 22.4 .! 0.1 26.2 .! 0.9 27.2:!: 0.7 1.07 0.96 
23.5 .! 0.6 23.5 .! 0.4 27.0.! 0.4 26.0 .! 0.8 1.00 1.04 
34.8 .! 0-3 23.0 .! 0-3 21.8 .! 0.6 20.4 .! 0.4 1.48 1.04 
27.2.! 0.4 26.5.! 0.8 22.8 .! o. 7 23.4 :!: 0.2 1.03 0.97 
Six determinations on a single sample of IPN virus 
Nine determinations on two separately produced samples of IPN virus 
Five determinations on a single sample of virus 
Four determinations on a single sample of virus 
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Figure 4 Electrophoregram of 32P- labelled IPl'J virus RNA (-o), and 
14c- labelled reovirus RNA (o-- o); 2.5% gel, 20 h migration 
from left to right (anode). The RNA of the two viruses was 
extracted by the urea-SDS method. Polyacrylamide gel electro-
phoresis was performed by the method of LOENING (1967). 
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as quickly as the native RNA and showed the same peak pattern although the 
peaks were broader. 
B - Effect of temperature on yirus replication and virus-directed RNA 
gm thesis 
All the experiments reported here were performed in FHM 
cells, an established cell-line from a cyprinid fish : the Fathead Minnow 
(GRAVELL and MALSBERGER 1965). These cells grow optimally between 28°c 
and 34°C1 but they can be perfectly maintained at temperatures as low as 
15°C. At 20°C1 their multiplication is very slow but effective. 
IPN virus multiplies to high titers in FHM cells bet-
ween 15°C and 26°C ; but at 28°C and above, one does not detect any multi-
plication. 
I- IPN virus multiplication at 20°C 
a) Infectivity 
Fig. 5 represents a typical one-step growth curve of 
IPN virus at 20°C ; once the virus had been absorbed, infected cells were 
maintained in suspension throughout the experiment. It should be pointed 
out that this same curve could be obtained in cells that were infected and 
incubated in monolayers. In all instances, new virus formation was first 
detected at 4-5 hours after infection, and maximum virus yields were obtai-
ned 10-15 hours after infection. 
b) Viral RNA gynthesis 
IPN virus infection does not inhibit host-cell RNA 
synthesis during the first 7-8 hours after infection (unpublished data). 
In a preliminary experiment we tested the effect of Actino~cin D on FHM 
cells to determine the lowest concentration that could markedly inhibit 
14-C Uridine uptake by non infected cells. Fig. 6 shows that the cellular 
uptake was completely shut off 4 hours after the addition of 0.5pg of 
Actino~cin D per ml. At that concentration, 24 hours virus yields were 
reduced by 4o% to 6o%. A concentration of 0.5 pg of Actino~cin D per ml. 
was used in all subsequent experiments aimed to analyse specifically virus-
directed RNA synthesis. In such experiments, 14o-Uridine was added to the 
cells 3 hours after Actino~cin D1 in order to minimize the level of lab-
elled cellular RNA. 
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Figure 5 IPN virus growth curve in FHM cells at 20°C. FHM cells are 
infected in monolayer with IPN virus at a multiplicity of 1 0 PFU/ 
cell. After a 45 min adsorption, cells are washed twice with 
fresh Eagle's Minimum Essential Medium (MEM, Stocker's modifica-
tion). Infected cells are then trypsinized and washed by two 
centrifUgations in MEM and finally suspended in MEM supplemented 
with 0.3% tryptose phosphate and 4% foetal calf serum. Cells 
are adjusted at 2.106 oells/ml 1 and incubated at 20°C in precise-
ly regulated water-bath. 0.2 m1 aliquotes of the suspension are 
collected at intervals and titrated after two cycles of freezing 
and thawing. 
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Figure 6 : Effect of different concentrations of Actinomycin D on 14o-uri-
dine uptake by FHM cells at 20°C. 24 hours-old FHM monolayers 
are trypsinized, washed and suspended as above in MEM containing 
the indicated concentrations of Actinomycin D. At zero time, 
0.1 uCi/ml of 14o-uridine was added. Every hour 0.2 ml of the 
/ 
suspension is precipitated by 5% cold Trichloracetic acid. The 
precipitate is washed, dried and counted on a Liquid scientilla-
tion counter (Intertechnique). 
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Kinetics of total and RNase resistant IPN RNA synthesis in FHM 
cells (20°). Cells are infected as above. The medium contains 
0.5)lg of Actinomycin D per ml. 2 hours after the addition of 
Actinomycin D, 14c-uridine is added at a concentration of 2 ~Ci/ 
ml. Total RNA synthesis is evaluated by counting the total 
radioactivity of 0,2 ml aliquotes after precipitation by 5% TCA. 
Duplicate samples are made for determination of RNase-resistant 
RNA : RNA is extracted with phenol-SD&-pronase, and precipitated 
with 5% TCA after or before treatment with pancreatic RNase 
(10,.ug,/ml, 30' at 37°C) in 300 mM NaCl 30 mM sodium citrate pH 
7, 4 buffer. 
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Fig. 7 shows the time-course of 14o-uridine uptake by 
infected cells into TCA-precipitable material : total RNA on one hand, 
RNase-resistant RNA on the other hand. The results clearly show that only 
a fraction of total RNA is RNase-resistant (25% at the 15th hour) ; there-
fore the curve for total RNA represents mainly the synthesis of single-stran-
ded, and probably messenger RNA. 
Maximum amounts of total RNA were found at 16 hours 
after infection. On further incubation these amounts diminished, suggest-
ing that a degradation process, affecting most probably the viral messenger 
RNA1 prevails from this time over any further synthesis. 
Now, if one considers double-stranded RNA synthesis, 
we observe that the curve is in good correlation with the time course of 
virion synthesis (fig. 5) ; this might indicate that newly formed double-
stranded RNA is rapidly coated into virions. 
II - Effect of supra-optimal temperatures 
a) Infectivity 
We first studied IPN growth-curves in a range of temp-
eratures comprised between 20°C and 28°C (fig. 8). We would like to empha-
size that, in all instances, the cells were infected and maintained at 20°C 
during 3 hours before being shifted to different supra-optimal temperatures. 
Under these conditions reproducible results were obtained. Two main impor-
tant facts may be retained : 
there is a sharp decrease in the virus yield 
around 27° c. 
there is no detectable virus production at 28°C. 
If we let the yield at 20°C be 10o%1 the following 
comparative figures are obtained : 73% (24°C), 47% (25°0) 1 22% (26°C) 1 
1% (27°C) and o% (28°C). 
In figure 9 we plotted these percentages against corres-
ponding temperatures the abrupt drop in virus yield between 26°C and 
28°C is very clear ; this sharp slope suggests that only one limiting fac-
tor might be responsible for IPN virus thermosensitivity. 
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Figure 8 Influence of incubation temperature on IPN virus multiplication 
in FHM cells. The experimental procedure is the same as above 
(see legend to fig. 5) ; all manipulations during the first three 
hours are carried out at a strictly controlled temperature of 
20°C. At 3 hours post-infection suspended infected cells are 
divided into 6 different flasks for further incubation at the 
indicated temperatures. 
Figure 9 
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IPN virus yield at supraoptimal temperatures as compared to 20°C. 
The figures obtained in the experiment shown in fig. 8 have been 
expressed in per cent of the yield at 20°C, and plotted against 
the corresponding temperatures. 
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Before going further, let us come back to the experi-
mental procedure shown in fig. 8 : starting the growth cycle at 20°C for 
3 hours turned out to be a necessary condition for the reproducibility of 
the results.All procedures including virus adsorbtion on monolayers, wash-
ings, trypsinization, resuspension of the cells and beginning of the incu-
bation were carried out at 20°C, In any other condition where the initia-
tion of infection did not proceed at this controlled temperature, we obser-
ved that comparative yields as a function of temperature were variable, 
particularly in the range of 25°C - 27°C ; at 26°C, for instance, virus 
yields ranged between 2o% and less than 1% as compared to 20°C. At 28°C, 
however, virus multiplication was always completely shut off, 
This might indicate that the thermosensitive function 
is expressed very early in the replicative cycle, 
b) Viral RNA synthesis 
It seemed of interest to determine whether virus RNA 
synthesis was, or not, directly affected by supra-optimal temperatures. 
Therefore, we measured the uptake of 14c Uridine in infected cells at 20°C, 
24°C, 26°C and 28°C (fig. 10 A and B) ; the conditions used for infection 
and incubation were the same as those used in the above infectivity experi-
ments (fig. 8) in that infected cells were kept at 20°C during the first 
3 hours post-infection, Taking into account the amount of label in non-
infected cells (fig. 10 B), we calculated the percentages of total RNA 
synthesized at each temperature as compared to 20°C ; here we got 
77% (24°C), 17% (26°C) , o% (28°C), 
These results indicate that virus-directed RNA synthe-
sis is inhibited by supra-optimal temperatures to the same extent as virus 
particles synthesis. Hence, it becomes clear that viral RNA transcription 
is very likely involved in the thermosensitivity of IPN virus. 
III - Temperature-shift experiment~ 
We can reasonnably assume that the increasing virus-
yield inhibition that we observe when temperatures increases reflects the 
progressive alteration of a same function, Since this effect was complete 
at 28°C , we chose 28°C as the restrictive temperature to carry out 
10 
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HOURS AFTER INFECTION 
IPN virus-directed RNA synthesis as affected by supraoptimal 
temperatures. Infection and incubation of infected cells are 
processed as previously (see legend to fig. 8) ; at 3 hours 
post-infection, the suspended cells are shifted at the indica-
ted temperatures. At intervals the amount of total RNA is 
measured by counting the radioactivity incorporated into TCA-
precipitable material. Panel A : 14c label in infected cells 
panel B : 14c label in mock-infected cells. 
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temperature-shift experiments, Where either infectivity, or RNA synthesis 
was followed. 
a) Infectivity 
Shift-down experiments (28°C to 20°C) 
Table 3 shows the result of a typical experiment in 
Which cells which had been infected and incubated at 28°C were shifted to 
20°C at different times after infection. Virus yields were titrated by 
24 hours after infection. The results indicate that, at least, during the 
early steps of the growth cycle, the temperature-dependent inhibition is 
perfectly reversible ; it is remarkable that slightly higher 24 hours-yields 
are found for those samples Which were shifted at 1 and 2 hours after infec-
tion ; this small but quite reproductible difference may probably result 
from a better adsorbtion and/or penetration of the virus at 28°C as compared 
to 20°C. 
Fig 11 shows some more details concerning the reversi-
bility of the 28°C inhibition : here we shifted the infected cells from 
28°C to 20°C at 6 hours after infection and we measured by infectivity ass~ 
the time at Which newly synthesized virus began to appear (Actino~cin D 
was added to avoid any inhibiting or delaying effect due to interferon). 
It is seen that after the shift a latent period of about 4 hours ensues 
before virus growth starts, as for the control curve at 20°C. We also not-
ice that the slope of the curve after the shift is nearly the same as that 
of the control. Therefore it seems that at 28°C virus development is block-
ed at some very early step. We know that this step is neither adsorption, 
nor penetration since IPN virus can induce interferon very efficiently at 
28°C. 
- Shift-up experiments (20°C to 28°C) 
Fig. 12 shows the results of experiments where infected 
cells had been shifted from 20°C to 28°C at different times between 1 and 
6 hours after infection. It is clearly seen that a shift to 28°C effects 
a sudden arrest in virions synthesis since the infectious titer at 20 hours 
post-infection is the same as that found at the time of transfer. It is 
important to notice that IPN virus is quite stable when exposed to 28°C 
during 24 hours or even more ; so, the thermosensitive function, if it is 
unic, is required as well for the very early steps of infection, as for 
Sample 
2 
3 
4 
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TABLE 3 
Reversibility of the 28°G-inhibition in the early steps of 
infection. The nuroero of each sample is the time at 'Which 
infected cells have been shifted from 28°C to 20°C. 
inf. titer at the inf. titer 
time of transfer 20 hrs 
PFU/ml PFU/ml 
4 4:• 10 7 4o2x 10 
3.3x10 4 3o2x 107 
4 4·5 y10 2 y 107 
4 3· 5 y1 0 1.4x107 
Control (20°C) 2.4 X 107 
at 
Figure 11 
' 10 
...... 
"' .. .. . 
10 
5 
10 
116 
10 11 12 
HOURS AFTER INFECTION 
Shift-down experiment from 28°C to 20°C : virus yield. 
The arrow indicates the moment at which shift was made. 
e---e Control virus yield in infected cells at 20°C. 
o---o Virus yield in infected cells shifted 6 hours after 
infection. 
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HOURS AFTER INFECTION 
Figure 12 Shift-up experiment from 20°C to 28°C : Virus yield. 
During an usual one step growth cycle at 20°C (.___•) samples 
of infected cells are transfered to 28°c every hour up to the 
6th hour after infection. At the 20th hour, virus yields are 
titrated ( o ). 
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the continuation of the exponential growth. 
Finally, we examined the fate of virus-directed RNA syn-
thesis following temperature-shifts from 20°C to 28°c. Fig. 13 shows that 
the control curve at 20°C is identical to that of Fig. 3 ; at the times 
indicated by arrows, 3 ml aliquots of the suspended infected cells were 
transferred to 28°C and the amount of TCA-precipitable radioactive material 
was determined : when the cells are shifted before the 10th hour, it is 
clear that RNA synthesis goes on during a space of time ; moreover we notice 
a slight increase in the rate of RNA synthesis for about 30 minutes ; then 
RNA synthesis ceases abruptly and a very quick degradation process takes 
place. After 9 or 10 hours after infection, shifts are immediately follow-
ed by a severe reduction in the amount of TCA-precipitable material. 
DISCUSSION 
A - Structure of the genome 
All the results obtained in our laboratory lead to the 
conclusion that the bulk of IPN virus RNA is double-stranded. Such a con-
clusion would agree with results obtained previously by ARGOT (1969) ; 
MOSS et GRAVELL (1969); SCHERRER et COHEN (1971) 1 but is in contrast to 
NICHOLSON (1971) and KELLY et LOH (1972). We are inclined to think that 
the different results could be accounted for either by a difference in the 
method used to extract the viral RNA (hot-phenol method by KELLY et LOH 
without reextraction of the interphase) or by contamination with cellular 
RNA. In fact it is known that for some multicomponent nucleic-acid ~stems, 
selective trapping of nucleic acid may occur in the protein layer and thus 
the isolated nucleic acid may not be representative of the composition 
that existed in the virion (DIENER et SCHNEIDER, 1968). During our studies 
we noticed that an important part of the viral RNA is indeed trapped in the 
interphase and that a successful recovery of this RNA could be achieved 
when the protein was treated with pronase. In our hands, virus RNA ext:r-
acted by the cold phenol-SD3-pronase method was relatively resistant to 
pancreatic RNase since the percentage of hydrolysis in 1 x SSC buffer never 
exceeded 40%• Additionally we found that the total yield of viral RNA was 
better at low temperature than high temperature. 
Sucrose gradient analysis of the virus RNA indicate 
that the bulk of the viral genome is double-stranded since it is resistant 
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Figure 13 Shift-up experiment from 20°C to 28°C : Virus directed RNA s.yn-
thesis. For the experimental procedure, see legend to figure 
7• At the moments indicated by arrows, 3 ml aliquotes of inf-
ected cells are shifted to 28°C, and the amount of TCA precipi-
table 14c-labelled material is determined. Control curve at 
20°C C.······~) ; curves after shifts to 28°C (o--o). 
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to hydrolysis by pancreatic RNase in 1 x SSC buffer. However we always 
noticed a slight increase in the proportion of the radioactivity found at 
the top of the gradient after treatment with RNase ; this may indicate that 
a single-stranded component is also present within the virion. 
Polyacrylamide gel electrophoresis indicate that the 
virus RNA consists of a single size group of RNA segments having a mol. Wt. 
6 6 between 2.9 x 10 and 2.5 x 10 • Although the peaks are rather broad in 
comparison to the reovirus RNA's (SHATKIN, SIPE et LOH 1 1968) 1 the size 
distribution of the segments does not seem to be a random distribution 
suggesting a fragmentation of a single molecule. 
B - Effect of temperature on virus replication and virus-directed RNA 
synthesis 
We have shown that in FHM cells, the virus yield drops 
abruptly between 26°C and 28°C (fig. 8 and fig. 9), and ·we also demonstra-
ted that this virus yield inhibition could be correlated with a decrease 
in viral RNA synthesis (fig. 10 A and B). Single-stranded RNA seems to be 
primarily involved in this process. 
We demonstrated that the thermosensitive event must 
involve a very early step in virus growth, since as long as infected cells 
were maintained at 28°C1 neither virus formation, nor viral RNA s,ynthesis 
could be detected (fig. 11). Moreover, we showed that the temperature-
inhibition process was perfectly reversible, at least up to the 6th hour 
of the growth cycle (table 3 and fig. 11). 
Temperature shift-up experiments showed that during a 
virus growth cycle at 20°C, any shift to 28°C immediately abolishes the 
synthesis of new virions (fig. 12). On the other hand, the RNA-synthesis 
pattern appeared to be more complex (fig. 13) : up to the 1oth hour after 
infection shifting the cells from 20°C to 28°C resulted in a RNA stimula-
' tion during about 30 1 followed by a rapid breakdown of labelled material. 
We first thought that such a stimulation coulc'!. be due 
to chain termination by an enzyme which is unable to reinitiate transcrip-
tion at 28°C. This hypothesis must reasonnably be ruled out because the 
time necessary to transcribe an IP~RNA molecule should be far less. 
121 
We know (SHEHEL and JOKLIK, 1969) that in Reovirus, the largest piece of 
RNA which corresponds roughly in size to the IPN RNA pieces is transcribed 
by Reovirus-associated transcriptase in 8 minutes. 
In our opinion, the stimulation would rather result 
from a two-step process in IPN RNA transcription : only the first step would 
be thermosensitive, the second step being allowed to go on as long as pro-
ducts from the first step are present. As far as comparison with Reovirus 
is possible, the first step might be the transcription of "plus" strands 
from parental double-stranded RNA, and the second the replication of "plus" 
strands into progeny double-stranded RNA (SCHONBERG et al., 1971 ; SAKUMA 
and WATANABE, 1971 ). 
When we started this work we had two important quest-
ions in mind : first, is the thermosensitivity an instrinsic property of 
IPN virus, or is it dependent on FHM cells ? Secondly, is there more than 
one thermosensitive step involved? The question of intrinsic thermosensi-
tivi ty was primary in our search due to our inability to isolate a "hot" 
mutant. In neither non-treated IPN virus, nor mutagenized stocks (utili-
zing nitrous acid, hydroxy-lamin, or Proflavin) could we isolate a virus 
able to overcome the 28°C inhibition (unpublished results)? 
Our results to the first question came from experiments 
carried out with other cell lines in which IPN virus grows perfectly well: 
EPC cells (Epithelioma Papulosum Carpio) and BB cells (Brown Bull-head), 
(MALSBERGER 1966). We observed that the pattern of IPN virus inhibition by 
temperature was nearly the same in these two different cell lines as in FHM 
cells ; thus at 28°C there was no viral multiplication at all, while either 
cell, like FHM cells grows optimally at 28°C. These observations favor the 
assumption that supraoptimal temperatures directly affect viral functions. 
Now can we answer the question : is there only one viral 
function involved ? If so, what is this function ? 
Until now, all data can be explained assuming that only 
one thermosensitive function is involved : this function, very likely to 
be one of transcription, plays a role at all steps during virus infection: 
indeed the results of fig. 8 and fig. 9 indicate that this function is 
necessary throughout the exponential growth period. On the other hand 
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shift-down experiments (fig. 7) show that it is also required at a very 
early time after infection. 
The existence of a IPN virus-associated transcriptase 
has not yet been shown. If such an enzyme is found it will be of interest 
to verify whether or not its activity is restricted at 28°C and above. 
12!3 
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Dr. Scholtissek 
particles ? 
Dr. Scherrer : 
DISCUSSION 
Did you find any replicase activity with your virus 
This was not found until now. In fact we tried to de-
tact a polymerase associated with the virions but our attempts were unsuccess-
ful until now. Perhaps we do not possess the best technique to activate 
the enzyme. Occasionnally we must use the methods Which have been success-
ful in the case of reovirus, namely by heating the virions under various 
conditions or by treating the virus particles with chymotrypsin or trypsin. 
Dr. Rott Is polymerase active at 28°C ? 
Dr. Scherrer : I think so because RNA synthesis continues during a 
space of time after a shift to 28°C. 
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Dr. Rott : Only the RNA s,ynthesis but not the polymerase activity. 
The question is : do you have a RNA polymerase activity at this high temp-
erature ? 
Dr. Scherrer : We must say that RNA appears after a shift to 28°C and 
so we can conclude that probably the RNA polymerase activity mus~ be found 
at this temperature. 
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REPLICATION AND TRANSLATION OF 
FOO'll-AND-MOUTH DISEASE VIRUS RIBONUCLEIC ACID 
by 
Howard L. Bachrach 
Plum Island Animal Disease Center 
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GREENPORT, NEW YORK 11944, U.S.A • 
.ABS'l'RAOT 
The replication and translation of foot-and-mouth dis-
ease virus (FMDV) ribonucleic acid (RNA) have been studied in cultures of 
baby hamster kidney (BHK) cells and in cell-free systems. A virus-specific 
RNA polymerase is formed, Which catalyzes the replication of both double-
and single-stranded FMDV RNA. After its isolation from cells,the polymerase 
is still active in synthesizing FMDV RNAs in a suitable cell-free system, 
and this activity is inhibited by antibody from convalescent animals. 
The crude polymerase is resolved in sucrose gradients into fractions with 
differing activities : a 2D-70 S fraction that synthesizes 20 S double-
stranded RNA and a 10Q-300 S RNA that synthesizes 37 S viral RNA. 
The translation of FMDV RNA has also been studied 
,!!l ~ and in a cell-free system. As has been firmly established for sev-
eral picorna viruses, the translation of FMDV RNA in cells produces large 
molecular weight precursor proteins that are cleaved into smaller capsid 
and noncapsid proteins. Most of the cleavage products of FMDV protein are 
analogous in molecular weight and molar ratio to those of other picorn&-
viruses, indicating a similarity in genetic maps. One of the major non-
capsid proteins NCVP5 (57,000 daltons) appears to be a component of FMDV 
RNA polymerase. The three major capsid proteins VP1, VP2, and VP3 have 
different amino acid compositions as well as different sequences of amino 
acids at their carboxyl terminal ends. Finally, a protein synthesis-initi-
ating factor (I factor) isolated from infected cells promotes the synthesis 
of precursor-like protein in a cell-free system programmed with FMDV RNA. 
INTRODUCTION 
Investigations on the molecular biology of foot-and-
mouth disease (FMD) are providing knowledge[ 1J that may lead to new me&-
sures for controlling the disease. Information has already accrued Which 
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indicates quite conclusively that the molecular events in FMDV multiplica-
tion are analogous to those for several other mammalian picornaviruses 1 
e.g., poliovirus, encephalomycarditis (EMC) virus, human rhinovirus (HRV) 1 
and mengovirusL2J. This conclusion is not unexpected because these viruses 
are classified together on the basis of similarities in size, structure, 
content of protein and ribonucleic acid (RNA), and other characteristics 
l3J· None has a demonstrable constituitive enzyme, but each contains enough 
RNA (2.6 x 106 daltons) to code for 2201 000 to 2601 000 daltons of protein, 
most of which has been accounted for in their stable translation products. 
There is enough information for about five functions: the known viral pro-
teins, two RNApolymera•e factors, a postulated but as yet unidentified 
host-synthesis repressor [2 14J 1 and a possible maturation factor L4J. 
The picornavirus capsid and noncapsid proteins and virus-specified RNA poly-
merase(s) have been the objects of intensive investigation and characteri-
zation. The purpose of the present paper is to review the progress which 
has been made, principally that by workers in the author's group, toward 
elucidating the molecular events in the replication and translation of 
FMDV RNA. Comparisons are made with results reported by others on related 
picornavirus diseases. 
REPRESSION OF HOST CELL SYNTHESIS 
Before replication and translation of FMDV RNA can 
begin, the virus must interfere with certain host processes that need to be 
supressed or redirected into viral multiplication pathways. The impairment 
of host cell protein and RNA synthesis by virus infection is well known 
for several small RNA viruses l2J. With foot-and-mouth disease virus 
(Type A12 ) infection of baby hamster kidney (BHK) cells (passage 21 1 clone 
13) 1 protein synthesis inhibition exceeds RNA synthesis inhibition through-
out the infectious cycle [5). Early in infection (90 minutes postinfection 
[P~) and at peak virus production (300 minutes PI), protein synthesis is 
inhibited approximately 50 and Bo%, respectively. By contrast, host cell 
RNA synthesis inhibition at 90 minutes PI is only 2o%; this inhibition in-
creases to 5o% at 300 minutes PI concomitant with the loss of 45 S riboso-
mal precursor RNA and appearance of 37 S viral RNA. 
Although protein and RNA inhibition are substantial, the 
most pronounced early inhibition of host cell metabolism detected after 
FMDV infection is the interruption of RNA methylationL6 1 7 1 8J. Thus, methy-
lation of 45 S precursor ribosomal RNA is inhibited by 5o% at 60 minutes PI 
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and leads to the disappearance of ribosomal precursor particles in the nuo-
leus. Apparently this methylation inhibition, which interrupts the process-
ing of 45 S RNA into ribosomal RNA, may, in part, be responsible for the 
observed decrease in extractable polysomes at 150 minutes PI, thus enhancing 
host protein synthesis inhibition. However, by 180 minutes PI, a >400 S 
class of viral-specific polysomes (actinomycin D-insensitive) has formed; 
these contain nearly 8o% of the radioactive amino acids incorporated during 
a 2-minute ,ir! !i!2. pulse. 
Methylation of transfer RNA (tRNA) is also inhibited. 
Met~ylation of tRNA which is depressed by 3o% at 60 minutes PI is restimu-
lated so that it approaches the normal level at 120-150 minutes, followed 
by a rapid decline thereafter to a 6o% inhibition at 240 minutes PI. The 
period of restimulated tRNA methylation just precedes the appearance of 
maximal amounts of viral-specific RNA polymerase(s) (210 minutes PI) and 
may be associated with their synthesis. 
REPLICATION OF FMDV RNA 
In vivo FMDV RNA Synthesis: 
The replication of most small RNA animal viruses occurs 
in the cytoplasm of cells. With FMDV infection, this conclusion is based 
on the distribution within BHK subcellular fractions of ~-uridine pulse-
labeled virus-specific RNA as well as of FMDV-induced RNA polymerase acti-
vity \:.91. Foot-and-mouth disease virus-specific RNA is defined as RNA 
synthesized in the infected cell in the presence of 5 ~/ml of actinomycin 
D, which inhibits DNA-dependent host-cell RNA synthesis by 95-98%. Three 
FMDV-specific RNAs are resolved on sucrose gradients: 37 S single-stranded 
viral RNA, 20 S ribonuclease-resistant double-stranded RNA, and heterogen-
eous RNA in the 20-70 S region of the gradient (Fig. 1A). The ratio of 
20 S double-stranded RNA to 37 S single-stranded RNA increases during the 
replication cycle, and both are infectious (Fig. 1B). The rate of virus-
specific RNA synthesis is highest at 300 minutes PI, coincident with the 
time of maximum virus production. 
The ,ir! !i!2. synthesis of FMDV RNA is inhibited by guani-
dine added at 200~g/ml [10]. The mechanism of this inhibition remains 
obscure; in polio infections, the guanidine marker maps in the coat protein 
region [ 4 J , indicating that viral RNA synthesis is in some manner dependent 
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Tube Number 
Sucrose gradient analysis of FMDV-specific RNA 5 hours after in-
fection of BHK cells with type A12 virus in the presence of acti-
nomycin D. The RNA was extracted with 1% sodium dodecylsulfate 
(SDS) at pH 5.1. A) Infected cells were pulsed with ~uridine 
for 15 minutes before harvest. Aliquots of each gradient frao-
tion were incubated with and without RNase, and the trichlora.-
cetic acid insoluble radioactivity was measured; B) Infected 
cells were pulsed with ~uridine for 1 or 30 minutes before oell 
harvest, RNA extraction, and gradient centrifugation. Adapted 
from [ 12]. 
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upon the cleavage or conformation of the virion proteins. 
Cell-Free F.MDV Synthesis: 
An RNA-dependent RNA polymerase that is active in the 
cell-free s,ynthesis of virus-specific RNA can be obtained from F.MDV-infeo-
ted BHK cells but not from normal cells (101 11 1 121 • This polymerase is 
most active when isolated 210 minutes PI. The RNA polymerase is dissocia-
ted from cytoplasmic membranes, but not from its viral-specific RNA temP-
lates, by means of deoxycholate (DOG) with dextran sulfate present as an 
inhibitor of ribonuclease (RNase). The enz.yme is not dependent upon addit-
ional F.MDV RNA template, but it does require the four ribonucleoside tri-
++ phosphates, phosphoenolpyruvate, pepkinase 1 and Mg • During a 60-minute 
cell-free reaction, the enzyme produces (Fig. 2A) the same three classes of 
virus-specific RNA that are formed ill ~: a 37 S viral RNA 1 20 S double-
stranded RNA 1 and heterogeneous RNA. Polymerase isolated late in infection 
(5 hours PI) produces considerably less 37 S viral RNA and more 20 S double-
stranded RNA (Fig. 2B)[ 9]. 
The cell-free synthesis of FMDV-specific RNA can be 
inhibited in several ways. It is inhibited by Mn++ but is unaffected by 
actinomycin D1 indicating the absence of a host cell DNA-dependent RNA 
polymerase [ 10J • It is also inhibited moderately by polyamines (putrescine) 
spermine)cadaverine) and more strongly by basic polyamine acids or basic 
protein (polylysine 1 polyornithine, polyarginine 1 or salmine)[ 13] • This 
inhibition and the binding between purified FMDV RNA and polyornithine are 
relieved by polyanions (e.g., polyglutamic acid and heparin sulfate) 1 indi-
cating a direct interaction of the basic compounds with the RNA template of 
the polymerase complex. 
It is more significant (see TRANSLATION OF F.MDV RNA) 
that the ill~ synthesis of FNDV-specific RNA can be inhibited by anti-
body to a virus-infection-associated (VIA) antigen that arises in infected 
or convalescent animals but not in animals vaccinated with inactivated 
virus vaccinee [14] (Table 1). The inhibition is cross-type specific; 
type 0 and A antibodies are equally inhibitory to polymerase derived from 
type A infection. No 37 S viral RNA is detected at the end of an antibody-
inhibited reaction; there is only a small peak corresponding to 20 S RNA. 
Controls have shown that the absence of 37 S RNA is not caused by RNase as 
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Figure 2 Sucrose gradient analysis of FMDV-specific RNA from 60-minute, 
cell-free reaction mixtures utilizing FMDV-RNA polymerase that 
had been harvested from BHK cells A) 2.5 hours postinfection 
and B) 5 hours postinfection. The RNA was extracted with SDS 
at pH 5.1. Adapted from[ 9] • 
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TABLE 1 
EFFECT OF AN'I'IBODY ON THE ACTIVITY OF FMDV RNA POLYMERASEa 
ADDITIVE 
NONE ( CONTROL) b 
NORMAL SERUM 
AN'l'ISERUM (INFECTED A) 
" (INFECTED 0 ) 
" 
" 
(INACTIVATED A) 
(INFECTED + VIA Ag)c 
NORMAL 6'- GLOBULIN 
IgG (INFECTED A) 
CPM ~-UTP INCORP./MG PROTEINb 
(% OF OONTROL) 
100 
96 
15 
19 
106 
100 
104 
10 
a) Adapted from [14l: using antibody from guinea pigs and type A poly-
merase. 
b) Ranged from 25,000 to 100,000 CPM for different controls. 
c) Treated antiserum had no residual free antibody to virus-infection-
associated (VIA) antigen. 
a contaminant. These results indicated that FMDV RNA polymerase and VIA 
antigen have a common antigenicity. 
Early in the cell-free reaction (e.g., after 5 minutes), 
its contents, before deproteinization, are distributed in two broad ~rate 
classes, a 20-70 S class and a 100-300 S class, both partly RNase resistant; 
after deproteinization, all the RNA has an a-rate of under 60 S and is partly 
RNase resistant L 15J. After a 30-45 minute cell-free reaction, the 100-
300 S heterogeneous RNA-containing component disappears concomitant with 
a marked slowing or cessation of RNA synthesis. The reaction restarts, 
however, when more of the polymerase-RNA complex is added. These results 
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provide evidence that only those RNA chains that have been initiated ,!a ~ 
are being completed in the cell-free system. It is postulated that the 
100-300 S component represents complexes of polymerase(s) with various size 
classes of replicative intermediate structures analogous to those reported 
for bacteriophage R17 RNA synthesis L16J. Electr•n micrographs of the 
R17 replicative intermediates were described as containing single to triple 
branched RNA structures, the branches representing growing RNA strands. 
Evidence for two polymerase activities in FMD has been 
obtained by resolving the DOG-treated polymerase-RNA complex on a sucrose 
gradient into three fractions that have differing activities: a light 
20-70 S fraction that synthesizes predominantly the 20 S RNase-resistant 
RNA, a 100-300 S fraction that synthesizes predominantly 37 S viral RNA, 
and a heavy (7300 S) pellet that synthesizes both the 20 S RNase-resistant 
RNA and 37 S viral RNA [ 17 j • The pellet is postulated to be comprised of 
the native polymerase complex still bound to cellular particulates. A simi-
lar fractionation of RNA polymerase activities has been reported in mango-
virus infection [ 18] ,and a requirement for two RNA polymerase factors in 
poliovirus RNA replication is predicted on the basis of two sets of temp-
erature-sensitive (~) mutants with differing polymerase defectiveness 
[ 4] • One set is defective in the synthesis of both double- and single-
stranded RNA, and the other is defective only in the synthesis of single-
stranded RNA. These mutant sets occupy loci at the 3' end of the polio-
virus genome. 
TRANSLATION OF FMDV RNA 
1n Vivo Synthesis of FMDV Protein: 
As has been established for poliovirus, EMC virus, ImV, 
and other picornaviruses, the translation of FMDV RNA in cells produces 
large molecular weight precursor proteins that are subsequently cleaved 
into smaller capsid virus proteins (VP) and noncapsid proteins (NCVP)[2,19} 
Mapping of these proteins on the virus genome has been reported for polio-
virus by using~ mutants that are defective in different viral functions 
[ 4] in conjunction with the use of inhibitors to interrupt virue-directed 
protein synthesis [ 4,19] • Mapping by the latter procedure, whioh also 
provides information on post-translational cleavage of the primary products, 
has also been described for EMC virus and IffiV-~A (19] • Although ~apping of 
the FMDV genome by using inhibitors has not been completed, analysis of 
the 35s-methionine pulse-labeled translation products chased with unlabeled 
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methionine for successively increasing intervals has been reported [ 20] • 
The results have provided information on the number of proteins translated, 
their molecular weights, time of appearance and disappearance, and molar 
ratios of FMD VPo-4 and NCVP1, 1a, 2_ 11 • The proteins were analyzed by SDS 
polyacrylamide gel electrophoresis (PAGE) in the presence af14o-amino acid 
labeled, poliovirus-infected cell cytoplasm or of ~leucine labeled, Maus 
Elberfeld virus protein markers. Seven of the FMDV-specific proteins, 
VP0, 1, 3 and NCVP5,9-11 , have molar ratios close to unity[2o] and are con-
sidered to represent stable cleavage products. The number of stable proteins 
and their total molecular weight (224,000 daltons) are both within the lim-
its of information that can be specified by the FMDV genome (2.6 x 106 dal-
tons). 
The order of translation and of cleavage as well as the 
molecular weights of the virus-specific proteins of poliovirus, EMC virus, 
HRV-1A, and FMDV, are depicted in Fig. 3. The F.MDV proteins were positioned 
by analogy with the genetic maps reported for the other three picornaviruses 
[ 4,19] • The similarities are striking and indicate that these four anti-
genically-unrelated viruses have codons specifying protease-sensitive pep-
tide bonds at nearly identical positions in their genomes. The slight 
differences that exist may be important in the differential stability of 
their virions. 
Of particular importance in F.MD is NCVP
5 
which has a 
molecular weight of 57,000 daltons. From the weight of evidence now avai-
lable, it is almost inescapable that NCVP5 is a virus-specified constituent 
of FMDV RNA polymerase: 1) FMDV RNA polymerase and VIA antigen have a common 
antigenicity; 2) NCVP 5 eo-electrophoreses with purified VIA antigen l21] 
(Fig. 4); 3) the size of FMD NCVP5 and its apparent 3' end locus are charac-
teristics that have been predicted for poliovirus RNA polymerase factors 
from mappings with 1!1. mutants [ 4 J (FMD NCVP 5 is analogous to polio NCVP 4 , 
Fig. 3); and finally, 4) the emergence of NCVP5 is delayed in the presence 
of guanidine [20], which is also known to inhibit the,!!!.~ activity of 
FMDV RNA polymerase. 
However, the large size of viral RNA polymerases and 
the borrowing, for example, by Q ~RNA polymerase of 3 host components for 
its completion L 22lsuggest a similar requirement for native FMDV RNA poly-
merase. This hypothesis is supported by the fact that purified VIA antigen, 
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S' l PRIMARY TRANSLATION PRODUG MW 22()..260 
EMCV A 100 
HRV 47 
POLIO cNCVP MW 
1
rm .. w 
1 rtiiDV _1_ll!L_. __ _ 
t ' I IKVP N.W Pouoc=a ;::-;95~---.--·:x:::37.1-c1bD5 
EMC V B 90 · F · .. 33 C 84 
HRV 92 : ; ; : ; ;381 84 
FMDV la 100 ___ ;;9;;;38 __ 2 87 
POLIO 3(j--y()"' Juvf?·;J. ' J 2 77 
EMCV 01 65 i;;;; 0 75 
HRV 67 5:;;;; 76 
FMDV '----'4_...;6:;.:3~ .§J14 : L.---=.3-..:.7...;4'-------' 
VPO !vP3 
eouo ~4;" · · · · ]1'''1' ·[/IICV 0::::::: 23::: 
HRV 39• • • · ••• ?.5· •• 
Fl\'.ov ;,.o::::::: 1213(26" 
VP4' VP 2 
POLIO 8'1 310 
E/\'.CV 9
1
1 30 
HRV 8 30 
FMDV 12 28(30)J 
Figure 3 : Legend. 
··~-:-=--· :r: ~~::: ::ill 
:. ::ss:::::::: 
:s::s7:::: :::: 
Comparison of the order of translation (lateral) and of post-translational 
prote1n cleavages (top to bottom) for poliovirus, EMC virus, HRV-lA, and 
FMDV. Transl~tion begins at the 5' end of the RNA. The poliovirus genetic 
map is adapted from [ 4] a."l.d [ 19 J , and that for EMC v1rus and HRV-lA from 
[19). That for FMDV is a tentative construct1on based on these maps and 
on date in [ 20] • 
NOTES : 
a) A and B for EMCV as well as 47 and 38 for HRV ma;y be altern~te early 
cleavage noncaps1d proteins ( 19 J • The capsid pr~te1ns of EMCV and for 
HRV are generally designated as e, .:><., (l, t, and c r~ther than VP 0-4 • 
b) Molecular weights (MW) are in thousands. Alternate values (27] for 
FMD VP1_ 3 are 1n parenthesis, VP4 ma;y be a group specific ant1gen of 
FMDV [28]. 
c) Stippl1ng des1gnates stable cleavage products before virus mat~rat1on. 
Several low-MW noncapBl.d proteins mapping 1n the middle two gap reg1ons 
[19] are not shown. 
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which is presumably identical to -FMD NCVP
5
, has no polymerase activity. 
In addition, actinomycin D markedly depresses the production of active FMDV 
RNA polymerase, suggestive of the inhibited synthesis of messenger RNA for 
host protein co-factor(s) of the en~e. 
Although FMD VP1_3 appear to have nearly identical mole-
cular weights by SD3-PAGE(Fig. 3) 1 they were resolvable from virions into 
separate VP1, VP2, and VP3 fractions under discontinous PAGE conditions and 
were found to have differing amino acid compositions and a-terminal sequen-
ces [23J • As expected, the weighted average amino acid composition of 
these three major capsid proteins was quite similar to the amino acid comp-
ositions of the total protein of the virion. From carboxy peptidase-A ana-
lysis, the a-terminal sequences were: (--- serine-glutamine) for VP1; 
(--- glutamic acid) for VP2; and (--- glutamine-alanine-leucine) for 
VP3. 
Cell-free Synthesis of F.MDV Protein: 
A protein synthesis-initiating factor (I factor), which 
promotes the synthesis of proteins in a cell-free system programmed with 
37 S FMDV RNA 1 can be isolated from infected BHK cells (Fig. 5) [24,25] • 
The I factor is obtained by 1 M KCl treatment of ribosomes from infected 
BHK cells. The system also requires ribosomal subunits from normal BHK 
cells. Without programming by viral RNA, incorporation of amino acids is 
only about one-third of that achieved with the added template. The proteins 
synthesized ill~ during a viral RNA-programmed1 60-minute reaction are 
of the high molecular weight NCVP type and are not converted in appreciable 
amounts into lower molecular weight proteins, indicating that this ill~ 
system is deficient in the required cleavage proteases [251. An I factor 
from normal guinea pig liver had practically no activity with FMDV RNA as 
the template although the factor was very active in the presence of poly-
uridylic acid in synthesizing polyphenylalanine 1 in accord with the multi-
plicity of UUU codons in this template. 
The ill~ protein product specified by FMDV RNA was 
not otherwise compared with FMDV-specific proteins made in vivo. It is 
known, however, that many of the tryptic peptides from ~4c-labeled pro-
duct of poliovirus RNA-directed ~ cell-free synthesis eo-migrate with 
those derived from ~-labeled poliovirus capsid and noncapsid proteins 
during the cation exchange chromatography or electrophoreses [26J • 
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I Factor, 
noninfected BHK cell 
~<~-~-=-~-=-~:.=.~-~-=-=-~·=·=·:·==·=·==·=·=~;actor, GPL 
10 20 30 
Minutes 
Figure 5 Incorporation of a mixture of 18 ~laoeled amino acids into 
TeA-insoluble polypeptides in the presence of I factors and FMDV 
RNA (300 ~ml) after subtracting any incorporation in the absence 
of exogenous FMDV RNA message. The I factors are from F.MDV-in-
fected BHK cells, noninfected BHK cells, or normal guinea pig 
liver (GPL). Adapted from[25]. 
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DISCUSSION 
Dr. Scholtissek : I have a comment on your fractionation studies concer-
ning the RNA polymerase. You got two fractions, one synthesizing single-
stranded RNA and the other fraction synthesizing double-stranded RNA. 
With our influenza enzyme we had the following experience. When we used 
the crude enz;yme, we get synthesis of single-stranded RNA, but when the en-
zyme was purified about two-hundred fold, we synthesized exclusively double-
stranded RNA. We have interpreted these results in the following way: 
the polymerase not only has to synthesize RNA along the template but it 
also has to displace it from the template and then this newly synthesized 
RNA has to be stabilized by some proteins or something else. You would not 
have double-stranded RNA apart because double-stranded RNA is the end of the 
reaction. If you purify the enzyme, this type of protein or factor is lost, 
and then you form the double-stranded structure. Could it not be that the 
synthesis of the single-stranded RNA has killed this stabilizing factor and 
the other fractions might not have it. This could explain the results 
shown in the slides. 
Dr. Bachrach : In addition, it was reported by Dietzschold that F.MDV 
RNA polymerase synthesizes mainly plus strands .!!!, ~· I think that there 
is a temporal relationship: at an early time there has to be negative stra-
nds and at a later time virus strands. Lazarus has reported that double-
stranded F.MDV RNA is formed exclusively in a cell-free system during the 
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first two minutes, after which the proportion of double-stranded form dec-
reases to about 2o% of the total RNA which is synthesized. 
Dr. Liess : I am not quite sure whether I am allowed to ask this 
question, but Dr. Bachrach mentioned quite a number of virus diseases which 
are exotic to the USA, and there is still one virus disease in the USA 
which is present as far as I know. This is hog cholera. Now could you tell 
us perhaps if you are informed on what is being done about hog cholera in 
the USA, particularly concerning the diagnostic point of view as well as 
the control of the disease. 
Dr. Bachrach : I will try to answer your question in some detail. You 
may know that for many years Canada has been free f~m hog cholera but not 
the United States. About 25 years ago the United States used the so-called 
simultaneous method of vaccination of pigs, inoculating live virus in one 
hind leg and antiserum into the other. This procedure, as you might expect, 
did not eliminate hog cholera, but appeared rather to contribute to its 
spread. Some twenty years ago the so-called "inactivated" vaccinee of the 
crystal-violet type were tried. About fifteen years ago live-virus vaccinee 
for hog cholera, modified by passages in tissue cultures or in rabbits, 
were developed. The programme with these modified live-virus vacoines was 
also unsuccessful. Consequently, approximately ten years ago our State and 
Federal governments started a programme of eradication,without the use of 
vaccines, which has virtually eliminated hog cholera in the United States 
at present. Elimination of the disease has been approached on a State-by-
State basis. The last outbreak occurred some three months ago in one of 
our southern states, at a time when 49 of 50 states were considered hog 
cholera free. This interrupted a period in excess of seven months since hog 
cholera has been last confirmed in the United States. 
Dr. Liess : It is very difficult to get information from the USA, 
and I think this will have some implication for the European countries too, 
This can stimulate our thinking about what to do. 
Dr. Bachrach : Hog cholera would appear to be a simple disease to elim-
inate. There is only one immunological type of virus and only one natural 
host. Yet, it could not be eliminated by the vaccination procedures that 
I mentioned. Hog cholera has been much more amenable to slaugbter,quarantine 
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and sanitary measures, and it appears that such practices will succeed be-
fore too long in the complete elimination of hog cholera from the United 
States. 
Dr. Leiss : There is still one question which we discussed this 
morning in our working group. The question is the connection to BVD-MD in 
cattle, and I just wonder whether you in the USA ever checked for antibodies 
in the pig population for BVD-MD antibodies in the cattle. Is there any 
idea what is going on in the pig population in this sense ? 
Dr. Bachrach I cannot answer that. 
Dr. Liess Because this is very important to us at least. 
Dr. Bachrach Mucosal disease ? 
Dr. Liess Yes. 
Dr. Bachrach : I do not know what the serological surveys have shown 
for that, but I would suspect that they have been carried out. But we hope 
that it will soon be an academic question in the United States insofar as 
hog cholera is concerned. 
Dr. A,ynaud Are there methods to differentiate between attenuated 
strains of swine fever and, attenuated and non cytopathic strains of muco-
sal disease virus ? This point is important for the diagnosis of latent 
infections of pigs in the field. In other words, how can you differentiate 
between an attenuated or low virulent strain of swine fever and a non cyto-
pathic strain of mucosal disease isolated in pigs ? 
Dr. Bachrach I cannot answer that. This problem is studied by our 
organization in Ames, Iowa, which is working on mucosal disease and hog 
cholera. They instituted fluorescent antibody studies for this, and I 
presume that they can differentiate by this method. 
Dr. Horzinek : May I ask one question on picorna's again ? Have you 
ever tried to immunize cattle with non-viral proteins such as the polymer-
ase ? Would this protein protect against a challenge infection ? 
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Dr. Bachrach : We have not done precisely that. However, when you 
degrade foot-and-mouth disease virus by acidification or by heating into 
the 12 S component and virus protein number 4, the degraded virus is very 
poorly immunogenic. It is difficult to prepare much purified virus protein 
4, because the latter constitutes only 6 percent of the total virus protein. 
Dr. Horzinek : And if you treat cattle with the virus-induced or in-
fection-associated-antigen, are they protected against foot-and-mouth dis-
ease ? You apparently have no type-specificity in this polymerase, so it 
would be a candidate for protection. 
Dr. Bachrach : There is no report that this antigen is immunogenic for 
foot-and-mouth disease. 
Dr. Van Bekkum Mr. Chairman, if I may in reply to two of the points 
that have been raised previously. First of all, the question Dr. Liess 
asked. 
I should perhaps point out that bovine virus diarrhea has 
been isolated in the United States from swine in the fields. So the dia-
rrhea problem is probably the same as in Europe. 
Secondly, with regards to the point raised by Dr.Aynaud, 
I should perhaps point out that in our experience all non-cytopathogenic 
strains of bovine virus diarrhea produce plaques using the same technique 
but with bovine testis cells that we used for swine fever virus. That is 
to say incubation under an overlay, staining with neutral red and keeping 
the cells in the dark for a couple of days. Thank you. 
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SUMMARY OF THE SESSION 
P. J. Enzmann 
The nucleic acids of Togaviruses and picornaviruses 
serve as both, genome and mRNA. The data which indicate that the viral RNA 
functions indeed as a messenger depend primarily upon the fact that RNA 
extracted from virus particles is infectious. The start of RNA-replication 
requires a step involving the synthesis of protein coded by the viral gen-
ome. During this process the virus-specific RNA-replicase is synthesized. 
The replicase seems to be identical with the transcriptase in the case of 
Togaviruses and picornavirusea. In contrast to this system, myxoviruses 
need as a first product in the course of virus replication a new species 
of RNA which functions as a mRNA on the ribosomes. These viruses require 
a new enzyme, the transcriptase,to synthesize RNA which is complementary 
to virion-RNA. The transcriptase is associated with the viridn. In the 
course of infection these viruses produce another enzyme, the replicase 
which is necessary to synthesize virion-RNA. 
Messenger RNAs in the Togavirus-group and picornavirus-
group are at least in part polycistronic1 whereas in the myxovirus-group 
there are monocistronic mRNAs because the genome is fragmented. During the 
replication of Togavirue-RNA several double-stranded structures appear in 
the infected cells. One of these, the replicative intermediate form RI 
of RNA consists of the minus strand which is associated with several nascent 
(+}-strands of varying length but is largely present in single-stranded 
form inside the cell. After ribonuclease treatment of this RNA form, a 
double-stranded RNA with single-strand breaks in the (+}-strand arises ·,Jhich 
is called replicative form ( RF ). It is not yet decided finally whether 
there is another replicative form of RNA which occurs as complete duplex 
without single-strand breaks. I think there is no real explanation until 
now in which way the (-}-strand RNA arises. 
In systems which work with polycistronic mRNAs the pro-
duct of translation is a precursor protein. Specific proteolytic enzymes 
have to cleave the precursor to get functional polypeptides. This cleavage 
has been shown definitly by the precursor-product relationship. 
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Now I would propose that we discuss the papers of this 
afternoon instead of giving a whole summary, because these papers are too 
heterogeneous. 
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GENERAL DISCUSSION 
Dr. Bachrach to Dr. Scholtissek : 
You indicated that the mutant shuts off both complemen-
tary and viral RNA s,ynthesis. The work reported by Cooper using polio mu-
tants gave evidence for two RNA polymerase factors. How do you reconcile 
this sort of difference ? 
Dr. Scholtissek : ~ data can be interpreted in such a way that the two 
enz,ymes synthesizing a minus strand and a plus strand are different in the 
sense that some additional proteins are complexed to one common ~irus 
specific protein and so far I cannot say that one and the same enzyme is 
synthesizing both strands. The only thing I can say is that there is one 
common protein involved in the s,ynthesis of both strands. 
Dr. M. Schlesinger :I'd like to ask Dr. Scholtissek and possibly Dr. Rott 
also to comment on the use of glucosamine because we have found that there 
is a certain hazard in using glucosamine. With envelope-viruses, where 
there are carbohydrates attached to the envelope-proteins and these attach-
ments are essential formaturation and secretion of viruses, the addition 
of glucosamine inhibits those attachments and therefore essentially inhib-
its viral maturation and replication. 
Dr. Scholtissek : That is true. In glucosamine-treated cells infected 
by Semliki-Forest virus, and using a glucose containing medium, the effect 
is mainly on the production of glycoproteins. In glucose containing medium, 
we do not have an effect on viral RNA, and under these conditions, we get 
a large primary translation product which is wrongly glycosylat~d and we 
get the normal splitting into the NP protein. The splitting into the car-
bohydrate containing envelope polypeptides, however, does not occur at the 
right sites. So we get a whole bunch of different molecules with different 
molecular weights which are - and these molecules are rather unstable -
broken down at least partially during further incubation of these cells. 
Therefore we don't get any particles because we don't get the right envelope 
proteins. I might mention here some observations we have made with vesic-
ular stomatitis virus. We can't inhibit the multiplication or the produc-
tion of infectious vesicular stomatitis virus under identical conditions, 
although we have the same effect on the synthesis of vesicular stomatitis 
virus glycoproteins. Now, if we isolate the virus particles from the 
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supernatant medium, we get the normal yield of infectious virus and these v1rus 
particles now conta1n wrongly glycosylated glycoprote1ns. So these viruses can 
tolerate the incorporation of the wrong glycoproteins wh1le the Semlik1-Forest 
virus does not, and also influenza virus does not tolerate the 1ncorporat1on of 
these wrong glycoproteins. It depends very much on the virus strain you are 
looking for! 
Dr. 1'·1. Schlesinger To illustrate that po1nt further, 1n my laboratory, we 
looked at the appearance of the envelope prote1ns in S1ndbis v1rus-1nfected 
BillC-cells 1n the presence of glucosam1ne us1ng glucose 1n the medium and there 
we found the two envelope proteins accumulated as 1ndividual polypept1des. 
They do not chase into the carbohydrate-conta1n1ng forms but they are stable 
and furthermore by subfract1onat1ng such infected cells 1nto various membrane 
fractions, we do find those non-glycosylated envelope polypeptides mov1ng into 
the plasma membranes. 
Dr. Bachrach : I could follow up something that Dr. Scholtissek was 
speaking about. That is cleavage of proteins. Some interesting observations 
have been made on the treatment of foot-and-mouth disease virus with trypsin. 
One of 1ts peptides w1ll be cleaved, and depending upon the strain, tnere will 
be a large drop in 1nfectivity or no drop in 1nfectivity. 
Dr. Scholtissek I have a quest1on to this last point concerning these 
two different stra1ns. In one you got cleavage with loss of infectivity, and 
with the other strain, cleavage without loss of infect1v1ty. Do you know whether 
the cleavage was at the same s1te ? 
Dr. Bachrach We presume that it is close to the same site because the 
products are s1m1lar in molecular we1ght. 
Dr. Becker : We are dealing here with essentially two different pheno-
mena. On the one hand we have viruses which can shut off cellular funct1on very 
efficiently and replicate in the whole cell, on the other hand there are groups 
of viruses which replicate very well but they do not shut off cellular funct1ons. 
It is of great importance to understand what is controll1ng the cell mechanism 
since one of these factors could be the in1tiation factor which may assist the 
ri bosomes to discriminate between viral and cellular messenger RiiA. 
Dr. Bachrach actually started to talk about the init1ation 
factor, which can be extracted from the ribosomes. Work 1s now being done by 
Dr. Kaempfer 1n the United states on what he calls the "Ini tlation factor 3" 
in mammalian cells. This 1s a very complicated multipeptide component wh1ch 
binds to the 40S ribosomal sub-unit and determines whether the sub-unit will 
attach to a messenger m•A molecule and become an active ribosome. One of the 
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suggestions that he makes 1s that the virus can perhaps mod1fy one or more 
peptides in this 1nitiation factor 3 (IF3), wh1ch will make the ribosome dis-
criminate between cellular and viral messenger RNA. This pertains to viruses 
which can shut off the mechanism of whole cell but it is not yet very clear, 
so maybe Dr·Bachrach can tell us a little bit more about th1s 1nitiation fac-
tor. 
Dr. Bachrach I can't contribute much more about it. I factor has not 
been characterized further in our laboratory other than being in the super-
natant from the one molar KCl-shock of infected ribosomes. Without this ini-
tlation factor, the cell-free system is 1nactive. 
Dr. Scholtissek I want to comment a little bit more on what Dr. Bachrach 
said concerning the initiation factor. Dr. Wengler in our institute has done 
experiments with Semlik1-Forest virus-infected cells. After the hypertonic 
shock of the infected cells, the Semliki-Forest viral specific IDTA still 
stayed on the polysomes synthesiz1ng specifically Semliki-Forest v1rus pro-
telns; but in the non-infected cells the cell-specific mlliiA was lost from the 
polysomes and after this shock, they did not synthes1ze any more cell-specific 
protein. This indicates that somehow the virus spec1fic ID<A has a high affi-
nlty to the polysomes. We don't know anything about the initiation factor 
because these experiments were done in vivo, but it m1ght be explained in a 
very similar line. 
Er.~ckeE I am not so sure that this has any connection with the 
initiation factor 3 (IF3) because, according to Dr. KAEMPFER, and this is 
true of other systems, the factor is released from the 40 S r1bosomal ~ub-unit 
the moment the active ribosome is formed on the message. Afterwards the ini-
tiation factor can re-cycle so that the number of IF 3 molecules in a cell 
actually determ1nes the number of ri bosomes which can bind messenger RNA and 
initiate polysome formation. This is a factor which 1s very well controlled 
in infected cells. This initiat1on factor is obviously important since it 
also has to do with the phenomena of interferon and sensit1v1ty of cells to 
viruses. These two phenomena seem to be tied to the question of the speclfi-
city of IF 3. 
I have another question wh1ch has to do with guanidine 
sensitivity. f.!any years ago it was claimed that a membrane 1s synthesized 
in the cytoplasm of polio virus infected cells. At a certain stage these 
were called virus-synthesizin~ bod1es, which had a sort of membrane. 
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Dr. PENMAN published a paper on increased choline uptake by poliovirus in-
fected cells. The question is1 if a membrane is synthesized under the con-
trol of the virus, we probably also need glycoproteins. Did anyone look 
for a glycoprotein in the case of picornaviruses and if so, could it be that 
guanidine sensitivity has to do with the formation of this membrane ? 
According to papers published in the last few years, in the presence of 
guanidine, the membrane structure which contains the RNA polymerase is not 
synthesized. After removing the guanidine, the whole membrane comes to-
gether once again and becomes functional. 
Dr. Scholtissek : I can report on preliminary data Dr. Kal~za has obtain-
ed in our institute. He has studied poliovirus multiplication under the 
influence of 2-Deoxy-glucose. Under certain conditions he can inhibit the 
multiplication of poliovirus. Our idea, of course, is that it has to do 
with this membrane formation. But I will not follow this up too much. 
Dr. Bachrach I presume that Dr. Becker was talking about the so called 
"guanidon"? 
Dr. Becker : I was very curious about the specific inhibitory effect 
of guanidine on poliovirus replication. 
Dr. Bachrach : One can hypothesize that guanidine might interfere with 
post-translational cleavages by inhibiting proteases. I think guanidine is 
known to have some inhibiting effect upon proteases. Non-capsid virus pro-
tein 5 in FMD appears late in the presence of guanidine, and therefore the 
active polymerase may not be present when it should be in the infection-
cycle. 
Dr. Scholtissek : Concerning the regulation how virus can or might switch 
off cell functions, I would like to call your attention to a recent result 
by Schweiger et al. on T7 phage of E. coli. He found that after virus in-
fection, a phosphokinase activity occurred and this enzyme phosphorylated 
several cell specific proteins. So they switch their function now in such 
a way that these cells are specifically synthesizing T7 specific proteins 
and they do not any more synthesize the cell specific proteins. I guess 
this is one thing that we really should look for whether we have induction, 
for example, of such general enzymes like phosphokinase which might then 
somehow change cellular proteins that they function in a different way. 
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Dr. M. Schlesinger to Dr Bachrach : 
There was a report by a group from Dupont that they 
found a cleavage enzyme - an enzyme that would cleave the polio non-viriGn 
protein, the precursor, and they could only isolate this from infected cells. 
Do you know if that result has been repeated, or do you have any informa-
tion ? 
Dr. Bachrach : Not much additional information, other than that the 
work was done by Bruce Korant at Dupont on a polyprotein produced during 
poliovirus infection. He was able to reproduce in vitro - as I recall -
the cleavages that occur in vivo. 
I might switch now to something that I didn't talk 
about previously. That is a control mechanism in foot-aad-mouth disease 
which contributes to the shut off of protein synthesis after virus infec>-
tion. Dr. Vande Woude showed that the earliest and strongest inhibition in 
the infected cell was the sub-methylation of 45 S ribosomal precursor RNA 
and also sub-methylation at a certain time of transfer RNA. The sub-methy-
lation of the ribosomal precursor RNA would stop the processing of the 
ribosomal precursor RNA into ribosomal RNA, and hence contribute to the 
shut off of normal protein synthesis. The temporal sequence of methylation 
of the transfer RNA was such that it appeared to be related to the synthe-
sis of the RNA polymerase. There was a decrease early in the methylation 
of transfer RNA, followed by an increase in methylation just prior to the 
formation of the RNA polymerase and then a decrease after that. 
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ABSTRACT 
Frog virus 3 may be a convenient model for study of the 
replication of members of icosahedral cytoplasmic deoxyviruses (Iridovirus) 
including African swine fever virus. 
Viral DNA synthesis commences about three hours post-
infection and continues throughout the replication cycle. Host DNA an<i 
RNA synthesis is rapidly depressed. The electrophoretic pat'tern of virus 
specific RNA transcripts in infected cells has been determined. When ana-
lyzed by gel electrophoresis, the transcripts separated in a size range of 
16-6s with the bulk migrating around 16s. These messenger RNA's contain 
polyadenylic acid tracts of about 15~200 nucleotides. In the absence of 
viral DNA replication, the rate of transcription is reduced but the mole-
cular size species correspond to those produced in normal infection. 'rhere 
is no evidence of distinct early and late RNA transcriuts. These aspects 
will be contrasted with other viral systems. 
INTRODUCTION 
The icosahedral cytoplasmic deoxyviruses (Iridovi~~ses) 
can, perhaps, be considered as a viral supergroup in which a number of ico-
sahedral viruses from insects, amphibians, fish and swine probably belong 
to various sub-groups within it. Characteristics of these viruses include: 
a) icosahedral symmetry of the virion 
b) a minimum size of about 130 nm 
c) replication apparently confined to the cytoplasm 
*Dept. Biochemistry 
University of Cincinnati Medical School 
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d) a double-stranded DNA genophore of molecular weight 
100.130 million daltons 
e) a single structural unit membrane associated with the 
virus nucleoid 
Of these viruses the most important economically is African swine fever 
virus (ASFV). 
The biochemistry of icosahedral cytoplasmic deoxyviruses 
(ICDV) has been the subject of a recent review (20) in Which we pointed out 
that knowledge of the biochemistry of their replication is fragmentary. 
Frog virus 3 (FV3 ) has been the most intensively studied and it will be of 
great interest to see if it can be taken as a representative model s,ystem 
for an understanding of the general aspects of replication of the Whole 
group and in particular for ASFV. 
FV3 replicates in the cell cytoplasm (7 1 20). Its geD-6 
ome is a double-stranded DNA of molecular weight 100 to 130 x 1 0 dal tons 
( 15 ). The programming of DNA synthesis by FV 3 resembles that of a number 
of DNA virus that replicate in the nucleus in that it continues throughout 
the onset of the virus maturation phase. In contrast, poxvirus DNA synthe-
sis reaches a peak and declines prior to the appearance of progeny virus 
( 181 19 ). The main features of poxvirus transcription are biphasic trans-
cription coupled to DNA synthesis (18 1 19) and the presence of a virion-
associated transcriptase that will synthesize early in RNA la !!!2 and 
la~ ( 131 14). In this report we will describe some general aspects 
of FV3 transcription and compare and contrast it with the transcriptional 
events of other deoxyviruses. 
MATERIALS AND METHODS 
Crude FV 3 st ock:s were grown in FHM mono layers ( 9 ) • 
Confluent monolayers were infected (moi = 0.1 or less) and incubated at 
28°C for 72 hours. Cells were harvested, washed in phosphate-buffered sa-
line (PBS) 1 disrupted by sonic vibration, and cellular debris removed by 
centrifugation (10 min1 2.500 xg). The crude supernatant was layered over 
3afo W/V sucrose in lx standard reticulocyte swelling buffer (RSB) and cent-
rifuged ( 30 mins, 25.000 RPM in an SW27 rotor). The pellet was diluted 
approximately 1 00 fold into PBS and was stored at -70° in ampule a. Stocks 
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used in these experiments contained 2 x 1cJ to 1 x 1010 plaque forming units 
(PFU) per ml (17). 
Electrophoresis 
Unless otherwise specified, all electropherograms refer 
to 1.7% acrylamide -0.5% agarose gels prepared according to Peacock and 
Dingman (21). Running buffer was 0.1 Tris-borate pH 8.3, 2.5x1o-)M EDTA. 
Gels were 13 cm in length and were run approximately 3 t hours at 5V/cm. 
A tracking dye, bromphenol blue was used and gels were aligned relative to 
the dye position. RNA samples were applied in 12% glycerol 0.4x running 
buffer with or without dimethyl sulfoxide (DMSO, Fisher Scientific Co.) as 
stated. Gels were cut into approximately 2 mm slices and were incubated 
90 mins at 60°C with 0.5 mls of a mixture of 9:1:10 protosol (New England 
Nuclear), water, and toluene. The digested material was then chilled for 
1 hr at -20° prior to counting in toluene based scintillation fl~d (Speo-
trafluor, Amersham). RNA could be extracted from gel slices with greater 
than 9o% efficiency by shaking the fractions in 1 ml of TSM buffer (0.01 M 
tris pH 8.0, 0.1 M NaCl and 0.001 M MgC1 2) at 37° for 4 to 5 hrs. 
gybridization 
Hybridization was performed at 66° in 4x saline-citrate 
(ssc, 0.6 M NaC11 0.06 M sodium citrate) 0.1% sodium dodecyl suflate (SDS) 
for 24 hrs using DNA trapped on filters (27 mm type B-6, Bao-~Flex, Schlei-
cher & Schuell, Inc.) as described by Green !l !l• (10); filters contained 
20 )lg of the indicated DNA. 
FV 3 DNA was extracted from virus purified according to 
Tan and McAuslan (27). Purified virus in lx RSB were exposed to DNase I 
( 1 00 p..g/ml) at 28° for 30 min. The virus was then re banded in a 20-55% 
sucrose gradient (27) and the viral band was concentrated by centrifugation 
through 3o% sucrose (see above). The viral pellet was resuspended in lx 
RSB containing 0.02 M EDTA and 0.1% SDS. Self-digested pronase was added 
(1 mg/ml) and digestion was allowed to proceed for 30 min at 37° prior to 
a second addition of an equal amount of pronase. After another 60 mins, 
the DNA was extracted with an equal volume of cold phenol-chloroform (1:1). 
The aqueous phase was re-extracted with the phenol-chloroform mixture and 
the final supernatant was extracted twice with ethyl ether. DNA was pre-
cipitated in 7o% ethanol and was exhaustively dialyzed against 0.1 x SSC 
158 
prior to use in hybridizations. 
FHM DNA 
NUclei were prepared from FHM (minnow) monolayer cells 
(9) by the NP40 method detailed below. DNA was extracted from the isolated 
nuclei by the same method used to isolate DNA from FV3 except that the 
nuclei were not exposed to DNase digestion. 
Hybridization in formamide 
Hybridization in 5o% formamide was performed exactly 
as described by Bachenheimer and Roizman (2). 
Infection of cells 
Unless stated to the contrary, all infections were 
carried out at an input multiplicity of 20 pfu/cell on monolayers. Mono-
layers were grown in plastic flasks at 28° in Eagle's Minimal Essential Medium 
(~11 Grand Island Biological Co., N.Y.) with added glutamine and 1o% in-
activated fetal calf serum. The cells were drained and washed in fresh 
medium containing 0.02 M MgC1 2 and 2% inactivated fetal calf serum. Virus 
was applied in a small volume of this adsorption medium and allowed to ab-
sorb for 1 hr. After adsorption, the inoculum was removed and fresh med-
ium was added. 
Labeling of infected cells 
At the indicated times after adsorption, samples were 
incubated with tritiated uridine or adenosine (10 uCi/ml, New England Nuo-
lear) for the indicated labeling periods. Incorporation was stopped by the 
addition of excess cold precursor and the cells were placed on ice. Mono-
layers were removed with a rubber policeman. Cells were collected and cent-
rifuged at 600 g for 4 mins and the pellet was washed in cold buffer A 
(0.01 M tris pH 8.5, 0.003 M CaC12, 0.01 M Mg acetate, 0.15 M KCL). At this 
point the cells were either fractionated into cytoplasm and nuclei or whole 
cell samples were disrupted by addition of sodium dodecylsulphate (SDS) to 
1% concentration. Whole cell lysates were then precipitated in 5% TCA and 
filtered. Extraction of RNA from whole cell samples by the host phenol 
technique is described below. Cells to be fractionated were collected, re-
suspended in cold NP40 buffer (Buffer A+ 0.5% NP40), and held at 0° for 
5 mins. Under these conditions, cells lysed spontaneously with less than 
1% of thymidine labeled DNA appearing in the cytoplasmic fraction. 
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The nuclei were removed by centrifugation (600 g, 3 min) and the cytoplasmic 
fraction was brought to 1% SDS (see below for extraction of RNA). The nu-
clei were also lysed in 1% SDS and both fractions were precipitated in 5% 
TCA and filtered on GF/C glass filters. The air-dried samples were digested 
and counted as described for acrylamide gel slices. 
Preparation of RNA from Whole cells 
Infected cells were labeled, collected, and washed as 
described above. Immediately after washing in cold buffer A, the cell 
pellet was reeuepended in pH 5.0 acetate buffer (0.05M). The cells were 
lysed in SDS (1%) and were extracted in hot phenol as described by Scherrer 
(24). After ethanol precipitation, the pellet of purified RNA was digested 
with RNase-free bovine pancreatic DNase I (Worthington, 25 ug/ml) at 37° 
for 30 mine. The reaction mixture contained 0,01 M tris pH 8.0, 0.04 M 
NaCl, and 0,01 M MgC1 2• RNA was re-extracted at 24° with an equal volume 
of phenol and chloroform and was re-precipitated in ethanol. Between 65 
and 8o% of the incorporated uridine label was recovered by this method. 
Preparation of RNA from cytoplasmic extracts 
The eupernatant from cytoplasmic fractions containing 
1% SDS was extracted with an equal volume of phenol and of chloroform. 
Phases were separated after extraction by centrifugation at 5° for 15 mine 
at 4,400 xg. Interphase material was re-extracted twice with fresh buffer 
A and the aqueous extracts were combined. RNA was precipitated by addition 
of 3-4 volumes of ethanol and allowed to stand at -4° for at least 24 hours. 
Unless otherwise stated, cytoplasmic viral DNA was removed by LiC12 preci-
pitation. The RNA in ethanol was collected by centrifugation at 4,500 xg 
for 30 mins. The precipitate was resuspended in 0.01 M tris pH 8.0 and 
brought to 2M LiC12• The RNA was allowed to precipitate for 12 hours at 
4°. The precipitate was spun down at 4,500 xg for 30 mins and was resue-
pended in 0.01 M tris pH 8,0 buffer and was again precipitated in ethanol 
and stored at -20° prior to use. 
Binding to polydeo;yt&ymi&ylate-cellulose 
Poly d~cellulose was kindly supplied by Dr. s. Kerwar. 
Purified RNA was applied to a lx 4 cm column of poly d~cellulose in 0.01 
M tris pH 7•5 containing 0.5 M KCL. The column was washed with 5 column 
volumes of this application buffer. The majority of the input RNA eluted 
in the application wash and contains ribosomal and transfer RNA as well as 
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mRNA and mRNA fragments which lack poly adenylic acid sequencee ( 1 ). The 
column was then washed (5 column volumes) with the same buffer containing 
0.01 M KCL. Less than 3% of the input RNA was eluted in this wash. The 
final wash was with buffer without salt and the RNA was eluted which bound 
to the poly dT-cellulose due to poly adenylic acid sequences. In the first 
wash, 1-2% of the total adenine labeled RNA was resistant to RNase digest-
ion at high salt. The second wash contained 0.3 to 0.8% and the final wash 
contained 11-12% RNase resistant RNA. RNase digestion was carried out at 
37° for 30 mina in 0.32 M NaC1 1 0.01 M EDTA with 14 units/ml of RNase Tl 1 
(Miles Laboratories) and 3.2 pg/m1 of RNase A (Seravac Laboratory). 
RESULTS 
Effect of FV) infection on host RNA grnthesis 
A number of papers have drawn attention to the obser-
vation that FV3 infection of cultured cells causes a rapid inhibition of 
host RNA synthesis ( 11 ). As FV 3 appears to replicate in discrete cytoplasmic 
factories (16, 20) 1 incorporation of tritiated uridine into the nuclear 
fraction of infected cells during a brief exposure period gives an approxi-
mate measure of host RNA synthesis, and incorporation into the cytoplasmic 
fraction is indicative of the rate of viral RNA synthesis. The rate of nuc-
lear RNA synthesis in infected FHM monolayers declines approximately 8o% 
within 4 hrs after adsorption of FV3 whereas incorporation into the cyto-
plasmic fraction increases (Fig. 1). However, although inhibition of s,yn-
thesis is significant, nuclear RNA production is not completely eliminated 
in the infected cells. Furthermore, the rate of the residual nuclear RNA 
synthesis is 10 to 2o% of the rate of the total RNA synthesis. These pre-
liminary experiments indicate that although host RNA synthesis is inhibi-
ted to a great extent, the residual synthesis of host species occurs at a 
significant rate relative to viral RNA synthesis. Furthermore, the pro-
cessing of host RNA to 28S and 18S species was not affected by FV 3 infec-
tion (data not shown). 
Viral RNA in FV3-infected cells 
Since labelled host RNA will contribute significantly 
to the overall species of RNA isolatable from infected cell, it was import-
ant to measure contamination by host RNA and to positively identify viral 
species by hybridization. Contamination by host species was successfully 
reduced by labelling for only a brief period and removing uuclei intact 
from the disrupted infected cells. RNA from the cytoplasmic extracts of 
Figure 
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Effect of FV3 infection on uridine incorporation into nuclear 
and cytoplasmic fractions. Infected FHM monolayers were labeled 
at the indicated times after infection for 15 mins with triti-
ated uridine. Mock-infected controls which were labelled and 
sampled in parallel with the infected cells exhibited a constant 
ratio of cytoplasmic to nuclear incorporation although this ratio 
(c/N) varied from 0.4 to 0.8 in different experiments. o-- o 
cytoplasm, e---e nucleus. 
Figure 2 
..., 
I Q 
15 
5 
0 10 20 
162 
30 40 50 60 
Gel slice 
Electrophoresis of RNA from the cytoplasmic fraction of uninfeo-
ted and FV3 infected FHM cells. FHM monolayers were infected 
with FV3• At 5 hours post-infection, cells were labelled with 
tritiated uridine (50 ~Ci/ml) for 15 minutes. Monolayers were 
rinsed with cold PBS containing 0.01 M uridine and cytoplasmic 
fractions prepared according to Methods. The cytoplasmic RNA 
was extracted and analyzed by acrylamide-agarose electrophoresis. 
An equal number of mock-infected cells were processed in the 
same way. o---o, RNA from infected cells; e---•, RNA from mock-
infected cells. The arrows indicate the position of c14-labelled 
HeLa cell 28S, 18S, and 4S markers run simultaneously. 
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briefly labelled infected cells form a series of peaks with the predominant 
species migrating at a position expected for a species with a sedimentation 
coefficient of 16S (Fig. 2), In contrast much less RNA of the same size 
species was obtained from uninfected cells. Very similar patterns were ob-
tained from infected FHM and BHK cells. Evidence for the viral origin of 
RNA in the 16-SS peaks was provided by hybridization of the RNA extracted 
from the gels (Fig. 3). Such RNA contained relatively little RNA hybridi-
zable to host DNA (Fig. 4). This combination of a short-labelling period 
to reduce the time available for host RNA to be transported from the nuc-
leus and separation of intact nuclei from the cytoplasm permits the isola-
tion of labelled viral RNA with reduced levels of labelled host RNA. 
"Early" viral RNA 
In a number of deoxyvirus systems distinct "early" RNA 
species whose synthesis is independent of viral DNA synthesis are transcri-
bed prior to initiation of DNA synthesis (see 18). To clearly separate any 
such species from "late" RNA 1 DNA synthesis was inhibited in order to per-
mi t transcription of __ only early species. In this system, DNA synthesis, as 
measured by a rise in thymidine Incorporation into the cytoplasmic fraction 
starts at 3 hours and continues for a further 12 hours. When hydroxyurea 
or cytosine arabinoside was added to cultures prior to or at the time of 
infection, FV3 DNA synthesis was inhibited (20); synthesis of viral speci-
fic RNA was greatly reduced compared to normally infected cells but virus 
specific RNA was synthesized over a long period of time (Fig. 5), When DNA 
synthesis was prevented indirectly by inhibition of protein synthesis (6) 
incorporation of uridine into RNA was markedly depressed (Fig. 6). This 
process was irreversible. 
To compare the RNA species made, RNA from normally in-
fected cells was compared irlth RNA from cells pretreated with hydroxyurea 
or cytosine arabinoside or cycloheximide (Fig. 7). 
It can be seen that if viral DNA synthesis is prevented 
by hydroxyurea or cytosine arabinoside, the pattern of RNA synthesized in 
the cytoplasm is similar to that of normal viral RNA. There is no evidence 
of a distinct early RNA species, at least not in the size range 28-4S. 
The case of RNA made by cycloheximide treated infected cells is not as clear 
due to the consistently low levels of incorporation. However, there appears 
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Figure 3 HYbridization to FV3 DNA of RNA extracted from acrylamide-agar-
ose gels. cytoplasmic RNA was prepared from FHM monolayers in-
fected with FV3• The cells were labelled with tritiated adeno-
sine for 30 mine. between ~ and 6 hours post-infection. Puri-
fied RNA was resuspended from an ethanol pellet into 8o% DMSO 
in 0.4 x running buffer prior to electrophoresis. The RNA from 
gel slices was extracted (see Methods). 
RN&se free DNase (2 pg/ml) was added to each fraction and allowed 
to incubate 30 mins. at 22° to remove any trace amounts of DNA. 
Samples of 0.5 ml were removed from each fraction and precipita-
ted in TCA (5%) and filtered (o---o). 
Frac~ions were pooled as indicated, re-extracted in phenol-chlo-
roform (24°) 1 and precipitated in ethanol. The precipitated RNA 
was hybridized against FV3 DNA. 
Background binding (120-231 cpm) to blank filters is subtracted 
and data is presented as the % of input CPM hybridized (-- -) 
for the pooled fractions. Maximum hybridization of the input 
counts corresponds to 2,887 cpm (35.2%). No significant hybrid-
ization was found in fractions 1-10 and 11-19 (less than 0.5%). 
Arrows indicate position of c14 HeLa RNA marker species run simul-
taneously. 
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Figure 4 Host RNA and viral RNA in briefly labelled cytoplasmic RNA of in-
fected FHM cells. See legend to Fig. 3 for preparation of RNA. 
Increasing amounts of purified labelled RNA 994 cpm/pg were hyb-
ridized against duplicate filters of FHM DNA, FV3 DNA and HeLa 
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of 65 to 131 cpm were subtracted ( t--t, FV 3 DNA; 0---01 FHM 
DNA). 
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Tlf.~E POST -INFECTION (HOURS) 
Effect of 1nhibition of DNA synthesis on viral RNA synthesis. 
FHM monolalfers were 1nfected w1th FV3 at a moi of 10. Immediately 
after the 1 hour adsorption period, half of the monolayers were 
exposed to medium conta1ning l.u.Ci tritiated uridine per ml and 10~ 
cold ur1dine. The other half received the same medium with 3.3 x l0-4M 
hydrowyurea. At the times indicated, 1.5 x 108 cells were harvested 
from each group. The cells were not fract1onated. The total cellular 
RNA was extracted by the hot phenol SDS method. The purified RNA was 
digested w1th DNase prior to ~vbridization against filters conta1ning 
either FV3 DNA (20~g) or no DNA. The hybridization was run in dupli-
cate and at two d1fferent concentrations of RNA of each t1me sample. 
Each point 1s the average of duplicates at one RNA combination and is 
presented at the percentage of input RNA ~ybridized. The specific 
activity of the RNA samples was from 98.5 to 421.7 cpm/U..~ and the 
background 46 corn average. The "zero" time point samole 1s RNA from 
un1nfected cells, 0.11% of wh1ch bound to FV3 DNA filters. (o---o 
infected cells without hydroxyurea; •---o infected cells plus l0-4M 
hydroxyurea). 
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Effect of cycloheximide on RNA synthesis in infected FHM mono-
layers. Four sets of FHM monolayers were exposed to cyclohexi-
mide for two hours and one group was not. All cells were infec-
ted with FV3 at a moi of 5 except for one control set of mono-
layers which was exposed to cycloheximide but not infected. H3-
uridine (1 ~Ci/ml) was added to all cells at 1 hour post-infec-
tions. At the times indicated, duplicate monolayers were samp-
led, the cells harvested and acid precipitable counts were det-
ermined (see Methods) from whole cell extracts. 
A, (.---e) infected cells, no cycloheximide 
B, (CJ-- CJ) infected cells, 10 ~g/ml cycloheximide 
c, (o---o) infected cells, 100 pg/ml cycloheximide 
D, (L:l- -t:,) uninfected cells, 100 ~ml cycloheximide 
E, (• - -•) infected cells, 100 pg/ml cycloheximide washed 
out at 2 hrs. P.I. 
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Figure 7 FV3 RNA from cells normally infected and exposed to hydroxyurea 
or cycloheximide. HYdroxyurea (10-~) was added to one set of 
FHM monolayers and cycloheximide (100 pg/ml) to another 1 hour 
before infection with FV3 (moi = 30). All three groups were in-
fected and at &:t hrs post-infection all were labelled with tri-
tiated uridine (10 pCi/ml) for 15 minutes. Inhibitors were pre-
sent continuously from the time of their addition. RNA was puri-
fied from cytoplasmic extracts and electrophoresized. A - normal 
RNA specific activity 1,343.8 cpm/pg, 9.2% of input hybridized 
to FV3 DNA filters (•-- •). B- cells exposed to hydroxyurea, 
specific activity 618.1 cpm/~g. 4.6% of input RNA hybridized to 
FV3 filters (o-- o). C- cells exposed to cycloheximide, speci-
fic activity 169.0 cpm/p.g RNA (Cl--C..) 3.8% of input RNA hybrid-
ized. 
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Stability of viral RNA in the presence of absence of cytosine 
arabinoside. Infected FHM monolayers were incubated (15 minutes) 
with H3-uridine, six hours after infection (see Methods). RNA 
was purified from cytoplasmic extracts from one third of the cells 
immediately after labelling. The remaining cells were washed 
with medium containing cold uridine (10-3M), divided into two 
groups (with and without 10-~ cytosine arabinoside), and were 
allowed to incubate for 6 hours in medium containing cold uri-
dine (1o-3M). During the 6 hours incubation period after labell-
ing, there was no decrease in incorporated label for either group 
as measured by TCA precipitable counts in whole cells from dup-
licate monolayers sampled at 11 4, and 6 hours after labelling 
(Table 1). Cytoplasmic RNA purified from the two groups of cells 
6 hours after labelling was compared with RNA isolated immediate-
ly after labelling by gel electrophoresis. HeLa cell RNA (c14 ) 
was used as a size marker. The amount of label applied to gels 
for the 3 samples was: RNA taken immediately after labelling, 
29 1 000 cpm applied (o---$); RNA from cells after incubated 6 
hours after labelling, no cytosine arabinoside, 50,000 cpm applied 
(o---o); RNA from cells inoubated 6 hours after labelling, plus 
10-~ ARA-C, 40,000 cpm applied (J:.- -6,). 
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to be a larger proportion of the RNA in the 10-4S region in the samples of 
cycloheximide treated cells. Similar results were obtained at high (100 
ug/ml) or low (10 ~ml) concentrations of cycloheximide. 
As there is no biological assay to demonstrate the in-
tactness of these RNA species, it is difficult to prove that they are not 
produced by degradation. The following experiment was designed to show 
that the cytoplasmic RNA (viral) species observed are stable within the in-
fected cell and do not undergo extensive degradation in the presence of cy-
tosine arabinoside. 
Infected cells were briefly incubated with H3-uridine 
late in infection. One sample was taken immediately after labelling and 
the remainder were washed with medium containing excess cold uridine. Half 
of these remaining cells were allowed to continue the course of infection 
in the presence of cold uridine while cytosine arabinoside was added to the 
other half. Addition of cytosine arabinoside to the infected cells rapidly 
inhibited incorporation of uridine from the internal pool, whereas the nor-
mally treated cells continued incorporation at a declining rate for at least 
6 hours (Table I). 
The pattern of viral RNA observed immediately after 
labelling (Fig. 8) was still present 6 hrs after the cold uridine chase. 
The only major difference is the appearance of 28S RNA in the cytoplasm as 
would be expected from the fact that the synthesis and processing of host 
RNA continues after infection. Analogous "pulse-chase" experiments using 
actinomycin D ( 1 0-~1) to block RNA synthesis in place of cytosine arabino-
side give similar results (data not shown). 
Polyriboadenylic acid in viral RNA 
It has been suggested that polyadenylic acid sequences 
at the 3' end of messenger RNA's might be involved in transport of RNA from 
the cell nucleus to the cytoplasm (5). However, poxvirus messenger RNA con-
tains polyadenylio acid sequences which are unlikely to be involved in such 
a transport process. It was of interest to know if FV3 RNA also contains 
polyadenylic acid sequences particularly in view of the possibility that 
they might be synthesized by a virion encapsulated enzyme as appears to be 
the case for poxvirus (8, 3). 
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TABLE I 
Effects of Cytosine Arabinoside on Incorporation into 
Cytoplasmic RNA after Briefly Labelling Infected Cells 
Hours after Addition 
of Cold Uridine + ARA-C* - ARA-C 
0 40,101 38,509 
190,172 202,885 
4 209,689 301,896 
6 194,089 343,550 
See legend to Figure 8. Cytoplasmic extracts (see Methods) were made from 
2 monolayers for each time point, Net incorporation into the cytosine arab-
inoside-treated cells stopped within one hour of addition of drug plus ex-
cess cold uridine. In the absence of cytosine arabinoside cells continued 
to incorporate label from the internal pool of uridine at a declining rate. 
* H3-uridine incorporated into TCA precipitable cpm. 
The majority of FV3 specific RNA contains polyadenylic 
acid sequences of sufficient length to bind to poly d~cellulose. FHM 
monolayers were infected with FV3 and labelled with either tritiated uri-
dine or adenosine for 15 minutes at 6 hours post-infection. Purified RNA 
(1x106 cpm) from the cytoplasmic fraction was passed over a poly d~cellu­
lose column. The bound fraction was eluted (see Methods) and brought to 
4 x SSC + 0.1% SDS. Approximately 1o% of this RNA was hybridizable to FV3 
DNA. Most (7o%) of the hybridizable RNA was found in the fraction binding 
to d~cellulose. Table II summarizes experiments which support the conclu-
sion that at least some of the viral RNA contains polyadenylic acid. 
Furthermore, the RNase resistant sequences (polyadenylic acid) occurs in 
all size classes of viral RNA 1 although certain species contain more resis-
tant material than others (Fig. 9). The RNase resistant material from FV3 
RNA has a size distribution which is about the same as that of a wide var-
iety of other viral and cellular mRNA 1 s (apparent size 150-200 nucleotides 1 
c.f. Fig. 10 and ref. 2). 
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TABLE II 
Poly-A in FV 3 RNA (%) 
ill!! Total CPM TCA Precipitable CPM Bound to CPM after RNase dT Cellulose after RNase 
H3-A RNA 6 1. 7x1 0 2.6x105 (15.1%) 2.2x105 (12.7%) 
H3-u RNA 4.4x105 1.4x1 o4 ( 3. 2%) 2 9.2x10 (0.2%) 
H3-A RNA 2.0x1{)4 2.4x103 (11.8%) 
--------
eluted from gel 
H3-A RNA eluted 2.9x104 
--------
3.1x103 (10.8%) 
from hybrid 
infected cells. 
Presence of polyadenylic acid sequences in RNA from FV3 
RNA was prepared at 6 hours post-infection from the cy-
toplasm of FV3 infected FHM monolayers after 15 minutes labelling with eith-
er tritiated uridine or adenosine. Part was subjected to RNase digestion 
(37° for 30 minutes with 1.6~/ml of RNase A and 7 units/ml of RNase T1 
in 0.32 M NaCl 1 0.02 M EDTA) and the RNase digest then passed over a poly-
dT cellulose column (Methods). Aliquots of bound material were hydrolyzed 
greater than 99% after 18 hours in 0.6 M KOH at 37°. Another portion of 
the labelled RNA was subjected to electrophoresis then eluted from gels and 
pooled. (See legend to Fig. 9 for details of elution of RNA from gels). 
Such RNA labelled with tritiated adenosine was hybridized to FV3 DNA (20 
ug/fil ter) in safo formamide - 5x ssc at 43° for 24 hours ( 2 ). The hybrid-
ized viral RNA was eluted from washed filters in 0.01 M tris pH 7·5 0.01 
M EDTA by shaking for 1 hour at 37°. Of the input RNA (5 x 105 cpm) 5·7% 
was recovered from hybrids. The eluant RNA also bound to polyU filters 
(36.3% of input) (23) prior to RNase digestion. The RNA was digested and 
was passed over poly-d~cellulose using the methods described above. CPM 
refers to acid precipitable counts. 
DISCUSSION 
One of the characteristics of FV3 Which has been singled 
out for attention is its ability to severely inhibit host cell function (4). 
Although the virus does cause a rather rapid decrease in host cell RNA s,yn-
thesis, residual RNA synthesis continues at a significant level. The in-
fected cell continues to produce ribosomal and messenger RNA and ribosomal 
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Distribution of RNase resistant RNA in viral RNA. RNA was puri-
fied from the cytoplasm of infected FHM monolayers after 15 mins. 
labelling with tritiated adenosine. The sample was applied for 
electrophoresis in 8o% DMSO- 0.04 x running buffer. RNA from 
gel slices was eluted (see Methods). The eluant was digested 
with DNase ( 2 ~ml) for 30 minutes at 25° and 0.5 mls was pre-
cipitated in TCA (.---e). The remainder was brought to 0.32 M 
NaC1 1 0.02 M EDTA and digested with 3.2 pg/ml RNase A, 14 units/ 
ml RNase T, at 37° for 30 minutes followed by TCA precipitation 
(o---o). Total recovery (%) of RNase resistant cpm from the 
eluant material is given in Table 1 (third line). 
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Figure 10 Size of RNase resistant viral RNA. RNA was purified from the 
cytoplasm of infected FHM monolayers after labelling 15 minutes 
with tritiated adenosine. The RNA was digested first with DNase, 
then with RNase (see legend to Fig. 9), and was precipitated 
in ethanol with cold polyadenylic acid carrier. The RNA was 
denatured in So% DMSO prior to application to acrylamide gels. 
Electrophoresis was carried out on 11 cm gels of 1o% acrylamide 
at 150 volts. Tritiated transfer RNA was run simultaneously 
as a size marker. The size of the RNase resistant material was 
calculated from its migration relative to the 4S marker to be 
an average of 60,000 daltons, or about 175 nucleotides. 
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RNA appears to be processed normally from precursor molecules (unpublished 
observations). FV3 RNA is transcribed at a comparatively low rate in fact 
about one tenth of that of poxvirus in the same cell (data not cited). 
This makes it difficult to readily study the pattern of FV3 transcription. 
Because of the problems implicit in the cytoplasmic 
replication of nucleic acids, it is of interest to compare the modes of tr-
anscription of the two virus groups represented by poxvirus and frog virus 
3. The transcriptional pattern of poxvirus can be understood in terms of 
the sequential events of uncoating (14 1 18) and the presence of a virion 
associated transcriptase (13). Frog virus 3 appears to be uncoated in a 
single step independent of protein ~thesis (25) and to date no virion RNA 
polymerase has been detected. 
The "early" messenger RNA of poxvirus is transcribed in 
a distinct wave of synthesis preceding DNA replication; this RNA is readily 
distinguished from "late" RNA species by size (14 1 28). FV3 RNA produced 
in cells infected in the presence of inhibition of viral DNA synthesis app-
ears to be identical to RNA from normally infected cells. In agreement with 
this observation is a report that most, if not all, viral proteins are pro-
duced in the absence of viral DNA synthesis (6). Because of the high in-
put multiplicity of infection and the efficiency of inhibition of viral DNA 
synthesis by cytosine arabinoside, it is unlikely that we ~<ere measuring RNA 
synthesized from "breakthrough" of some viral DNA synthesis. A very simi-
lar situation occurs in Herpes virus infected cells where parental DNA is 
transcribed for the production of most viral structural proteins (23). 
At least some FV3 transcripts contain stretches of poly-
adenylic acid and in this regard FV3 resembles poxvirus and a great many 
other viruses. However, we v1ere unable to detect any virion-associated en-
zyme which might give rise to these polyadenylic acid tracts when various 
assay methods described for poxvirus (12 1 3) were applied to purified or 
crude virus. 
FHM cells infected with FV3 under conditions that permit 
extensive FV3 replication (20) do not show a distinct burst of FV3 RNA syn-
thesis preceding DNA synthesis nor can any such burst be magnified by in-
fection in the presence of cycloheximide as is the case for poxviruses (18). 
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The very low rate of RNA synthesis in FHM cells pre-
treated with cycloheximide and infected with FV3, precludes extensive stud-
ies and determination whether the 6S RNA species (Fig. 7) represents pre-
early messenger. We can only point out that (i) it does appear to be the 
predominant species unlike the case for RNA produced in the presence of 
cytosine arabinoside, that (ii) the available evidence on FV3 uncoating 
which is not extensive (25) gives no indication of why RNA made in -the pre-
sence of cycloheximide should differ from RNA made in the presence of cyto-
sine arabinoside; currently there is no early en~atio marker of FV3 that 
could be used to readily test the function of this RNA. 
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DISCUSSION 
Dr. s. Schlesinger :When you got some RNA in the presence of cycloheximide 
did you see if that RNA would hybridize with the viral DNA or was it just 
host ? 
Dr. McAuslan : It was difficult to get enough RNA under these condit-
ions for hybridization so we have not done that. But I want to point out 
that other people, Gravell for one, have found a considerable amount of RNA 
that is synthesized in the presence of cycloheximide and this suggests that 
either the virus does carry a transcriptase or uses a pre-existing RNA poly-
merase in the cell. I think it would be very interesting to sort this one 
out. Not only for hog virus but also for African swine fever virus. 
Dr. Scholtissek : Does the viral DNA contain poly DT structures ? I mean 
if this is the case you do not need a special enzyme to put a poly A at 
the end. 
Dr. McAuslan : I don't know if that is the case. We have not looked 
to see if there are DT regions in FV3 DNA. In the poxviruses there has 
been some change in the results. Initially Kates reported that they found 
evidence for poly DT regions in Pox DNA. More recently this has been corr-
ected. A poly A polymerase distinct from the transcriptase has been demon-
strated. We have looked for such an enzyme in FV3• As far as I know no one 
has conclusively demonstrated a poly A polymerase or a transcriptase, in 
FV3. 
Dr. Bachrach Is there a double-stranded ribonuclease associated with 
this virus ? 
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Dr. McAuslan Yes, I'll talk about that later to-day. 
We found ribonuclease acitivity associated with FV3• 
This activity can degrade single or double strand RNA. Perhaps we can dis-
cuss later its possible function. Certainly it will add to the problem of 
transcription. I might point out that we did some experiments at Plum 
Island where we looked for such an activity in African Swine fever virus. 
We found no trace at all which is a pity since it would have been a charac-
teristic marker of the virus. 
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IN-VITRO SYNTHESIS OF HERPES SIMPLEX 
VIRAL DNA IN ISOLATED NUCLEI 
Yechiel Becker1 Yael Asher, and Menachem Gordin 
Laboratory for Molecular Virology 
Hebrew University-Hadassah Medical School 
JERUSALEM- Israel 
SUMMARY 
Nuclei from Herpes simplex virus (HSV) infected cells 
were isolated and incubated ~~ in the presence of the four deoxynu-
cleoside triphosphates, (including 1a-TTP) 1 6 mM Mg++ and 8% (w/v) sucrose. 
Under these conditions, the nuclei continue to synthesize DNA. CsC12den-
sity gradient analysis revealed that most (9o%) of the~-~ synthesized 
DNA banded at the density of HSV-DNA (1.718 g/ml). The rest banded at the 
density of cell DNA ( 1. 700 g/ml ). The .!.!!--~ synthesized viral DNA mole-
cules were heterogenous in size and their sedimentation coefficient ranged 
from 65S to 4S. 
Nuclei isolated from HSV infected cells treated .!.!!--~ 
with metabolic inhibitors were used to study the nature of the inhibitory 
effects exerted by several antiviral drugs. 
INTRODUCTION 
Herpes simplex virus (HSV) DNA, a linear molecule with 
a molecular weight of about 108 daltons (Backer~ !11 1968), is replicated 
semiconservatively (Kaplan and Ben Porat 1 1964) in the nuclei of infected 
cells (Munk and Sauer, 1964) by a virus coded DNA polymerase (Kier ~ !11 
1966; Miller~ !11 1973; Weissbach, 1973). However, the replicative form 
of HSV-DNA has not yet been isolated. To obtain information on HSV-DNA 
replication, we have studied DNA synthesis in nuclei isolated from HSV in-
fected cells and incubated under~-~ conditions, an approach which was 
also used by Radsak (1973) and Kolber (1973). We have also investigated 
the nature of the DNA molecules synthesized .!.!!--~ in infected nuclei 
which were treated~-~ with inhibitors of DNA replication. These stud-
ies demonstrated that under~-~ conditions, the infected nuclei syn-
thesize mainly short double stranded DNA molecules which have the density 
of HSV-DNA. 
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RESULTS 
In-vitro DNA grnthesis in isolated nuclei 
Preliminary studies with nuclei from actively growing 
uninfected BSC1 cells were carried out to determine the conditions for ill-
~ DNA synthesis which would eliminate the synthesis of cellular DNA. 
The conditions selected for ill~ DNA synthesis by E. coli DNA polymer-
ase (Goodman and Spiegelman, 1971) were found suitable for the study of DNA 
synthesis in the nuclei from HSV-infected cells. No DNA synthesis was found 
in uninfected nuclei (not shown), while 3H-TMP was incorporated into DNA 
molecules by nuclei from infected cells (Fig. 1A). The synthesis of DNA 
ill-~ was dependent on the presence in the reaction mixture of the four 
deoxyribonucleoside triphosphates 1 since ommission of either one or three 
of them prevented ~-TTP incorporation into DNA (Fig. 1A). The synthesis 
of DNA in the nuclei isolated from infected cells was also dependent on the 
presence of Mg++ in the reaction mixture, 6 mM being the optimal concentra-
tion (Fig. 1B ). The ill-~ synthesized DNA molecules were extracted with 
phenol and characterized by banding in CsClggradients. It was found (Fig. 
2) that most of the DNA molecules synthesized ill-~, had a density of 
1.718 g/ml 1 which is the density of double-stranded HSV-DNA. The remaining 
DNA banded at the density of cellular DNA. These results indicate that nuclei 
isolated from HSV infected cells continue to synthesize both viral and cell-
ular DNA lEi~1 similarly to the synthesis of DNA in infected cells ill-
~· 
The nature of the in-vitro synthesized DNA 
Two methods were used to characterize the in-vitro DNA product: 
a) analysis of the DNA molecules by centrifugation in sucrose gradients, 
to determine the molecular size and, b) characterization of the DNA by el-
ution from hydroxylapatite columns. The nuclei incubated in the reaction 
mixture in-vitro were separated from the supernatant fluid by centrifuga-
tion and the supernatant fractions were analyzed by centrifugation in su-
crose gradients. The results of a typical experiment are presented in Fig-
ure 3· It was found that even after 5 min of in-vitro DNA synthesis, most 
of the radioactivity banded at the top of the sucrose gradient with a co-
efficient of about 4S. However, only part of the in-vitro synthesized DNA 
molecules were released into the supernatant fluid of the reaction mixture. 
Some radioactive DNA also banded in the position between intact HSV-DNA 
(65S) and the low molecular weight DNA (Fig. 3A). Analysis of DNA synthe-
sized d<~ing a 2- min period revealed a pattern essentially resembling that 
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Figure 1 : In-vitro DNA synthesis in nuclei isolated from HSV infected cells. 
Four day old monolayers of BSC1 cells were infected with the HF strain 
of herpes simplex virus at 10 pfu/cell. The cells were incubated in modi-
fied Eagle's medium without serum. Under such conditions, the virus growth 
cycle is completed within 18 hrs after infection. The infected cells were 
scraped into reticulocyte standard buffer (RSB: 0.01M Tris.HC1 1 pH 7.7, 
0.01M KC1 1 0.015M MgC12 ) and homogenized in a glass Dounce homogenizer. 
After centrifugation for 2 min at 800 rpm in a PR-2 refrigerated centrifuge, 
the nuclear pellet was washed in phosphate buffer (O.Q75M phosphates, pH 7.4 
containing 8% w/v sucrose [RNase free] ). The nuclei were resuspended at a 
concentration of 106 nuclei per 100 pl phosphate buffer to which was added 
3 mM mercaptoethanol, 6 mM MgC1 2, 40 pM each of dATP 1 dCTP, dGTP (Sigma eo., 
St. Louis, Missouri USA) and 50 ~Ci ~-TTP (specific activity, 15 Ci/mmole; 
The Radiochemical Centre, Amersham 1 England), in a final volume of 200 p1 
phosphate buffer. The reaction mixture was incubated at 37°C and duplicate 
samples of 25 pl each were removed at different time intervals to tubes 
containing 1o% (w/v) trichloroacetic acid (TCA). 
A. Requirement of deoxyribonucleoside triphosphates for in-vitro DNA 
synthesis. 
B. Effect of Mg++ concentration on in-vitro DNA synthesis. 
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Figure 2 : Characterization of in-vitro synthesized DNA. 
To suspensions of infected nuclei incubated in-vitro for 10 min 1 sodium 
dodecyl sulfate (SDS) (1% w/v final concentration) and pronase (1 mg/ml) 
were added and the suspensions were further incubated overnight at 37°C. 
The DNA was extracted with phenol and afterwards extracted several times 
with chloroform: isoamyl alcohol (1:25) solution until the interphase was 
clear. The DNA 1-re.s precipitated in ethanol and kept at 4°C. When needed, 
the DNA centrifuged for 30 minutes at 2000 rpm in a PR-2 centrifuge and 
dissolved in TEN buffer (0.2M Tris.HC1 1 pH 8.01 0.001M EDTA and 0.8M NaCl). 
14o-HSV-DNA ( 0 - - - 0) was added to serve as a marker and CsC12 crystals 
were added to bring the density to 1.70 g/ml. The gradients were centri-
fuged in the R50 Ti rotor at 40 1 000 rpm for 48 hrs at 20°C in the Beckman 
preparative ultracentrifuge. The gradient was collected dropwise, the de~ 
sity and radioactivity in the fractions were determined. 
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Figure 3 : Sucrose gradient analysis of in-vitro synthesized DNA released 
from the nuclei. 
Infected nuclei were incubated for 5 (A) 20 (B) and 60 (C) min under 
in-vitro conditions. The nuclei were centrifuged at the end of the incu-
bation period (for 2 min at 800xg) and the supernatants were layered on top 
of sucrose gradients, (5- 25% (w/v) sucrose (crystalline density gradient, 
ribonuclease free; Schwarz and Mann, Division of Becton and Dickenson, 
Orangeburg, New York), made in TEN buffer (0.01M Tris.HCl, pH 7.4, 0.001M 
EDTA, 0.1M NaCl)). The gradients were centrifuged at 39,000 rpm for 2 hrs 
in the SW41 rotor of the Beckman model L-2 ultracentrifuge. 14o-HSV-DNA 
(o---- o) was added as a marker. The gradients were collected drop-
wise and the TCA precipitable radioactivity was determined. 
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of intact HSV-DNA (Fig. 3B ). It should be noted that in Fig. 5A and B, 
only a fraction of the labeled DNA sedimented in the sucrose gradients as 
large DNA molecules (larger than 100 x 106 daltons). Analysis of the DNA 
molecules synthesized for a 60 min period, showed that most of the in-vitro 
synthesized DNA molecules banded at about 208 1 while some radioactive DNA 
also banded at 65S (Fig. 3C). At this time, most of the newly synthesized 
DNA had been released from the nuclei, since no more DNA appeared on fur-
ther in011bation. 
The in-vitro synthesized DNA molecules present in both 
the supernatant and the pellet fractions of the nuclei, which were incuba-
ted for 5, 15 1 and 30 min 1 were characterized by chromatography on hydroxy-
lapatite columns. It was found (Fig. 4) 1 that the in-vitro synthesized DNA 
molecules were divided into two species: molecules Which were eluted by 
0.2M phosphate and, DNA molecules Which were eluted by 0.4M phosphate. After 
in-vitro DNA synthesis for 5 min, the two DNA species were found in equal 
amounts in the supernatant fraction. On further in-vitro incubation, the 
amount of radioactive DNA eluted by 0.2M phosphate remain almost constant, 
While the DNA molecules eluted by 0.4}~ phosphate gradually increased (Fig. 
4A). Analysis of the nuclear pellet (Fig. 4B) revealed a low level of 
radioactive DNA which was eluted by 0. 2M phosphate, and remained constant 
throughout the in-vitro incubation. Most of the radioactive DNA in the nu-
clei was eluted by 0.4M phosphate and it increased linearly during a 30 min 
incubation period in-vitro (Fig. 4B). This result indicated that most of 
the in-vitro synthesized DNA consists of double-stranded molecules which 
are eluted from a hydroxylapatite column by 0.4M phosphate (Gordin ~ ~~ 
1973). It is not yet known Whether the DNA molecules Which were eluted by 
0.2:M phosphate are the precursors for the double-stranded DNA molecules. 
The in-vitro synthesized DNA molecules which were elut-
ed by 0.2M and 0.4M phosphate were further analyzed by centrifugation in 
CsCl2 density gradients. As shmvn in Figure 51 the labeled DNA molecules 
extracted by 0.4M phosphate from the hydroxylapatite column banded as doub-
le-stranded HSV-DNA molecules at a density of 1.72 g/ml (Fig. 5B and D). 
These preparations also revealed minor peaks of cellular DNA. The radio-
active DNA molecules eluted from the columns by 0.2M phosphate also banded 
as double-stranded DNA molecules (Fig. 5A and c). It should be noted that 
a smaller peak of single-stranded DNA molecules banded at a density of 
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Chromatography of in-vitro synthesized DNA on hydroxylapatite 
The nuclei from HSV infected cells were incubated in-vitro for 5, 15, 
and 30 minutes. The nuclear preparations were centrifuged, and the super-
natants (A) and nuclear pellet (B) were treated with sarcosyl (3% w/v) and 
pronase (500 ~ml preincubated for 2 hrs at 37°C). The two preparations 
were layered onto hydroxylapatite columns (Gordin ~ !lt 1973) and eluted 
stepwise with 15 ml each of 0.01M, 0.2M and 0.4M sodium phosphate solutions. 
The TCA precipitated radioactivity in each prepatation was determined. 
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Figure 5 : Density gradient analysis of the DNA species eluted from hydro-
xylapatite columns. 
The DNA preparations from a 30 min reaction in-vitro were eluted from 
hydroxylapatite columns by 0.2M and 0.4M phosphate. Samples of each were 
transferred to CsC12(initial density 1.72 g/ml) and centrifuged for 48 hrs 
at 401 000 rpm in the Beckman model L-2 preparative ultracentrifug~. Heat 
denatured and native HSV-DNA were used as density markers (1.80 and 1.718 
g/ml respectively). The gradients were collected and the radioactivity in 
each fraction was determined. The density of different fractions in each 
gradient was determined by weighing 100 pl samples. 
A. Labeled DNA from the supernatant fraction after elution from hyd-
roxylapatite column by 0.2M phosphate. 
B. As above, but eluted with 0.4M phosphate. 
c. Labeled DNA from the nuclear pellet after elution from hydroxylap-
atite column by 0.2M phosphate. 
D. As in C1 but eluted with 0.4M phosphate. 
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1.80 g/ml (the density of single-stranded HSV-DNA) with an additional peak 
close to the bottom of the gradient (Fig. 5A). It is not yet known whether 
the DNA molecules, which were eluted by 0.2M phosphate were originally elu-
ted as single-stranded DNA molecules and afterwards reassociated to form 
double-stranded DNA molecules. Further studies are in progress using DNA 
nucleases to determine the amount of single-stranded DNA molecules in these 
preparations. 
Effect of metabolic inhibitors on in-vitro DNA synthesis 
To study the effect of metabolic inhibitors on the ex-
pression of viral functions, HSV infected cells were treated in-vivo with 
cytosine arabinoside (ara-C), cordycepin, and distamycin A. All three in-
hibitors were sho1m to inhibit HSV replication in-vivo (Levitt and Becker, 
1967; Becker ~ !1• 1972; Becker and Olshevsky, 1973a). At 18 hrs after 
infection, the nuclei were isolated and their ability to synthesize DNA 
in-vitro was studied (Fig. 6). It was found that treatment of the infec--
ted cells with ara-C allowed DNA synthesis to continue for 10 min in-vitro 
before ~-~W incorporation was stopped. Similarly, after treatment with 
cordycepin, the nuclei had a low level of DNA synthesis, while distamycin A 
had a marked inhibitory effect. To characterize the in-vitro synthesized 
DNA, the nuclei were extracted with phenol and the DNA molecules were ana-
lyzed by banding in CsCl2gradients. It may be seen that in ara-C treated 
cells, only cellular DNA molecules were synthesized under in-vitro conditi-
ons (Fig. 7B), in contrast to the synthesis of viral DNA in untreated HSV 
infected nuclei (Fig. 7A). Cordycepin, on the other hand, prevented the 
virus mediated inhibition of cellular DNA synthesis (Becker and Olshevsky, 
1973a), and although the level of DNA synthesis was reduced (Fig. 6) both 
cellular and viral DNA molecules were synthesized in-vitro in nuclei from 
cordycepin treated cells (Fig. ?C). In this respect, the in-vitro system 
is similar to DNA synthesis in-vivo (Fig. 7D). These results are taken to 
indicate that the synthesis of nucleic acids in the infected nuclei in-vitro 
reflects the presence of the virus coded DNA polymerase. 
DISCUSSION 
The results of the present study demonstrate that nuclei 
isolated from HSV infected cells are capable of synthesizing HSV-DNA ~ 
~· The infected nuclei continue to incorporate ~-TMP into HSV-DNA as 
determined by CsCl2density gradient analysis of the labeled DNA molecules 
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Figure 6 : In-vitro DNA synthesis in nuclei isolated from HSV-infected cells 
treated in-vivo with inhibitors. 
HSV infected cells were treated with 50 ~g/ml of ara-C, cordycepin, and 
distamycin A, added at 3 hrs post-infection, and incubated at 37°C. At 18 
hrs p.i., the cells were harvested, infected cells serving as a control. 
The nuclei were isolated and incubated under in-vitro conditions. The am-
ount of ~-TMP incorporation into DNA was determined. 
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Figure 7 : Analysis of DNA synthesized in-vitro by nuclei from HSV infected 
cells treated with metabolic inhibitors in-vivo. 
The DNA synthesized in-vitro for 10 min by infected untreated nuclei 
(A) and nuclei from ara-C (B) and cordycepin (C) treated HSV infected cells 
was extracted with phenol, as described in the legend to Figure 2. Cordy-
cepin treated HSV-infected cells labeled with ~-thymidine (specific acti-
vity, 2 Ci/mM, Nuclear Research Centre, Negev) for 15 hrs in-vivo were also 
extracted with phenol (D). The DNA preparations (•- •) were mixed with 
14c-HSV-DNA ( o - - - o) and centrifuged in CsC]2 density gradients. The 
distribution of the radioactive DNA in the density gradients was determined 
after centrifugation for 48 hrs at 40,000 rpm in a preparative Beckman L-2 
ultracentrifuge. 
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synthesized in-vitro. The major in-vitro DNA product (more than 9o%) band-
ed at the density of HSV-DNA (1.718 g/ml) 1 while the rest of the labeled 
DNA banded at the density of cellular DNA (1.700 g/ml). In this respect, 
the in-vitro DNA synthesis resembled the synthesis of DNA in the nuclei un-
der in-vivo conditions (Beaker and Olshevsky 1 1973a1b). It is of interest 
that although we selected in-vitro conditions, which would eliminate the 
synthesis of cellular DNA in uninfected nuclei, cellular DNA was synthesized 
in the HSV-infected nuclei. This result suggests that the synthesis of 
cellular DNA in the infected nuclei might be carried out by the virus coded 
DNA polymerase, which functions under the in-vitro conditions. This con-
cept is further supported by the use of ara-C (Fig. 7B). In the presence 
of ara-C 1 viral DNA synthesis is completely inhibited (Levitt and Becker 1 
1967) while the translation of proteins from the viral mRNA transcribed from 
the viral parental DNA, continues (Beaker and Olshevsky 1 1973b). In nuclei 
from ara-C treated HSV infected cells only cellular DNA is synthesized. 
This suggests that the viral DNA polymerase is synthesized in the ara-C 
treated cells together with the viral structural peptides. In the absence 
of viral DNA, the virus coded DNA polymerase is capable of synthesizing only 
cellular DNA. Since the affinity of the viral DNA polymerase for the cell-
ular DNA template is restricted, DNA synthesis under in-vitro conditions 
takes place for only 10 min. 
Nuclei from cells infected with polyoma virus (Winnacker 
~!11 1971; 1972 1 Magnusson ~ !11 1972 1 1973) and adenovirus (Sussenbach 
and van der Vliet, 1972; van der Vliet and Sussenbach, 1972) synthesize 
viral DNA under in-vitro conditions. In these systems, intact viral DNA 
molecules were synthesized in-vitro, and were separated from the host cell 
DNA. Unfortunately, herpesvirus DNA is too large to be effectively separa-
ted from cellular DNA by the Hirt procedure (Hirt, 1967) which leads to the 
precipitation of both the viral and cellular DNAs. To avoid some of the 
difficulties, we therefore analyzed the labeled DNA molecules, which were 
released from the nuclei during incubation in-vitro. These analyses revealed 
that most of the in-vitro synthesized DNA molecules are double-stranded, 
and have a low sedimentation coefficient in sucrose gradients. Some radio-
active ~W was also found to be incorporated into the DNA molecules which 
banded at 65S 1 the position of intact HSV-DNA, while some radioactive DNA 
molecules sedimented further into the sucrose gradient in the position of 
cellular DNA. The nature of these labeled DNA molecules is under study. 
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Analysis of the labeled DNA by chromatography on hydroxylapati te shm~ed that 
the amount of double-stranded DNA molecules synthesized in the nuclei grad-
ually increased after the start of in-vitro DNA synthesis. 
It is of interest that part of the in-vitro synthesized 
DNA molecules were eluted by 0.2M phosphate, the conditions for elution of 
single-stranded HSV-DNA molecules (Gordin ~ !11 1973). Nevertheless, in 
the CsC~ density gradient, these viral DNA molecules banded at the density 
of double-stranded DNA molecules, except for a small peak of single-strand-
ed DNA molecules. It is not known whether the DNA molecules, which are el-
uted by 0.2M phosphate are indeed single-stranded molecules which self-anneal 
to form double-stranded molecules. Further studies are needed to charac-
terize the in-vitro synthesized DNA molecules and to determine the mechan-
ism of viral DNA replication. 
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DISCUSSION 
Dr. Labonnardiere : You told us about the alkali-sensitive regions in Herpes 
virus DNA and if I heard right you assumed that these regions of DNA might 
correspond to the initiation points of replication such in OKAZADI's model. 
Is that right ? 
Dr. Becker Yes. 
Dr. Labonnardiere : So why do you think this would be special to this virus 
whereas I think for bacterial DNA for instance where OKAZAKI's model might 
imply as well here are no such alkali-sensitive regions. 
Dr. Becker : The working hypothesis is that this supposed "RNA" se-
quence or ribonucleotide containing sequences in the viral DNA might be 
part of the mechanism of replication of the viral DNA. The ribonucleotide 
sequences are in one strand since there is only one strand which contains 
these alkaline sensitive regions. This sequence is a signal for the DNA 
polymerase to initiate on the opposite strand. The deoxyribonucleotides 
are then polymerized and the turning point for the enzyme to continue to 
synthetize DNA on the opposite strand is controlled by a second ribonucleo-
tide sequence. In other words when there is the opening of the duplex, the 
polymerase will go to the first to the alkali-sensitive region and then the 
polymerase will turn back with the synthesis of the OKAZAKI piece. 
So opposite to the alkali-sensitive region on the new 
strand of DNA should be a gap opposite to the ribonucleotide sequence. 
At the end we will find ourselves with two progeny DNA molecules: in one 
molecule the old strand will contain the alkali-sensitive sequenc~s and the 
new strand will be alkali-resistant. In the second molecule the old strand 
will be alkali-resistant and the new strand alkali-sensitive. 
This is just a working hypothesis but we are trying to find 
out if indeed we have the pieces of DNA synthetized this way both in vivo 
and in vitro. 
Dr. Scholtissek : It is known that OKAZAKI pieces have about 3000 nucleo-
tides. Does this correspond to the size of DNA alkaline treatment which 
you get ? Are these pieces of DNA also about 3000 nucleotides big? 
Dr. Becker Well they seemed to be different sized. So the spacing 
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of this region is different. But this does not rule out the possibility 
that they are not the only signals for DNA synthesis. We think there are 
four or five alkali-sensitive regions but this is not yet settled, 
Dr. Scholtissek : Can you get your in vitro system free of ribonucleotide-
triphosphates because if you can and you do not supplement your system with 
the ribonucleotide-triphosphate ¥OU should be able to get either only the 
pieces or no DNA synthesis in-vitro? 
Dr. Becker : When we add ribonucleotide-triphosphates to the in vitro 
DNA synthesizing reaction mixture containing nucleotides from infected cells 
we do not stimulate it. However, we did not try to eliminate completely 
the ribonucleotides from the nuclei or dialyse them out. I do not think the 
ribonucleotide-triphosphates are going to influence the reaction. 
Dr. Scholtissek : But I mean you need some RNA synthesis in any case, in 
order to start the DNA synthesis according to your model. 
Dr. Be9ker : We do not know the DNA polymerase under in vitro cond-
itions completes what was initiated in vivo. 
Dr. Scholtissek : But then I want a different question. At the beginning 
you showed a slide in which you showed that about 10 to 15 percent of the 
DNA synthetized in vitro banded at a density of the cellular DNA, Did you 
also hybridize this material with viral DNA because it could be if you syn-
thetize your DNA in pieces that just by chance that the G + C content might 
be distributed at random during the total length of DNA in such way distrib-
uted that you might end up with viral DNA with a lower density ? 
Dr. Backer We spent quite a long time on studying the density of 
fragmented DNA molecules; it was found that all the HSV-1 banded sharply 
at the density of 1.718. Nothing in any experiments banded at a lower den-
sity, So whatever happens that there are no sketches of a dA-dT sequence 
more than twenty or twenty-five, I think of twenty nucleotides becauae 
Herpes DNA is very sensitive to Distamycin A which preferentially binds to 
poly-~~ sequences and requires DNA with about twenty nucleotides in size. 
But more than that, by no means you can fractionate the DNA in fragments 
of Herpes virus DNA to find a fraction which will band at a lower density. 
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The DNA which appears at density of 1.70 apparently is cellular. 
Dr. McAuslan : How positive are you that this was in fact Herpes DNA 
that you were looking at ? Did you actually hybridize it against Herpes 
DNA? Or are you only going on faith in the density ? 
Dr. Becker : Although we are quite confident that the DNA which app-
ears is synthesized in the Herpes virus infected cells and bands at the 
density of 1.718 is only Herpes DNA, we are doing hybridizing this DNA to 
viral DNA. 
Dr. McAuslan : A second question concerns this question of nicks in 
the Herpes DNA. I seem to remember that Dr. BICKEN from England mentioned 
that if they prepared DNA fro~ freshly grown Herpes virus they could see no 
evidence of any nicks. Whereas if they stored the virus for some time nicks 
appeared. And I am wondering if these experiments with a former made have 
really been done at the same time and at the same batch of Herpes virus as 
the alkaline denaturation. 
Dr. Becker In parallel and on the same preparations and in so many 
times that it seems to be real we have alkali-sensitive sequences in fresh 
and old virus. As a rule we do this experiment on fresh virus. It is our 
observation that on storage of the purified virions the viral DNA is frag-
mented due to double strand breaks. The reason for the degradation of the 
DNA is not yet known. 
Dr. Bachrach I wonder if in purified DNA from Herpes virus you find 
ribo-C there and if you analyze also, is there an enzyme which will hydro-
lize that ribo-C runs ? 
Dr. Becker : We can demonstrate the presence of ribo-C only if we 
label the cells with radioactive uridine. The uridine is incorporated into 
deoxy-C but there is also a small amount of radioactivity in a base which 
runs in chromatography to a postition very close to the ribo-C marker. 
This is done by digestion with a variety of DNAses, to isolate the ribo-C. 
This is as far as we have got. But as the label did not run exactly as 
ribo-C, I still have some reservations ab,out it. Incidentally, Dr. Herbert 
Rozenkranz at Columbia University, New York, had found a similar situation 
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in T5 DNA and also in Herpes virus DNA. 
Dr. M. Schlesinger :I think this is something Dr. Bachrach was asking about. 
There is an enzyme in E. coli that will split a deoxynucleotide, ribonucl-
eotide double strand hybrids, namely ribonucleic H. Have you tried this 
or can you get this or does it work ? 
Dr. Backer : Not yet. It could be that this is a very short sequence; 
Dr. Rosenkranz estimates that it contains not more than 20 ribonucleotides 
in one stretch. 
Dr. McAuslan can you tell us a little bit more about the mechanism 
of action of synthesizing an enzyme after inhibiting DNA synthesis and can 
you refresh my memory about some studies I think you reported about the 
synthesis of Herpes DNA in the presence of inhibitors ? 
Dr. Backer : Under in vitro conditions nuclei from infected cells 
treated with inhibitors which affect the DNA (e.g. Distamycin) do not s,yn-
thesise DNA at all. Nuclei from cells treated with inhibitors which do not 
affect the DNA but inhibit a biosynthetic step (e.g. ara-C and hydroxyurea) 
a DNA polymerase is synthesised which synthesises DNA for a period of 10 
minutes only and stops. The DNA product has a density of cellular DNA. 
Dr. s. Schlesinger :Two question; the first: how is it that you prevent the 
uninfected cells from incorporating thymidine ? and the second is: as I 
understand the inhibition experiments were all done by killing the cells 
by inhibitors, what happens if you treat the nuclei with the inhibitor ? 
Dr. Backer : The conditions for the in vitro DNA synthesis of those 
used for E. coli DNA polymerase assays. By testing a variety of conditions 
for DNA polymerase activity in vitro synthesising we found conditions which 
shut off the uninfected cells but not the infected ones. We showed that 
9o% of the in vitro synthesised DNA had viral specificity and 1o% was cell-
ular DNA. When we used inhibitors to inhibit in vitro DNA synthesis, we 
had found that only cellular DNA was synthesised in vitro. It is possible 
that the same enzyme might be responsible for the cellular DNA synthesis 
and this will explain why in vivo we get the synthesis of viral and cellular 
DNA since the latter was completely shut off due to the viral infection. 
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This is the answer to the first question. 
The answer to the second question: If you add inhibitors to the isolated 
nuclei in vitro the inhibition depends on the mode of action of the inhibi-
tor e.g. Distamycin which binds to DNA and will inhibit nuclei in vitro 
while ara-C or hydroxyurea, which function only in vivo, will have no effect 
in vitro. 
Dr. Scholtissek : I have one additional question to the first one; may 
I ask you- did you try to label your viral DNA in vitro by using non-lab-
elled deo~ nucleoside-triphosphate and one or two labelled ribonucleoside-
triphosphates ? 
Dr. Becker Not under these conditions. 
Dr. Scholtissek : But this would be a good experiment to show that RNA 
synthesis is necessary. 
Dr. Becker : Addition of ribonucleoside-triphosphates to the in vitro 
reaction mixture had no effect on the extent of TMP-H3 incorporation into 
DNA. 
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MODIFICATIONS OF SOI1IE MAIN PROPERTIES 
OF THE A~ICAl~ SWI~m FEVER VIRUS 
C. SANCHEZ BOTISA, A. ORD.AS, A. SOLANA, T. MATE, 
J.M. SIE~~, J. OLIAS, M.E. CARNERO and S. DIAZ 
I.N.I.A. - CRIDA- 6, Department of Animal Virology, 
Emba.jadores, 68 - MADRID- Spain 
The knowledge of some properties of the African Swine Fever virus (ASFv) 
brings some interesting tests for the practical diagnosis and control of the 
disease !n the field. 
Among them, one can find : 
a) the ability for hemadsorP.tion (Malmquist and Hay, 1960) 
b) the fixation of fluorescent antibodies (Heuschele and all, 1966 
- Boulanger and all, 1967 - Carnero and all - Sanchez Botiza 
and all, 1970 - 1971). 
c) the cytopathic effect in cell cultures 
d) the ability of the virus ada~tatin~ survivin~ in ticks (arga-
sidae) (Sanchez-Botiza, 1963) 
The three first ~ro~erties are considered as essential and stable for 
the identification of the virus and they constitute the basis of the present 
techniaues used for the diagnosis of African Swine Fever. 
It is the ability of the virus to survive i~ ticks, as observ~d in Spain 
(Sanchez Botiza, 1963) which could explain the transmission of the disease 
the mechanism of which being ignored at this time, apd lead to the new sani-
tary rules for the control of the disease. 
Nevertheless, the ability for hemadsorption, the fixation of fluorescent 
antibodies, anti_african swine fever virus and the cytopathic effect changed 
to some extent during the epizooty and induced new difficulties for the ra~id 
identification of the virus, and subseauently for the control of the disease. 
Modifications of the ability of the ASFV for hemadsorption 
The modifications which were observed could be related to some changes 
in the antigenecity of the virus due to the persistence of the epizooty. 
The antigenic composition of the ASFV is still not enou~h known. The 
existence of some specific soluble antigens which could be revealed by different 
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immunological reactions (complement fixation, immuno precipitations in agar 
gel, inhibitions of hemadsorption, etc.) was demonstrated. But one does not 
know the native antigens of a complete virion and what are the antigens pro-
duced by the infested cell during the viral replication and which are not 
incorporated in the virion. 
The mechanism of hemadsorption as observed by Malmquist and Hay (1960) 
in ASFV infected leucocytes -cultures is not well known. Onecould think of 
a specific antigen produced by the infected cell and associated in the me-
chanism of viral replication. 
This hemadsorbing antigen (infectious antigen) does not seem to be 
essential for the ~owth and the maturation of the complete virion. 
This hypothesis was confirmed by the presence in the natural field of 
non-hemadsorbing ASFV strains, as it appears in vitro after a certain number 
of passages of the virus on cell cultures. 
It was shown that the virus ability for hemadsorption changed during 
the epizooty. It is interesting to remind that during the two first years 
(1960 - 1962) of the epizooty in Spain, the wild ASFV always produced re-
gularly the hemadsorption in leucocyte cultures. 
Since 1963 and 1964 (Sanchez Botiza, 1965) one observed for the first 
time non~hemadsorbing wild ASFV strains (0,09 to 0,21 %which produced a 
cytopathic effect without the expected hemadsorption ). During the follow-
ing years (from 1965 up to 1974) 0.32 to 5.19 up to a total of 216 of non 
hemadsorbing ASFV strains were isolated each year. 
Table ! shows the figures established for the non hemadsorbing virus 
strains from pigs which died from African Swine Fever,and the number of 
field samples which required one, two, three or four passages on leucocyte 
cultures to produce the hemadsorption. 
In parallel, it was observed that during the epizooty the time required 
to produce the hemadsorption reactions was increased (table 2). 
These observations prove the existence in the natural conditions of non 
hemadsorbing viral strains. The identification of the virus can be confirmed 
by inoculation to pigs and by immuno fluorescence. On another side, Coggins 
(1968) succeeded inmolating the non-hemadsorbing fraction from two ASFV 
strains and more recently Pini and Wagenaar (1974) isolated a non-hemadsorbing 
strain. 
T A B L E I 
NECESSARY PASSAGES FOR H~·UlDSORPTION AND NON HEMADSORBING VIRUS STRAINS 
Total Number Number of samples and necessary passages for hemadsorption 
of positive Year 
samples from First Passage Second PassagE Third Passage Fourth Passage 
the Field Samples ~ Samples 1ft Samples dl /C Samples ~ 
1965 909 841 92,51 50 5,50 6 o,66 2 0,22 
1966 2.184 2.044 93,58 103 4,71 7 o, 32 - -
1967 2.413 2.295 95,10 67 2,67 2 o,o8 - -
1968 1.332 1.199 90,01 102 7,65 8 o,6o - -
1969 1.144 1.076 94,05 43 3, 75 - - - -
1970 1.345 1.260 93,68 60 4,46 10 0,74 - -
1971 1.428 1.308 91,50 86 6,02 14 0,98 1 0,07 
1972 911 842 92,42 53 5,81 6 0,65 1 0,10 
1973 622· 594 95,49 21 3,37 5 0,80 - -
1974Jl 462 413 89,39 25 5,41 - - - -
'IOTAL 12.750 11.872 93,11 610 4,78 58 0,45 4 0,03 
fl First six months 
Samples with non-
hemadsorbing virus 
Number et/, 
10 1,10 
30 1, 37 
49 2,03 
23 1,72 
25 2,18 
15 1,11 
19 1,33 
9 0,98 
2 o, 32 
24 5,19 
206 1,61 
to:» 
0 
~ 
-· 
!_!l?__u_~ 
P"ERCENTAGE OF POSITIVE HEMADSORPTION REACTIONS FOR AFRICAN SWINE FEVER DURING THE PERIOD OF OBSERVATION 
OF THE LEUCOCYTE CULTURES IN S~!PLES FROM THE FIELD 
·~ 
Total number D a y s Year 
of samples 1 2 3 4 5 6 7 8 more than 8 
1970 1.354 60,0 17,3 6,3 3,2 3,0 1,4 1,0 0,4 7,30 
1971 1.443 53,5 16,2 9,0 5,8 2,3 1,3 1,2 0,3 10,4 
1972 929 49,0 22,9 8,6 4,7 2,5 1,4 0,7 0,3 9,9 
1973 1.413 37,9 19,1 I 13,3 8,8 7,0 4,1 2,2 1,7 4,8 
~ 
In this table one can observe the progressive increase during the disease of the necessary time for the ASFV 
to perform the hemadsorption. 
too:) 
0 
en 
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TABLF. 3 
W~BER OF NECESSARY PAS~Ar.ES ON LEUCOCYTE CULTURES FO~ 
OBTAINING THE UISAPPEARANCE OF THE HF,¥ADSORPTION ABILITY 
0 J<, THE 'TIB.tTS. 
Strain ~umber of pa.ssa.ges 
EH .10 
Cba x R 110 
B86 50 
CD 60 
AL 70 
LG 80 
Cba 90 
L 100 
PV 150 
VP 230 
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In vitro most of the ASFV strains can loose their hemadsorb1ng property 
afte~ a variable number of passages on cell cultures. 
Table 3 shows the results on 11 strains, of the study of the relat1onsh1ps 
between the serial passages on leucocyte cultures and the hemadsorbing abi-
lity. From these results the loss of the hemadsorb1ng ability is obtained 
after 40 to 80 passages on leucocyte cult11res for eight strains. For the 
three other strains, the loss of the hemadsorption property is observed res-
pectively after 100, 150 and 230 passages on leucocyte cultures. 
Modification of the abil1ty of the wild virus for the fixation of fluores-
cent antibodies 
Among the main modifications of the propert1es of the wild v1rus, one finds 
the loss of ability for fixing the fluorescent antibodies. 
During the 1968 and 1969 years, 1t was possible to ident1fy the v1rus in ani-
mals died from African Swine Fever qy the direct immunofluorescence. In 1973, 
it was only possible to 1dentify qy this technique, the viral ant1gen in 55% 
of the ident1fied breaks of Afr1can Swine Fever. 
The virus present in tissues of died an1mals from African Swine Fever, can 
now escape the diagnos1s through the presence of anti-ASFV antibodies which 
block the fixation of fluorescing ant1-ASFV antibodies. 
The blockade of the v1rus qy ant1bodies and the frequent formation of anti-
bo~-antigen complexes which cannot be revealed qy fluorescing antibodies is 
due to numerous building of antibodies which eo-exist with the virus and 
react 1n fix1ng to the peripheral surface of the virus. 
Modif1cations in the cytopathic effect 
The cytopath1c effect of the wild ASFV on the leucocyte cultures was esti-
mated to be the most constant characte~. All the field strains (from 1961 
up to 1971) produced a cytopath1c effect during the first passage on leuco-
cyte cultures. In 1972 and 1973, wild strains appeared wh1ch did not pro-
duce cytopathic effect on a primary culture but only after several ldenti-
cal passages. 
So, it was possible to isolate in our laboratory ASFV strains which did pro-
duce a cytopathic effect only ten passages on leucocyte cultures. The identi-
ficatlon of the v1rus was nerformed qy immunofluorescence; one of the two 
v1ral strains does not induce hemadsorption and behalves as a non-hemadsor-
bing non-cytopath1c strain 
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The other viral strain produc$only hemadsorption after 7 or 8 passa~es. 
The titer of the virus after the tenth passage on leucocytes cultures 
-'i.6 -6. 'i 
sets up 10 to 10 • 
The loss of cytopathic effect is an imPOrtant change if one takes in 
account that although the percenta~e of strains presentin~ such a loss is 
presently weak, the presence of non-hemadsorbing and non-cytopathic ASFV 
strains could raise some difficulties in diagnosis and localising t~e disease • 
.!!!!E!::ct_~,!__!~~dificat~~~_£!_!~pr~_E~ti~~~!_!he_~ild ASF~~~-th~ 
diagn~~is~ the~.!:_se~ 
In addition to the changes in the properties of the virus, the clinical 
framework of the African Swine Fever changes in some extent during the epizooty. 
The delay between the natural inoculation of the virus into the animal and its 
death is presently shorter than some years ago. Now, most of the breaks pre-
sent a clinical phase of 14 days. Previously death occured between 6 to 8 days 
after infection. 
Presently the subacute form of the disease is very frequent and the number 
of subclinical and chronical forms IS increasing. The general mortality de-
creased and the symptons and lesions loosed their first typical characteristics. 
Due to these changes in the clinical aspects, difficulties arived not 
only on the field but also at the level of the speed of the assessment of the 
laboratory diagnosi~. 
On the field, the new clinical forms can be ignored or considered as 
other pig diseases clinical forms. At the laboratory level, the usual Im-
proved technicrues for the diagnosis of ASFV can loose presertly their effi-
ciency in assessing a quick diagnosis of the subclinical and subacute chroni-
cal forms of the disease. 
The technique which was usually applied before the presence of the modi-
fications of the virus for the quick diagnosis of the African Swine FevP~ was 
based on the presence of direct immunofluorence on homogenates from tissues 
and organs (Bool, Ordas and Sanchez Botiza 1969). This method requires only 
2 to 3 hours. The negative samples are submitted to the inoculation in leuco-
cytes cultures in view of the hemadsorption test. 
Presently the virus provokes, during the new clinical forms of the 
209 
disease, the formation of h1gh levels of ant1bodies and consequently a high 
percentage of p1gs died from African Swine Fever contains the v1rus and the 
ant1 bodies. 
The presence of ant1bodies at the tissue level or the small titers of virus 
which can be demonstrated in the subacute or chronical forms lead to the 
loss of sens1t1vity of the application of the d1rect immunofluorescence 
technique on homogenated for the quick diagnos1s of the disease. 
In 1970, 76% of the samples were positive to this test. In 1973, only 55% 
were pos1tive 0 
Nowad~s, the frequency of the suspect samples for ASFV where the virus is 
blocked qy the antibodies needs a new technique for the quick diagnos1s of 
the antibodies extracted from organs usual~y sent to the d1agnostic labo-
ratory. 
The new method set up and performed in our laboratory 1s based on the iden-
t1ficat1on of IgC anti-ASFV extracted from tissues of animals wh1ch died 
from a disease, th1s qy indirect immunofluorescence. The sensitivity of our 
method ra1ses 80% of the Afr1can Swine Fever cases. Presently the search of 
antibodies is more sensitive for the diagnosis than the ident1fication of 
the v1ral antigen 1n tissues qy means of immunofluorescence. 
The concomittant use of both tests lead to a great progress : direct immu-
nofluorescence for the viral antigen and 1ndirect immunofluorescence for 
the identificat1on of tissular antibodies. Recent studies permit the diag-
nosls of 93.4% of the cases of African Swine Fever in 3 to 4 hours. 
!daptation and survivance of the ASFV in the tissues of t1cks 
The finding of the virus in ticks (orn1thodorus erraticus) dur1ng the spa-
nish ep1zooty (Sanchez Botija, 1963) shows the transm1ss1on of African 
Swine Fever to pigs by this vector. This finding was conf1rmed in Tanzany 
qy Plowright (1969) with Ornithodorus Moubata present on wild pigs (Phaco-
choerus, Potamochoerus). The study of this contaminat1ng mechanisms, un-
known 1n Spain by those times, contr1buted to improve the knowledge on the 
d1sease in Africa. 
The studies of the survival of the virus in Ornithodorus showed its adapta-
tlon in the tissues of this arthropod where he could survive several years 
as a virus "tanker". 
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The adaptat1on and the surv1val of the v1rus in the tick during the Span1sh 
epizooty was certainly fac1litated because the v1rus which came in the Iberic 
pen1nsul had 1ts natural "tanker" in African t1eks. 
On the basis of such observations new sanitary control measures against the 
d1sease were taken includinP, the measures against the development of th1s 
arthropod. 
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Slmn~Y OF THE SESSION 
B.R. McAuslan 
If we look at the programming of DNA for various vir-
uses we see some differences. Pox viruses show a distinct short phase of 
DNA synthesis followed by the maturation of virions. While it is said to 
replicate entirely in the cytoplasm, no-one yet, I believe, has been able 
to get viral production from enucleated cells. One does get viral DNA and 
proteins made in such artificially enucleated cells, but not mature virus, 
so one is not sure of the significance of the role of the nucleus in the 
replication of cytoplasmic viruses. In fact, I believe that there is some 
evidence that pox virus DNA may in fact enter the nucleus and perhaps inte-
grate with its DNA. If we look at the nuclear viruses such as Adeno virus 
and Heroes viruses, their DNA is synthesised over a much longer period of 
time and virus maturation then follows a few hours behind DNA synthesis. 
Nevertheless, viral DNA synthesis and viral maturation are proceeding simul-
taneously through the maturation cycle. If we now shift attention to the 
icosahedrial cytoplasmic deoxy viruses such as frog virus and presumably 
the other viruses, these apparently replicate in the cytoplasm like pox 
virus but the programming of their macromolecular synthesis resembles more 
the herpes viruses. In fact, these ICDV's are a sort of missing link bet-
ween pox viruses and herpes viruses, although that's not to employ the phra-
se in evolutionary sense - perhaps a missine piece of the mosaic rather than 
a missing link. If one wants to study DNA synthesis per se, then the ani-
mal viruses are probably not the best systems for us to work with, although 
as Dr. Beaker has so neatly shown it is feasible to study viral DNA synthe-
sis using the nuclei from infected cells. However, I think what is easiest 
to approach and what is most interesting among the animal DNA viruses is 
the number of structural aspects one uncovers when one takes a close look 
at viral DNA per se. For example, in the Parvo viruses, there is now evi-
dence that there are complementary sequences at the end of the DNA so that 
it can form a sort of pan handle structure. In the pox viruses from sedi-
mentation data of Berns, it appears that there could be some interesting 
cross-linking so that it forms a hairpin structure. 
If we consider Herpes simplex virus DNA there is the 
evidence that at least one strand appears to be extensively nicked, but 
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we don't know the significance of that at this time. Herpes simplex virus 
DNA is infectious and incidentally, Dr. Bachrach and Adeldinger and eo-
workers showed some time ago that African swine fever virus DNA is also in-
fectious. It would be interesting to see if other members of the ICDV group 
have infectious DNA, and this could be done very readily with the frog virus. 
Frog virus DNA has been reported by Kelly, whose work is in press, ·to be 
extensively nicked also, so that one only gets about 1o% of the total DNA 
molecules that come out as intact strands. 
Again, we know almost nothing about the significance 
of all these unusual structural aspects of the various DNA viruses, but I 
suggest that we certainly should continue a study of the physical chemistry 
of the DNA of all these virus groups and especially African swine fever 
virus, where to date, all of the work has been almost exclusively concerned 
1rith the epidemiology for obvious practical reasons. Finally, I would like 
to point out that some of the more complex DNA viruses such as pox and frog 
virus, adeno virus, perhaps herpes virus, have associated enzymes that app-
ear to be essential components of the virion. At least some of these enzymes 
are nucleases. Pox virus, for example, has one or two nucleases associa-
ted with the particle. Adeno virus has been reported to have an endonuc-
lease associated with the pentons. Frog virus has two endonuclease acti-
vities within the particle. Pox virus also has a DNA dependent ATPase 
within it and frog virus has an ATPase in it. Now, for want of a better 
idea, one usually says that such enzymes must have some sort of role in 
repair or re-combination or packaging of DNA or modifying the DNA in some 
way that it can initiate replication. In fact, we really don't know any-
thing about the function of these DNA associated enzymes and I think that 
this is one area which will need some continual investigation. 
SESSION III 
sYNTHESIS OF VIRAL PROTEINS 
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IN VITRO SYNTHESIS OF VIRAL PROTEINS USING VIRAL mRNA 
by 
B.A.M. van der Zeijst 
UTRECHT 
INTRODUCTION 
Until now we have occupied ourselves mainly with the 
synthesis of viral nucleic acids. From now on we will focus on the synthe-
sis of viral proteins. Yet, this means in practice first the synthesis of 
a nucleic acid, the mRNA 1 which is translated into a protein by the normal 
machinery of the cell. The strategies which have been used to obtain the 
translation of the viral genome into proteins are varied. DNA-viruses have 
a pattern which is rather lH-e that of the normal cell; animal RNA-viruses 1 
however, behave in a more complex way (see Table I). 
A first criterion for the classification of RNA-viruses 
according to their replication mechanism, is the polarity of the viral gen-
ome which can be plus (+) 1 minus (-) or double-stranded (~). We define 
plus as the polarity of mRNA. Connected with this criterion is the occurr-
ence of a RNA polymerase in the vir~on, which is obligate in -s+randed and 
double-stranded RNA-viruses. A second criterion is the occurrence of a 
multipartite genome or in the case of -stranded viruses the synthesis of 
several mRNA's on a larger genome. A third criterion is the occurrence of 
post-translational cleavage of viral precursor proteins. 
From Table I we see that using these criteria there 
are 6 different combinations in 7 different structural groups of animal 
RNA-viruses. 
What is the sense of this variety ? If we may be tele-
ological for a moment we perceive several ways 1'1hich Nature has found to 
circumvent the use of polycistronic mRNA 1 the commonly used mechanism in 
bacteria and their viruses, but unknown in eucaryotic cells. However, re-
search in virology is much more complicated than philosophy. Stringent 
proofs for the schemes given in Table I, require the use of advanced tech-
niques to assay the information content of mRNA 1 s. 
TABLE I 
Classification of RNA-viruses according their replication 
mechanism. The protein cleavage found in reovirus has been 
ignored, as it is not essential for virus replication. 
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In this paper I will summarize some results of the use 
of in vitro protein ~thesizing systems and demonstrate that this tool is 
very useful for this purpose. In addition these systems can contribute to 
the elucidation of regulatory processes connected with virus replication, 
like the influence of virus infection on the RNA and protein synthesis of 
the host cell on one side and the working mechanism of interferon on the 
other side. 
The cell-free systems 
At this moment there are some standard cell-free systems 
in use for the assay of putative mRNA 1 s. In general these systems are crude 
lysates of animal cells. By preincubation under conditions which favour 
protein synthesis, ribosomes are freed from their endogenous mRNA 1 thus mak-
ing them available for the translation of added mRNA 1 s. Then low molecular 
weight compounds are removed (by dialysis or gel filtration) in order to be 
able to measure incorporation into protein of added radioactively labelled 
amino acids. All necessary compounds are added, together with fractions 
which are supposed to contain mRNA. Experiments of this type are designed 
to answer the questions of 1 ) whether there is a stimulation of protein s,yn-
thesis and- if this is the case - 2) whether the newly formed polypeptides 
can be identified or correlated 1rith known viral proteins. 
Systems derived from rabbit reticulocytes (33 1 341 37 1 
38) 1 Krebs II ascites cells (3-5 1 12 1 18 1 21 1 31 1 32 1 37 1 38, 68, 77) 1 
Ehrlich ascites cells (15 1 45) 1 L-cells (12 1 15 1 16 1 181 21 1 22 1 32 1 36 1 
37) 1 HeLa-cells (15 1 37) 1 Chinese hamster ovary cells (37 1 38) and Sarcoma 
180 cells (27) have been used. 
More recently a wheat germ system has been introduced. 
h~eat germs do not contain polyribosomes and it appeared that a lysate can 
faithfully translate a number of mRNA's from animals and their viruses giving 
a very low background incorporation and thus a prominent stimulation of pro-
tein-synthesis (14 1 38 1 51, 53). This facilitates in particular the analy-
sis of the products which are formed. 
Before looking at the results which have been obtained 
I want to discuss two problems in more detail, namely: 
1. How can one get mRNA and how much is needed? 
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2. How can the polypeptide products formed in vitro be identified ? 
Isolation of mRNA 
The most direct method is to isolate polyribosomes and 
dissociate them in order to liberate mRNA. Standard methods are now avai-
lable to isolate polyribosomes from cells in culture (19). If the approxi-
mate molecular weight of a mRNA is known one can make an estimate of the 
sedimentation coefficient of the polysomes in which it will be present. The 
number of ribosomes which are attached to a mRNA is dependent on the equili-
brium between initiation and elongation (and release) during protein synthe-
sis. About one ribosome is present per 90 nucleotides (i.e. 30,000 daltons) 
mRNA (23, 71). Moreover for eucaryotic polyribosomes the following relation-
ship exists between the number of ribosomes (n) and the s20 ,w of the poly-
somas (sn) (44): 
log Sn = log 80 + 0.60 log n 
When combining these two data we obtain 
were 
MW log 80 + 0.60 log RNA 
3x104 
MWRNA is the molecular weight of the mRNA. 
If, for example, the MWRNA of 2.6x106 for poliovirus is inserted into this 
formula, a maximum s20,w of 1160 can be calculated for the virus specific 
polysomes. In fact a sedimentation coefficient of 400 S is found early in 
infection (47). This discripancy could be due to a different ratio between 
initiation and elongation for viral mRNA as has been found during the late 
infection of HeLa cells be adenovirus-2 (48). 
It is evident from these calculations that some predic-
tions can be made about the position of virus specific polysomes in a den-
sity gradient. Recently, several groups of investigators employed ts-mut-
ants, which cannot form nucleocapsids under restrictive conditions for the 
study of togavirus-specific polysomes (30, 41, 56). We found that there 
is no need for such an elaborate approach. If one assumes that the 26 S RNA 
6 (1.5 x 10 daltons) serves a messenger function in alphavirus infection, a 
sedimentation coefficient of 840 S can be calculated. Confusion with viral 
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nucleocapsids sedimenting at about 150 S is therefore not likely to occur. 
In fact in our hands Semliki forest virus polyribosomes have sediment co-
efficients of 400 S and more, provided that so called "runn of" of ribosomes 
from polysomes which would reduce their size is prevented. This can be done 
by the addition of cycloheximide to cells before lysis which "freezes" the 
polysomes. 
Another way of obtaining mRNA consists of extraction of 
the whole RNA content of the infected cell with subsequent isolation of the 
appropriate fractions. 
For most RNA-viruses one can easily discriminate between 
host cell RNA-synthesis and viral RNA-synthesis using actinomycin D. The 
detection of oncornavirus specific polysomes, however, is not so simple. 
In this case rather intricate methods like hybridization of DNA transcripts 
from the virion RNA with polysomal RNA are required (17 1 73). From DNA-viru-
ses which do not depress cellular RNA synthesis mRNA has also to be isolated 
by hybridization with viral DNA. This has been done for simian virus 40 
(55). 
In some cases it is possible to synthesize the mRNA 1 s 
in vitro, a technique which has been exploited~· for reoviruses (2 1 21 1 
37 1 66) and vacciniavirus (3 1 18, 28 1 29). From these in vitro systems one 
can obtain large amounts of mRNA. This is convenient as generally at least 
about 1 pg of viral mRNA is needed to obtain enough incorporation. In most 
cases this amount is not saturating. 
Identification of products 
There are several methods which have been used to corre-
late proteins formed in vitro to viral proteins. First coelectrophoresis 
can be used as a indication for the identity of two proteins. A more strin-
gent proof however should be given by analysis of tryptic digests. Also 
immunoprecipitation can be used (34 1 63, 75). 
It has appe~ed that in cell-free systems no post-trans-
lational proteolytic cleavage occurs (5 1 21 1 31 1 36 1 37). On this place I 
should mention another method which can be used to assay mRNA: the injection 
of mRNA into Xenopus laevis oocytes. In the case of encephalomyocarditis 
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virus mRNA all the normal cleavage products were formed (35). 
Survey of results obtained in cell-free systems 
I should like to give a short review on the kind of 
information one can obtain using these in vitro systems. 
DNA-viruses 
1. Poxvirus 
RNA can be obtained by in vitro incubation of vaccinia 
virus. It is complementary to a part of the viral DNA and it has properties 
similar to those of early mRNA (28, 29). Its messenger function has been 
directly proven by the stimulation of protein synthesis which it exerts la 
~ (3, 18). The products, however, have not yet been compared with auth-
entic viral coded proteins. 
2. Papovaviruses 
Recently the translation in a wheat germ system of simian 
virus 40 mRNA, purified by oligo (dT)-cellulose chromatography from infected 
cells, has been described. A polypeptide which was in size and tryptic pep-
tide composition identical to the major capsid protein of the virion was 
synthesized (51). The mRNA could be further purified by hybridization to 
the viral DNA. Several other peptides which were also formed have to be 
analyzed into more detail. 
RNA-viruses 
1. Picornaviruses 
There is now ample evidence that the viral RNA (mole-
cular weight 2.6x106 ) has one initiation site for protein synthesis. The 
translation product, a "polyprotein", is processed by proteolytic cleavage 
to smaller proteins. The stable fragments are produced in equimolar amounts 
(8, 13, 26, 52). Detailed studies of the products of cell-free protein 
synthesis have clearly shown indeed that there is only one initiation site 
for protein synthesis (45, 68). Moreover, larger proteins than the capsid 
proteins, containing the same tryptic peptides as the capsid proteins, were 
produced (4, 12, 15). However, no translation product equivalent to more 
than 6o% of the viral genome could be found. Several discrete proteins are 
formed which all initiate at the beginning of the genome, but which are 
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prematurely terminated. No proteolytic cleavage was observed (5, 31). As 
has been mentioned before allnormal cleavage products has been found in 
Xenopus oocytes (35). An interesting observation was that an initiation 
factor from Krebs II ascites cells is necessary for protein synthesis direc-
ted by encephalomyocarditis RNA but not by globin RNA (77). This might be 
a factor which determines the ability of cells to support virus replication. 
2. Reoviruses 
The study of the functioning of reovirus mRNA's has 
been greatly facilitated by the possibility to prepare in vitro the messen-
gers for all ten pieces of the double-stranded genome (2, 66). Direct evi-
dence that the RNA transcribed in vitro is indeed functional mRNA has come 
from tests in cell-free systems (21, 37). Proteins were formed which eo-
electrophoresed with the reovirus specific proteins. When the mRNA's were 
fractionated, medium sized and short proteins were formed after addition of 
medium sized and short messengers respectively (21). No proteolytic clea-
vage of the f 1 protein to f 2 occured (21, 36, 37). 
3. Togaviruses 
Tnis group will be discussed in the last section of this 
paper. 
4. Orthomyxoviruses 
The virion contains an RNA-polymerase (10, 46, 67). 
Strands of the same and of reversed polarity have been detected in viral 
polysomes (43, 50). In an Escherichia 221i cell-free system the RNA of in-
fluenza virus was translated into a polypeptide antigenetically identical 
with the viral ribonucleoprotein (61, 62). On the other hand no messenger 
function could be found in an eucaryotic system, whereas in this system the 
matrix protein was synthesized after addition of RNA from infected cells 
(34). If indeed some viral RNA strands are+ and others- it should be poss-
ible to determine in this way the polarity of all strands. 
5· Paramyxoviruses 
These viruses have -stranded genomes. The virions con-
tain a RNA-polymerase (24, 54, 55, 72). From infected cells polysomes have 
been isolated which contain mRNA which can hybridize with the viral RNA 
(6). Newcastle disease virus codes for at least seven mRNA's having a mole-
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cular weight from 0.55 to 1.53x106 (11). Until now these species have not 
peen tested separately. Unfractionated preparations were able to direct the 
synthesis of a protein immunologically 
peptides (33). 
6. Rhabdoviruses 
identical to one of the virion poly-
Rhabdoviruses contain a single molecule of RNA that is 
complementary to the mRNA's (25). A RNA-polymerase is present in the vir-
ion (1). By sucrose density gradient centrifugation the mRNA's could be 
separated into a homogeneous 28 S species and a heterogeneous group, con-
taining at least 3 species, of 13-15 S (25, 57). Recently, it could be 
demonstrated that the 28 S species in vitro directs the synthesis of one of 
the viral proteins, the 1-protein. L~ agreement with the heterogeneity of 
the 13-15 S RNA, these code for 3 or 4 other viral proteins (38). 
7. Oncornaviruses 
Oncornaviruses contain a 60-70 S genome which is not 
multipartite in the same sense as the genomes of reoviruses and orthomyx-
oviruses. It can be split, however, after denaturation into smaller RNA's 
(see Ref. 9 for a discussion). Evidence for a +stranded genome is the abili-
ty of mRNA from infected cells to hybridize with DNA complementary to the 
viral RNA (17, 73). The 35 S messenger seems to code for a large precursor 
protein Which is split into the viral proteins (75). Until now a poor trans-
lation has been obtained using eucaryotic cell-free systems (42, 74). Sur-
prisingly, more success was obtained in an Escherichia coli system in which 
it was possible to translate the RNA of several oncornaviruses before and 
after denaturation of the RNA (20, 63). 
Conclusion and prospects 
From this survey it is clear that a considerable amount 
of information has been obtained with the aid of cell-free systems. There 
are some difficulties in translating very large genomes until the end. How-
ever, conclusive results are in this case obtained by comparison of tryptic 
peptides. When better methods have been developed to separate RNA's of 
about the same size, it will be possible to correlate all proteins of many 
virus groups to mRNA. Moreover, more light will be shed on the controver-
sial results Which have been obtained with orthomyxoviruses. Interesting 
questions like the specificity of cellular enzymes for virus replication (77) 
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and the working mechanism of interferon await an answer. Evidence for an 
effect of interferon on the level of translation in vitro has been obtained 
by several groups (16, 22 1 32). An exact mechanism, however, has not yet 
been established. 
Finally, we can ask ourselves the question: what is the 
potential usefulness of these techniques for work with the viruses of hog 
cholera or African swine fever ? Dr. McAuslan later at this symposium will 
give us the answer for African swine fever virus (or rather for iridoviruses 
in general). In the first paper at this meeting given by Prof. Horzinek1 
we have heard that togaviruses (to which hog cholera virus belongs) seem 
to use mRNA molecules that are smaller than the whole genome which has a 
molecular weight of about 4.4x106 (64). 
From virus specific polysomes of togavirus infected 
cells several different types of mRNA have been isolated (301 41 1 56). The 
major species is a 26 S RNA, having a molecular weight of 1.5x106• This 
RNA is large enough to code for all structural proteins, which have been 
demonstrated to origin by proteolytic cleavage from a large precursor pro-
tein (71 39 1 401 49 1 58-60, 65, 69, 701 76). A possible model has been 
given recently by Morser & Burke (40). They have summarized a number of 
findings in a scheme which is reproduced in Fig. 1. 
The scheme is partly based on pulse chase experiments of proteins in virus 
infected cells. A strict proof, however, requires the comparison of tryp-
tic digests as has been done by the author of the following paper, Dr.Schles-
inger1 who in fact has done the work to prove all but the two upper lines 
of the scheme (58-60). 
Whether the 26 S species is really the mRNA for the pre-
cursor of the structural proteins and what the role of the other RNA 1 s is, 
is one of the questions which can be resolved by an in vitro system. In 
our laboratory we try to answer this question by examining the products of 
cell-free synthesis of Semliki forest virus RNA 1 s. 
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26S RNA r---------------~ 
f NVP-165 
t NVP-127 
NVP-97* 
NVP-63* ~ 
I;' 
-I 
+'! 
~ A possible cleavage mechanism for the production of the virus-
specified polypeptides of togaviruses. C is the capsid protein. 
E1 and E2 are the two envelope proteins. NVP = non-virion poly-
peptide. G-20 and the other starred polypeptides are glycosylated. 
The direction of translation is from left to right (Taken from Ref. 
40). 
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DISCUSSION 
Dr. McAuslan : Could you just briefly tell us a few of the features 
of the best system available now for translation of proteins ? I think we 
mentioned before that this wheat germ system is particularly a good one. 
What are currently the best systems to use ? 
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Dr. Van der Zeijst :There are two aspects. The first is that we want to 
get a stimulation Which is as large as possible and therefore the wheat 
germ system seems to be fairly appropriate. On the other hand, we want to 
be sure to have got a system in which RNA can be translated. 
There have been some results from Lodish group about reovirus messenger RNA's 
Which were translated in several systems. The system in which most of the 
RNAs were translated is the reticulocyte system Which has, on the other 
hand, a rather high background which is reduced by the addition of exogen-
ous messenger RNA. The results which have recently been obtained with sim-
ian virus 40 indicate that in this case the Wheat germ is the system of 
choice. However, Dr. Schlesinger has got a very clear result using the 
reticulocyte system. It is necessary to have all systems in the lab. - at 
least, most of them. 
Dr. M. Schlesinger :Let me just make a comment about the Wheat germ system 
which we tried to use without success. I can report that the people at 
MIT in the laboratory of Harvey Lodish informed me that they had also heard 
from a number of laboratories throughout the country, in fact, throughout 
the world, that had been unsuccessful in using the Wheat germ system and 
apparently the trick is that in trying to obtain a wheat germ system that 
has good capacity for synthesizing proteins in vitro, one has to disrupt 
the wheat germ in a very gentle way and most people grind the wheat germ 
very vigorously with sand. Routinely, that leads to inactive extracts -
it certainly did in our laboratory. When I talked to the Lodish group they 
said that the problem people had was that in fact, they weren't making the 
extracts properly and that it wasn't so critical- that it's true that some 
sources of wheat germ are better, but that the m~in problem was how you 
made the extracts. I was told that there was one laboratory at Cold Spring 
Harbour that had sent all over the world for 30 different kinds of wheat 
germ and when they finally learned how to make the extract, they all were 
essentially the same. 
Dr. Scholtissek : Dr. Schlesinger, you just told us how not to treat the 
wheat germ but what is the trick ? 
Dr. M. Schlesinger :We've not had success in our laboratory but I was told 
that one has to very gently break open the cells - the most gentle grind-
ing possible. 
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Dr. Barr;y : I understand that in some systems, the presence of any 
double-stranded RNA is inhibitory. You may have mentioned this early in 
your talk- I didn't hear it. Could you comment perhaps on the importance 
and relative sensitivity of systems to the presence of double-stranded 
RNA? 
Dr. Van der Zei.jst :In fact, I didn't mention experiments because of lack 
of time but there have been some experiments about inhibition of single-
stranded systems by double-stranded RNA. However, no comparisons have 
been made to my knowledge between the translation of endogenous RNA and 
translations of viral RNA. These are the experiments which have yet to 
be published. 
Note added : There is, hol~ever, one report ( H.D. Robertson and 
M.B. ~athew (1973) Proc. Nat. Acad. Sci. u.s.A. lQ, 225-229) in which such 
a comparison has been made. No difference in sensitivity for double-stran-
ded RNA of the translation of mouse globin RNA and encephalomyocarditis 
virus RNA could be found. 
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FORMATION OF RNA AND PROTEIN IN CELLS INFECTED WITH 
STANDARD AND DEFECTIVE SINDBIS VIRUS 
Sondra Schles~nger, Barbara Weiss, Daniel Goran, 
Milton Schlesinger and Ranieri Cancedda 
Department of Microbiology 
Washington University School of Medicine 
St. Louis, Missouri 63110 
SUMMARY 
Sindbis virus is a relatively simple enveloped virus. 
The RNA of the virion is single stranded with a molecular weight of 
4 X 106 daltons; it is infectious and can be translated in vitro. The major 
species of viral mRNA found in ~nfected cells has a molecular weight of 
1.6 X 106 daltons (26S) and contains only one-third the nucleotide sequen-
ces of the virion RNA. The 26S RNA is believed to code for the three viral 
structural proteins. Two of these proteins (El and E2) are glycoproteins 
and are located on the surface of the virion : the th~rd protein is found 
as part of the nucleocapsid. The capsid protein and El accumulate in chi-
cken embryo fibroblasts or BHK cells infected with Sindbis virus. E2 1 
itself, deos not accumulate in these cells; instead a larger molecular 
weight precursor (PE2) accumulates and is slowly converted to E2. The 
conversion of PE2 to E2 includes changes in carbohydrate content. 
~fuen Sindbis virus is passaged at high multiplicity on 
BHK cells, defective-interfering (Dl) particles accumulate after 8 or 9 
passages. Furthermore, coinfection of cells with early and late passage 
virus causes a marked reduction in viral yield. It has not been possible 
to separate Dl particles from standard virions, but RNA isolated from late 
passages ia heterogeneous compared to early passage virion RNA. BHK cells 
infected with late passage virus have a number of properties distinct from 
cells infected with early passage v~rus. 
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One of the most striking is the appearance of a new species of RNA of mol. 
wt. 9 X 105 daltons (20S) accompanied qy a decrease in 26 S RNA. Nucleic 
acid hybridization experiments have demonstrated that the 20 S RNA is re-
lated to 26S RNA. It differs from 26S RNA, however, in its ability to 
function as a messenger. 20 S RNA is not found on polyribosomes in vivo 
and is not translated in vitro. Cells infected with late passage Sindbis 
virus show a marked inhibition in the formation of intracellular nucleo-
capsids. This inhibitioK is correlated with a decrease in the synthesis 
of capsid protein. 
INTRODUCTION 
Togaviruses are a relatively new group in the taxonomy 
of animal viruses. Members of this group are classified together based on 
similarity in size and structure; they are quite diverse in their disease 
potential for man and animals. A number of these viruses are extremely 
pathogenic and for this reason have not been amenable to detailed exami-
nation. Sindbis virus and Semliki Forest virus are two members of the group 
A togaviruses that show minimal hazard to man. Studies with these viruses 
have provided valuable information on the properties of togaviruses. We have 
been investigating the structure and replication of Sindbis virus. I will 
discuss two aspects of these studies : the processing of the viral proteins, 
and the effects of defective-interfering particles on viral replication in 
BHK cells. 
The RNA of Sindbis virus is single stranded with a 
molecular weight of about 4 X 106 daltons (49S) (1). The virion RNA is 
infectious - a property that distinguishes the togavirus group from other 
RNA enveloped viruses. The major species of viral RNA sy.thesized in infec-
tei cells is not virion RNA, but an RNA 26S of molecular weight 1.6 X 106 
daltons. This RNA has the same polarity as virion RNA and contains only one-
third the nucleotide sequences of virion RNA (1). 26S RNA in found on poly-
ribosomes in infected cells (2, 3) and can be translated in vitro (4). It is 
believed to be the messenger RNA for the structural proteins of the virioKo 
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Sindbis virions contain three distinct prote~ns (5). These proteins were 
identified after disruption of the virus and separation of the polypeptides 
b,y polyacrymalide gel electrophoresis (Fig. 1). Two of the proteins (El and 
E2) are glycoproteins with apparent molecular weights of about 50,000 dal-
tons and are located on the surface of the virion (5, 6). The relationship 
of El to E2 in the virion is not known, however E2 ma;y be located external 
to El. In experiments reported b,y Sefton, et al. (7) the intact virion was 
labeled with iodine using lactoperoxidase; a procedure that should label 
only those proteins exposed to the external environment (8, 9). Only El 
and E2 were iodinated, and E2 was labeled more extensively than El. When 
the virion was disrupted before treatment with lactoperoXidase the two 
glycoproteins were labeled equally and the internal capsid protein (c) was 
also iodinated. The latter protein is associated with the RNA in the nucleo-
capsid. In the virion a lipid bila;yer separates the nucleocapsid from the 
envelope proteins (10). The lipid and envelope of the virion are acquired 
as the nucleocapsid buds from the plasma membrane. 
roRMATION OF SINDBIS VIRUS PROTEINS 
There are a number of experiments to suggest that the discrete virion 
polypeptides are formed b,y post-translational cleavage of large molecular 
weight precursors in a manner analogous to that established for picornavi-
ral proteins (11 - 13). Although El and the capsid protein accumulate in 
infected cells, E2 is not detected in these cells after a short pulse of 
radioactive amino acids. Instead a significant proportion of the radioac-
tiv~ty is found in a protein with a molecular weight of approximately 
60,000 daltons (Fig. 1). This observation led us to suggest that E2 was 
formed b,y cleavage of the larger molecular weight protein and that the 
conversion was an essential and rate-limiting step in the budding process 
(5). We have obtained evidence to support the first part of th~s hypothesis 
from kinetic studies and b,y a comparison of tryptic peptides of the pro-
teins. Figures 2 and 3 show the results of an experiment ~n which chicken 
embryo Fibroblasts were labeled for 20 min with a mixture of 14c-labeled 
amiBo acids five hours after they had been iBfected with Si•dbis virus. 
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• 
Cell Virus 
Figure 1 Autoradiogram of an extract from l4C-labeled cells infected with 
Sindbis virus and of 35s-labeled purified virus electrophoresed 
in a SDS-acrylamide slab gel. Chick embryo cells, infected with 
virus for 6 hours, were labeled with a mixture of l4C-amino 
acids for 10 Minutes. Details of the procedures have been des-
cribed (5). 
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Figure 2 Autoradiograms of 14c-labeled viral proteins at several periods 
after a 20-min pulse of radioactive amino acids. The details of 
the pulse-chase experiment, slab gel electrophoresis, and auto-
radiography, have been described (14). 
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Figure 3 
The fate of labeled virus-specific proteins after a 20-min pulse of 14c-
amino acids. The amount of radioactivity in each protein at several chase 
times was quantitated from the autoradiograms shown in Fig. 2. Top, Data 
obtained for the proteins in the virion; bottom, data obtained for the pro-
teins in the infected cells. After the 20-min pulse, the total acid-insolu-
ble counts per minute in the cells were 1.37 X 105• They decreased to 
5 5 5 1.2 X 10 , 1.05 X 10 and 0.9 X 10 at 20 min, 40 min, and 60 min, respec-
tively, during the chase. The total acid-insoluble counts per minute reco-
vered in the virus after purification b,y sucrose gradient centrifugation 
were 234 after the 20-min pulse. They increased to 600 1 2.330 and 8.950, 
respectively, at the 20-, 40- 1 and 60-min chase time. Capsid protein, 
c=r----cJ; El, 0----0; E2 1 t----1; the putative precursor to E2 ~ • 
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The radioactivity was then chased by the addition of an excess of unlabeled 
amino acids. After the 20 min pulse most of the radioactive protein was 
represented qy the capsid proteins, El and the putative precursor to E2, 
PE2. During the chase period the decrease in isotope in PE2 was accompa-
nied qy an increase in E2. The amount of radioactivity detected in the puri-
fied virions increased during the chase period. In this time interval, 
however, only a small fraction of the total radioactivity appeared in 
virions. 
Infected cells were also labeled with 14c-arginine and 
the labeled proteins purified qy electrophoresis in polyacrylamide gels 
(14). The fingerprints of the tryptic peptides obtained from the different 
proteins proved that PE2 and E2 were closely related and that El was dis-
tinct (Fig. 4). 
Subsequent studies qy Sefton et al. have provided evi-
dence to support the hypothesis that the conversion of PE2 to E2 is an 
important step in virion formation. They analyzed the carbohydrate content 
of PE2 and E2 and found that the conversion involves the addition of galac-
tose and fucose as well as the loss of mannose (15 ) . Furthermore, iodina-
tion of infected cells using lactoperoxidase labeled both El and E2 but 
not PE2 (7). Thus, when PE2 is converted to E2, it becomes more exposed to 
the outside surface of the cell. 
A larger molecular weight viral protein has been detec-
ted in BHK cells ((16 ) and Fig. 5) but not in chicken embryo fibroblasts. 
We established the relationship of this protein (Bl) to the envelope pro-
teins qy analyzing the 14c-arginine-labeled tryptic peptides (17). Al-
though Bl is metabolically unstable its role as an essential intermediate 
in the formation of virion proteins has not yet been determined. 
It has not been possible to accumulate larger molecular 
weight viral proteins uhder normal conditions of Sindbis virus infection 
even by using very short pulses of radioactive amino acids or qy the addi-
tion of amino acid analogues (18). 
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Figure 4 Autoradiograms of tryptic-peptide fingerprints. l4C-arginins-
labeled proteins were purified on SDS-polyacrylamide gels prior 
to digestion with trypsin. The fingerprint of protein El is on 
the right, E2 in the center, and the proposed precursor on the 
left. 
Figure 5 
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SDS-acrylamide gel electrophoretic patterns of viral proteins 
from infected cells. The bottom panel shows the accumulation 
of a large molecular weight protein when chicken embryo fibre-
blasts were infected with the ts-2 mutant of Sindbis virus at 
non-permissive temperature (17). The gel was 7.5% acrylamide and 
the arrow indicates the mobility of Bl run in a parallel gel. 
The top panel is the pattern of viral proteins on a lo% polyacry-
lamide gel from BHK cells infected with Sindbis virus (17). 
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Snyder and Sreevalsan have reported that h1gh molecular weight prote1ns 
accumulate in aged chicken embryo fibroblasts infected with Sindb1s virus 
(19). The strongest evidence that there may be a single site for the ini-
tiation of protein synthesis comes from results obtained with a particular 
class of temperature-sensitive (ts) mutants. At non-permissive temperature 
these mutants accumulate a protein (ts-2 protein) of molecular weight grea-
ter than 130,000 at the expense of the virion proteins ((16, 18) and Fig 5). 
Our analyses of the 14c-arginine labeled tryptic peptides from the ts-2 
protein established that it contained peptides of the capsid prote1n as 
well as those of the envelope proteins (17). It has been difficult to 
reconcile the results with the ts mutant with the fact that the amount of 
capsid protein found 1n infected cells always exceeds the amount of enve-
lope proteins Qy at least three-fold. The possibility must be considered 
that the single init1ation site is a peculiarity associated with the tem-
perature-sensitive mutation. The existence of the ts-2 protein, however, 
proves that the capsid protein can be covalently l1nked to the envelope 
proteins; therefore, these proteins must be translated from the same mRNA. 
Studies on the in vitro translation of 26S RNA have established that this 
RNA codes for the capsid protein (4); consequently, it must also code for 
the envelope proteins. 
DEFECTIVE INTERFERING PASSAGES OF SINDBIS VIRUS 
The appearance of defect1ve-interfering (DI) particles 
is now a wellrecognized phenomenon associated with high multipl1c1ty passa-
ging of many different viruses in tissue culture (20). In those examples 
where DI particles have been well-characterized, they have been shown to 
contain less nucleic acid than the standard virion. One of the most inte-
resting features of these defective particles is their ability to interfere 
w1th the replication of homologous standard virus; they show little or no 
effect on heterologous virus. 
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We reported several years that when Sindbis virus was 
passaged at high multiplicity in BHK cells, Dl particles accumulated after 
8 or 9 passages (21). The presence of these particles was readily detected 
b,y their ability to inhibit the replication of early passage virus (table 1). 
We have not been able to separate Dl particles from standard virions (22) 
and this has made their characterization difficult. Preparations of purif~ed 
Sindbis virus that contain Dl particles have a decreased PFU to CPM ratio 
compared with standard virus (table 2). Th~s find~ng indicated that Dl par-
ticles must contribute significantly to the mass (radioactivity) of purified 
v~r~ons. RNA ~solated from standard virions contained a s~ngle peak of radio-
activity corresponding to the molecular weight of 4 x 106 daltons reported 
for virion RNA, but the RNA obtained from Dl passages was alw~s heteroge-
neous (22). The degree of heterogeneity was variable but there did appear 
to be a correlation between the amount of RNA found outside the peak of 
virion RNA and the ability of the preparation to ~nterfere w~th the yield 
of standard virus (22). We do not yet know the reason why the viral RNA is 
heterogeneous. It is possible that the defective particle population is 
heterogeneous or that some of the particles are unstable and the small pie-
ces of RNA represent degraded virion RNA. 
Infection of BHK cells with late passage virus alone 
or coinfection with late and early passages led to a marked drop in virus 
production (tables 1 and 2). We observed, however, that cells from such 
infections incorporated amounts of 3H-uridine into RNA that were completely 
unrelated to the degree of inhibition of virus production. In an experiment 
in which the virus yield was reduced by about 90 per cent there was no 
effect on the rate of RNA synthesis (fig. 6). Despite the large accumulation 
of RNA very little of the RNA was encapsidated in cells ~nfected with Dl 
part~cles. Figure 7 presents a sucrose gradient profile of the distribution 
of viral-specific RNA in cell extracts treated with 0.002 M EDTA to disso-
ciate polyribosomes and permit more clear visualization of the nucleocapsid. 
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Table 1 
Inhibition of Virus Yield qy 
Defective Particles 
Passage added (MOI )a Yield PFU/ml x 108 
6 (2.3) 8.7 
(9.2) 10 
(23) 13 
(92) 12 
6 (9.2) + 8 (2.5) 2.1 
(6.2) 1.3 
(25) 0.52 
6 (9.2) + 9 (.34) 1.5 
(. 85) 0.45 
(3.4) 0.25 
8 (2.5) 0.87 
(6.2) 0.65 
(25) 0.4 
9 ( 0.34) 0.37 
(0.85) 0.27 
(3.4) 0.17 
a) Samples of virus from the passages 1ndicated were added in a final volume 
of 0.4 ml to monol~ers of 107 BHK cells. After 1 hr adsorption at 37°, 
7•5 ml of Eagle's medium plus 6% fetal calf serum were added to each 
dish. The media were harvested 11 hr later. 
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Table 2 
Virus y~elds, radioactivity and PFU/CPM ratios 
for early and late passage infections. * 
Passage 
2 
8 
PFU/ml 
X 109 
30 
0.6 
CPM/ml 
180,000 
24,300 
PFU/CPM 
X 105 
0.25 
* Cells were labeled with ~ uridine (24.3 Ci/mM, 50 ~c/ml) between 
5 and 10 h postinfection. Labeled virus produced during this inter-
val was purified through a sucrose gradient. 
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Figure 6 Comparison of the k~netics of 3H-uridine incorporation following 
infection with passage 5 (MOl = 10) or coinfection with passages 
5 (MOl= 10) and 9 (MOl= 1). 3H-uridine (lJ.LCi/ml, 2 x l0-5M) 
was added 2 hours after infection. Actinomycin D (1 )J.g/ml) was 
present from the t~me of infect~on. 
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Figure 7 Comparison of the distribution of viral-specific RNA in extracts 
prepared from cells infected with passage 5 or coinfected with 
passages 5 and 9 under interference conditions. Cells were labe-
led with ~ uridine between 1 and 12 h after infection in the 
presence of 0.25~g/ml Act D. Extracts were prepared and a por-
tion was l~ered onto a 15-3o% sucrose gradient and centrifuged 
for 2 h at 34,000 rpm. Passage 5 (-0-); passage 5 + 9 (-t-); 
14c amino acid labeled viral nucleocapsid ( !J. ) • 
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14c-Amino acid-labeled viral nucleocapsid obt~ned qy 
Nonidet P40 disruption of purified standard virus was run concurrently to 
obtain more certain identification of the nucleocapsid. In the cells infec-
ted with standard v1rus about 4o% of the RNA was present in structures sedi-
menting with viral nucleocapsid. When cells were coinfected with passages 5 
and 9 a maximum of 8% of the RNA was 1n the nucleocaps1d region. 
In many experiments we did observe a decrease in viral 
RNA synthesis, but it was never as extensive as the decrease in virus yield. 
Differences in the amount of viral RNA synthes1zed were not as striking as 
the d1fference in the species of RNA (Fig. 8). When cells were infected with 
standard virus, the main fraction of RNA had a molecular weight of about 
1.6 x 106 daltons (26S). The larger molecular weight species of RNA corres-
ponded to virion RNA (49S). When cells were infected with late passage virus, 
the peak of 26S RNA was greatly dimin1shed, and was replaced qy a new peak 
of RNA with a molecular weight of 0.86 x 106 daltons. This RNA is probably 
identical to the 20S RNA species reported qy Eaten and Faulkner (23). 
We have determined that this new species of RNA (20S) 
is related to 26S RNA qy sequence homology. 20S RNA was able to compete 
with 32p-labeled 26S RNA in hybridization experiments, but only to the 
extent of 50 per cent (Fig. 9). This is the expected result if the defective 
RNA is homogeneous at it is only half the molecular weight of 26S RNA. 
Cells infected with late passage virus also showed dif-
ferences in viral-specific proteins. The amount of capsid protein synthesi-
zed qy these cells relative to PE2 and El was less than that produced qy 
cells infected with standard virus (Fig. 10). The finding of a decreased 
amount of capsid prote1n in cells infected w1th both standard and defective 
virus provides an explanation for the reduced levels of assembled nucleo-
capsids in these cells. 
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Figure 8 : Comparison of the viral specific, intracellular RNA species syn-
thesized in cells infected with early or late passage virus b,r 
polyacrylamide gel electrophoresis. 
253 
100 
0 265 
• 205 
0 
w 
N • -
0 • 
~ 
CO 
>-
I 
<( 
z 
~ 
I 
0.. 0 
N 
M 
~ 0 0 
0 
0 1000 2000 3000 4000 5000 
CPM 3H-RNA ADDED 
Figure 9 : 
Determination of the degree of sequence homology between 26S and 20S RNA 
b,y compet~tion hybridization. HYbridization was performed in sealed capil-
lary tubes in a volume of 50Jkliters of 4 x SSC (SSC = 0.15 M NaCl, 0.015 M 
sodium citrate). Each sample contained unlabeled viral-specific dsRNA 
(2.5,u.g), 500 counts/min of 32P labeled 26S RNAj and increasing amounts of 
~-uridine labeled 26S (--0--) or 20S (--t--) RNA. Approximately 0.8fLliters 
of diethylpyrocarbonate was present in each annealing mixture. Samples were 
heated for 3 minutes in an ethylene glycol bath at ll0-120°C. Annealing was 
carried out at 68°C for 17 hours. Following annealing, samples were either 
immediately TCA precipitated or incubated with 40 ,u.g/ml ribonuclease A in 
2 x SSC for 30 minutes at 37°C and then TCA prec~pitated. 
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Figure 10 Comparison of the viral specific proteins synthesized in cells 
infected with passage 5 and passage 11 virus by polyacrylamide 
gel electrophoresis. (For this experiment, passage 5 virus was 
first passaged at low multiplicity to dilute out any Dl parti-
cles that might be present this early in passaging). Cells were 
pulse labeled with 35s met (10-5M) for 40 minutes at 5 hours 
after infection and extracts were prepared with Nonidet P40. 
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We have also observed the presence of a protein migra-
ting between Bl and PE2 1n extracts of cells infected with late passage 
virus, but not with standard virus (Fig. 11). This protein was stable 1n a 
pulse-chase experiment although the metabol1c instab1lity of Bl was appa-
rent. It 1s tempting to suggest that this new protein might account for the 
decrease 1n capsid protein; on a quant1tative basis, however it does not 
compensate for the loss of counts 1n the caps1d protein. We have not f1nger-
pr1nted this protein to determine its relation to the capsid protein. 
In our initial studies we considered that Dl particles 
of Sindbis virus would be analogous to those described for poliovirus (24, 
25). We suspected that the 20S RNA was a deleted form of 26S RNA, that it 
was deleted in those sequences that coded for caps1d protein, and that it 
might code for the new polypeptide associated w1th late passage infections. 
Although 20S RNA does have 50 per cent of the nucleotide sequences of 26S 
RNA and conta1ns PolyA (26) it apparently does function as an effect1ve 
viral mRNA. Very little, if any, 20S RNA has been found on polysomes of 
infected cells. A comparison of the polysome profiles from cells infected 
with early and late passage virus is shown in Fig. 12. When cells were in-
fected with passage 3 virus almost all of the viral RNA was found in the 
heavy region of the gradient (peak II). In contrast, when cells were infec-
ted with passage 9 or passage 11 virus the labeled RNA shifted toward the 
top of the gradient (peak I). 
RNA was extracted from the two regions of the gradients 
and was analyzed b,y polyacrylamide gel electrophoresis (Figs. 13 and 14). 
Peak II from the gradient of passage 3-infected cells contained the two 
expected peaks of RNA -- 26S viral mRNA and 49S virion RNA. The latter was 
most probably present in nucleocapsids which sediment at 140S. 49S and 26S 
RNA were also detected in the heavy polysome region of both passage 9-
and passage 11- 1nfected cells. In passage 9- infected cells 20S RNA repre-
sented 41 per cent of the total 3H-uridine-labeled RNA but none of it was 
found in this region of the gradient. 
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Figure 11 Autoragiograms of 35s met-labeled intracellular viral proteins 
of early and late passage virus. Two experiments are included in 
this gel. The samples labeled D and H refer to a 40 minute pulse 
label~ of cells infected with passages ·5 and 11; and are iden-
tical to those analysed in Fig. 10. Samples labeled A-C and E-G 
refer to a 30 minutes pulse, followed b,y a 30 and 60 minute 
chase with 10~ met~onine, in cells infected with passages 5 
and 11, respectively. 
Figure 12 
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A comparison of polysome profiles obtained for cells infected 
with early and late passage virus. Cells were labeled with 
3H-uridine (20~C/ml) in the presence of actinomycin D (l~g/ml) 
from 1 to 12 hours postinfection. Cell lysates were centrifuged 
through l0-4o% sucrose gradients for 200 minutes at 40,000 rpm. 
Fractions were pooled as indicated for RNA analysis. 
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Passage 3 
Peak U 
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Passage 11 
Peak U 
Po~acr,ylamide gel electrophoresis patterns of RNA isolated 
from region II (polysome region) of the sucrose gradients dis-
pl~ed in Fig. 12. 3H-uridine labeled RNA was electrophoresed 
through 1.8% po~acr,ylamide-agarose gels for 2-1/2 hours at 
60 volts and 5 ma/gel. 14c-uridine labeled BHK ribosomal RNA 
markers were coelectrophoresed with each viral RNA sample 
a.nalyzed. 
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Figure 14 Polyacrylamide gel electrophoresis patterns of RNA isolated 
from region 1 of the gradients 1llustrated 1n fig. 12. The 
conditions of electrophoresis were identical to those described 
in fig. 13. 
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Essentially all of it was present in peak I (Fig. 14). In cells infected 
with passage 11 virus 20S RNA represented 71 per cent of the total 1s-
uridine-labeled RNA. At least 70 per cent of this RNA was found in peak 
I of the grad~ent. Although the remaining 30 per cent was actually in 
the polysome region its presence there was most probably due to contami-
nation from the large peak in region I (Fig. 12). 
FUrther support for the inability of 20S RNA to serve 
as an mRNA was obtained using cell-free systems from rabbit reticulocytes 
or Krebs ascites cells (4). Both Sindbis virion RNA and viral RNA (26S) 
prepared from infected cells stimulated the incorporation of 35S-methionine 
into protein. When similar experiments were performed with viral RNA pre-
pared from cells infected with preparations of Sindbis virus containing 
Dl particles or with purified 20S RNA no stimulation of protein synthesis 
was observed (Table 3). 
The major product obtained from the in vitro transla-
tion of Sindbis viral RNA was identified as capsid protein b,y its mobility 
in polyacrylamide gels (Fig. 15) and b,y an analysis of the fingerprints 
of 35s-methionine-labeled tryptic peptides. Although no stimulation of 
protein synthesis was observed with RNA from cells infected with Dl parti-
cles, the reaction mixtures were also subjected to electrophoresis in 
polyacrylamide slab gels. No protein bands distinct from those present 
in the endogenous reaction were detected. 
These results and our observations that cells infected 
with preparations of Sindbis virus containing Dl particles show decreased 
cytopathic effects (26) suggest that Dl particles of Sindbis virus m~ not 
be capable of producing viral products b,y themselves. In this respect, 
they resemble Dl particles of vesicular stomatitis virus rather than those 
of poliovirus (20). 
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TABLE 3 
Stimulation of protein synthesis in cell-free extracts 
by Sindbis viral RNA 
Cell-free Source of JJ-g RNA cpm Incorporated 
System RNA added into Protein 
1. reticulocyte 12,910 
from cells infec- 7.0 57,612 
ted with passage 2 
from cells infec- 8.0 8,974 
ted with passage 9 
2. ascites 2,579 
from std. virions 2.5 8,281 
from cells infec- 8.0 2,309 
ted with passage 9 
20S RNA from pas~ 3·7 2,299 
sage 9 infection 
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Figure 15 Autoradiogram of 35s met-labeled proteins synthesized b.y 
cell-free extracts from reticulocytee and ascites cella. 
Details of the methods have been described (4). 
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CONCLUSION 
The studies presented here raise a number of questions 
about the processing of Sindbis viral RNA and protein. Infection of BHK 
cells with Sindbis virus containing Dl particles affected capsid protein 
and envelope proteins in a disproportionate manner. This result provides 
further evidence that is inconsistent with there being a single initiation 
site for the synthesis of virion proteins. Instead, it suggests that the 
regulation of capsid protein synthesis m~ be different from that et the 
envelope proteins. 
One of the essential definitions of Dl particles is 
that they possess a deleted form of the viral genome (20). Although we have 
not identified this form in Sindbis virions, we have established that 20S 
viral RNA is a deleted version of 26S viral RNA. 
In cells infected with standard Sindbis virus, virion 
RNA is transcribed and replicated so that the predominant species of viral 
RNA in the cell is 26S RNA. More detailed knowledge of this process is 
required if we hope to understand how in cells infected with Dl particles 
the format~on of 20S RNA replaces that of 26S RNA. 
20S RNA not only does not contain all of the genetic 
information of 26S RNA but it also does not function as an efficient mes-
senger. Undoubtedly one of the important factors ~n the interference of 
Sindbis virus formation b,y Dl particles is the diminished amount of 26S 
RNA. A significant decrease in 26S RNA would greatly curtail the synthesis 
of the viral structural proteins. 
Dl particles have been isolated from a number of dif-
ferent viruses. They are providing a useful probe in the analysis of viral 
replication but they have also been attracting considerable interest as a 
possible factor in persistent viral infections or in slowly progressing 
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neurological diseases (27). The establishment of a persistent infection 
of Sindbis virus in mouse embryo cells was shown to depend on maintaining 
a balance among infectious virus, Dl particles, and interferon (28). More 
recently Doyle and Holland (29) have been able to transform the rapidly 
fatal disease caused b,y injecting mice with VSV into a slowly progressing 
one b,y also injecting large quantities of Dl particles of vsv. These two 
examples suggest that Dl particles may have ari important role in determi-
ning the outcome of viral infections. 
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DISCUSSION 
Dr. ROTT 
RNA of Semliki forest virus 1n Germany behalves like 26S RNA of S1ndbis 
v1rus in the United States. 
Dr. Bangler in our group 1solated the 26S RNA from a polyribosomal fraction 
and tested 1t 1n an in vitro system but 1n this case using the Krebs II 
ascitis tumor cells. Th1s 26S RNA stimulated protein synthes1s and in the 
slide of the polyacrylam1de gel you can see that capsid protein is formed. 
Fingerprints of the tryptic peptides of virion nucleocapsid protein and 
the product synthes1zed in vitro are identical. Thank you. 
Dr. HORZINEK 
• 
To my knowledge 20 S RNA that was single-stranded, was isolated by 
several groups from 1nfected cells. What would be your interpretat1on, 
would there be defective interfering particles that they d1d not know 
about or 1s 20 S RNA also produced normally during infect1on ? 
Dr. s. SCHLESINGER 
I see no ev1dence for any 20S RNA w1th early passage v1rus. In some 
preparations of RNA we d1d see more heterogene1ty 1n the RNA than I 
showed in the sl1de and there could be some degradation of RNA to 20S. 
We have character1zed the 20 S RNA from defective passage 1nfections 
b,y its molecular weight and b,y the fact that 1t has half the sequences 
of 26S RNA so I believe that it 1s homogeneous. 
I might point out that in a paper b,y Eton and Faulkner on defective 
interfering part1cles, they cla1med that they could see the 20S RNA 
after five passages, even though the accumulation of Dl particles 
themselves did not appear until later. 
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Dr. SCHOLTISSEK 
In Semliki-Forest viruses Dr. Simons from Helsinki found a third enve-
lop glycoprotein, the E 3o 
Did you find this also in your system ? 
Dr. S. SCHLESINGER 
We never had any evidence from more than three proteins. Either b,r 
isotopes or b,y staining our gels with protein stain. 
Dr. SCHOLTISSEK 
But I saw very little bump on the left side. 
Could not this be the E 3, because this should have a very small 
molecular weight and it could occur in equal molar amounts compared 
with tie other envelope components. 
Dr. s. SCHLESINGER 
I really have not looked for it. 
Dr. SCHOLTISSEK 
Because if it is there it should be there very low amounts. 
Dr. SCHLESINGER 
It might have run off the gels. 
Dr. ROTT 
There are defective particles found in influenza virus and rhabdoviruses 
and now also in togaviruses after undiluted passage of the viruses. 
And the question now arises if there is a general mechanism underlying 
the formation of these incomplete or defective particles or not. What 
is your feeling about the mechanism of the formation of these defec-
tive particles in togaviruses ? 
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Dr. s. SCHLESINGER 
One really has to ask several questions. With regard to the formation 
of the particles, why do delet~ons occur during the synthes~s of viral 
nucleic acids ? Secondly, how do defect~ve particles interfere with 
normal virus replication ? And finally is the mechanism of interferen-
ce going to be similar for all the different viruses ? 
There ~s a big difference between the polio-defective virus, on one 
extreme, and the enveloped viruses using VSV as the other extreme. 
Defect~ve interfering particles of polio and I would guess it to be 
true for all of the picornav~ruses are able to carry out many func-
tions of the normal virus but are not able to assemble ~nto intact 
virions, whereas with VSV, and we th~nk it is true also for Sindbis, 
the defective interfering particles qy themselves are not able to 
carry out any viral functions. 
Dr. ROTT 
Is it possible to isolate this defective particles in pure form ? 
Dr. s. SCHLESINGER 
lie have not ever been able to separate them from the normal virus. 
Dr. ROTT 
But it should be possible to isolate the RNA, the 20 S RNA from the 
49 S RNA? 
Dr. s. SCHLESINGER 
I can isolate the 20 S RNA but this is found in the cell. The RNA 
in the virion is very heterogeneous and as yet I do not know the 
reason for the heterogeneity. 
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Dr. DALSGAARD 
You mentioned into the beginning of your report that the P.E.2. pro-
tein was a precursor of the E 2 protein. I should like to know whe-
ther you know if these proteins are antigenetically related using 
immunological techniques. 
Dr. Sa SCHLESINGER 
We haven't tried to do this type of experiment. 
Dr. SCHOL'l"'SSEK 
You mentioned that the smaller molecular weight RNA's are breakdown 
products but I guess you can exclude this possibility because you 
get a 50 % competition only; if this would be breakdown products you 
should get 100% competition. 
Dr. s. SCHLESINGER 
The smaller RNA 1 s were from the virions. The 50% competition was 
between the 20 S and 26 S RNA in infected cells. 
Dr. HORZINEK 
Has anybody looked at the morphology of interfering particles. Do 
they differ structurally, do they agglutinate ? 
Dr. Sa SCHLESINGER 
They seem to agglutinate very well; we have some evidence that they 
are more labile; when we try to look in the electron microscope for 
defective particles we find much degradation compared to the normal 
virus where we got very nice particles. 
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BIOGENESIS OF THE INFLUENZA VIRUS ENVELOPE 
R. Rott and H.-D. KLENK 
Institut fUr Virologie, Justus Liebig-Universitat, 
Giessen, Germany. 
There are close relationships between the structure and 
replication of a virus on one hand and the structural and physiological 
properties of the host cell on the other hand. Such relat1onships are 
particularly obvious in the case of enveloped viruses. The envelopes of many 
viruses are derived from areas of the plasma membrane which are composed of 
cell-specific as well as virus-specific const1tuents. Such envelopes, there-
fore, can be considered as pieces of a plasma membrane modified specifically 
by the virus. 
Analysis of the b1ogenesis of an enveloped virus should 
throw some light on the synthesis of the virus-specific envelope components 
and on their interaction with cellular membrane constituents. Such studies 
might also provide information on the possible role of the structural and 
functional membrane modifications for the pathogenic1ty of a virus. 
Influenza virus is a suitable object for such studies, 
because its structure has been well characterized and because its envelope 
proteins can be easily detected in the infected host cell. 
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Composition of influenza v1rus envelope 
The envelope of influenza virus meets all the criteria for 
cellular membranes. Morphologically it possesses a trilaminar or unit 
membrane structure. Chem1cally it is composed of lip1ds 1 proteins, and 
carbohydrates, the carbohydrates being covalently linked to prote1ns and 
to l1pids (for ref. see Klenk, 1973). 
It 1s generally accepted that the lipids are derived from 
the host cell. So far not a single enzyme involved in l1pid metabolism has , 
been found to be coded for by the viral genome. It was not surprising 
therefore that the composition of the virus lip1ds resembles that of 1ts 
host cell plasma membrane. 
A substantial portion of the total polar l1p1ds is glyco-
sylated (Klenk and Huang, 1973). Some of these glycolip1ds are classical 
heteroph1lic antigens, e.g. the Forssman-anligen, which are present in the 
corresponding host cell (Spr1nger and Tritel, 1952 ; Rott et al., 1966). 
If such host cell antigens are found in the enveloped viruses, 1t 1s 
supposed that carbohydrate mo1et1es represent the antigenic determinant. 
There is no doubt that these glycolipids are host-specific. 
In contrast to th• lipids the envelope proteins in 
influenza virus are specified by the viral genome. This holds true for 
weights of 50,000 and 30,000 1 respectively, wh1ch are l1nked by d1sulfide 
bonds. HA1 is rich in carbohydrate and represents the peripheral part of 
the spike. It is responsible for virus adsorpt1on. HA2 appears to be lo-
cated on the inner side of the spike and it is supposed to interact with 
the lipid layer by a hydrophob1c segment. 
The neuraminidase sp1ke is built up by four glycoprotein 
subunits with a molecular weight of about 60,000. Like the rremagglutinin 
it possesses a hydrophobic part which enables the spike to interact with 
the lipids of the envelope. 
Lipids are arranged in a b1layer structure as could be 
shown by spin-labelling experiments (Landsberger et al., 1971 1 1973). 
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Beneath the central lipid bil~er an unglycosylated 
protein, the membrane or M-protein is located (Compans et al., 1970; 
Sc~lze, 1970). As will be shown later it has a definite membrane affinity. 
This supports the concept that the M-protein is an integral part of the 
viral envelope. 
Biosynthesis of virus-specific envelope components 
According to our present knowledge the virus-specific 
envelope components of influenza virus are synthesized independently. 
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Figure 2. Polyacrylamide gel electrophoresis of polypeptides of fowl pla-
gue virus (14c-amino acids o---o) and fowl plague virus infected 
cells ( 3H-amino acids (.---.). 
Cells were labelled 4 hr after infection. 
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In cells infected with fowl plague virus two other virus-
specific proteins can be detected in addition to the structural proteins 
of the virion (Fig. 2). The function of protein NS is not known. Protein 
HA is a glycoprotein of an apparent molecular weight of 76 1 000. It has been 
suggested to be a precursor molecule from which glycoproteins HA1 and HA2 
are derived by proteolytic cleavage (Lazarowitz et al., 1971). Such a 
precursor-product relationship can be demonstrated by the pulse-chase 
experiments shown in Fig. 3 where glycoproteins HA1 and HA2 are formed 
during the chase period on the expenses of glycoprotein HA. This can also 
be shown, if infected cells are kept at 25° C (Klenk and Rott, 1973). If 
infected cells are labelled at this temperature 24 hr p.i. for 1 hr with 
radioactive amino acids one finds glycoprotein HA in addition to proteins 
P and NP, but in relatively much higher amounts than under similar label-
ling conditions at 37° C (Fig. 4). The small glycoproteins HA1 and HA2 are 
missing. However, this accumulation of HA is reversible. If the pulse is 
followed by a chase period at 37° C1 it can be seen that there is a drastic 
decrease of HA, and HA1 and HA2 are being formed. If the chase at 37° C is 
performed in the presence of a protease inhibitor, HA does not decrease 
and HA1 and HA2 are not being formed. These experiments show that glyco-
protein HA1 and HA2 ar~se by proteolytic cleavage of glycoprotein HA. 
The biosynthesis of these glycoproteins has been also 
inhibited at another stage. High doses of D-glucosamine and 2-deoxy-D-
glucose inhibit the formation of influenza virus glycoproteins, whereas 
carbohydrate-free polypeptides are still being synthesized (Kaluza et 
al., 1972; Klemk et al., 1972). If glycosylation is inhibited by one of 
these sugars, a protein (HA ), not present under normal conditions, can 
0 
be detected (Fig. 5). We assume that this protein (molecular weight 
64,000) is the unglycosylated or incompletely glycosylated polypeptide 
of glycoprotein HA. We have obtained fairly good evidence that this 
concept might be correct (Klenk et al., 1972) : (l) There is a similarity 
in the amino acid composition of HA and HA
0
• (2) If the inhibitor is 
removed, the block of glycosylation can be released. Under these con-
ditions HA
0 
is shifted to a position on polyacrylamide gels similar to that 
of HA. Since radioactive carbohydrates fail to label HA
0 
whereas they are 
readily incorporated into HA, it is suggested that HA
0 
might be carbo-
hydrate-free. 
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Figure 3. Polyacrylamide gel electrophoresis of FPV polypeptides 
synthesized in chicken embryo cells. Cells were labelled 
4 hr after infection b,y a 10 min pulse with 3H-leucine. 
Top : cells were scraped off immediately after the pulse 
~ : the pulse was followed by a chase period with cold 
leucine for 15 min ; bottom : the chase period was 60 min. 
Figure 4 
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3H-valine. Top cells were scraped off immediately after the 
pulse ; middle the pulse was followed by a l hr chase at 
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37 C ; bottom : the pulse was followed by a l hr chase at 37° C, 
and the media added to the cells during the chase period contai-
ned diisopropylfluorophosphate (20 ~ol/ml). 
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Figure 5. Polyacrylamide gel electrophoresis of FPV proteins synthesized 
in chick embryo cells in the presence of glucosamine (20~ol/ml). 
Cells were labelled at 4 hr after infection with 3H-amino acids. 
Marker ·tirus labelled with 14c-amino acids was coelectrophoresed 
on the same gel. 
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Further information on the relationship of HA to HA 
0 
could be obtained from an analysis of the intracellular lOcation of these 
proteins. Cells were homogenized and cytoplasmic extracts were separated 
into cell fractions by equilibrium centrifugation on sucrose grad1ents 
(Compans, 1971 ; Klenk et al., 1974). 
The proteins of the rough membranes labelled at 4 hr p.i. 
for 10 min with ( 1H)-amino acids are shown in Fig. 6. After the short 
pulse in the absence of glucosamine there is a large peak of the uncleaved 
glycoprotein HA. After the chase HA can no longer be detected either in 
the uncleaved or in the cleaved form. This indicates that HA has completely 
disappeared from this fraction. Corresponding experiments wh1ch were per-
formed in the presence of high doses of glucosamine indicate that HA
0 
like HA disappears from the rough membrane. 
The smooth membranes (Fig. 7) contain a significant 
I 
amount of the uncleaved glycoprotein HA after a short pulse. After the 
chase the hemagglutinin-protein is still present in this fraction but now 
almost exclusively in the cleaved form as HA1 and HA2• In the presence of 
glucosamine, after the short pulse only HA
0 
is visible in the smooth 
membranes. After the chase the corresponding cleaved products called 
HA
01 
and HA
02 
can be detected in addit1on to HA
0
• The data indicate t:1at on 
smooth membranes HA and HA
0 
stay longer than on rough membranes and that 
they are cleaved there. 
In conclusion, cell fractionation studies have revealed 
that the hemagglutinin glycoprote1n migrates from the rough to the smooth 
endoplasmic reticulum. There it accumulates with the other constituents of 
the virus envelope. It can be assumed that these glycoproteins then 
migrate further to the plasma membrane, where they are incorporated to form 
the viral envelope. In the course of this migration the glycoprotein HA is 
cleaved by host cell-specific proteases into the smaller glycoproteins HA1 
and HA2• 
The behaviour of HA
0 
further underlines a close 
relationship between HA and HA
0
• The membrane affinity of HA
0 
together 
with its lack of carbohydrates suggest that the carbohydrates are not 
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Figure S. Polypeptides of fowl plague virus associated with rough membrane 
fraction after a 10 min pulse with 3H-leucine, 3H-valine, and 
1H-tyrosine at 4 hr post infection and after a pulse followed 
by a chase period with cold amino acids. The virus-specific 
polypeptides of 14c-amino acid-labelled whole cells were included 
as internal markers. 
Upper left panel : cells were labelled by a pulse ; lower left 
panel : cells were labelled by a pulse followed by a chase ; 
upper right panel : cells incubated in the presence of glucoca-
mine (20 ;wnol/ml) were labelled by a pulse ; lower right panel : 
cells incubated in the presence of glucosamine were labelled by 
a pulse followed by a chase. 
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essential for binding of glycoproteins to lipid membranes and for their 
transport. For hemagglutinating activity, however, the carbohydrate moiety 
appears to be necessary, because HA
0 
does not exert hemagglutination. 
Incorporation studies with radioactive sugars and amino 
' 
acids suggest differences in the carbohydrate content of the uncleaved and 
cleaved hemagglutinin glycoprotein (Klenk et al., 1974). Such experiments 
showed that the incorporation of glucosamine in HA is 1.5 times as high 
as in HA1 and HA2, whereas that of fucose is only 0.5 times as high. These 
data are compatible with the idea th~; in the course of glycoprotein 
synthesis carbohydrates are attached in a stepwise manner and that fucose is 
added later than glucosamine.This means that glucosamine presumably forms 
the carbohydrate core of the oligosaccharide side chains. It must be added 
to the hemagglutinin quite rapidly at a time, when the polypeptide is still 
located on the rough endoplasmic reticulum, because so far it has not been 
possible to detect the unglycosylated polypeptide under normal condition. 
As has been pointed out already the available evidence 
suggests that the structure of the carbohydrate side chains of the viral 
glycoproteins is determined to a good deal by the glycosyl transferases 
of the host cell, It is possible, however, that in addition to these enzymes 
the viral neuraminidase plays an important role in designing the carbo-
hydrate moiety of the viral glycoprotein. There are some indications 
(Schulze, 1974) that the absence of neuraminic acid is essential for a 
functional hemagglutinin which enables it to interact with the neuraminic 
acid containing virus receptor of the host cell. 
In addition to the hemagglutinin glycoproteins the 
smooth membranes also contain the neuraminidase and the M-protein, whereas 
the other virus-specific proteins are lac~ing in this cell fraction, The 
smooth membranes, therefore, contain all envelope proteins, a fact which 
shows again the membrane affinity of these viral proteins. 
The envelope components and the nucleocapsid apparently 
move to the cell membrane through different routes. Whereas the envelope 
proteins are transpor~ed along cellular membranes, the nucleocapsid is 
alw~s found in soluble form. 
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Assembly of influenza virus envelope 
The envelope of influenza virus is assembled in a 
budding process at the plasma membrane (for ref. see Klenk, 1974). 
During this proce$the unit membrane of the viral envelope is continuous 
with and morphologically similar to the plasma membrane of the host cell. 
On the other hand, the areas of virus budding show several virus-specific 
modifications. On their outer surface they are studded with spikes, which 
react with anti-hemagglutinin antibodies. They differ from the normal cell 
membrane also by the absence of neuraminic acid. On their inner side these 
reg~ons carry an additional layer which is not found in the normal cell 
membrane and which is most likely formed by protein M. 
There are some ~ndications that prote~n M might be rate 
limiting for virus assembly. At 25° C mature virions are not formed, and 
protein M is the only virus constituent which cannot be detected ~n infected 
cells under these conditions (Klenk and Rott, 1973). Moreover cell 
fractionation studies revealed that the snooth membranes of infected cells 
contain all envelope proteins. Protein M, however, is found in lower 
amounts than 1n the virus envelope (Stanley et al., 1973; Klenk et al., 
1974). This suggests that only a small fraction of the membrane areas with 
hemagglutinin glycoproteins contain also the M protein and that only these 
areas are converted into viral envelopes. 
No significant amounts of host cell proteins can be 
found in the membrane of the virus particle. The viral envelope must, 
therefore, be derived from segments of the plasma membrane from which the 
host cell proteins are excluded. It is not yet understood, how the virus-
specific glycoproteins reach the surface of the plasma membrane. 
Influenza virus-induced membrane modification 
The close interactions between viral envelope and cel-
lular membrane cause alterations of the structure and function of the cell 
surface. Such a modification of the membrane structure is, for instance, 
a rearrangement of recaptor sites for Concanavalin A wh~ch render the cells 
agglutinable by this phytagglutinin (Becht et al., 1971, 1972; Rott et al., 
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1972, 1974), a phenomenon which is well known for transformed cells. There 
is good evidence that the agglutinability of infected cells by Con A is 
mediated through viral spikes incorporated into the cell membrane. This 
concept is supported by the finding that isolated virus particles can be 
readily flocculated by the lectin and that removal of the viral glyco-
proteins ~ proteases leaves a spikeless particle which is no longer ag-
glutinable by this phytagglutinin (Klenk et al., 1972). 
The essential role of this kind of membrane changes 
brought about by the viral envelope component is underscored in experiments 
where 2-deoxy-D-glucose interfered with the synthesis of glycoproteins. 
Administrat1on of this antimetabolite immediately after infection of chick 
fibroblasts with fowl plague virus did not impair synthesis of viral poly-
merase and RNP-antigen, but depressed the formation of viral hemagglutinin 
and neuraminidase and prevented the host cells to be agelutinated by Con A 
(Kaluza et al., 1972; Rott et al., 1974). 
All data available suggest that binding of the phytag-
glutinin to the outer l~er of the cell membrane has no significant effect 
on the synthesis of the membrane-associated hemagglutinin and neuraminidase, 
but interferes with virus release and probably with viral maturation. 
Treatment of infected cells with Concanavalin A appears to shift virus 
budding from the cell surface to intracellular vesicles, and one has the 
impression that budding takes place through the membranes of these vacuoles 
(Rott et al., 1974) (Fig. 8). Therefore it might be conceivable that 
intracellular membranes represent the site of second choice - and therefore 
a less efficient one - for the formation of envelope material after the 
location of optimal maturation had been disturbed. 
The structural alterations of the cell membrane are 
accompanied by functional changes of the cell membrane as can be 
demonstrated by an altered uptake of low molecular weight precursors into 
the cell. We could show that the uptake of uridine into the cell is 
stimulated after infection with influenza virus, although there is no change 
in the uptake of adenosine, which is a good internal control. As far as 
uridine is concerned only the velocity of the uptake is changed but not the 
apparent K value (Rott et al., 1974). Similarly the uptake and incorpora-
m 
Figure 8 Electron micrographs of fowl plague virus-infected chick embryo 
cells. 
(a) cells were fixed for thin sectioning and stai ned with ruthe-
nium red 8 hr after infection. 
(b) immediately after infection the cells were treated with 50 
pg/ml Concanavalin A. 8 hr after infection cells were fixed 
and stained (Electron microscopy : M. Reinacher). 
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tion of sugar derivatives like glucosamine and 2-deoxy-D-glucose into acid-
insoluble material is enhanced after infect ion with influenza virus 
(Scholtissek 1 1973). 
Besides these different characteristics of a membrane 
altered by the insertion of virus-specific components one has to take 
into consideration that the anpearance of these viral structures at the 
cell surface means that the cell as a whole carries a different antigenic 
mosaic. Since such a cell can no longer be recognized by the organism as 
"self", the described maturation process of the virus envelope should cause 
immunopathological reactions, which may have repercussions on the course 
of the disease. 
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SUMMARY 
Since FV3 messenger transcriptio• does not appear to 
involve distinct early aad late phases, it raises the questio~ of whether 
there is any regulatio• of FV3 protein synthesis. This question will be 
approached from consideration of synthesis of virus structural proteins Md 
from virus i1tduced ell.zymes. Thymidi1te kiJaase aad endoribonuclease are both 
induced by FV 3 • ThymidiJte killase appears to be M early function which is 
also synthesized at late times. Ribonuclease appears to be a typical late 
function. Most virus structural proteins seem to be synthesized at both 
early Md late times but all cM be considered as early fUllctions. I• this 
respect the system resembles Herpesvirus. Evidence for these points will be 
drawn from the data published by others aad from some recent original expe-
rime:ats. 
291 
INTRODUCTION 
There is ll.o clear distinctioJt between "early" ud "late" 
mRNA tr&ll.scripts of frog virus 3 (FV3) as determiRed qy their electrophore-
tic mobilities oR polyacrylamide gels (see Paper I). With the reservatio• 
that the specific functio•s of various FV3 messe~er RNA traRscripts, ide•-
tified o•ly qy their apparent molecular sizes, have •ot bee• determined it 
appears that most FV3 proteins could be syathesized UKder the direction of 
iKput DNA templates. This raises the question of what co•trols there are, 
if any, on the biosyathesis of FV3 protei•s i• particular and of icosahetral 
cytoplasmic deoxyvirus (ICDV) proteins ill. ge•eral. During frog virus 3 re-
plication, 17 virion structural polypeptides are synthesized and at least 2 
•ew eRzyme activities are elicited (13). We will outline some regulatory 
aspects of their synthesis using data from experiments already published 
aad from recent work. 
MATERIALS AND METHODS 
~· Procedures for the production and purificatio• of 
frog virus 3 were those published (13). 
Q!!l!• The cell liRe used to study iRduction of thymidi-
ne kinase was a thymidine ki.ase deficieRt mouse cell (LTK-) (12). 
Thy!idiRe Kinase. The methods used were exactly as des-
cribed qy Auberti11 and Lo:ngchampt (2). 
DNA Sy!thesis. Virus-iRfected LTK- cells were continu-
ously labelled with H3-thymidine (O.lJ!C/ml). Methods to determine iRcorpo-
ratio• of label iRte •uclear and cytoplasmic fractio•s have been described 
in detail (11 1 2). Usi~ the system described, there was •egligible incor-
poration into uninfected cells. Upon fractionation of iafected cells, most 
of the viral DNA associated with nuclei (see 11). 
292 
Structural Pelzyeptides. Isetopic labellillg' and analy-
sis of structural polypeptide& was co~ducted as described b,y Taa aad McAualan 
(13) or b,y others (7). I• some experiments infected cella were labelled 
for 2 hours with s35-methionine (30~C/ml; Sp act. 150 Ci/mM) and the poly-
peptide& i• the soluble fraction (100,000 xg auperaatant of aonioally dis-
rupted cella) r~selved b,y polyacrylamide slab electrophoresis (9) and de-
tected b,y autoradio~aphy. 
RESULTS 
Inductien of Thy!idine Kinase. I• LTK- cells infected 
with FV3 (m~o.i. lOO or 10 pfu/cell), vi~al DNA was synthesiz'!d ad thyllli-
ciine kinase activity elicited. The increase in th;ymidine kinaRe activity was 
parallel to the incrt!ase in viral DNA synthesis (Fig. 1). These date are 
eBS'!ntially in accorci with tl).ose of Aub~rtin aJ.ld Lollg'champt (9) except that 
we detected a much earlier increase in activity; this increase terminated 
at 12-14 hours post-infection. When hydroxyurea was added at the time of 
infection, neither the rate of increase in kinase activity nor ita subse-
quent termination was affected significantly (Fig. 1). 
If the messenger for kinase is st•ble, we would possibly 
have an indirect approach to iete:rmining if mRNA transcribed from input vi-
rions in the presence of cycloheximide was functional. To determine the 
atabili ty of messuger for i~~tduced kil!~e, acti~OIIIYCiJI. D ( 5 p.g/rd final 
co:n.centration) was adcied to cells at times after FV 3 infection and the acti-
vity of thylt.ilti.Jl• kin~e (TK) w~ det•rmined. Actinomycin D added before or 
after the onset of kinase synthesi~ rapidly ar~ated ~ further increase 
in activity (Fig. 2). 
Assuming actinomycill D Wlal! inhibiting at the transcrip-
tional level and Jlot the trQslatiol'lal level (cf Ref. 6), the results sug-
gest that the mesaellger for ki]lase has a very short life. This is in coJt-
trast to the messenger for TK i•duced b,y herpes simplex or poxvirus (5, 10) 
and ill contrast to other RNA tr~cripts of FV3 (1). 
Figure 1 
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Figure 2 : Effect of actiJutmyci• D G!l FV3 iltduotio• of thymidi:ae kiJtase 
b LTK- cells. I:aorease ill thylllid.ine ki.Jlase with :ao acti:aomyoiJl 
aided. (e) or with actiJl.omyobt. D (5 p.g/ml) acid.ed. at 0,3 or 6 
hours post-iBfeetion as iadicated. 
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Induction of Ribonuclease. The properties of a novel 
FV3- induced endoribonuclease that degrades double-strand RNA has been 
describet (8). The appearance of this activity is dependent upon FV3 DNA 
synthesis and it is classed, therefore, as a late functioa. Because the 
assa.y measures oJtly endonucleelytic cleavage it is difficult to measure 
precisely the kinetics of its synthesis duriRg the virus replication cycle. 
Structural Po~eptides. The major virion structural pe-
lypeptides (VSP) are shown in Figure 3. VSP 1, 2, 1, 9 are prebably i1tternal 
polypeptides associated with the virus nucleoid and VSP 3, 5, 10, 14 are 
probably outer coat polypeptides as they are readily removed b,y mild deter-
gent treatment of virions (3). 
The structural polypeptides are synthesized throughout 
the infection cycle. If iafection is initiated in hydroxyurea to prevent 
viral DNA synthesis, all major structural polypeptides are still synthesi-
zed (Fig. 4). Therefore they are early gene products. It is noteworthy that 
we can also detect b,y the slab gel method many other viral polypeptides 
that are probably •on-structural. Our preliminary studies on the effect of 
actino~cin D on their synthesis suggests that the messe~rs for m~ vi-
ral proteins are Bot very stable (or that actino~cin D has a direct effect 
on translation); this is at variance with our observations on stability of 
the messenger profile (1). 
DISCUSSION 
From determinatioa of the RNA transcripts qy gel eleo-
tropheresis, the overall pattern of messengers does not appear to ehaage 
qualitatively during the replication cycle, suggesting that most FV3 pro-
teins could be synthesized at early times. This is supperted qy studies o• 
synthesis of virion structural polypeptides u.ier conditio•s where viral 
DNA synthesis is iRhibited. All virion structural polypeptides so far de-
tected are early viral gene products; a somewhat similar situation is true 
for herpesvirus protein synthesis (4). There is some evidence that the ra-
tes of synthesis of the differe•t FV3 polypeptides during the replicatio• 
cycle change aad that these changes in rate ma.y be mediated qy other viral 
functiOJlS (7)o 
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Figure 3 The structural polypeptid.es of FV 3 • FV 3 was grown ill BHK cells 
i•cubatei with H3-labelled ami•o acits. Viral polypeptides were 
aalyzeti on pslyacrylamide gels (13). 
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.A 
Figure 4 : 
FV1 pelypep~ides i.teetei LTK- cells. FV~ iafeetei LTK- cells eithe)5uatrea-te« er iBhibitea with hytro~ea or aet!nemycin D i•cubated with S -methi-
oni•e fer2 heurs at tifferent times after iafectien. The soluble supe~atant 
fraction from iisrupte~ cells was analyzei o~ 10% pelyaerylamide slab gels 
(9) and visualized by autoraii~tgraphy. 
Gel 1, uaiafected UTK- cells; gel 2, LTK- plus heatea FV3• 
Gels 3, 4, 5 represent LTK- cell plus heated FV3 tq ~duce baekgrouad., plus 
life FV3 (50 ptu/eell). Cells were i•cubated W1th S methioni•e 1-3 heurs 
p.i. (gel 3), 5-7 hours (gel 4) er 9-11 heure (gel 5). 
Gel 6, 7, 8 represe•t LTK- cells pl~~ heatea FV3 plus life FV3 plus hydro-
xyurea. Cells were incubated with S methio•ine 1-3 heure (gel 6); 5-7 
hours (gel 7) er 9-11 hours (gel 8). 
Gel 9 represents LTK- cells plus heated FV3 plus li)~ FV3• Actinomycin D 
was aiiei at 5 hours aat the cells i•cubated with S methionine frem 7-9 
heurs. Fig. 4a, 10% gels. Fig. 4b, 15'% gels. 
B 
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However, if one considers non-virion proteins, for example, induced thymi-
dine kinase and ribonuclease, there are clearly other modes of regulation. 
ThymidiAe kinase is an early function whose messenger is 
short lived but which is synthesized throughout the replication cycle. This 
is in contrast to both herpesviruses and poxviruses. Ribonuclease seems to 
be a late function. The role of this activity, which is incorporated into 
virions is a ~stery. It is co•ceivable that it cleaves certain viral trans-
cripts to produce functional messengers. From the studies we have begun with 
FV3, it is clear that no single approach is likely to give the complete 
picture of the control of ICDV protei• synthesis. 
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DISCUSSION 
Dr. s. SCHLESINGER 
I was a little bit confusei about what you said with the unstable mes-
senger RNAs. I do not remember in your talk this moraing that you haa 
evidence that the messengers were unstable. 
Dr. MCAUSLAN 
As we look at the transcripts on the gells they seem to be very stable. 
At least the six hours er more after actino~eine D, if we now look at 
the speeif~e tu.ction for one of the enzymes this seems to be synthesi-
zed from an unstable messenger. 
Dr. s. SCHLESINGER 
But you define an unstable as a fact that the polypeptide is not conti-
nuing the synthesis. But there could be other explanat~ons. 
Dr. MCAUSLAN 
Such as. 
Dr. s. SCHLESINGER 
Translations control. 
Dr. MCAUSLAN 
Yes but the evidence for actino~cine affect~ng translation is not 
exactly strong at the moment; but on the other hana if we look at the 
structural polypeptides some of them seem to be synthes~zed in the 
presence of actinomycine D and some certainly not. 
What I am s~~ng is, that just looking at transcripts on our gels is too 
rough a method, we have to get down to each specific function and ask 
the question about each one. Overall the regulation in this virus and 
perhaps in all viruses of this group seems to be mest unusual and just 
about all polypeptides can be considered as early functions. 
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We do not see in this system a late shift with the one exception of the 
ribonuclease situation. And for that we can not even imagine what this 
function would be, except that it might convert some messenger to a state 
suitable for translation as described recently for T7. 
Dr. s. SCHOLTISSEK 
I have a rather theological question. 
To what does the virus neei timing in Kinase for ? 
Because normal cell has a thymidine Kinase and further more thymiaine 
and the TMP synthesis denovo in the cell; and this is used for DNA syn-
thesis. 
Dr. MCAUSLAN 
In :ao case of any DNA virus, paxvirus, herpesvirus, has there been a 
good argument for the function of thymidine Kinase, and the only thing 
that I can suggest to get ~elf out of tricky situations Dr. SCHOLTISSEK 
is that one really has consider infection of the whole organism; m~be 
when viruses infect an animal they m~ start their replication in macro-
phages for example which do not normally undergo division. There m~ 
have a good supply of thymidine and thus a virus which can induce thymi-
dine kinase has a selective advantage. It's the best I can do for a 
suggestion at short notice. 
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VIRUS INFECTED BSC-1 CELLS 
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SUMMARY 
Analysis of 35s-methionine labeled herpes simplex virions 
b,y electr~phoresis in polyacrylamide gels revealei 12 distinct peptides b,y 
autoradiography. These bands corresponded to the 12 major bands detectable 
b,y staining with Coomassie blue. Electrophoresis of homogenates of infected 
cells labeled with 35s-methionine for long periods revealed 12 major pep-
tide bands which corresponded to the structural viral peptides and several 
nonstructural peptides. However, labeling for short periods with the radio-
active amino acids revealed 39 peptide bands. These include the stable struc-
tural and nonstructural peptides as well as short-lived nonstructural pep-
tides. Different rates of synthesis were found for the different peptides 
synthesized in the ~nfected cells. Arginine deprivation affected the amount 
of peptides synthesized ani only some of the structural peptides were syn-
thes~zed. This might explain the lack of virion formation in the absence 
of arg~nine. 
INTRODUCTION 
Recent studies b,y Honess and Roizman (1973) using high 
resolution polyacrylamide gel electrophoresis described 49 peptides to be 
synthesized in herpes simplex virus (HSV) infected cells. These were 23 
structural, 16 nonstructural, and 10 unclass~fied peptides, which comprise 
7 'Jfo of the genetic information inscribed in HSV-DNA (molecular weight 100 
x 106 daltons (Becker, et al 1968)) assuming asymetric transcription. 
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In the present stuQy, we used 358-methionine to label the peptides sy.the-
sized in HSV infected cells which were studied b,y radioautography after 
electrophoresis i~ acrylaaide gels. From the analyses, we concluded that 
39 peptide bands can be detected in the electropherograms. However, only 12 
major peptides were detected i• the aRalyses of purified virions b,y radio-
autography. The add.i tional 10 baRds were detected b,y Cooaassie blue staining 
(Becker and Olshevsky, 1972) simce they were hardly labeled b,y 358-methio-
nine. Thus, attention was focused on the major viral structural and non-
structural peptides synthesized in HSV infected cells. In addition to the 
12 major virion structural peptides, 9 nonstructural peptides were detec-
ted. The rest, 18 peptides were found in minimal amounts which did not all.w 
accurate ieterminations or were detected only after short pulses with 35s-
methionine, indicating short lived peptides. 
RESULTS 
Electropherograms of infected cells and purified virions 
a. Purified virions 
Analysis of 35s-methionine labeled purified herpes simplex virions b,y 
radioautography, revealed the presence of 12 major structural peptides 
(Roman numerals in Fig. 1). These labeled peptides are identical with the 
12 major peptides which were detected b,y staining electropherograms of 
purified HSV with Coomassie blue (Backer and Olshevsky, 1972). In the 
stained electropherograms, 10 additional peptide bands were detected 
(which stained very faintly) bringing the total number of virion-associa-
ted peptides to 22. This is in accord with the 24 peptides described b,y 
Gibson and Roizman (1974). However, the absence of these 10 minor peptide 
bands from the radioautograms of purified herpes v1rions m~ indicate 
that they are present in small amounts, undetectable b,y the present tech-
nique, or they are con~aminants which the virions obtain from the :i<nfec-
ted cells. 
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The molecular weights of the peptides detected by radioautography were 
determined (Table 1) by their position in the gels in respect to markers 
myosin M.W. 210.000, bovine albumin M.W. 67.000, egg albumin M.W. 45.000, 
and pepsin M.w. 35.000. Peptide 15, the major capsid prote1n of the viri-
ons (previously designated II and also VP5 by Honess and Roizman(l973) 
has a molecular weight of 190.000 daltons 1n our analyses and 155.000 
daltons as determined by Honess and Roizman (1973). The discrepancies 
could be accounted for by differences in the positioning of the viral 
peptides in respect to the markers used for the construction of the refe-
rence gel. Nevertheless, the present estimations of the molecular weights 
of the viral structural peptides are higher than those published previous-
ly by us (Olshevsky and Backer, 1970 a; Backer and Olshevsky, 1972). If 
we sum up the total molecular weights of the 12 major viral structural 
peptides which were detected in the analysis of purified virions, it 
comes to 1.55 x 106 daltons. This requires 28% of the genetic information 
encoded in one strand of HSV-DNA (5.6 x 106 daltons unique amino acids) 
assuming assymetrical transcription. 
b. Infected cells 
In Figure 1 1 we compared the structural v1rus pept1des with the pept1des 
detectable 1n the 1nfected cells and the cytoplasmic and nuclear frac-
tions. A total number of 39 peptides were detected in electropherograms 
of cells which were labeled for long and short periods. Certain peptides 
were detected only after very short pulses with 35s-meth1onine and com-
prise the group of unstable,presumably nonstructural, peptides. The pep-
tides detectable after long labeling periods, are the stable, presumably 
the structural peptides. The total number of 39 labeled peptides which 
appear in the infected cells can be compared to 49 peptides (described 
by Honess and Ro1zman (1973). As can be seen from Figure 1, 21 pept1de 
bands were detectable in the electropherogram of infected cells which 
were labeled with 35s-methionine for 15 hrs (throughout the virus growth 
cycle). Peptides numbered 6 (M.w. 310.000), 9 (M.W. 260,000), 13 
(M.W. 210.000) 1 14 (M.W. 200.000), 17 (M.W. 180.000), and 33 (M.W. 45.000), 
are nonstructural stable peptides which can be found in the infected cells 
and their function if not yet known. 
Table 1. 
1 
2} 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15) 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
~~ 
30 
31 
32 
33> 
34 
35 
36 
37 
38 
39 
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Herpes Simplex Virus Peptides 
Peptide _3 Honess & Beaker & M.W.* x 10 Roizman** Olshevsky*** 
350 
320 
320 
310 
285 
260 
240 
230 
220 
210 
200 
190 
180 
165 
150 
140 
130 
120 
110 
100 
94 
85 
80 
74 
70 
60 
55 
51 
45 
41 
36 
33 
31 
27 
21 
VP 1-2 
3 
VP 4 
VP 5 
VP 7 
VP 8 
VP 12 
VP 14 
VP 15 
VP 16 
VP 22 
VP 23 
Structural Peptides 
I 
IIa 
II capsid 
IIIa 
III glycoprotein 
IV a 
IV glycoprotein 
V glycoprotein 
VI capsid 
VII internal 
VIII C!i-psid 
IX 
Rate of Synthesis during 
Infection **** 
I 
+ 
+ 
+ 
+ 
+ 
+ 
D 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
c 
+NS 
+ 
NS 
+NS 
NS 
NS 
+NS 
+NS 
+ 
+ 
NS 
NS 
NS 
* Total molecular weight 5.504.000 (total (calculated) 5,6 x 106 daltons 
of unique amino acid sequences) Total major viral peptides 1.550.000 
Daltons • 28% of the informati~n in the viral genome. 
** J. Virol. P. 1352, Figure 3, 1973 
*** Oncogenesis and Herpesviruses. Eds., P.M. Biggs, G. de The, & L.N. P~e, 
P• 421, 1972. I -increase, D- decrease, C- constant, VP- viral pep-
tide, NS -non-structural peptides 
**** Calculated from Figure 3 (Arginine +) 
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Figure 1 s Eleetropherograms of HSV infected, 35s-methionine labeled, ~ells 
and viriona. BSC1 cell monol~era were infected with HSV (10 pfu/cell) and 
labeled for 15 hrs (starting at 3 hrs p.i.) with 35s-methionine (lO~Ci/ml) 
in Eagle's medium containing 1/40 of the regular methionine concentration 
35S-methionine (specific activity of 100 Ci/mmole) purchased from the Radio-
chemi cal Centre, Amersham, England. The infected cells were harvested qy 
sgraping into reticulocytes standard buffer (RSB) and soni cated. Part of the 
cells were homogenized in a Dounce homogenizer and the nuclei were separated 
b,1 centrifUgation (800xg for 5 min) and resuspended in RSB. HSV was purified 
from nuclei on infected cells b,y centrifugation in sucrose gradients (12 -
52 % w/w) as previously reported (Backer and Olshevsky, 1972). Samples from 
homogenized cells (T) cytoplasmic (C) and nuclear (N) fract i ons as well as 
from the purified virions (V) were electrophoresed in 7,~ polyacrylamide 
gels as previously described (Olshevsky and Backer, 1970a). The gels were 
sliced longitudinally, dried on a filter paper, and put in contact with X-
r~ film. The exposed film was developed and the bands were detected. The 
arabic numbers (4 to 38) designate the position of bands detectable in a 
number of analyses. Missing numbers indicate peptides synthesized and detec-
table only during short pulses with 35s-methionine. The roman numerals desi-
gnate the major viral structural peptides previously detected i n analyses of 
purified virions (Backer and Olshevsky, 1972). VP designate the virus struc-
tural peptides determined b,y Honess and Roizman (1973). 
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It is of interest that peptides 6, 9 1 13 1 17, 23 and 33 are found mainly 
in the cytoplasm, while peptide 19 (M.W. 150.000) is detectable mainly in 
the nuclei of the infected cellse The other peptides can be found in the 
nuclei and cytoplasm. Of the peptides which are confined to the cytoplasm 
of the infected cells, the function of peptides 6, 17 1 and 33 are not yet 
known. Peptide 23 (M.W. 110.000) is peptide IVa of the virion structural 
peptides. Peptide number 19, which is found mainly in the nuclear frac-
tion, is a glycoprotein previously designated III, which is present in 
the virion envelope. 
The nature of the labeled peptides which band in the upper part of the 
polyacrylamide gel (peptides 1 to 9) and have high molecular weights 
(from 350.000 to 260.000) is not yet known. Peptide 4 (M.W. 320.000) which 
is the major peptide in this region, can be found in both the cytoplas-
mic and nuclear fractions of infected cells as well as in purified viri-
ons. The function of these peptides in herpes virions is still to be 
studied. 
c. Quantitative analyses 
The long labeling of HSV infected cells with 35s-methionine allows the 
analysis of the long-lived viral peptides (Fig. 2). It was found that the 
viral structural peptides were detected, as well as several nonstructu-
ral proteins. The profile shown in Figure 2 can be used for the computa-
tion of the quantity of the different peptides b,y determining the area 
underneath each peak. This analysis is not very accurate because some 
peptides band in close proximity to each other. However, it provides a 
useful analytical tool. 
I 
to 
_J 
<{ 
1-
0 
1-
E 
c 
0 0.5 
"' 
"' 
c:i 
0 
0 0 
Ilia 
1rTm 
7 :1 
' I 
309 
w 
-r 
~: 
: I 
DISTANCE 
5 
(cm) 
vm ,.... 
Figure 2 : Radioautography of 35s-methionine labeled herpes simplex virus 
proteins synthesized in infected cells. BSC1 cell monolalfers were infected 
with HSV (10 p~/cell) and labeled (3 to 18 hrs post infection) with 35s-
methionine (10 ~Cl/ml; specific activity lOO Cl/mmole purchased from the 
Radiochemical Centre, Amersham, England) in Eagle's medium containing 1/40 
of the regular methionine concentration. At the end of the labeling period, 
the cultures were washed with reticulocyte standard buffer (RSB) (l0-2M 
Tris., 10~2M KCl, 15 x 10-4 Mgel, pH 7.7), scraped into 1 ml RSB and soni-
cated for 1 min. The sample was treated with sodium dodecylsulfate, urea, 
and 2 mercaptoethanol. The samples were electrophoresed in 7.5% polyacry-
lamide as previously described (Olshevsky and Backer, 1970). At the end of 
the electrophoresis, the gels were fixed in acetic acid (7.5% w/v), sliced 
longitudinally, dried and exposed to X-r~ film for several d~s. The film 
was developed and scanned in a Gilford Spectrophotometer and the optical 
density of the bands was determined at a wavelength of 550 ~· 
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Analysis of proteins synthesized at different stages of the virus growth 
cycle 
To obtain information on some of the short-lived virus 
coded peptides, the PSV infected cells were labeled with 35s-methionine for 
3 hr periods during the virus growth cycle. At the end of the labeling pe-
riod, the cells were harvested, homogenized by sonication, and analysed by 
electrophoresis in acrylamide gels . A similar labeling procedure was done 
with HSV infected cells which were maintained in an arginine deficient 
medium, to study the effect of arginine deprivation on the synthesis of 
the viral structural and nonstructural peptides (Fig. 3). Every electro-
pherogram was scanned in a Gilford .spectrophotometer and analyzed by com-
puting the area underneath each band of the labeled peptides. 
The results presented in Figure 3 (Arginine +) demons-
trate that a large number of peptides (29) were synthesized in the infected 
cells. The additional 10 peptides were detected only when short pulses with 
35s-methionine were given to the infected cells (not shown). Most of the 
peptides were synthesized throughout the virus growth cycle, but differed 
in the rate of synthesis (Fig. 3) . This was determined by a quantitative 
analysis of the areas underneath each band. The different rates of synthe-
sis of the various peptides are presented as arbitrary units of area, which 
indicate the relative amounts of peptides synthesized. The peptides were 
divided into three major groups (Fig. 4) . Group A constitutes those pepti-
des (Fig. 4 A) having. a rate of synthesis which increases during the growth 
cycle. In this group, we find peptide 19 (glycoprotein III), 23 (peptide 
IVa), 24 (peptide IV glycoprotein), 30 (peptide VI, a capsid peptide), 
33-34 (peptide VII, internal arginine rich protein), and 36 (peptide VIII, 
a capsid protein VIII). The latter peptide differs from the others in that 
it decreases in amount towards the end of the virus growth cycle. 
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~~gure 3 : ~ynthesis of proteins during different stages of- the virus growth 
cycle in the presence and absence of arginine. BSC1 cultures were infected 
with HSV (10 pfu/ml) and incubated for 3 hrs at 37°C. The medium was then 
removed and replaced in 5 cultures with Eagle's medium containing arginine 
and 1/40 methionine. In another group of 5 cultures the medium was replaced 
b,y Eagle's medium containing 1/40 methionine but without arginine. To each 
culture, 35s-methionine was added for a 3 hr period starting at 3 1 6, 9, 12 1 
and 15 hrs after infection. At the end of the labeling period, the cells we-
re washed, harvested, sonicated, and the samples were electrophoresed in 
polyacrylamide gels. Radioautograms were prepared as described in the legend 
to Figure 1. 
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Figure 4 : 
Quantitative analysis of electropherograms presented in Figure 3. To obtain 
quantitative data on the peptides synthesized in HsV infected cells, the 
radioautograms were scanned in a Gilford Spectrophotometer at a wavelength 
of 550 p:m and the tracings were analyzed by computing the areas underneath 
each ba~d ~he aid of grafjpen sonic digitizer and a PDP-15/20 computer. 
1-ll.th 
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Group B peptides (Fig. 4 B) are characterized Qy a h1gh 
rate of synthesis early 1n infection and a gradual decrease thereafter. 
These peptides are : 15-16 (capsid protein II), 17 (nonstructural (NS) pep-
tide), 18 (v1rion associated peptide, III a), 21 (NS pept1de), 23 (peptide 
IV a, virion associated), 34 (NS pept1de), 35 (NS peptide), 37(NS pept1de), 
and 38 (NS pept1de). It is of interest that the major structural peptides 
II, III a, IV a, which are part of the viral capsid were synthesized at 
h1gh rates early in infection and the rate decreased toward the end of the 
virus growth cyele (Fig. 1). The other peptides are nonstructural pept1des. 
Group C peptides (Fi~. 4 C) are synthesized at a cons-
tant, relatively low rate, and consist of peptide 4 (NS peptide), 1~ 
(peptide IIa, virion associated), 20, 25, 27, 39, (NS peptides), and 28-29 
(peptide V, virion glycoprotein) (Table I, Fig. 4 C). 
Effect of arg1nine deprivation on the synthesis of viral proteins 
The results presented in F1gure 3 (argine -) reveal 
that HSV infected cells s;vnthesize less viral structural pept1des than cells 
which were incubated in arg1nine containing medium. Pept1des 15-17, which 
are the capsid protein II, were synthesized in detectable amounts through-
out the virus growth cycle. The same is true for peptide 18 (peptide III a), 
19 (glycoprote1n III), 24 (glycoprotein IV), 28-29 (glycoprote1n V), and 
33-34 (pept1de VII). Other peptides, especially the h1gh molecular weight 
pept1des (1 - 14) were not detectable qy the present technique in the ab-
sence of arginine in the medium. 
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Virion associated peptides : 
With the aid of 35s-methionine and radioautography of 
polyacrylamide gel electropherograms it was possible to determine the num-
ber of the peptides present in the purified virions. This analysis was com-
pared to previous analyses in which the virion associated proteins were 
determined b,y Coomassie blue staining. The latter technique revealed 12 
major and 10 minor peptides. In the rad~oautograms of 35s-methionine labe-
led peptides, the 12 major peptides were detectable while the 10 minor ones 
were not. It is not clear whether this is because the 10 minor peptides were 
not synthesized or whether the exposure time of the polyacrylamide gels was 
not sufficient, or the methionine content of these peptides is low. Whatever 
the explanation m~ be, this result suggests that the 12 major peptides are 
the structural peptides o~the virion. Some of the 10 minor peptides corres-
pond to certain nonstructural peptides found in the infected cells, which 
suggests that they m~ have been taken up nonspecifically b,y the virions. 
The 12 major viral peptides are similar to the 12 pepti-
des (VP) described b,y GibBon and Roizman (1974) and Honess and Roizman (1973). 
The visible peptide bands which can be seen in their autoradiograms, m~ 
also be regarded as the major viral peptides (Table 1). It seems that the 
same viral peptides were detected b,y Roizman•s and b,y our groups. 
Synthesis of viral peptides in HSV infected cells 
Analyses of electropherograms of HSV infected cells la-
beled for short and long periods with 35s-methionine revealed a total of 39 
peptides. Of these peptides, 14 were with molecular weights higher than 
200.000 daltons. This is in contrast to Honess and Roizman (1973) who found 
only three peptides with molecular weights higher than 200.000 daltons. 
This difference could be accounted for either b,y the difference in the cells 
used for the study (BSC1 in this study and HEp-2 b,y Honess and Roizman (1973)) 
or due to the difference in the virus strains. 
315 
In addit1on 1 in the analyses of Honess and Roizman (1973), the different 
peptides were better separated from each other than in the present study. 
Labeling of cells for long periods (e.g. 15 hrs, Fig. 1 
and 2) revealed the stable v1rus structural peptides and only a few stable 
nonstructural peptides like peptide 17 (M.W. 180.000) which was synthesized 
in large amounts shortly after infection and its rate of synthes1s then 
gradually decreased. The nature of these peptides is not yet known. Labeling 
for shorter periods of time revealed more peptides in the infected cells. 
This indicates that certa1n v1ral structural peptides are synthes1zed through-
out the virus growth cycle at a d1minish1ng rate. 
The total molecular we1ght of the genetic informat1on 
encoded b,y HSV-DNA corresponds to 5.6 x 106 daltons of unique amino acids 
(Olshevsky and Becker, 1970 a; Honess and Ro1zman, 1973). The sum of the 
molecular we1ghts of the 39 pept1des described here, was calculated to be 
5.5 x 106 daltons. If all the peptides synthes1zed in the HSV infected cells 
are 1ndeed unique v1ral pept1des, then almost all the v1ral genome is trans-
cribed and translated 1n the infected cells. Further stud1es are st1ll nee-
ded to identify the function of each nonstructural pept1de and its relation 
to the v1rus replicat1ve cycle. 
Effect of arginine deprivat1on on the synthesis of v1ral proteins : 
Previous stud1es on the effect of arginine deprivat1on 
on the repl1cat1on of herpes simplex virus (Becker et al,l967; Alshevsky 
and Becker, 1970 b) showed that HSV-DNA is repl1cated 1n infected cells incu-
bated 1n an arginine deficient med1um although virions are not formed. 
Analysis of 35s-methionine labeled HSV 1nfected cells by electrophores1s in 
acrylamide gels revealed that most of the viral structural and nonstructural 
p~9pt1des were synthes1zed in the absence of arginine (as was also shown b,y 
Mark and Kaplan, 1972). The proteins were transported from the cytoplasmic 
to the nuclear fractions of the 1nfected cells (not shown). However, the 
sJ~thesis of certain pept1des was markedly affected while others were affec-
ted to a lesser extent. Under these condit1ons 1 virions are not formed. 
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DISCUSSION 
Dro DALSGAARD 
I just wondered, Dr. Backer, for the sake of resolution in polyaQryla-
mide gel electrophoresis is a very complex mixture to separate. Have you 
considered the use of two-dimensional polyacrylamide gel electrophore-
sis, possibly also including a gradient in the gel ? 
Dr. EmKER 
You are absolutely right that the resolution could be improved b,y using 
better techniques, but we wanted to get an idea first of all from a tech-
nique that we know and we have used for quite a while. We plan to extract 
from the gels the heavy bands and resolve it b,y a different technique to 
find how many different peptides are present in each band. One of the 
methods is the hydroxy apatite resolution of SDS treated proteins. 
Dro VAN OIRSCHOOT 
I have just read in your introduction that 7'J% of the viral genome is 
transcribed, and this is in contradiction with the book of Tooze where 
they S!liY only 5CY}1. of the viral genome is transcribed during the whole 
efficient cycle, in human epithelium cells. 
Dro BECKER 
What we could do obviously is to calculate the total amount of informa-
tion that is present in a 50 million daltons molecular weight single-
stranded DNA, assuming that the single-stranted DNA is transcribed. The 
total amount of unique amino acids coded b,y HSV is 5,6 million daltons. 
Now if we sum up all the peptides that we have seen here, we obtain a 
figure which is about 1oaj1, of that - 5,5 million daltons molecular weight. 
However, we have the feeling that some of the peptides, especially those 
with molecular weights higher than 200.000 daltons (Peptide No. 2 is 
200.000 molecular weight) might be cellular proteins, and we are not abso-
lutely sure if this is a group of cellular membrane glycoprotein. We do 
not know if the herpes virus really completely blocks the synthesis of 
cellular proteins. 
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Dr. SCHOLTISSEK 
Do you have any ~ndicat~ons whether some of the non-structural prote1ns 
are precursors of structural proteins - this means that they m1ght be 
spht to structural proteins ? 
Dr. BECKER 
We did not f1nd precursors to the v~ral pept1des. 
Dr. MCAUSLAN 
Dr. Horzinek raised the poss~bility of using frog v~ruses as tools to switch 
off the synthes~s that we have done and then to look at the synthesis of 
other viral prote1ns and all I can do is to recommend to try in your sys-
tem that most of the frog viruses have very funny effects on d1fferent sys-
tems, for example, it would inhibit right messenger transcript1on in the 
cells readily infected w~th pox v~rus that would not inhibit messenger wh1ch 
is transcribed from coated cores; we don't know what it does to herpes v1rus 
systems, but my guess is it would probably stop it because it does inh1bit 
first ARN polymerase act~vity fa1rly extens1~ely so 1t ~s said the quest~on 
is reliable to 1nfluenza virus activ~ty; I have two confl~cting reports, one 
group s~s that free 1nfect~on with frog v1rus will imply polymerase actlvi-
ty and also other enzyme implications, and another group said 1t doesn't, 
so it would be 1nteresting for some expert to do this, but anyw~ 1t m~ght 
be an ~nteresting tool and even for something l1ke African sw~ne fever it 
might be worthwhile to try w~th just all the background of the first prote1ns 
and then 1nfect1on with African swine fever and then w~th the polypept~des 
simply synthesized. 
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The technique of quantitative immunoelectrophoresis (crosse~ 
(immunoelectrophoresis) and its application in the stu~y of 
viral antigens 
K. Dalsgaard, State Veterinary Institute for Virus Research, 
Mindholm, DK- 4771 Kalvehave, Denmark 
Crossed immunoelectrophoresis was introduced in 1965 as an analytical tool 
for the study of human serum proteins (1). The technique was modified the 
following year (2), and recently a team from the Protein Laboratory at the 
University of Copenhagen have published a book on the method (3), and a lot 
of soph1sticated modifications. 
In principle the method is a combination of electrophoretic separation of 
proteins in agarose gel and subsequent electrophoresis in an antibody-con-
taining gel. The macro-techn1que adapted qy us is performed as follows : 
15m1 of a heated 1% agerose solution (55~) in barbital buffer is poured 
onto a glass plate (90 x 110 x 1,5 mm) placed on a horizontal table. When 
the gel is congelated four wells are punched. After placing the plate in an 
electrophoresis aparatus with a cool1ng plate, the samples are applied and 
the plate is connected to the buffer vessels qy means of paper wicks. First 
dimension electrophoresis is carried out using 8 V/cm. The temperature of 
the cooling water is 15°C, and the electrophoresis is run for li hour. 
B,y means of a 15 cm long razor blade a 5 mm broad edge all round the gel 
is cut aw~. The rest of the gel is divided into four slabs (20 x lOO mm), 
and each of the slabs is transferred to an agarose coated glass plate 
(100 x 100 x 1,5 mm). The glass plate is placed on the horizontal table and 
12 ml of an antibody-containing gel (55°C) is poured onto the rest of the 
plate, adjacent to the first dimension slab. After congelation the second 
dimension electrophoresis is carried out using 1,5 V/cm, at l5°C overnight. 
After the electrophoresis the gel is pressed (filter paper), washed, pressed, 
dried and stained b,y Coomassie brilliant blue, R. 0,~ solution in lo% 
~elution of glacial acetic acid in 5o% ethanol. 
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Destain1ng lS performed in the solvent. ~ means of pressing and swelling 
the gel, the whole procedure can be carr1ed out 1n the course of 2 hours, 
which means that 1f you start the first dimension electrophores1s in the 
afternoon of day 1, you w1ll obtain the f1nal result at noon of day 2. 
+ 
I 
+ 
I 
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0 
. 0 0 0 
Crossed immunoelectrophoresis lS superior to the class1cal immunoelectropho-
resis accord1ng to Grabar and W1lliams because it provides a more powerful 
resolut1on. Furthermore, the area enclosed b,y an indiv1dual precioitate 1s 
proport1onal to the antigen/antlbody ratio of the system. With a standard 
polyvalent ant1serum it is thus possible to separate and quantitate more 
than 30 serum proteins by a single run. 
Crossed immunoelectrophores1s has recently been used 1n the character1za-
t1on of herpesv1rus hom1nis type 1 and 2 ant1gens (4). In our laboratory 
we have adapted th1s technique for the study of the ant1gens of HCV and 
BVDV. 
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The antigens are obtained in the following w~ : Monolayers of susceptible 
cells are infected with the vi~ts. 48 hours after infection (maximum fluo-
rescent titre) the cells are scraped off the ~lass, uacked and treated with 
a lOOfo solution of triton X-100 in neutral tris buffer. The mixture is soni-
cated and centri~1~d at 100.000 g for one hour. The supernatant contains 
the solubilized antigens, and it is used in crossed electroohoresis without 
further purification. Control plates are alw~s included. The control anti-
~en is the same amount of non-infected cells prepared as described above. 
Using a hyperimmune serum against HSV (prepared in Brescia ~r Nardelli) it 
is oossible to demonstrate 3 antipens speci.fic of HCV0 The same antiserum 
reacts with one anti~en soecific BVDV, and b,y means of a modification of 
the crossed electrophoresis called tandem electrophoresis (3) it has been 
demonstrated that this antigen of BVDV is identical to one of the antigens 
of HCVo 
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Antigen: 15pl HSV (see text for preparation) 
Anti body : 500 pl swine anti HCV (Nardelli) 
( 
Antigen : 15 Ml BVDV (see text for preparation) 
Antibody : same as above 
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( 
Antigen : left hole 15 }ll HCV·right hole 15 pl BVDV 
Antibody : same as above 1 
Note the fusing to a double peak indicating identity. 
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DISCUSSION 
Dr. KNORN ldELGAR 
You can also do this techn1que in slides and you can produce the slides 
so stained that you don't need to make a photograph on your electrophe-
rograms. I also used this technique for characterising corona viruses, 
'l'G virus, immunoglobulins specific and I only used the slides in LKB 
diffUsion chamber and that goes ver,y well. But I was a little worried 
about your first picture because you said that the immunoglobulin was 
at a very high level, and I don't think so. Could I see once your first 
diapositive ? 
Dro DALSGAARD 
This is true. You can make it directly and put it into the projector but 
for the 10 x 10 plate you need a large projector. 
Dr o KNOR.li MELGAR 
But I wondered about what you said. How much time do you electrophorese 
it ? Eight hours, or longer ? 
Dr. DALSGAARD 
In the second dimension ? I electrophorese overnight. And then once the 
precipitates have formed then they are precipitated. 
Dr. KNORN MEI.GAR 
Do you characterize also the immunoglobulins ? 
Dr • DALSGAARD 
You can characterize the immunoglobulins, but then you have to alter the 
electric net large of the immunoglobulins because the reason why you can 
use this technique is that the immunoglobulins, namely the IgG fraction, 
in the second dimension at this pH of 8.6 they will not move, whereas 
the antigens they will move under these_ conditions and of course this 
counts for the IgG- here, it will not move the correct w~ so you can-
not determine the correct amount of IgG in this system. 
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This you can do in another way. If you carbamylate your IgG fract1on 
or you can carbamylate your ant1serxm here, then you w1ll alter the 
electr1c net charge and you can alter the pH of the med1um to have a 
pH of 6 or 5 where the immunoglobulines will move up. 
Dr. KNORN MELGAR 
But that doesn't comply Wlth your first slides. 
Dr. DALSGAARD 
IgG is a heterogeneous population. There is anodic IgG and cathodic IgG 
and what you see in my picture is the anodic IgG. 
Dr o KNORN li!ELGAR 
But you must also see the anodic IgG. 
Dro FROST 
I have a question concennng your second graph •nth the Hog Cholera 
ant1gen. I th1nk you have only two ant1gens demonstrated and one with a 
dimeric form showing 1dent1ty. 
Dr. DALSGAARD 
I agree, th1s is one possib1lity that a d1meric form may have another 
electrophoretic mob1lity 1n the system and then you will see them fuse 
1n the system. This is a great possibility, but as I told you, these 
data are very prel1minarJ and we have a lot of work to do. This is a good 
explanation, I bel1eve it too. 
Dr • HORZINEK 
Could you comment on the sens1tiv1ty of the method with respect to micro-
gram nitrogen detected ant1gen ? 
Dr. DALSGAARD 
Th1s I could not tell you because I am not famillar with the microgram 
ant1gen detectible but I can say 1t's at least five to six times more sen-
Sltlve than normal immuno diffusion because th1s is a forced transmission 
of ant1gens. In normal immuno diffusion, you will have a c1rcular diffu-
sion to all sides but 1n th1s system you just have one unidirect1onal mo-
vement of the ant1gens and th1s means alone six t1mes more sensitivity. 
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DT. CORTHIER 
You s~ that it is more sensitive. I don't understand why. I agree if you 
s~ that it is more precise and quantitative but sensitive I don't agree 
because you delute this more than in a simple electrophoresis. 
Dr. DALSGAARD 
No, you include quite a lot of antibody into your gel in the second di-
mension - about half a milliliter in the second dimension - for a normal 
two microliters serum sample in the first dimension. In normal electro-
phoresis in the long well you only have about 50 microliters for two 
microliters in the first dimension, so this corresponds in sensitivity 
ver.y well to the normal technique, but it is five times more sensitive 
because it's a unidirectional movement of the antigen, if you have a 
normal hole for immunodiffusion, your substances will diffuse radially 
out and you have your antibody here. Only this antigen will be available 
for precipitation. The rest of it is lost, whereas in this system, the 
whole antigen is forced into the antibody. 
Dr • V AN OI RSCHOT 
These hog cholera and BVD-MD antigens, are they membrane associated anti-
gens ? 
Dr. DALSGAARD 
This we do not know. We know that they are associated to the infection, 
because we see them in our infected cell isolates and we do not see them 
in control cells, but whether they are incorporated into the envelope or 
not, anyw~ 1 Dr. Matthaeus is probably going to argue that tomorrow. 
Dr. VAN OIRSCHOT 
How do you get the hog cholera antigen ? 
Dr • DALSGAARD 
We propagate the hog cholera in primar.y pig kidney cells. We could use 
PK 15 cells but they were not so good. After 48 hours of infection, we 
discard the supernatant and then we scrape the cells together and pack 
them so that we end up with 1 milliliter of infected cells from· about 8 
or 10 roller bottles which represents quite a large concentration. And 
then we treat with sonication and triton X-100. 
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Dr. MCAUSLAN 
Dr. HORZINEK and I have just been talking about the possibility of using 
a rad~o labelling techn~que as well. Would it be possible to have the 
antigens labelled up with iodine or something? 
Dr. DALSGAARD 
This has been done already for the studies of IgE antibodies in connec-
tion with allergic reaction. There is a group in Copenhagen working on 
that and since the IgE level is normally quite low, they have tried to 
label it w~th iodine, and you can make autoradiography of these plates, 
especially if you cool them wh~ch is a more sensitive technique. 
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SUMMARY OF THE SESSION 
s. Schlesinger 
I just would like to s~ a few words in summary of this afternoon's meeting. 
I was struck qy the fact that we talked about a spectrum of different viru-
ses this afternoon, but what came through at least to me in a very clear 
w~ were the number of different approaches that were used. These different 
approaches are a reflection of both the complexity of the viruses that are 
being studied and the extent of our knowledge. In the case of frog virus 
and herpes virus, it is clear that one is still in the stage of identifying 
the viral proteins both the number of viral specific proteins in the infec-
ted cells, the number of prote1ns is the virion itself, the time at which 
these proteins are being synthesized during replication, and if both the 
amounts of proteins and the time at which they are synthesized is regulated. 
In the case of influenza virus (and also in the case of S1ndbis virus) it 
is now possible to localize these proteins in the cell, particularly in the 
case of the glycoproteins; it's possible to follow their movement between 
the smooth and the rough membranes. It has been clear both this afternoon 
and in the previous lectures that the use of inhibitors has been a very 
important approach to the study of viral replication. Inhibitors will be 
particularly valuable for the study of the viruses that are less well-known. 
The studies with in vitro protein synthesis are now just beginning to be 
explored. Techniques are being worked out so that this approach can be used 
to answer questions about viral replication, about v1ral RNA, and about the 
proteins of the virus. I think defective 1nterfering particles will also 
turn out to be very valuable in analysing the different processes in viral 
replication. It will be important to use these diverse approaches in trying 
to obtain more information about hog cholera virus and African swine fever 
virus. 
SESSION IV 
VIRAL ANTIGENS 
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HOG CHOLERA VIRAL ANTIGENS (BRIEF REVIEW) 
AND SOME RECENT RESULTS ON THE RELATIONSHIP 
TO ENVELOPE ANTIGENS OF BOVINE VIRAL 
DIARRHEA-MUCOSAL DISEASE VIRIONS 
B. Liess, H.R. Frey, u. Bucksch, 
B. Roeder and J. Frost 
Institute for Virology 
School of Veter1nary Medicine Hannover 
Hannover, Germany 
Although Hog Cholera (HC) antigens have been demonstrated qy a variety 
of methods, little is known on the character of these antigens, their 
orig1n and their relation to viral structures. For a long t1me most of 
the studies pointed at the demonstration of soluble antigens qy lmmuno-
diffusion techniques using pancreatjcor spleen t1ssue from HC infected 
pigs as source of antigens. Since Molnar (1954) first published results 
which showed the presence of precipitating antibodies 1n pig sera, many 
attempts were undertaken to make the agargel diffusion techniques of use 
for the diagnosis of HC qy e1ther demonstrat1ng antigens 1n organ tis-
sues or ant1bodies in blood sera. Apparently there are still some labc-
ratoriElS in which the agargel d1ffusion test 1s believed to be of value 
for HC d1agnosis when it is worked with pieces of pancreas or crude pan-
creas suspensions. 
It was not earl1er than 1966 when van Aert first described a method for 
extraction and part1al purification of a precipitating HC antigen prepa-
ratlon and later opened the w~ for stud1es on the physico-chemical and 
biolog1cal characterization of organ derived soluble antigens (van Aert, 
1970). 
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Although the agargel diffusion test had meanwhile lost its former signi-
ficance for the practical diagnosis of HC after the introduction of the 
immunofluorescence technique applied to organ sections of HC suspected 
animals, Matthaeus et al. (1970, 1971) tried further to eluc1date the 
nature and HC specificity of ant1gens which are demonstrable in pancreas 
tissue of HC infected pigs and which react with antisera prepared not 
only against HC virus but for comparison against the virus of Bovine Vi-
rusdiarrhea-Mucosal Disease (BVD-MD), too. An important result obtained 
b,y Matthaeus (1972) was the isolation of an antigenic component which 
showed identical immunoelectrophoretic behav1our when tested in parallel 
with BVD-MD antigen in the same run of experiment. Besides these HC and 
BVD-MD specific antigen-antibody reactions Matthaeus (1972) described un-
specific precipitations of non-antigen-antibody character which can hardly 
be distinguished b,y agargel diffusion, and therefore he recommended the 
additional use of auxiliar.y techniques like immunoelectrophoresis. We pro-
bably can expect to hear more informations from Dr. Matthaeus which he is 
going to present in the following paper, on the nature of the soluble HC 
antigen and its relation to viral strnctures. But it ma,v be said here al-
ready that future work on soluble HC antigens needs more efforts for the 
large scale product1on of HC virus in tissue culture 1n order to avoid reac-
tions which are due to host components like enzymes or other metabolic sub-
stances present e.g. in pancreas tissue. 
From the practical as well as from the theoretical point of view surface 
antigens of HC virions are at least as interesting as soluble antigens • 
• Envelope antigens of HC virus offer the possibility to study antigen1c 
strain differences even in relation to BVD-MD virus b,y neutralization tech-
niques using tissue cultures as indicator system. The latter is important 
since it is known that BVD-MD virus infects pigs which might harbour the 
virus for a rather long period without development of any sings of illnes 
but with induction of antibodies (13, 14). 
Within a WHO/FAO programme on comparative virology a working group on small 
enveloped RNA viruses deals with the differentiation of HC and BVD-MD virus 
strains b,y means of seroneutralization. One of the most interesting results 
obtained b,y Dr. Aynaud and his coworker, Dr. Corthier, was the finding of 
one strain of HC virus (No. 331) obtained from Dr. Mengeling (u.s.A.), 
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which reacted to a h1gher degree of neutralization w1th ant1serum prepared 
against the BVD-MD reference virus strain NADL than other stra1ns of HC 
virus. 'rhough testing for antigen1c variat1on employ1ng Grade I - antisera 
preparecl against purif1ed strains of HC and BVD-MD virus in gnotobiotic 
pigs or calves, respectively, is 1mportant and certa1nly spould be carr1ed 
on, the question arises whether stra1n differences c~~ be detected by the 
apphcai;ion of virus neutralization tests to sera from :oigs exposed to virus 
by natural infections. 
W1 th th:LS quest1on in mind 1 t should be allowed to re:oort on recent lnves-
tlgatlOns wh1ch we had the opportun1 ty to carry out wi th1n in prop-ramme of 
serolo/S:.cal surveys for the detect1on of latently plg breed1ng herds dur1ng 
the yeru· 1972. At that t1me the ep1demiolo~ical situat1on of HC 1n the Fede-
ral Republlc of Germany was characterized by a sllghtly hi15'her 1nc1dence 
of cl1nical HC than 1n the forego1ng years, but d1d not lead to an exten-
sive use of HC vacc1nes as it did in feeder lots dur1ng the second half 
of 1973. Therefore when the blood samples were taken the ep1demiolog1cal 
situation could be descn bed as not abnormal coJJpared with the rievelcpment 
exper1enced in 1973 when the number of cl1nical HC outbreaks rose tremend 
ously. Using a neutralizatlon technHrue wh1ch might be simply called NIF 
test (neutrallzation and 1mmunofluorescence test : L1ess and Frey, 1971) 
ani whic:h employs constant virus doses, blood sera sam:oled 1n about Ll.OO 
pig breeding herds were screened at an in1 t1al d1lution of l to 5. Such 
herds 1n which one or more ser!l. w1th neutrallzing activ1ty could be detec-
ted were called posl tive. For comparison an errual number of herds was ran-
domly solected where no neutrallzing sera could be found (NIF negat1ve 
herds). Neutrallzing t1tres of NIF posit1ve sera were determined for HC 
virus strain Alfort as well as for BVD-MD v1rus stra.1n 1138/69 wh1ch is a 
highly c:yto-oatho~Senlc strain and can be used in the mi.croli ter system as 
described previously (Frey and L1ess, 1971). The qualitat1ve results of 
neutral:.zat1on tests with both v1ruses can be seen in F1gure l. If one con-
siders only those sera from NIF pos1t1ve herds wh1ch showed neutral1z1ng 
activity a~a1nst HC v1rus and the group of sera from NIF negat1ve herds 
and compares the results of BVD-~ID neutral1zation 1n both groups it can 
be seen that less half the percentage of sera 1n the NIF negat1ve group 
shows neutrallzing act1vity aga1nst BVD-MD virus compared with the NIF 
psoit1ve group of sera. 
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NIF 
TEST 
BVO-MD 
NEUTRALIZATION 
42,3% 94,6 % 
Figure 1 Percentage of BVD-MD neutralizing antibodies in pig sera from 
the field w~th or without neutralizing activity against HC virus 
(strain Alfort) 
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These re•sul ts justify the question whether the NIF test picked those sera 
wh1ch derived from pigs infected with HC virus previously and which cross 
reacted with BVD-MD v1rus or the other wey around. An approach to answer 
th1s question might be offered by the comparison of the neutralizing titres 
of ind1vidual sera against both v1ruses. Figure 2 shows first the range of 
titres obtained with both viruses. The l1nes drawn in Figu~ 3 connect the 
t1tres measured for neutralizing antibodies against HC and BVD-MD virus in 
a total of 50 individual pig sera showing a rather scurile graph with all 
kinds of comb1nation ranging from very low titres against one virus and 
high titres against the other one. Some sera showed titres which differed 
for less than one log2• Sera with complete absence of neutralizing activity 
against the other one, some of them piling up to 1/640 and more in the case 
of antibodies against BVD-MD virus, are not included in this figure. 
It might be all01·red to cast a view on experimental results des cri bed in the 
litterat·~re with respect to measurable antibody formation after experimen-
tal infections of pigs with HC and / or BVD-MD virus. While some invest1-
gators W<3re not able to demonstrate neutraliz1ng anti bodies against BVD-MD 
virus after primary HC virus inoculation before challenge (Figure 4), others 
were able to do so 1f they used virus strains which had undergone only a 
few passages in tissue culture after primary isolation (Figure 5) • If we 
compare these experimental results with the results of serological testing 
of sera from pigs which were exposed to natural infections in the field, all 
these combwations are reflected (Figure 6). 
One of the question which arises from the review of some published reports 
mentioned and which puzzles with regard to high titres of antibodies against 
BVD-MD virus and low titres against HC virus is whether the results publis-
hed qy Sheffy, Coggins and Baker (1961) reflect natural conditions in so 
far as HC infections in the field induce specific antibodies to a lower 
titre if BVD-MD antibodies were formed already and which rises to an even 
higher titre secondarily. If this is so future meetings like this one todey 
can hardly devote to Hog Cholera only and treat BVD-MD virus 1nfections in 
cattle as of secondary importance. 
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NEUTRALISATIONTITER 
DESP 
Figure 2 Range of neutral1zing titres against BVD-MD and HC virus, res-
pectively, measured in pig sera from the field. 
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Figure 6 1 Patterns of serological responses of pigs to hypothetical natural 
infections with HC or BVD-MD virus as revealed b,y differences of 
neutralizing antibody titres. 
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Finally for future work on antigen1c variation of HC and BVD-MD v1rus the 
suggestion drawn from the results reported here m1ght be gLven to use not 
only antisera from experimentaly infected pigs or calves but selected sera 
from the field, too, particularly those ones which show monospecific acti-
vity aga1nst one strain of virus. 
Knowledge of the antigen1c variat1on of HC virus and its relat1on to BVD-
MD virus in pigs has some practical implications, especially with regard to 
the question of latent HC infect1ons in pigs. Th1s question employed us 1n 
the last few months dur1ng experiments des1gned to f1nd out the percentage 
of pigs wh1ch are to be expected to react cl1nically to the Glentorf strain 
of HC v1rus after contact to inoculated p1gs. The virus strain had been 
found to produce no clinical signs of illness in sows but to be able to in-
duce malformations in foetuses. Of n1ne weaning pigs six developed febrile 
reactions of a few dalfS duration and neutral1zing ant1bodies first to HC 
v1rus and secondly with a delalf of about 2 to 6 weeld to BVD-MD Vlrus, too. 
The remain1ng four pigs died several weeks later sporad1cally after long 
per1ods of undulating fever and w1th no signs of any format1on of neutra-
lizing ant1bodies (Figure 7). We were not able yet, to evaluate all the 
leucocyte fract1ons collected in intervals in order to look for viremia. 
Th1s is on the programme for the near future. 
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DISCUSSION 
Dr. NE\iBY 
Do you know anythlng about the antigenlc response ln these pies which 
are not respondlng to the virus ? Do they respond to other antigens ? 
Have you triea to work on thls ? 
Dr. LIESS 
No; we do not know this yet, but we have some lndlcatlons from other expe-
rlments that they are able to respond, though I have not a clear proof, 
but we know that they are not agammaglobulinemic, 
Dr, V AN BEKKUJII 
Does this glentorf straln produce normal immunofluorescence ln the PK 15 
cells ? 
Dr. LIESS 
Yes, there is no dlfference whatsoever, Perhaps I might say that it is a 
straln which does not multiply very well at 37° C and we have to try 
whether it lS capable of multiplying at lower temperatures. 
Dr, V AN BEKKUM 
You showed us some antibody patterns ln swlne that mlght develop under 
dlfferent conditions, Would you expect the patterns to change lf one used 
a dlfferent virus strain ? Vlral dlarrhea or hog cholera Vlrus ? 
Dr. LIESS 
We are well advised to use other strains, partlcularly one which lS charac-
terized like strain No. 331, one whlch appears to be more related to BVD-
li!D virus, 
Dr. KNORN MELGAR 
Did you look also for the antibody class respond1ng to BVD-li!D and also for 
the antibody class responding to HC ? 
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Dr. LIESS 
No, not yet. But there is certainly something which can be done and the 
question is what kind of antibody class are we expecting ? 
Dr. KNORN MELGAR 
There is a publicat~on that the IgM response will be ver.y specific against 
the pathogenic strain. You are using, in fact, your antibodies, but the 
IgG class is not so specifically directed against the antigens. 
Dr. LIESS 
This is probably a question of time. IgG is produced later during the run 
of the infection and we see that the quality of BVD apparently appears 
with a del~ of at least 14 d~s compared with the appearance of antibo-
~ies against HC virus. 
Dr. VAN BEKKUM 
What is your reason for assuming that the glentorf strain is hog cholera 
virus ? 
Dr. LIESS 
Because it produces malformations and it was isolated from HC field out-
breaks. 
Dr. KNORN MELGAR 
Did you also look for a specific neutralizing antibody against SMEDI 
virus ? 
Dr. LIESS 
No, we did not. 
Dr. TERPSTRA 
Refering to the case which you mentioned in which you got piglets with a 
persistent viremia without producing antibodies; at what stage of preg-
nancy was the sow infected ? Was this perhaps a case of immunotolerance 
due to infection of the sow at a ver.y early period in gestation ? 
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Dr. LIESS 
Are you referlng to those p1gs wh1ch were infected b,y contact ? Than the 
sow was not 1noculated. The plgs were 1n contact w1th inoculated pigs and 
at an age of eight weeks they did not have, as far as we know, any expe-
rlence w1th HC virus before, so I don't think that there was any contact 
intrauterin. 
Dr. CORTHIER 
Do you think 1t m~ be that you infected the sow wlth a strain of hog 
cholera VlMlS that looks like the 331 ? We observe that this type of 
strain 1n certaln cases produces a very small amount of antibod1es aga1nst 
Alfort stra1n and llke th1s, you cannot detect it qy cour technique. 
Dr. LIESS 
This virus strain produced 1n the other animals whlch reacted serologi-
cally titres of more than 1/600 measured against the Alfort strain of HC 
v1rus. 
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ON THE SPECIFITY OF ANTIGENS OF HOG CHOLERA VIRUS 
DETECTED BY THE AGARGEL DIFFUSION TEST AND 
IMMUNOFLUORESCENCE 
by 
W. MATTHAEUS, and G. KORN 
Federal Research Institute for Animal Virus Diseases, 
TUbingen, German Federal Republic 
SUMMARY 
Extracts from various organs and cells of infected and noninfected animals 
and tissue-cultures, respectively, were fractionated by precipitation, ion-
exchange, gelfiltration and centrifugation. In the agargel diffusion test, 
these fractions were compared with the precipitating antigens, derived from 
the pancreas of hog cholera virus (HCV)-diseased animals, as well as tested 
with regard to the1r capacity to adsorb fluorescein-labelled antibodies of 
anti-HCV-hyperimmune sera. Analogous experiments were performed using puri-
fied intact or splitted HCV. Immunoelectrophoretic studies of the HCV revea-
led a precipitating behaviour differing from that of the precipitating HCV-
pancreatic antigens. It is discussed that the antigens detected in the agar-
gel diffusion test by reaction of porcine anti-HCV-hyperimmune sera against 
pancreas of infected pigs and in the immunofluorescence against infected 
cultured cells do not represent virus-specific structural components, but 
rather disease-specific cell antigens. 
abbreviations used : 
HCV • hog cholera virus; MDV = mucosal disease virus; ADT = agargel diffu-
sion test; IE = immunoelectrophores1s; IF = immunofluorescence; HC-PAS = 
porcine anti-HCV- hyperimmune sera; HC-RAS = rabbit anti-HCV immune sera; 
MD-BAS = bovine anti-MDV hyperimmune sera; prec. HCV-0-antigens = precipita-
ting HCV-antigens from pancreas of diseased pigs. 
351 
INTRODUCTION 
Togaviruses have a genome of s1ngle-stranded RNA w1th a 
molecular weight of 3 to 4 x 106 daltons. These viruses cons1st of an 1some-
tr1c nucleocapsid surrounded by a lip1dprote1d envelope. Most of the inves-
tlgations, so far, showed that the nucleocapsid conta1ns a structural pro-
tein while the envelope conta1ns host cell lipids and v1rus-specif1ed poly-
peptides 1ncluding one or more glycopeptides. 
With1n the togav1rus fam1ly d1fferent genera, namely 
alphaviruses, flav1v1ruses and rub1v1ruses have to be distinguished. It is 
possible that the complex of hog cholera virus (HCV) /mucosal disease virus 
(MDV) represents a particular genus •n thin this virus faffilly. The equine 
arteritis virus and the lact1c dehydrogenase virus of m1ce are further 
ungrouped v1ruses that ma,y probably be togaviruses. 
Stud1es about the structure of the alpha- and flavivi-
ruses suggest that the HCV may poss1bly consist of two to three structural 
prote1ns, wh1ch may be distingu1shed serolog1cally as d1stinct viral subu-
nits. The usual way to demonstrate such antigenic subunits of a virus lS to 
isolate the subun1ts after hav1ng spl1tted the pur1fied and concentrated 
v1rus and to produce monospecif1c antisera with them. Hm.;ever, at present 
th1s 1s not a pract1cable way with regard to the HCV because the large-
scale cultivat1on of h1ghly titred HCV encounters diff1cult1es. Su1table 
experiments are 1n progress to el1minate these diff1cult1es. 
With the aid of the agar,o:el dlffusion test (ADT), lmmu-
noelectrophoresls (IE), and immunofluorescence (IF), therefore we tried in 
the meantime to a~alyse ant1gens of the HCV 1n the following systems using 
porcine anti-HCV hyper1mmune sera (HC-PAS) and bovine ant1-rillJV hyper1mmune 
sera (MD-BAS), partly : 
extracts of pancreas and spleen from HCV-1nfected and non1nfected ani-
mals; 
- extracts from HCV-infected and non-1nfected homogen1zed PK 15 cells; 
- homogen1zed lymphocytesand leucocytes from normal and HCV-diseased pigs; 
- spl1t products of pur1f1ed and concentrated HCV. 
.. 
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The diagnosis of HCV was performed in the past with the 
aid of the ADT on the basis of antigens detectable in organs (pancreas, 
spleen, lymphatic glands) of HCV-infected pigs. Immune precipitation lines 
were formed b,y the reaction of preferably pancreatic tissue as antigen 
against HC-PAS or isolated¥ -globulins thereof. This diagnostic technique 
was problematical but it was frequently used before the fluorescence method 
was introduced. A lot of papers with contradictory results dealth with it. 
This is the reason that we started studies on the technical conditions and 
specifY of the ADT. 
The aim of our experiments was to isolate the precipi-
tating HCV-antigens from the lymphatic organs and the pancreas of infected 
animals (prec. HCV-0-antigens), ~n order to characterize them and to deter-
mine whether there is a structural relationship between these prec. HCV~ 
antigens and the HCV itself. It is of interest to know whether these anti-
gens are viral structural proteins or cellular metabolic products (cellular 
antigens) produced in the course of the infection. 
RESULTS 
§pecifity and Properties of the Prec. HCV-0-~igens 
Our experiments revealed the following results : we were 
able to demonstrate two specific antigens in the pancreas and spleen in dif-
ferent amounts (14). 
Both antigens are noninfectious; they are proteins with-
out any prosthetic group. After heating for 30 min at +56° C or treatment 
with proteases (trypsin, propase P) and detergents (helarin, zephirol, tween 
80 deoxycholate) they lose their property to react with HC-PAS and MD-BAS 
in the ADT (16) and in the IE. In the purified state these antigens are 
very labile, but may be stabilized b,y ammonium sulfate to a limited degree 
(1). 
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Immunoelectrophoretic precipitation lines of 1)ancreas from HCV-
infected pigs in the ~ - globulin region . 
0 
Both antigens do not show serolo~ical relationshi1) with each other. and one 
of them gives a cross- reaction \vi th iiiD-BAS ( Fi) . 
MD-BAS 
Figur e 2 : Demonstration of two prec. HCV-0-ant i~ens in the ~ - globulin 
- 0 J 
region and t heir serolo~ical relationship t o the s oluble 1IDV-ant igen using 
a combination of imrnunoelect r ophoresis and agargel diffusion test . 
It is poss ible, that there are some additional ant igens . 
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The molecular weights of both antigens as determined by gelfiltration are 
27 - 29 x 103 dal tons ( 16). At least one of them appear in a dimeric form 
with a molecul ar weight of 56 - 59 x 103 (17). The monomeric and the 
dimeric forms exhibit uniform electrophoretic mobilities expressed by two 
immunoelectrophoretic precipitation lines one upon the other. ~sides, one 
of these antigens seems to be able to transform and to change into forms 
differing in their net charges, i.e. ele·ctrophoretic mobilities. 
In vivo immunisation experiments using purified and concentrated prec. 
HCV-0-antigens failed to protect pigs against HCV infection. 
Reactions in order to characterise the chemical nature of the antigens in 
the prec i pitates formed in the ADT and in the IE, surprisingly resulted in 
hints of the presence of activities similar to those of trypsin and 
chymotrypsin , respectively. Attempts to demonstrate cholinesterase, 
carboxypeptidases, trypsin, and a-amylase gave negative results. 
Experiments to Isolate Substances from Infected and Non-infected 
Or gans and Cells Serologically Related to the Prec. HCV-0-Antigens 
The hint for the protease character of the antigens prompted us to perform 
expe riments with pancreas from noninfected pigs in order to detect antigens 
that may react with HG-PAS and MD-BAS in the ADT. 
Fractions isolated by precipitation, ion-exchange chromatography and 
gelfiltrat ion (1, 5 , 16, 17 ) from extracts of powdered normal pancreas (3), 
noninfected as well as infected homogenised PK 15 cells (22) displayed a 
physical-chemical behaviour identical to that of the prec. HCV-0-antigens. 
These fractions partially cross-reacted in the ADT with MD-BAS and showed 
serological identity to ~- and y-chymotrypsins/-chymotrypsinogens, 
respectively; less to ~chymotrypsin/-chymotrypsinogen. 
Moreover, an antigen could be demonstrated not only in leucocytes and 
lymphocytes , isolated from HCV-infected animals (4./7./9./l0./14.dpi.), 
but also in those from clinical healthy ones. In gelfiltration experiments 
this antigen was detected in the 4 S region. It produced an identical 
precipitation reaction in the ADT with HCV-antigen-containing pancreatic 
tissue from infected pigs and cross-reacted with MD-BAS. The precipitation 
generally showed little intensity and mos[y occurred only with the use of 
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Fi~~~ : Precipitation lines of concentrated extract (EP- ) and residue 
(P-) from normal pancreas coalescing with prec. HCV-0-anti gens (P+). 
Figure 4 : Precipitation lines of{b- and ~-chymotrypsin/-chymotrypsinogen 
(~, l( ) isolated from normal swine pancreas confluent with prec. HCV-0-anti-
gen ( P+) . 
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concentrated HG-PAS or preparations of ~-globulins thereof. Cells from 
infected animals reacted as antigens somewhat more intensively. In general, 
homogenates from lymphocytes displayed reactions more clearly than did those 
from leucocytes. 
In sera and plasma from acutely (6.- 14. dpi.) and chronically (19. - 54· 
dpi.) infected pigs precipitating antigens could be demonstrated in small 
amounts. Reactions partially ·occ~red not Uijtil after concentration and 
purification steps involving precipitation,ultracentrifugation, gelfiltration, 
rate zonal centrifugation and density gradient centrifugation in saccharose. 
The antigen only appeared in fractions that contained no virus. 
Let me summarise: 
We succeeded in de~onstrating an antigen in pancreas and white blood cells 
from infected and noninfected pigs as well as in serum and plasma from 
infected animals, and, moreover, in infected and noninfected PK 15 cells 
that reacted with HC-PAS and MD-BAS. In this connection the question arises, 
whether this antigen represents a structural component of the HCV, at all. 
Splitting of Purified HCV 
HCV from infectious sera and infected tissue cultures was purified and 
concentrated by the above-mentioned procedures. Neither this antigen did 
react in the ADT and IE with HG-PAS or MD-BAS 1 nor after treatment with 
triton X-100 1 tween-ether, nonidet P 40 1 saponin, deoxycholate or other 
detergents and chemicals. 
Immunoelectrophoretic Behaviour of Highly Virulent HCV 
' 
Against our experiments it could be argued that the HCV-preparations used 
may have contained not enough antigen for a positive reaction. However, 
material of all purification and concentration steps as well as the split 
products were controlled by virus-specific precipitation lines in the IE 
occurring with rabbit-anti-sera against HCV (HC-RAS). These sera were 
produced by hyperimmunising rabbits with HCV isolated from viremic swine 
sera and infected tissue cultures. 
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All these HC- RAS, in contrary to HC-PAS , 1-1ere able to precipitate purified 
HGV as wel l as HCV in infectious sera or i nfected cell cultures in tneoc 2-
globul in region (18). This result corresponded to the electrophoretic 
mobility of the virus reported by several authors (4 , 6, 13). 
Figure 5: Immunoelectrophoretic preci pitation line of HCV after adsorption 
of normal components in the agargel . 
.. 
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The adsorption in the agargel is produced by applying two holes for antigens. 
The hole nearest to the antibody trough is filled with pig normal serum 
(PNS) and the other one with HCV-preparations. The electrophoretically 
separated normal components adsorb the corresponding antibodies from the 
HC-RAS in the course of the diffusion process, while those antibodies 
directed against the virus are not prevented from diffusing &!d precipitating 
with the HCV. 
This precipitation line was demonstrated to be specific for the virus by the 
following tests: 
/reactions against HG-RAS were only demonstrable with infectious material as 
antigen; 
/rabbit anti-sera against pig normal serum did not produce this specific line; 
/antibodies in the HG-RAS against normal components were adsorbed by porcine 
normal serum or homogenised uninfected cell material in vitro or in the 
agar gel ( 18 ); 
/the antigen-antibody complex of the precipitate, extracted from the agargel 1 
caused HG-infection in pigs. 
The technique according to OSSERMAN (21) failed to demonstrate normal 
components in the virus-specific precipitation line. 
There are some indications for some more virus-specific precipitates, which 
may be virus structural elements. 
These can be demonstrated under distinct conditions in infectious sera or 
infected tissue cultures before and after treatment with triton X-100 and 
nonidet P 40, respectively using HG-RAS. Lipoproteide could be shown to be 
present . Further experiments are in progress to isolate and to characterise 
the antigens of these virus specific precipitates. 
In all these immunoelectrophoretic analyses, HG-PAS did not react. The 
specific viral precipitate was only produced by HG-RAS. Virus-precipitating 
antibodies could not be detected in HG-PAS used for the precipitation of 
HCV-o-antigens in the ADT and in the IE. Mixing HCV-antigen with HG-PAS (one 
to three parts) the immunoelectrophoretic virus precipit ation line was not 
affected. Obviously HG-PAS possess no virus-precipitating antibodies at all. 
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(+) (-) 
Figure 6 : Immunoelectrophoretic precipitate of purified HCV using 
adsorption of normal components in the a-ee~rgel and the 
technique of OSSERillAN. 
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Figure 7 : Innunoelectrophoret ic virus- specific p·recipi tat ion lines 
of various HCV- preparations using adsorption of normal 
components in the agargel (x) ; after treatment with triton X-100 ). 
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Fluorescence-serological Reactions in Infected PK 15 Cells 
The fluorescence method, without any doubt, is known to be specific for HC. 
The question arises whether it is specific for the virus or another antigen, 
which is connected with the disease like the prec. HCV-0-antigens. 
The antibodies of the HC-PAS neutralise the HCV, and precipitate the prec. 
HCV-0-antigens, but lack obviously such precipitating activities for the 
virus itself. FITC-conJugated antibodies of HG-PAS produce fluorescence in 
HCV-infected PK 15 cells. 
Antibodies of HG-RAS neutralise the virus too, but in contrast to HG-PAS, 
precipitate HCV. After conjugation fluorescence could not be demonstrated 
in infected cells. This is amazing. 
To get some more information about the character of the antigen detected by 
immunofluorescence, the conjugates were treated by several distinct antigens 
(powdered organs; extracts froill pancreas, and cells, infected and not; 
HCV-preparations) to adsorb corresponding antibodies. The reaction time was 
30 min. at +18°C 1 the dilutions of the conjugates were 1:100 and 1:200. 
The fluorescence was diminished by: 
/extracts and powders from pancreas, isolated from normal and infected animals; 
/extracts of uninfected and infected PK 15 cells; 
/lymphocytes from normal and infected pigs; 
/chymotrypsinogens and chymotrypsins c~. ~-. ~-), respectively. 
~ or only small effects on the fluorescence could be observed after 
adsorption of the conJugates with: 
/HCV-preparations, containing intact or detergent-treated virus (virus-titer 
107/ml); 
jpig kidney powder; 
/extracts of uninfected and infected PK 15 cells after treatment with triton 
X-100; 
/extracts of powdered pancreas from infected and not infected pigs after 
treatment with triton. 
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Table 1: Adsorption of the fluorescing antibodies 
of conjugated HG-PAS 561 (30 min, +18° c) 
PK 15 cells infected with HCV-ALD 104 fluoresc. dos. 24h pi. 
Virus controle 
conj. 561 (1:100; 1:200) adsorbed with 
HCV-ALD (tissue-culture; titer 10-6/0.1 ml) 
HCV-ALD, concentrated 
HCV-ALD, concentrated + triton 
HCV (serum; titer 10-6/0,l ml) 
HCV, conoantrated 
HCV, concentrated + triton 
ALD-infected PK 15 cells (cone. extract) 
ALD-infected PK 15 cells (cone. extract) + triton 
powder from HCV-pancreas (or cone. extr.) 
powder from normal pancreas (or cone. extr.) 
powder from pig kidneys (trypsinised) 
normal lymphocytes 
immune lymphocytes 
+++ 
+++ 
+++ 
+++ 
++ 
++ 
+++ 
+ 
+++ 
+ 
+ 
+++ 
+ 
+ 
The aberration of the fluorescence was seen in the background fluorescence 
(not infected cells) and the infected cells. On the one hand, the shining 
was diminished (qualitative process ) there by the weakly shining plaques 
disappeared (quantitative process). 
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DISCUSSION 
The results of these experiments give rise to reflect on the specifity 
of the reactions in the ADT using material from organs of infected pigs and 
infected cells. It is felt, that it should be discussed, whether these 
reactions reveal structural components of the HCV or cellular substances, the 
production of which is ~ossibly increased during the infection. 
From the fact that HG-PAS does not show any precipitating activities 
with the HCV itself or its split products in contrast to the prec. HCV-o-
antigens and antigens,isolated from organs of noninfected pigs as well as 
from infected and noninfecte~ cells, makes us believe that in this system the 
reaction is not specific for viral structural antigen but indicates the presence 
of the disease. This assumption is supported by identical reactions in the 
ADT and in the IE 1 caused by proteases and their zymogens, such as the 
chymotrypsin group. 
Immunofluorescence in He-disease was studied by several authors (2 1 7, 
10 1 12 1 19 1 20 1 23-25). Only RESSANG and BOOL (23) made an effort to test 
the specifity of this method by virus adsorption experiments. They adsorbed 
the conjugate with viremic porcine serum and stated a reduction of the 
fluorescence without showing the absence of prec. HCV-0-antigens in the 
serum used for adsorption. other authors examined the specifity of the test 
using other viruses and by covering the infected cells with HG-PAS that in 
any case contains antibodies against the pancreatic antigens, too. They then 
stated aberrations of the fluorescence and concluded the test to be specific 
for the virus. Up to this day, there is no proof that the immunofluorescence 
reaction is specific for the virus. 
The presence of precipitating substances serologically related with the 
prec. HCV-0-antigens is demonstrated in concentrated material of noninfected 
cells and in normal pancreas. Therefore we think that this antigen is cell-
related and that there is only a gradual difference between the reaction of 
material derived from noninfected and infected cells. In the immunofluorescence 
the same problem arises and this may be the reason that authors report on 
'unspecific' fluorescence of leucocytes in normal animals. This 'unspecific' 
fluorescence in normal leucocytes could be explained to be specific for 
cellular antigen(s) in noninfected cells or tissues. 
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Considering this LINDENMANN (ll) ought to be cited. In his article on 
interferon he says: 11 • • • • there is some reason to assume that during the 
process of a viral infection, there is not only produced virns, incomplete 
virus, soluble antigen, hemagglutinin, toxic products, lysozyme, cell 
detritus and interferon, but a lot of products which are worth to be invest-
igated •• •"• It is the character of the prec. HCV-0-a.ntigens and the 
properties of the precipitating antibodies of HG-PAS that suggest a 
connection to cellular substances produced in an increasing rate during the 
course of a viral infection. And this antigen seems to behave like 
chymotryps~/chymotrypsinogen. 
Studying the serological relationship between a mucosal disease of 
cattle and hog cholera, DARBYSHIRE (26) does not exclude the possibility 
that the antigens are cellular products which are liberated arising out of 
virus multiplication within infected cells. This product may be identical 
in the case of each virus and thus may act as an auto-antigen in the 
stimulation of specific antibodies. The antisera would possess this common 
antibody and it would be this which is detected in the gel diffusion reactions. 
Moreover, it is interesting to state that the disturbance of the 
antibody production during the HCV-infection coincides with the viremic 
period. At this time (4. - 8. dpi.) high virus ti.ters in blood are measured, 
but no or little antibody production occurs (8). The production of anti-
bodies starts with decreasing virus titers, and this could be the explanation 
for the lack of virus-specific precipitating antibodies. 
On the other hand, the most intense rate of lysis of white blood cells 
and cells in the lymphatics occurs between 8. - 12. dpi. (9). This is 
accurately the time that the prec. HCV-0-a.ntigen is demonstrable. At the 
end of the third week of the infection, antibodies against this antigen being 
related to an antigen from lymphocytes and PK 15 cells can 1:e detected. In 
the sera of animals vaccinated with dead vaccinee, i.e. crystal violet vaccinee, 
even applying 15 or 20 doses, one can detect neither precipitating nor 
fluorescent antibodies. Both antibody species appear after challenge 
infection, when the animals suffered some days from a mild form of the disease, 
including a virus replication phase. 
Considering the above-mentioned findings, the fluorescent antigen seems 
to be more closely and directly related to-the prec. HCV-0-a.ntigens than to 
structural components of HCV. 
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DISCUSSION 
Dr. DALSGAARD 
You ment~oned in your summary that these ant~gens in the ~nfected cultu-
red cells do not represent virus specific structural components, but 
rather disease specific cell ant~gens. So I feel that - could it be pos-
sible that these antigens that cross-react with cell antigens could be 
incorporated into the v~ral capside ~n some w~ or another, as you see 
~n influenza virus. The ~nfluenza virus surface carr~es antigens that 
are s~m~lar in some respects and cross-react serolog~cally to most of 
the host antigens. Even if they are host antigens, they could be incor-
porated ~nto the virus surface. 
Dr. MATTHAEUS 
We know that ~n polio virus synthesis part of the messenger RNA is trans-
cr~bed ~nto a g~gant~c polypeptide at the r~bosomes and thereafter, this 
polypeptide is spl~t into functional pept~des by a protease. Th~s enzyme 
m~ possibly act in hog cholera virus synthes~s, and there is other evi-
dence that a similar mechanism acts in toga viruses. I do not know which 
funct~on this antigen has in the infection. 
Dr. DALSGAARD 
When you isolated the v~rion by density gradient centrifugation, you had 
a preparation of pure hog cholera v~rus, which react with a rabbit ant~­
serum and my quest ion is, did you try to degrade the isolated virus by 
Triton X lOO and then see how it reacted w~th the rabb~t antiserum ? 
Dr. MATTHAEUS 
Yes, we did. In virus preparations treated with Triton X-100 or Non~det 
P-40 1 we found the same precipitation line like against the virus non-
treated. After sucrose density grad~ent centr~fugation these prec~pita­
tion lines are given by a split product at a buoyant density of about 
1.10 - 1.125 g/ml. 
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I think that ~ be the envelope of the virus as the hog cholera virus 
particle itself shows a buoyant density of 1.15- 1.16 in a sucrose den-
sity gradient. 
Dr. TERPSTRA 
We have examined spleens from quite a number of normal pigs in compari-
son with the hog cholera infected ones, and we have not been able to de-
monstrate a precipitating antigen in the spleens of the normal animals; 
I was interested in your remarks that you detected also precipitating 
antigen in non-infected pigs PK 15 cella. How consistent in this observa-
tion and under what circumstances and how long after seeding the cells 
did you examine those because we have examined also non-infected PK15 
cells and we have not been able to demonstrate precipitating activity ? 
Dr.MATTHAEUS 
Concerning this question I wish to mention that we harvested non-infected 
cella as well as hog cholera-infected cella from fifty Roux-flasks. Af-
ter washing each sort of these cella and disrupting them by Bonifica-
tion, insoluble particles were removed by centrifugation and extracted 
twice with buffer. The gathered aupernatants were concentrated by vacuum-
dialysis or salt precipitation ( 6<>% final concentration), and separated 
by ion-exchange chromatograpby • In this manner, we were able to demons-
trate antigens, but we did not succeed in demonstrating them in harves-
ted cells from five Roux-flasks, however. 
Dr. TERPBTRA 
How long after seeding was this ? 
Dr.MATTHAEUS 
It was eight d~s after. We trypsinized the cells and after three to four 
d~, we got mono-l~ers completely (loo%) covering the flasks. Then we. 
added to the non-infected mono-l~ers the same maintenance medium as to 
the infected cella and harvested after four ~· incubation. 
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Dr • TERPSTRA 
In those cases where you have a mixture from a pooled sample from 15 
bottles, did you check for 1nfectivity in those samples - virus infec-
tivity ? 
Dr. MATTHAEUS 
No, I did not, as I knew from experiments formerly made that the V1rus-
titer in PK15 cells ranged between 105•5 - 1o6•0jo.1 ml as fluorescing 
unities. 
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ANTIGENIC COMPARISON OF SWINE FEVER VIRUS (SFV.) 
AND MUCOSAL DISEASE VIRUS (MDV) 
G. CORTHIER 
Laboratoire de Pathologie porcine 
78850 THIVERVAL-GRIGNON (FRANCE) 
INTRODUCTION 
Mucosal disease virus (MDV) and Swine fever virus (SFV) 
are different in regards to their natural host, although their structural 
and antigenic properties are quite the same (1). Immunodiffusion (2), immu-
nofluorescence (3) and complement fixation (4) tests provide evidence for 
an antigenic relationship between the two viruses. 
In seroneutralization tests the relationship between the 
2 viruses seems very weak. Only hyperimmune sera cross react (5), (6), (7), 
(8), (9). 
This paper summarises a previous work (10). Using sera-
neutralization techniques we described antigenic difference between various 
strains of SFV 01) and we analyzed the antigenic relationship between each 
SFV serological variants and MDV. 
I • SEROLOGICAL VARIANTS OF SFV 
Tables 1 and figure 1 show results obtained b,y 3 diffe-
rent seroneutralization methods. An antigenic overlaps between studied 
strains is observed. However, two serological variants can be distinguis-
hed according to their antigenic properties : 
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Stud1ed sera : 
Thiverval 331 Rabbit Stud1ed chinese Seroneutraliz1ng methods 
strain strain strain strain 
antisera antisera 
ant1sera 
Alfort 3,4 (1) 1,8 (2) 3,5 (3) Variable virus -constant 
sera 331 1 (1) 3,2 (2) o,o (3) 
Neutralization index 
Values for : Thiverval 3,5 (1) - -
Variable sera - constant Alfort 28.000 1.000 -
virus : 50 % sera dilu- 331 2.000 16.000 -
tion for : 
Thiverval 20.000 1.000 -
Alfort 1,31 (4) 4,6 19,6 Neutralization kinetics 
K values for : 331 0,37 (4) 17 ,o 8,2 
Table 1 Characterization qy different technics of serological 
differences between SFV strains 
(1) final dilution 1/1600 
(2) final dilution 1/800 
(3) final dilution 1/200 
(4) sera prepared with purified Thiverval strain 
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lapin anti souche chinoise 
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331 
-1-
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log V/Vo log V/Vo 
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pore anti 
Thiverval purifiee 
1/20 
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B D 
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Figure 1 Neutralization Kinetics 
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- the largest includes both virulent strains (Alfort) and attenua-
ted strains (Thiverval, Chinese, GPE-); 
- the other includes 331 subacute SFV strains and field strains 1So-
lated from chron1c disease (11). 
The relationship between these 3 serolog1cal variants is symetric. 
II. RELATIONSHIPS BEI'WEEN SFV AND MDV 
a) Neutralizing activity of specific SFV antisera. 
Twenty one serologically distinct MDV strains had been studied with 
SFV ant1sera specific for Alfort strain (table 2). We observed no spe-
cific neutralization. Us1ng another seroneutral1zation method the NADL 
strain of MDV was slightly neutralized qy SFV antisera with high homo-
logous titer (table 3). 
b) SFV neutralizing activity of specific MDV antisera. 
Sera prepared with serologically distinct MDV strains had a neutrali-
Zlng activity against the 2 serological var1ants of SFV (table 4). 
The serorelationship of the first variant (331) and MDV is more pro-
nounced than with MDV and the second SFV variant (Alfort and Thiverval 
strains). These results are confirmed b,y neutral1zation kinetics. 
CONCLUSION 
The relationship between the seroneutral1zation ant1gens 
of SFV and MDV is summarized in figure 2. 
Antibodies prepared aga1nst the two distinct serological 
SFV variants are not able to neutralize MDV, except some sera with high homo-
logous titer. Antibodies prepared against serologically different MDV strains 
neutralize to a large extent the SFV variants. The relationship is more pro-
nounced with the 331 subgroup in which there are various chronic SFV strains. 
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Virus Souche I.N. Virus Souche I.N. 
VPP Alfort 6 
AR4 < 0,1 
VMM 
Tl < 0,1 MM4 < 0,1 (2) 
T2 < 0,1 MM5 < 0,1 
T4 < 0,1 
T5 < 0,1 !lOO < 0,1 
VMM !153 < 0,1 T6 < 0,1 VMM (1) !155 < 0,1 T7 < 0,1 (3) 
T8 < 0,1 DK167 < 0,1 
TDVF <O,l MQN < 0,1 
TA < 0,1 
NADL < 0,1 
TP <O,l VMM 
Diam < 0,1 
(4) 
C24V <O,l 
Table 2 1 Neutralizing activity of an anti Thiverval SFV strain 
(diluted 1/20) against MDV strains 
(1) strains given qy Dr GILBERT 
(2) stra~ns given qy Dr FAYE 
(3) strains given b,y Dr WELLEMANS 
(4) u.s. strains 
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Souches du virus de la : 
maladie 
Serums des Peste Porcine 
muqueuses 
Espece Specifique NADL 331 Alfort animale 
Pore Souche 1 < 1/4 1/6.000 
331 
2 1/150 1/50.000 1/1.000 
Pore Souche 1/300 1/2.000 1/28.000 Thiverval 
Souche 1 < 1/8 1/2.500 1/17.000 Lap in Chinoise 
Italienne 2 1/200 1/8.000 1/12.000 
Souche 
Pore Chinoise 1 N.D. 1/2.500 1/40.000 
"SUVAC" 
Pore "LOUD" 1 < 1/4 1/120 1/16 
Table 3 Neutralizing activity of SFV antisera against MDV 
strains and SFV strains (the number indicate the 
5o% sera dilution) 
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Antiserums Virus de la Maladie Virus de la des muqueuses Peste porcine 
espece Specifi- titre vis A vis 
Provenance animale que de la de la souche NADL Alfort Thi-
souche homologue verval 
Dr. Corthier Mouton NADL 2.000 2.000 160 160 
et Pore NADL 28.000 28.000 1.800 3.000 
Dr. 1\Ynau.d Pore NADL 3.000 3.000 50 -
Dr. Gilbert V eau C24V 
-
8.000 500 2.000 
V eau CG 1220 32.000 (1) 5.000 1.600 3.500 
V eau SAN 16.000 (1) 7.000 300 350 Dr. Ferneliue 
V eau HUB 
-
4.000 800 1.000 
V eau vw 16.000 (1) 3.000 900 1.600 
La pin SAN 
-
1.300 < 20 < 40 
Dr. Castrucci Lap in 66/l237St 600 (2) 650 (20 40 
Lap in TVM2 300 (2) 250 < 20 20 
Table 4 Neutralizing activities of MDV specific antisera against MDV 
(NADL strain) and SFV 
(1) Fernelius and al 1971 
(2) Castruoci and al 1970 
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DISCUSSION 
Dro LIESS 
We have to look for a conclusion, and as far as I can see, you are thin-
king of intermediate types or strains of BVD/MD and hog cholera virus. Is 
that right ? 
Dr • CORTHIER 
In my study 1 I have not seen strains of swine fever virus which are bet-
ween the Mucosal disease and swine fever strain. 
Dro LIESS 
I think it's very important to look for this question again and to do more 
investigation on this question as this is very important for future. 
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ANTIGENIC STIMULATION IN THE PIG 
Bourne, F.J., Newb,y, T.J. & Brown, P.J. 
Department of Animal Husbandry 
University of Bristol 
The immune system of the pig has many features in common 
with those found in other mammalian species, but it also possesses features 
that appear to be pecular to it. 
Structural features of the pig IgA molecule have been 
reported and the possible consequences of this to the pig have been discus-
sed (Bourne, 1973 & 1974). 
In addition to this, recent work has shown the d1stribu-
tion of immunocytes in the pig differs from that descr1bed in other species 
(Brown & Bourne, 1974, in preparation) and the response of the pig to anti-
genic stimulation also shows a species peculiarity (Bourne, Newb.y & Chidlow, 
1974). 
Distribut1on of immunocytes in the pig 
Using peroxidase conJugated antisera we have made a com-
prehensive study of the distribution of immunocytes producing A, G and M 
immunoglobulins in the pig body tissues (Brown & Bourns, 1974, in prepara-
tion). 
The densest population of cells occur in the duodenum. 
IgA forming cells predominate at all levels of the gut but to a much lesser 
extent that found in other species and there is a large population of !gM 
and IgG contain1ng cells. 
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In the adult gut the ratio of A to M cells varies from 1 : 1 to 2 : 1 al-
though in the young animal in the first two weeks of life M cells predomi-
nate 1 the ratio being 2 : 3. Between 4-8 weeks the A cells increase in num-
ber relative to M and assume predominance. 
There are less G forming cells than A or M but it would 
appear that the majority of immunoglobulin forming cells for all three clas-
ses occur in the gut with relatively few in other tissues such as the spleen 
or lymph nodes, which are regarded as major sites of immunoglobulin forma-
tion in other species. 
Preliminary experiments performed in this laboratory on 
the site of formation of immunoglobulins would support the above view that 
the gut is a major source of immunoglobulins in the pig and contributes 
significantly to systemic as well as local immune systems. 
A further extension of this work has been a study of the 
secretory pathwa,ys of immunoglobulin across the gut epithelium (Brown, Brad-
lay & Bourne, 1974, in preparation). 
Immunoglobulin IgA and IgM staining can be show• on the 
mucosal epithelium of crypts 1 whereas I gEl staining is absent. Also epi the-
lial cells have been demonstrated which probably represent a transcellular 
secretory pathwa,y for immunoglobulins IgA and IgM. Such a pathwa,y for IgG 
could not be shown. This would in part accouqt for the high levels of IgA 
and low levels of IgG found in intestinal secretions (Bourne 1 Pickup & 
Honour, 1971). 
Stimulation of pig mammary gland 
Virtually all mi]li: IgA and a large proportion of IgM and 
IgG has been shown to be locally formed in pig mammary tissue (Bourne & Cur-
tie, 1973). It has further been demonstrated in other species that intramam-
mary vaccination of antigen is necessary to produce IgA antibodies in colos-
trum (Genco & Tauban, 19,9, McDowell, 1973). 
385 
We have investigated the 1nfluence of the route of vac-
Clnation on the development of local and systemic immunity in the pig and 
determined the class of 1mmunoglobul1n involved (Bourne, Newb,y & Chidlow, 
1974). 
Non-replicating antigens were used, either horse spleen 
ferrltin, bovine gamma globulin, DNP-albumen or E.coli K88 antigen. Antlbo-
dy activity was determined b,y using 1mmunoabsorbents of the above antigens 
(Newb,y, Bourne, Chidlow & Steel, 1974). The intramuscular route was compared 
with the intramammary route of vaccination and in one experiment ant1gen was 
given orally. The following observations were made : 
1. Intramammary vacc1nation is far superior to intramuscular vaccina-
tion 1n producing not only a local but a systemic response. Thus, 
if following intramuscular vaccination the total serum response is 
x mg/ml of antibody, the colostrym response in this animal would be 
2x and the milk response only 1/10 x. Following intramammary vaccl-
nation, however, the serum response is increased two-fold to 2x and 
the colostrum response three-fold to 6x but the milk response shows 
a ten-fold increase. 
2. Following stimulation b,y either the intramuscular or the intramammary 
route antibody act1vity is found ln all three in all three classes 
of immunoglobulin, the major amount of antibody activ1ty in a body 
fluid correlating w1th the major immunoglobulin class in that fluid. 
3. Vaccination of one mammary gland g1ves rise to s1gnificant antibody 
act1vity 1n the other glands. The reasons for th1s are not clear, 
but our findings suggest that 1t is not due to passive transfer from 
serum but to local product1on. It m~ be due to a general dissemina-
tion of ant1gen from the site of injection, and a further poss1bility 
1s that immunoglobulin producing precursor cells from the vaccinated 
areas m1grate to other immunoglobulin producing areas. A combina-
tion of events m~ also occur since Griscelli, Vassali & McCluskey 
(1969) have shown that 1mmunoglobulin producing precursor cells accu-
mulate in areas that conta1n their specific ant1gens. 
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4• Oral vaccination of gilts with a living non-pathogenic strain of 
E.coli, possessing K88 antigsn, led to local production of K88 anti-
bo~ in pig mammary t~ssue. The dissemination of antigen from the gut 
to the mammary gland in this experiment is unlikely and provides 
fUrther evidence of an interrelationship between the various immune 
systems. 
5. The cellular mechanisms of antibo~ production basic to parenteral 
immunisation would appear to operate during local stimulation also. 
6. In view of the importance of mammary secretions in providing both 
systemic and local intestinal tract immune protection to the young 
suckling pig, the above findings could be very important in develo-
ping vaccination schemes to enhance this protection. The possibility 
of a cellular interrelationship of the various immune systems also 
demands fUrther intensive stu~. 
7• The above experimental findings question the concept of distinct 
local and systemic humoral immune systems. 
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SUMMARY OF THE SESSION 
J.M. AYNAUD 
Results of immunoprecipitation of the immuno electropho-
resis test suggest that swine fever viral material contains at least 2, and 
perhaps 3 antigens, some of which seem to be directly related to mucosal 
disease virus. But among these antigens, we are unable to identify the struc-
tural components of the virus particle. Seroneutralization reactions, being 
directly related with the external surface of :the virion, we can assume that 
on the viral envelope there exists at least one structural component having 
a common antigenic activity between swine fever and mucosal disease. 
Results of immunological and immunochemical methods, and 
also classical biochemical methods, could be compared. In these conditions 
it will be perhaps possible to determine the localization and the fUnction 
of the different structural proteins of the virus particle for swine fever 
and also mucosal disease. On this aspect, it will be suitable to determine 
first of all the number and the nature and the localization of different 
antigens involved in precipitation, neutralization or immunofluorescent 
tests. It will also be suitable to determine the nature and the fUnction of 
the soluble antigen and its relation to porcine immunity. 
These results have large practical applications in diag-
nostic and epidemiologic study of swine fever in pigs. For example, it would 
be very useful to differentiate easily between low virus strains of swine 
fever from mucosal disease strains in latent infection of pigs. With respect 
to swine fever eradication, this point is very important. 
liORKING GROUPS 
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SUMMARY OF THE WORKING GROUPS 
ON CLASSICAL SWINE FEVER 
WORKING GROUP 1 : VIROLOGY 
c. TERPSTRA 
Centraal Diergeneeskundig 
Instituut, LELY3TAD 
During the meeting several research workers pointed out that the low yield 
of virus from infected cells was felt as a major draw back for studying the 
characteristics of the multiplication of hog cholera in v1tro. There appears 
to be no agreement on the ratio of cell free v1rus to cell associated v1rus 
produced in the same cell system. 
1. It was therefore felt that it would be worthwh1le to study the factors 
influencing the yield of hog cholera virus and in doing so attent1on 
should be paid to the circumstances which might account for the dlscre-
pancies obtained so far b,y research workers. 
2. In the case of Bovine viral diarrhea (BVD), antigen1c differences have 
been observed between various field isolates. The same may apply to dif-
ferent strains of hog cholera. In view of the high 1ncidence of neutra-
llslng antibod1es against BVD in pigs, as was demonstrated in Germany, 
and cons1dering the antigenic relationsh1p between hog cholera and BVD 
v1rus, it is recommended b,y the group that further stud1es should be 
undertaken to identify the antigenic character1stics of var1ous BVD and 
HC strains, in order to select those strains which are most antigenically 
distinct for both viruses. 
3. In view of the antigenic relationship between BVD and HC-v1rus, it lS 
recommended that stud1es should be undertaken to identify the structural 
protein(s) of these viruses which induce neutralizing antibodies. 
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4• In order to eradicate hog cholera in the countries of the EEC, it is 
recommended that the governments of the member-States should uniform their 
regulations on the control of hog cholera. 
An appeal to this effect to the authorities concerned should come either 
from this meeting or from the research coordinating committee. 
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WORKING GROUP 2 : EPIDEMIOLOGY 
Bo LIESS 
Institut fur Virolog1e 
der Tierartzlichen 
Hochschule - HANNOVER 
===================== 
Work1ng group 2 d1scussed the epidemiological situation as far as Hog Cho-
lera is concerned. 
It was agreed that one of the main 1nterests of the European countries and 
probably even countries outs1de the CEE is to control this permanent threat 
to the pig population because of clear reasons. 
Furthermore it was agreed that a common policy of controlling HC does not 
exist and that there are only two w~s in order to get a proper control 
over HC,(l) general vaccination or (2) eradication. 
Though the group realised that certain implicat1ons might hinder immediate 
steps, eradication of HC should be the aim. 
In order to come to a decis1on in one w~ or another, economists should be 
asked for advice on the least costly w~ to get information wh1ch can be 
used for recommendations. If general vaccination procedures prove to be 
less costly than eradication procedures recommendations should be put 
strai~ht to O.I.E. In this case the recommendations should include that a 
certain standard vacc1ne taking the new Japanese tissue culture vaccine un-
der considerat1on, too, might be recommended or work in1tiated on the deve-
lopment of a better vacc1ne preferably one which guarantees no spread of 
virus and that the best route of vacc1nation should be investi~ated. 
If, however, a new meeting organised qy CEE comes to the conclusion that 
eradication of HC in Europe should be followed immediate steps should be 
taken in order to 1mprove and formulate the bas1s for an erad1cation pro-
gramme which necessarily includes the 1ntroduct1on of standard techn1ques. 
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In this case the working group recommends to set up and support reference 
laboratories for culture i.e. PK (15) cell, selected virus strains and an-
tisera which meets the requirements of the WHO/FAO programme on comparati-
ve virology. Moreover, the research programme must devote in this case not 
only to Hog Cholera, but to BVD-MD virus in pigs, too. Pathogenetic stu-
dies will be necessary in connection with immunology especially on the 
question, which factors are involved for the occurence of latently infec-
ted pigs. 
It was felt, that work even on the Border disease in sheep, which might 
be caused by a BVD-MD related virus, should be supported. 
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WORKING GROUP 3 : IMMUNOLOGY 
RoDo BARRY 
Department of Pathology 
~~~;:~~~=~,£~:QG~ 
Members of Working Group 3 agreed that their discussions were of benefit 
and interest to those present, and recommend that the policy of conducting 
small, informal discussion groups should be adopted at future meetings of 
this type. It was concluded, however, that better grouping of participants 
in relation to the topics discussed could have been arranged at this mee-
t~ng, should be adopted for future meetings. 
Working Group 3 discussions began with a brief introduction b,y each parti-
cipant of his research interests. Those d~rectly concerned with hog cholera 
virus then outlined in detail the principal problems encountered in their 
work. Extens~ve discussions followed from which emerged a number of practi-
ced suggestions and proposals for future exper1mental work with HC virus. 
The following general proposals for future meetings were agreed 
1) "Mixed" meetings, with participants drawn approximately equally from the 
field under consideration, and from related field should cont~nueo 
2) Meetings should begin with a review of the main topic(s). This would 
be of particular help to external special~sts. In addition, participants 
should be provided in advance with a detailed statement of objectives, 
and where appropriate, with reference material. 
3) Careful planning of work1ng groups. 
4) Possible topics for future meetings might include epidemiolog~cal as-
pects of disease, standardization of vaccination procedures, and the 
rationalization of diagnostic procedures. 
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SUMMARY OF WORKING GROUP 4 
ON AFRICAN SWINE FEVER VIRUS 
Be R. McAUSLAN 
Division of Animal Genetics, 
c.s.r.R~=:=~~ 
African swine fever virus (ASFV) which in the past has caused considerable 
economic loss in Spain and Portugal, now seems to be under control but not 
completely eliminated. Attempts at eradication should be continued and 
potentiated because vaccination against this virus is not possible. 
The control of the disease is due in part to improvements in husbandry 
practices and to the development of techniques for the rapid diagnosis of 
the disease. The diagnostic methods employed depend to some extent on the 
clinical condition of the infected animals 1 but in general indirect immu-
nofluorescence is the technique of choice. 
For this technique, antibody is extracted from the spleen
1
lung 1 lymph no-
des or kidneys of animals suspected to be infected and tested in vitro 
against cells infected with ASFV. 
The value of this procedure lies in its specificity so that ASFV can be 
distinguished from classical swine fever. All diagnostic services in Spain 
have been centralised. Recently the applicability of the techniques of 
immunodiffusion and immunoelectro-osmophoresis to diagnosi~ are being in-
vestigated. 
Despite the valuable improvements in husbandry practice the control of 
transmission of ASFV b,r the Argasid Tick still merits some study. 
It is suggested that consideration be given to employing biological popu-
lation control methods and chemical agents now in use b,y parasitologists 
to eradicate insects and other pests. Perhaps a detailed study of the Orni-
thodorus tick species and control of its population should be undertaken 
since it has been shown that ASFV can reside in such tick populations for 
at least 8 years. 
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Very little has been done on the molecular biology of this virus. However, 
detailed knowledge of 1ts replicat1on and macromolecular synthes1s might 
be a valuable adjunct to studies of viral antigens and to the poss1ble de-
sign of ant1viral chem1cal agents. It 1S reported that some of the rifamy-
cin ant1biotics m~ be effective against ASFV and 1t would be most helpful 
to have more 1nformat1on about the eff1cacy and mechan1sm of action of the-
se compaunds. 
Some specific recommendations are : 
(i) Continuation of investigat1on 1nto improved 1mmunological techniques 
for the rapid detection of the disease, particularly where 1ts man1-
festat1ons are sub-cl1nical; 
(ii) Invest1gation of the antigens synthesised by the virus in cultured 
cells and of the stF~ctural proteins of the virus. Such studies might 
complement the diagnost1c tests; 
(iii) To undertake a thorough study of the biology of the Argasidae - 1n 
part1cular into means of introducing biological population control or 
chemical eradicat1on; 
(iv) Study of the pathogenesis of the disease and of the 1mmunolog1cal 
responses in infected animals should continue. 

Silli!MA.RY OF THE MEETING 
Yo BECKER 
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It ~s a little difficult to summar~se such a meeting 
which has dealt not only with major problems ~n the molecular b~ology of vi-
ruses, but also with the under currents wh~ch every one ~s aware of and which 
came out very clearly in the recommendations of the discuss~ons groups. The 
quest~on is how to apply the knowledge that was developed ~n Virology to two 
viruses, hog cholera and African swine fever viruses, which st~ll rem~n a 
major problem. The object of this meeting was not only to try and br~ng into 
one room people with knowledge ~n different fields, but also to try and 
po~nt out in the clearest w~ possible, where the problems are and what can 
and should be done to advance the field of swine fever v~ruses one step fur-
ther. We all know that it ~s a tremendous task to eradicate a virus. We 
have many models of efforts to overcome virus infections in animals. A typi-
cal example is that of the foot and mouth disease virus, which has been stu-
died for so many years. We know a lot about its molecular b~ology and ant~­
gen~c variants and in spite of all the attempts to get r~d of it, the v~rus 
still persists. Certa~n w~s have been clearly indicated to us by Dr. BACH-
RACH, but these require a generalised effort in many countr~es. The most 
striking fact ~s that the two v~ruses we are concerned with -hog cholera 
(HC) and African swine fever (ASF) viruses - have been stud~ed for quite some 
time and yet there are many aspects which we know very little about. This is 
one of the things that we would like to understand in order to see where the 
difficulties lie and what should be done to overcome them. 
CHAPI'ER I - THE BIOLOGIVAL ASPECTS OF HOG CHOLERA AND AFRICAN SWINE FEVER 
VIRUSES 
A. The pers~stence of the virus in nature and the economic problem 
These two viruses persist all over the world and even these coUntries which 
have succeeded in eradicat~ng the virus are under constant treat of its re-
entry. The persistence of the virus in nature, wh~ch means that it has one 
or two hosts poses a very important economic problem. 
Obviously, there is a tremendous need for act~ve veterinary services concer-
ned with how to get rid of the virus infection and how to stop it from re-
entering the country. 
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The education of personnel is ovbiously a task which each country must un-
dertake, and if this going to be on an international level, it must be cen-
trally organised. This is something that various organisations must think 
about and invest in. There is also demand for diagnostic laboratories which 
alwa.ys have to be re~ for the appearance of new variants or new mutant 
strains, and we need active diagnostic services. Tremendous investment is 
needed for the control of diseased animals in the fields, and of course this 
concerns all possible hosts of virus infection that are in the country. 
This requires the development of new vaccinee as well as standardization of 
the present vaccinee and vaccination procedures which needs manpower and 
facilities. 
This means that every country has to put aside part of its national budget 
so as to combat a disease and make life a little bit better for the people. 
Basic researoh is also obviously required to give us a better understanding 
of immunogens. This is actually why we decided to devote this meeting to the 
basic aspects of virology, because if you start with the practical aspects, 
you obviously get to the practical ones, but in addition, you try to develop 
a concept to overcome the disease and some of the practical problems which 
we all know exist. 
B. The biology of the viruses 
Fig. 1 sununarizes some aspects of the biology of both HO and ASF viruses. 
Viruses are built in such a wa.y that they can persist in nature. The virus 
is defined as being nucleic acid coated b,y protein, so that its genetic in-
formation is protected from the ill-effects of the conditions in which it 
exists. We start with the virus which is excreted and if we have susceptible 
animals they become infected. This means entry of the virus into susceptible 
cells in the host where virus replication takes place. This is actually what 
we have dealt with during entire meeting - all the rest of the discussion 
had to do with the question of how antigens stimulate the immunological sys-
tem to yield antibodies. We heard about the unique system of the pig from 
Dr. BOURNE. More knowledge of this system is needed since we cannot speak 
about viruses and animals in general. 
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Once agaln we have to focus our attention on one animal, because we are dea-
llng Wlth two viruses which affect the same host - the plg. We understand the 
immunologlcal machinery of thlS host whlch is different from others and so of 
course we can progress a llttle further. 
CHAPTER II - VIRUS REPLICATIVE CYCLE 
The virus replicates in the host and causes either a clinical or a sub-cll-
nical infect1on. Once the virus replicates in the host, it re-cycles. It lS 
released from the infected host and will again 1nfects sensit1ve animals. 
This summarizes the major biological cycle for both viruses. In the case of 
the ASF v1rus, there is also a smaller cycle wh1ch Dr. BOTIJA expla1ned to 
us in detail. The virus can pers1st in the tick and be transmitted to a sen-
sitive animal. 
One can attempt to interrupt the biological cycle qy vacc1nation w1th a kil-
led or live vacc1ne. On the other hand, we could try to eradicate the virus 
which means that we have to get rid of the host 1n order to get rid of the 
virus. Both the immunolog1cal and the eradication approach pose great pro-
blems since the v1rus may continue to persist. ASF virus can persist in t1cks 
and if we do not eliminate th1s part of the cycle, then of course we do not 
el1minate the virus and nature will probably find other ways to help the Vl-
rus to persist 1n different hosts. The epidemiology of the virus must be un-
derstood and characterised and as was said, we need a general international 
effort to overcome this problem. But as the subject of the meet1ng is virus 
replication, let us focus our attention only on the b1olog1cal cycle of the 
virus and try to see what information obtained at this meet1ng can be utlli-
sed for an understand1ng of the particular problems. 
I would like to divide the discuss1on into two parts 
a) hog cholera virus and 
b) African swine fever and finally to try to draw certa1n conslusions. 
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Figure 1 Some aspects of the biology of Hog Cholera and African swine 
fever viruses. 
Excreted 
Virus 1 '\ ) 
Infection 
(Botija) 
Entry into the host 
~ 
Entry into susceptible cells 
~ 
Virus replication (at different si tea) ------..., 
(synthetic pathw~s) 
/ \ 
'';xcretion Virions Antigens 
Virus~,/ of ASFV on/ 
'\Y 1.:-
sensitive/ 
Animal ,------
Ticks 
(Infected) 
Attempts to interrupt 
the cycle : 
~ ~ Stimulat~on of the ~ 
;:. immunologioal systems 
Antibodies 
l 
Immunity (HC) 
(or lack of immunity) (AFSV) 
V' 
> Different forms of the 
disease (clinical, sub-
clinical, etc) 
Vaccination with killed or live vaccine 
Eradication of diseased animals 
407 
.A.o HOG CHOLERA VIRUS 
1. The replicative cycle 
Fig. 2 summarizes the replicative cycle of an RNA virus. Understanding 
the replication of an RNA virus in the cytoplasm of the cell m~ ass1st 
in understanding some of the major problems that people have with HC 
virus, which is a Togavirus. A lot of work has been done on this group 
of viruses which was very clearly summarized qy Dr. HORZINEK. 
- Firstly 1n order to analyse and characterize the virus, it has to be 
purified. As Dr. HORZINEK told us, the virion contains 37 S single-stran-
ded RNA. The morphology of the virus is known but we know very l1ttle 
about its antigen1city. In nature, there are viruses which are related 
antigenetically, but which differ in other properties. This is a very 
important point, because as 1n the case of Marek's disease wh1ch causes 
tumours 1n chickens, the problem of 1mmunisation was solved qy finding a 
turkey virus which shared antigens with Marek's d1sease virus. Immunisa-
tion of chickens with the turkey v1rus overcame a disease wh1ch was dif-
ficult to control before hand. ~ searching for v1ruses which share com-
mon antigens we m~ hit on a very useful approach in the case of other 
diseases, namely to find a virus which will replicate 9ut w1ll not cause 
disease and moreover which will block the entry of the v1rulent strains 
that we are so worried about. Thus 1f we know the nature of viruses from 
the Togavirus group, we m~ be able to utilise this approach. 
- The second step in the infection of the cell is the uncoating and re-
lease of the parental RNA. Translation of parental RNA was summarized qy 
Dr. HORZINEK. The third step is the interaction of parental message with 
the ribosomes to form polyr1bosomes which synthetise the peptides. 
Although we know a little about HC v1rus proteins and the1r synthesis, 
Dr. SCHLESINGER was able to bring us important data about the prote1ns of 
another v1rus of the myxov1rus group. He described the translat1on of the 
genet1c formation into a large polypeptide which was later cleaved to 
yield different prote1ns. One of these proteins is obviously the RNA 
polymerase. 
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Figure 2 A. Togaviruses - Hog Cholera replicative cycle. 
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When we talk about proteins, we actually talk about antigens and Dr. AYNAUD 
was able to demonstrate to us b,y immunofluorescence the antigens of BC virus 
in the infected cell. 
- The synthesis of the RNA polymerase is obviously one of the most important 
events in the lif.'e cycle of a RNA virus. RNA polymerase in the picornaviruses 
were described b,y Dr. BACHRACH. We heard about RNA polymerase in myxoviruses 
from Dr. BARRY and Dr. SCHOLTISSEK. It is very obvious that in the case of 
HC virus, the RNA polymerase is responsible for the replication of the RNA, 
but we don't know much about this enzyme. The enzyme will probably be isola-
ted and characterised in the near future. After all, this enzyme is also an-
tigenic and m~ be of interest to the immunologists. 
The interaction of the RNA polymerase with the parental RNA (step 5) leads 
to the synthetic of double-stranded RNA (step 6) which we know is an essen-
tial part of the replicative cycle. We heard about RNA replication in a va-
riety of systems. The replication of RNA in Togaviruses was very clearly 
summarised b,y Dr. HORZINEK. Dr. SCHERRER summarised the replication of RNA 
in a virus which replicates at low temperatures and Dr. SCHOLTISSEK brought 
us some of the problems of RNA pools in infected cells. One of the problems 
of course is how to label HC virus efficiently with radio-isotopes since 
there are alw~s problems with the RNA pools. Dr. SCHOLTISSEK described how 
one can control the uridine pool and if this is possible, then one can label 
the virus more efficiently. I believe that Dr. HORZINEK has the right ideas. 
The subsequent step (n° 7) is the synthesis of the various RNA molecules. 
From Dr. SCHLESINGER and from Dr. HORZINEK we heard about the translation 
of the genetic information and the replicative intermediates which are re-
quired for the synthesis of RNA and we have seen a variety of RNA species. 
I don't want to go into deteil, but we have a 40 S viral RNA, a 26 S and a 
20 S RNA species. Each RNA species has its own function and the timing of 
the synthesis of these RNA molecules is easily controlled. Step n° 8 has to 
do with the association of the messenger RNA with the cellular ribosomes. 
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The virus utilizes the cellular machinery of the host in order to produce 
~ts own macro-molecules. A variety of proteins, peptides and glycoproteins 
are synthezised. We have heard about an ~nitiation factor in the case of 
picornaviruses that Dr. BACHRACH brought up. The d~fferent glycoproteins and 
capsid proteins have specif~c functions 1n the cells and ~t is obvious that 
people will be interested 1n test1ng the genetic ability of the RNA species 
under in vitro condition. We heard from Dr. SCHLESINGER and from Dr. VAN 
DER ZEIJST about experiments in which one can study the ability of the RNA 
to be translated by r~bosomes and yield the viral spec~fic proteins. We now 
have better tools to understand th1s and m~ be 1n the future we w1ll be able 
to develop systems ~n which the RNA could be translated under in vitro condi-
t~ons. The pept1des could then be used as ant1gens for immunisation, if they 
are immunogenic, and one would not have to grow v~ruses in cells any more. 
Thus theoretically speaking one would be able to isolate the RNA polymerase 
and replicate the RNA under in vitro condit~ons. The RNA synthesized in v1tro 
would be transferred into an in vitro protein synthes1zing system and the 
proteins synthes~zed in v~tro used to immunise an animal. Th~s m~ be an 
efficient method but we have to wa~t for the future to tell us. 
One we have the different proteins we certainly have to speak about antigens 
and I mentioned that Dr. AYNAUD, Dr. MATTHAEUS and Dr. CORTHIER described 
the different antigens and attempted to relate - which is what we actually 
need - the different peptides to the d1fferent antigens in order to separa-
te them for further ~nvest~gation. In the summaries of Dr. DALSGAARD and 
also Dr. LIESS we have seen that one can isolate antigens from infected cells, 
and study different kinds of antigen - antibody reactions under in vitro 
conditions. 
One of the subsequent steps in the case of Togaviruses is the formation of 
the membrane. This includes 1ntegration of the glycoprote1ns which are syn-
thesised into membranous formations because after all, the ribonucleoprotein 
complex of the v~rus must bud through a membrane. We heard from Dr. ROTT 
about his studies of influenza virus which is an entirely different virus, 
but the concepts are the same. 
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The concept is that the glycoprotein which is synthesised in the cell will 
find its w~zy into a membrane structure and will be organised in this membra-
ne either as a floating or as a fixed protein molecule. We certainly know 
very little about the formation of membranes in the Togaviruses, specifical-
ly in HC virus infected cells. 
This brings us to step ll, which is the assembly stage. This means that the 
ribonucleoprotein complex must move in the direction of the membrane, which 
contains the viral glycoprotein& and by passing through this membrane it 
will assemble into an enveloped and nature virion. This could take place in 
the cytoplasmic vesicles or at the surface of the cell, but finally the vi-
rus is released and the replication of an RNA virus is completed. 
I hope you can all see that the research done on various other viruses has 
contributed much to our information in the field of this specific virus. 
B. AFRICAN SWINE FEVER VIRUS 
Here we have an entirely different virus, a DNA virus which poses a threat 
in many countries and yet little is known about it. One of the most amazing 
things about this virus is that when it infects an animal, the pig, no neu-
tralizing antibodies are formed. The virus can circulate without the animals 
being able to develop a means to counteract the infection. We know very lit-
tle about this group of viruses, the Iridoviruses, and we are very fortuna-
te that we have Dr. MoAUSLAN here to contribute to our knowledge in this 
field. I feel that we have to think about w~zys and means to use the know-
ledge on the iridovirus group to supplement the field of the African swine 
Fever virus • 
l.The replicative cycle 
In fig. 3 the replicative cycle of a cytoplasmic DNA virus has been presen-
ted. I am sure that this is known to everyone, but it can give us an idea 
of what information we alreu.dy have, not as regard of ASF virus, but about 
the Iridovirus group and what problems we have to face. The virus contains 
a DNA genome of about 130 million daltons, which can synthesize a larger 
number of proteins. 
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Figure 3 B. Iridovirus - African Swine Fever Virus. 
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Figu.re 3 1 Legend. 
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It has a capsid and an envelope and this obviously makes it a virus with a 
very complex structure. People working ~n the field of ASF virus have great 
difficulty in purifying the virus as well as in grow1ng it. If we cannot 
isolate and purify the virus, it is very difficult to label the v1ral com-
ponents and obv1ously the information that can be obtained is very limited. 
We have to ask the questions : "What is the reason that a virus grows in 
such a Walf ? What are the methods that we have to develop in order to sti-
mulate the virus to grow in larger quant1 ties for its further analys1s ?" 
Dro McAUSLAN presented us with some analyses done on purified frog virus and 
we also have some idea about the structural proteins in some of the Irido-
viruses. We know absolutely nothing about the ASF v1rus prote1n composition. 
The second step in the cycle 1s of course the absorption and entry of th& 
virus into the cell and the uncoating of the virus. Once aga1n, we know very 
little about the uncoating of the ASF virion in the infected cell. The third 
step, as Dr. McAUSLAN ind1cated to us, is transcription. We do not know whe-
ther the enzyme responsible for transcription is an enzyme carried in the 
virus particle, or whether it is a cellular enzyme 1n the cytoplasm. But as 
a result, we know that we have messenger RNA. If we can block the initial 
transcription of the DNA b,y any means and Dr. BACHRACH ind1cated to us in 
the discuss1on that rifamycin derivatives can prevent the replication of 
the virus, then we malf be able to do something about the transcript1on stage 
b,y the 1ntroduct1on of anti-viral substance. 
The following step is the interaction of messenger RNA with ribosomes to 
form polyribosomes and I th1nk I have indicated that one has to be very care-
ful in defining polyribosomes -not what seem to be polyr1bosomes but what 
are indeed ribosomes. There are various interactions between messengers and 
proteins in the cytoplasm of cells and one has to be very careful in sorting 
these out. 
One of the major proteins synthes1sed in the cycle is of course the DNA poly-
merase wh1ch will interact with the parental DNA and with the repl1cative 
DNA. I have been able to describe some experiments w1th another v1rus, a 
herpes virus which replicates in the nucleus and which can be studied under 
semi-in-vitro conditions. 
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Obviously these experiments could also be done with ASF virus infected cells 
and certainly with other Iridoviruses. Step n°5 is the synthesis of the pro-
geny DNA and one lots of DNA is synthesised in the cell, the subsequent 
step is again transcription as was discussed b,y Dr. McAUSLAN. The genetic 
information is released b,y the synthesis of the messenger RNA from the paren-
tal DNA. We do not have to ,wait for the synthesis of structural proteins 
before the replication of the DNA. This is true for cytoplasmic DNA viruses, 
and also for the Iridoviruses and some of the nuclear viruses, including the 
herpesviruses. 
Onoe again if we have transcription of the progeny which means that we have 
more and more proteins synthesised, more RNA synthesised, and more messenger 
associated to ri bosomes, we have a cycle in which the virus takes over the 
cellular machinery. Dr. McAUSLAN mentioned that the Iridoviruses even control 
nuclear function and this is'true also for the herpesviruses. The cell is 
shut off and the machinery is turned on for the virus b,y an initiation fac-
tor, a specific protein which is controlled b,y the virus and which makes 
the ribosomes recognize the viral messenger RNA. If there are still cellular 
messengers which are long lived in the cytoplasms, they eventually become 
degraded.We have a large variety of proteins as can be seen in the experi-
ments of Dr. McAUSLAN and the paper b,y Dr. OI.SCHEVSKY on herpes simplex vi-
rus. This means of course that we have more antigens than we except and in 
addition, b,y refinding our system, we m~ discover new proteins. There is 
the possibility that many of the proteins are not antigenio or are only 
slightly antigenic and they have nothing to do with the immune mechanism 
or the immunisation of the animal against the disease. But we must remember 
that we do not have neutralising antibodies and the question is why ? We 
have a large DNA genome which can synthetize more than 100 coat proteins, 
and yet in the animal these proteins do not express themselves. The main 
difficulty is that we cannot develop a vaccine and therefore we cannot act 
against the disease. Perhaps as Dr. BACHRACH indicated to us, the only w~ 
is just to eradicate the animal. This does not mean of course that we eradi-
cate the virus, since all pigs would then have to be eradicated. Who knows 
whether this will be successful. There are more questions to be asked than 
answers brought here during this meeting. 
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CHAPI'ER III - GOALS 
In concluding this summary, I hope that those who are not familiar with the 
DNA viruses, but are familiar with RNA viruses, and those who are familiar 
with other aspects of molecular virology, after being acquainted with the 
difficulties will be ~n a position to try and help those who are engaged in 
research on HC and ASF viruses. If possible, and I bel~eve that there will 
be support, they could not only develop new concepts but also formulate 
experiments together. 
This is one of the messages that we would like to come out with from this 
meeting. People can collaborate with each other if they wish and do experiments 
in other laboratories in order to help answer specif~c questions as well as 
to learn new techniques. What we would like to have, is the opportunity to 
obtain bas~c knowledge on the molecular biology of these two viruses. It is 
about time that we knew all the ins and outs of this group of viruses, which 
should be documented so that we can solve this problem at a molecular level 
and then use the ~nformation to solve some of the major problems which I 
nave already d~scussGd. We now have the tools of molecular biology in our 
hands and they are easy to learn. There is tremensous interest ~n the diffe-
rent groups to know all the techniques, and then obviously, when we have 
more people thinking and working in this field, it will be possible to study 
the molecular biology of these viruses. One of the things which we did not 
discuss here and which Dr. AYNAUD brought up are the different mutants of 
the viruses. Dr. AYNAUD has d~fferent viral strains in his laboratory whioh 
are both cols and hot strains. There are strains brought in from Japan which 
are being used for immunisation, but very little has been done on the gene-
tics of the viruses. Here I think it is appropriate to repeat what I said 
before - we not only have to learn the genetics of these viruses, we also 
have to search for viruses wh~ch do not cause the disease in the pig, but 
replicate to a certain extent thus prevent~ng sensitive cells from being 
infected b,r the wild strain of HC virus. In addition to this, it became 
clear at the meeting that we have to study the antigenic properties not only 
of HC v~rus, but also of the bovine mucosal and related ~ruses. 
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I have no doubt in mw mind that there is a lot of work to be done and new 
techniques to be applied to the understanding of the antigenic properties 
as well. If we combine all the knowledge that we have gained here with the 
knowledge that we have in other fields, I am quite confident that we will 
be able to obtain basic information on some of the problems. 
There are many more details that one could bring into the summary of the 
meeting but I don't think that this is necessary. All the details are in 
the papers and I want to congratulate the speakers on presenting very com-
plicated information in a very clear w~. 
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